data_2mnh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mnh _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 93.8 m . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 120.546 0.212 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 82.8 p -149.4 154.39 38.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.867 -1.145 . . . . 0.0 109.779 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.2 m -136.11 137.69 41.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.418 -0.801 . . . . 0.0 110.06 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.79 138.05 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 47.6 m -156.58 133.59 10.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.217 -0.927 . . . . 0.0 110.367 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.35 176.12 44.72 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.09 -120.85 0.78 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -139.46 158.92 43.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.482 -1.01 . . . . 0.0 109.228 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.2 117.4 14.5 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.143 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -106.76 144.63 33.13 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.3 p -150.12 154.08 37.46 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.342 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -77.22 154.32 33.17 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.436 ' CB ' ' HB2' ' A' ' 17' ' ' GLN . . . -125.76 98.57 5.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.099 -1.001 . . . . 0.0 111.821 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -80.13 115.68 19.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.396 -0.815 . . . . 0.0 108.802 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.51 -14.09 59.43 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.436 ' HB2' ' CB ' ' A' ' 14' ' ' ALA . 96.6 mt-30 -115.05 160.03 20.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.439 -1.036 . . . . 0.0 109.402 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.1 ttm -98.99 137.96 36.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 111.052 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.6 t30 64.63 138.59 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.541 -0.724 . . . . 0.0 111.099 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -69.17 177.79 2.59 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.613 -0.679 . . . . 0.0 110.128 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 68.9 mtm -129.16 169.91 14.2 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.343 -0.848 . . . . 0.0 110.724 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -152.68 128.94 2.61 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.09 177.28 19.67 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.78 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -108.54 139.99 42.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.709 -0.877 . . . . 0.0 109.785 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -121.4 125.68 47.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.43 -0.794 . . . . 0.0 111.394 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.1 tp -119.94 135.08 55.04 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HD2' ' CD1' ' A' ' 40' ' ' ILE . 24.8 ttpt -138.91 144.98 39.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.489 -1.382 . . . . 0.0 111.754 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -110.34 145.18 37.93 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.6 ttm-85 -128.74 146.72 50.81 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.186 -0.946 . . . . 0.0 111.78 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -136.21 133.86 37.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.736 -0.603 . . . . 0.0 109.412 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -141.06 153.91 45.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.154 -0.966 . . . . 0.0 110.131 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 0.0 110.0 179.734 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo . . . . . 0 N--CA 1.483 0.862 0 N-CA-C 111.045 -0.406 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.0 tp -92.02 125.27 36.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.262 -0.899 . . . . 0.0 110.043 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.71 134.4 7.44 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.57 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.41 131.8 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.422 ' CD1' ' HD2' ' A' ' 27' ' ' LYS . 33.0 pt -127.0 145.63 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.895 -1.128 . . . . 0.0 112.041 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.6 120.18 4.32 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.0 t -125.18 144.47 50.43 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.191 -1.182 . . . . 0.0 111.657 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -114.57 144.41 43.43 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.3 m -131.61 138.61 48.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.925 -1.11 . . . . 0.0 110.883 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.4 ' CE2' ' OE2' ' A' ' 47' ' ' GLU . 60.7 t80 -133.19 109.6 9.55 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.9 m -123.07 143.82 49.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.395 -0.816 . . . . 0.0 111.147 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.4 ' OE2' ' CE2' ' A' ' 45' ' ' TYR . 93.9 mt-10 -137.82 165.34 26.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.406 -0.809 . . . . 0.0 110.316 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 tttt . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.539 -0.726 . . . . 0.0 109.719 179.459 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 . . . . . 0 N--CA 1.495 1.814 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -120.38 100.82 7.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.249 -0.907 . . . . 0.0 111.011 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -102.81 142.56 33.74 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.77 158.06 27.66 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 118.63 -1.748 . . . . 0.0 111.173 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.3 pt -121.79 137.17 56.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.3 p -150.21 139.59 21.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 110.919 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.29 155.09 24.21 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.0 175.25 42.86 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.414 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.21 165.73 31.51 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.93 1.489 . . . . 0.0 110.538 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.65 140.68 26.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.487 -0.758 . . . . 0.0 110.079 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -123.66 143.75 50.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.543 -0.723 . . . . 0.0 109.978 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.542 -0.724 . . . . 0.0 110.962 -179.311 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.344 0.593 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.2 m -134.93 147.33 49.76 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.591 -0.693 . . . . 0.0 109.573 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.464 HD12 HG22 ' A' ' 79' ' ' ILE . 43.5 pt -129.8 138.72 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.01 -1.056 . . . . 0.0 110.607 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -147.47 167.91 23.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.448 -0.782 . . . . 0.0 111.202 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.83 164.95 21.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.87 135.48 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -1.112 . . . . 0.0 110.7 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.5 p -141.05 147.83 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.18 -149.94 20.16 Favored Glycine 0 N--CA 1.477 1.426 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.442 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.411 HG13 ' CD1' ' A' ' 107' ' ' PHE . 34.1 m -135.5 -172.72 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.527 1.156 . . . . 0.0 113.272 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.09 152.18 23.04 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -123.82 133.8 53.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -1.166 . . . . 0.0 109.916 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -116.2 113.23 2.78 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.2 mttt . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.622 -0.928 . . . . 0.0 109.492 179.541 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.9 t0 . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -136.17 170.78 15.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.075 -1.016 . . . . 0.0 111.778 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -157.56 -178.0 31.2 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.411 ' CD1' HG13 ' A' ' 85' ' ' VAL . 99.4 m-85 -108.25 152.41 24.65 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.033 -1.275 . . . . 0.0 110.876 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -125.51 153.9 42.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.414 -0.804 . . . . 0.0 110.515 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -154.83 146.75 23.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.465 -0.772 . . . . 0.0 109.868 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 169.03 -178.23 42.39 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.841 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -165.16 165.88 19.45 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.695 -0.885 . . . . 0.0 108.915 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -155.94 -173.74 24.91 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.8 155.44 49.82 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.352 -1.087 . . . . 0.0 110.072 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -115.73 141.87 47.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.178 -0.951 . . . . 0.0 109.564 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -146.12 150.02 35.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.41 -0.806 . . . . 0.0 110.438 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.432 ' HB2' ' HA ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER 175.66 138.43 0.19 Allowed Pre-proline 0 N--CA 1.503 2.178 0 O-C-N 121.65 -0.656 . . . . 0.0 111.553 179.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -88.69 48.09 1.26 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.576 1.303 . . . . 0.0 109.168 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.433 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 86.5 mtp -147.15 137.01 23.13 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.459 -0.776 . . . . 0.0 108.945 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.43 -38.19 89.14 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.778 -0.576 . . . . 0.0 112.43 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -109.26 7.81 25.44 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.67 -1.269 . . . . 0.0 112.66 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 60.8 t -122.45 138.69 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.739 -1.226 . . . . 0.0 110.063 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.432 ' HA ' ' HB2' ' A' ' 116' ' ' ASN . . . -146.45 139.18 25.34 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.386 -0.926 . . . . 0.0 112.338 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.8 tp -122.13 135.58 54.81 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -139.06 153.8 48.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.458 -1.401 . . . . 0.0 112.167 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -124.44 138.94 54.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.804 -0.56 . . . . 0.0 109.616 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.1 p -146.2 157.22 43.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.843 . . . . 0.0 110.191 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -133.82 143.1 48.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.519 -0.738 . . . . 0.0 110.342 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -150.98 143.86 24.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.509 -0.744 . . . . 0.0 110.164 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -113.78 146.61 39.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.403 -0.811 . . . . 0.0 109.97 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.5 t -129.18 139.61 51.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.44 -0.787 . . . . 0.0 110.246 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.3 ttp85 -127.98 127.89 44.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.475 -0.766 . . . . 0.0 109.837 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 89.5 mt -119.15 56.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.668 -0.645 . . . . 0.0 109.56 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 66.05 -57.26 0.35 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.884 -0.51 . . . . 0.0 111.647 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.07 -7.32 11.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.085 -1.009 . . . . 0.0 111.401 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.9 t -119.64 130.82 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.967 -1.083 . . . . 0.0 110.653 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -133.44 114.01 13.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.561 -0.712 . . . . 0.0 109.242 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.5 m -124.65 149.3 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 110.506 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.89 103.65 2.34 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.126 -1.989 . . . . 0.0 108.126 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.3 m -111.03 145.49 38.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.42 -1.047 . . . . 0.0 111.765 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 60.2 p-90 -132.1 145.37 51.36 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.434 HG21 HD12 ' A' ' 141' ' ' ILE . 75.4 mt -117.35 131.11 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.252 -0.905 . . . . 0.0 110.175 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -149.27 145.54 27.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.44 -0.787 . . . . 0.0 110.185 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -177.09 -128.71 1.17 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.381 -1.39 . . . . 0.0 111.163 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.2 m -117.87 171.51 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.861 -0.788 . . . . 0.0 111.383 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -148.81 135.56 5.48 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -130.46 149.56 52.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.576 -0.956 . . . . 0.0 109.394 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -131.89 122.38 25.57 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.261 -0.899 . . . . 0.0 111.478 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.494 -0.754 . . . . 0.0 110.181 -179.986 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.936 0.398 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.7 t -128.08 144.85 51.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.903 . . . . 0.0 109.793 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 146' ' ' TYR . 26.9 m -136.01 136.31 40.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.873 . . . . 0.0 109.996 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -107.69 139.37 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.579 -0.701 . . . . 0.0 109.26 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.5 m -154.8 129.66 9.39 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.08 -1.012 . . . . 0.0 110.323 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -164.12 169.05 38.85 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.56 -130.4 1.34 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -127.3 158.24 37.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.45 -1.029 . . . . 0.0 109.763 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.79 116.5 16.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 111.066 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -113.75 142.36 46.15 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.1 p -153.63 154.6 34.5 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.695 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.409 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 88.5 m-20 -93.85 153.15 18.42 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.59 119.16 17.0 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.775 -1.203 . . . . 0.0 111.878 -178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -71.17 119.88 15.94 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.03 -15.25 44.09 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -115.79 156.44 26.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.603 -0.939 . . . . 0.0 109.138 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 65.6 mtt -96.24 -77.69 0.48 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.09 -1.006 . . . . 0.0 110.985 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -66.06 134.45 52.89 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.372 -0.83 . . . . 0.0 110.962 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -68.8 178.5 2.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.525 -0.734 . . . . 0.0 110.103 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.3 mtm -124.05 163.29 21.73 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.273 -0.892 . . . . 0.0 110.69 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.94 125.68 2.02 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.0 -159.34 7.9 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.523 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -129.19 161.16 30.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.537 -0.978 . . . . 0.0 110.047 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.433 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 45.5 t-20 -141.34 132.26 26.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.46 -0.775 . . . . 0.0 111.359 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.0 tp -118.62 141.15 48.87 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 47.3 mttt -134.86 146.72 49.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.403 -1.436 . . . . 0.0 111.26 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -115.91 138.97 50.68 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -129.5 143.04 50.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.202 -0.936 . . . . 0.0 111.817 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -134.15 133.0 40.5 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -142.99 149.99 39.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.169 -0.957 . . . . 0.0 110.48 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.337 -0.852 . . . . 0.0 109.462 179.663 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo . . . . . 0 N--CA 1.483 0.88 0 N-CA-C 111.142 -0.369 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -87.77 98.97 11.75 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.941 . . . . 0.0 110.11 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.98 131.66 10.71 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.78 129.36 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.558 -0.966 . . . . 0.0 108.721 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.452 ' CD1' ' CD1' ' A' ' 80' ' ' TYR . 77.8 mt -123.55 142.57 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.101 -0.999 . . . . 0.0 111.339 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 27' ' ' LYS . . . -109.46 145.45 16.76 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 107.086 -2.406 . . . . 0.0 107.086 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.401 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 34.7 t -139.71 142.46 36.86 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 118.969 1.384 . . . . 0.0 112.174 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -123.42 137.83 54.72 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.6 m -132.03 140.07 48.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.823 -1.173 . . . . 0.0 111.074 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -134.33 110.28 9.37 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.2 m -119.48 146.5 45.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.525 -0.734 . . . . 0.0 110.276 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -124.6 158.96 31.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.114 -0.991 . . . . 0.0 110.416 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.8 pttt . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.549 -0.72 . . . . 0.0 110.485 179.97 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 120.981 0.419 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -114.08 126.91 55.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.346 -0.846 . . . . 0.0 110.88 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.499 ' CD2' ' CE1' ' A' ' 87' ' ' TYR . 97.8 m-85 -110.38 137.06 48.6 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.802 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.28 115.02 0.74 Allowed Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.411 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 76.5 mt -104.53 136.14 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 3.3 p -151.23 139.33 20.12 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.291 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.94 151.6 33.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.08 165.14 37.54 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.34 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.07 172.7 15.43 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.858 1.451 . . . . 0.0 110.741 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.43 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . . . -144.34 138.91 28.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.587 -0.696 . . . . 0.0 109.675 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -120.79 135.86 55.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.439 -0.788 . . . . 0.0 110.779 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.1 ttp85 . . . . . 0 N--CA 1.491 1.581 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.024 179.394 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 121.606 0.717 . . . . 0.0 111.82 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.7 m -126.75 161.48 28.06 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.697 -0.627 . . . . 0.0 109.526 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.3 mt -118.01 136.67 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.002 -1.061 . . . . 0.0 110.222 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.452 ' CD1' ' CD1' ' A' ' 40' ' ' ILE . 85.7 m-85 -132.58 154.16 50.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.685 -0.634 . . . . 0.0 110.284 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.13 163.06 21.11 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.32 132.06 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.094 -1.239 . . . . 0.0 111.281 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 66' ' ' THR . 59.5 t -140.74 145.31 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 160.87 -149.02 17.77 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 119.346 -1.407 . . . . 0.0 110.848 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.3 m -127.21 158.19 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.315 1.055 . . . . 0.0 112.977 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 63' ' ' TYR . . . -140.57 130.69 4.67 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.499 ' CE1' ' CD2' ' A' ' 63' ' ' TYR . 43.6 p90 -151.89 164.2 37.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.002 -1.293 . . . . 0.0 111.242 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.32 154.58 20.4 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.8 tttp . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.825 -0.809 . . . . 0.0 110.332 -179.843 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 56.2 t0 . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.471 ' CD2' ' CB ' ' A' ' 87' ' ' TYR . 85.9 m-85 -114.85 162.52 16.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.172 -0.955 . . . . 0.0 111.042 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -160.94 -176.86 33.51 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -116.02 156.78 25.71 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.017 -1.284 . . . . 0.0 111.398 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.9 m -124.58 154.9 39.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.53 -0.731 . . . . 0.0 110.417 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -153.06 145.19 23.83 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.421 -0.799 . . . . 0.0 109.907 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 171.47 -177.59 44.25 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.908 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.28 163.47 13.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.653 -0.91 . . . . 0.0 108.949 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -157.33 -172.05 24.07 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.58 -1.295 . . . . 0.0 109.93 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.6 tp -130.74 152.44 50.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.467 -1.019 . . . . 0.0 109.673 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -118.52 149.39 41.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.998 -1.064 . . . . 0.0 109.771 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -115.36 154.96 28.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.51 -0.744 . . . . 0.0 109.705 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -113.94 64.09 1.2 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.844 . . . . 0.0 111.279 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.69 -14.26 36.05 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.436 1.23 . . . . 0.0 109.904 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.429 ' HB2' ' CG2' ' A' ' 121' ' ' VAL . 64.9 mtt -145.4 139.87 27.24 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -60.92 -38.69 86.65 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.69 -0.631 . . . . 0.0 112.209 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 46.2 p-10 -94.94 -3.73 48.08 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.777 -1.202 . . . . 0.0 112.745 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.46 HG13 ' CE1' ' A' ' 146' ' ' TYR . 30.1 m -150.42 121.46 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 120.809 -1.182 . . . . 0.0 111.604 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -117.78 154.66 31.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.502 -0.749 . . . . 0.0 109.249 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.0 mt -113.3 144.45 42.71 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.114 -0.991 . . . . 0.0 109.776 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.7 p30 -138.79 151.04 46.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.139 -0.975 . . . . 0.0 111.267 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -133.01 141.64 48.39 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.2 p -145.91 164.44 31.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.238 -0.914 . . . . 0.0 111.159 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -112.42 127.87 56.15 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -127.47 132.13 50.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.239 -0.913 . . . . 0.0 111.262 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -123.28 127.04 47.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.607 -0.683 . . . . 0.0 109.282 178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.6 t -130.35 143.73 50.95 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.198 -0.939 . . . . 0.0 110.742 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -124.04 129.68 51.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.591 -0.693 . . . . 0.0 109.718 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.427 HD11 HG22 ' A' ' 132' ' ' ILE . 17.3 mm -114.74 63.1 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 66.42 -59.96 0.33 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.562 -0.711 . . . . 0.0 111.224 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 51.6 p -124.38 6.66 8.36 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.062 -1.024 . . . . 0.0 111.394 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.1 t -125.87 133.34 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.124 -0.985 . . . . 0.0 110.646 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -131.44 112.27 12.53 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.409 ' CG1' ' O ' ' A' ' 13' ' ' ASP . 55.5 t -119.18 146.28 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.151 -0.968 . . . . 0.0 110.742 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -109.5 107.34 2.35 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.0 m -109.78 139.58 44.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.328 -1.101 . . . . 0.0 112.02 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -111.49 142.16 44.12 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.7 mm -112.65 129.6 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.115 -0.991 . . . . 0.0 110.659 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -137.96 128.61 26.7 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.52 -0.738 . . . . 0.0 109.027 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -164.73 -158.04 10.05 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 118.715 -1.707 . . . . 0.0 112.13 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -110.82 170.02 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 122.211 -0.582 . . . . 0.0 110.221 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -142.15 134.95 6.38 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.932 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.46 ' CE1' HG13 ' A' ' 121' ' ' VAL . 83.3 m-85 -122.86 138.5 54.63 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.3 ttt-85 -126.74 121.21 31.36 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.936 -1.103 . . . . 0.0 111.108 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 55.8 t80 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.51 -0.744 . . . . 0.0 110.224 -179.883 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 70.0 p . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.9 p -109.19 152.31 25.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 0.0 109.531 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.8 m -135.34 138.66 43.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 110.52 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.7 t -115.76 136.52 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.548 -0.72 . . . . 0.0 109.333 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.2 m -154.01 129.59 9.96 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.272 -0.892 . . . . 0.0 110.247 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -165.48 172.5 41.03 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.65 -132.14 1.64 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -143.55 161.94 37.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.485 -1.009 . . . . 0.0 109.688 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.03 136.03 28.0 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.679 -1.208 . . . . 0.0 112.131 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -107.32 125.53 51.29 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.5 m -126.94 148.55 50.05 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.808 -177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.422 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 52.5 t0 -95.55 152.22 18.62 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 137' ' ' VAL . . . -135.83 122.95 21.56 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.697 -1.201 . . . . 0.0 111.837 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -73.31 116.4 13.81 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.3 -30.87 8.94 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -115.07 99.02 7.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.644 -0.915 . . . . 0.0 109.052 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 65.1 mtt -62.33 -40.22 95.67 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.411 -0.806 . . . . 0.0 111.146 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -57.77 119.83 7.35 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.264 -0.898 . . . . 0.0 111.228 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -71.41 162.43 29.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.617 -0.677 . . . . 0.0 109.704 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.7 mtm -127.19 157.66 39.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.205 -0.935 . . . . 0.0 111.463 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 46' ' ' THR . . . -142.39 124.08 2.33 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.84 -174.41 13.36 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.501 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . 0.457 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . 99.2 m-85 -122.97 160.51 26.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.7 -0.882 . . . . 0.0 110.157 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.403 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 34.4 t-20 -140.8 131.71 26.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.543 -0.723 . . . . 0.0 111.101 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.39 132.85 54.09 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.462 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 74.6 mttt -131.3 145.4 51.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.639 -1.288 . . . . 0.0 111.595 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -116.24 132.19 56.73 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -125.16 138.85 54.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.104 -0.997 . . . . 0.0 112.149 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -119.5 138.82 52.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -149.2 163.71 36.86 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.973 . . . . 0.0 110.858 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.166 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 N--CA 1.48 0.728 0 N-CA-C 111.085 -0.39 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.0 mt -88.87 139.45 30.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.251 -0.906 . . . . 0.0 109.817 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.56 140.3 8.19 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.538 -1.315 . . . . 0.0 111.039 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.68 129.71 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.1 tt -129.13 143.58 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.977 -1.077 . . . . 0.0 111.322 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.8 135.67 12.95 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.462 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 61.1 p -130.26 142.71 50.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.125 -1.221 . . . . 0.0 111.759 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -126.22 135.34 51.47 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.9 t -135.77 148.31 48.73 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.645 -1.222 . . . . 0.0 111.498 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 24' ' ' PHE . 42.7 p90 -141.88 111.43 6.56 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 22' ' ' GLY . 73.4 m -121.97 137.02 54.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 110.672 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 85.5 tt0 -155.63 164.33 38.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.585 -0.697 . . . . 0.0 109.566 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.4 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 29.2 tttp . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.865 . . . . 0.0 109.795 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -112.89 90.17 3.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.431 -0.793 . . . . 0.0 110.589 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -116.92 141.35 48.35 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.48 168.58 38.19 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.027 -2.035 . . . . 0.0 112.298 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.431 HD13 HG22 ' A' ' 65' ' ' ILE . 49.8 pt -105.68 140.55 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 114.48 -0.86 . . . . 0.0 109.246 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -150.87 141.55 22.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 110.619 -179.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.94 154.55 29.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 108.946 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.46 163.61 37.05 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.493 -1.336 . . . . 0.0 110.276 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.38 173.06 14.41 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.91 1.479 . . . . 0.0 110.679 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.437 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . . . -141.11 136.5 31.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.811 -0.556 . . . . 0.0 109.617 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -126.28 145.78 50.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.698 -0.626 . . . . 0.0 110.67 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.492 -0.755 . . . . 0.0 109.554 179.058 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.057 0.456 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m -139.34 155.07 47.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.335 -0.853 . . . . 0.0 110.565 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.409 ' CG2' ' CD2' ' A' ' 113' ' ' LEU . 50.6 pt -121.14 144.35 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.331 -0.856 . . . . 0.0 109.716 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 93.6 m-85 -132.41 154.44 49.83 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.328 -0.857 . . . . 0.0 111.169 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.87 162.66 17.81 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.137 -1.985 . . . . 0.0 108.137 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.2 m -142.66 132.63 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.96 -1.318 . . . . 0.0 111.683 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 66' ' ' THR . 33.0 m -142.99 150.66 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.12 -151.06 22.16 Favored Glycine 0 N--CA 1.479 1.553 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.049 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 p -129.59 144.62 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.488 1.137 . . . . 0.0 113.502 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.41 149.62 19.19 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.41 ' CE2' ' HB2' ' A' ' 89' ' ' LYS . 66.4 t80 -126.67 129.47 48.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.002 -1.293 . . . . 0.0 111.577 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -109.56 113.51 3.67 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 107.934 -2.066 . . . . 0.0 107.934 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.41 ' HB2' ' CE2' ' A' ' 87' ' ' TYR . 36.3 tttp . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.493 -1.004 . . . . 0.0 111.609 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 47.6 t0 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.044 0.45 . . . . 0.0 110.44 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -112.03 156.69 21.78 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.376 -0.827 . . . . 0.0 110.601 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -144.25 161.54 27.91 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -97.63 145.8 25.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.927 -1.337 . . . . 0.0 110.937 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.0 t -122.46 148.65 44.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.482 -0.761 . . . . 0.0 110.3 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -154.01 145.67 23.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.494 -0.754 . . . . 0.0 109.661 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 171.84 -178.9 43.85 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.906 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -167.2 163.7 15.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.818 -0.813 . . . . 0.0 108.812 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -156.06 -173.32 24.5 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.409 ' CD2' ' CG2' ' A' ' 79' ' ' ILE . 76.3 mt -128.44 152.85 47.75 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.373 -1.075 . . . . 0.0 109.278 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -119.53 140.97 49.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.818 -1.176 . . . . 0.0 109.971 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -117.35 161.1 20.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.508 -0.745 . . . . 0.0 110.061 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.96 86.59 42.1 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.464 -0.773 . . . . 0.0 110.459 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.4 -7.39 20.81 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.664 1.35 . . . . 0.0 111.535 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.529 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 80.0 mtp -149.95 175.66 11.47 Favored 'General case' 0 C--N 1.311 -1.077 0 O-C-N 121.056 -1.027 . . . . 0.0 108.452 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.88 -39.7 95.27 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.807 -0.558 . . . . 0.0 110.993 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -121.99 18.16 10.9 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.201 -0.937 . . . . 0.0 112.2 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 21.3 t -118.46 139.38 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.933 -1.105 . . . . 0.0 109.729 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.34 137.48 32.4 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.736 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.445 ' N ' ' CD2' ' A' ' 123' ' ' LEU . 4.4 mm? -112.29 152.24 28.73 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -145.49 139.42 26.81 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.719 -1.238 . . . . 0.0 110.736 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -124.7 126.24 45.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 109.179 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -130.64 151.46 51.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.32 -0.863 . . . . 0.0 111.178 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -113.97 126.87 55.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.597 -0.689 . . . . 0.0 109.187 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -137.74 152.31 49.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.339 -0.85 . . . . 0.0 111.172 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -138.63 147.89 43.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 0.0 109.405 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 51.1 m -134.62 145.96 49.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.197 -0.939 . . . . 0.0 110.822 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -132.54 128.55 37.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.489 -0.757 . . . . 0.0 109.828 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 91.4 mt -119.8 59.26 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.47 -0.769 . . . . 0.0 109.709 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 93.2 mtt-85 64.65 -57.46 0.26 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.908 -0.495 . . . . 0.0 111.912 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.0 p -117.69 -3.29 11.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.959 -1.088 . . . . 0.0 111.539 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.4 t -124.72 131.44 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.025 -1.047 . . . . 0.0 110.457 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -131.53 111.52 11.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.345 -0.847 . . . . 0.0 109.16 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 59.0 t -119.29 145.88 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.93 . . . . 0.0 110.525 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -107.18 120.27 6.12 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 107.813 -2.115 . . . . 0.0 107.813 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 59.3 m -118.29 137.25 53.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.232 -1.158 . . . . 0.0 111.9 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -114.44 140.15 48.93 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.429 HD13 HG23 ' A' ' 141' ' ' ILE . 73.7 mt -113.66 133.1 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.103 -0.998 . . . . 0.0 110.903 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.81 133.93 22.77 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -170.5 -146.0 4.97 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.041 -1.552 . . . . 0.0 111.503 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.8 m -117.32 177.03 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 122.113 -0.639 . . . . 0.0 111.142 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -153.26 138.58 6.39 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -134.65 153.4 52.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.571 -0.958 . . . . 0.0 109.714 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -133.82 122.03 22.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.368 -0.833 . . . . 0.0 110.986 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 65.8 t80 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.474 -0.766 . . . . 0.0 110.216 -179.662 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 66.3 p . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.004 0.43 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.6 t -124.16 137.64 54.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.427 -0.796 . . . . 0.0 109.728 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.1 m -137.84 145.48 42.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.788 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.6 p -126.4 140.36 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.607 -0.683 . . . . 0.0 109.705 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.9 m -156.45 130.61 8.59 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.301 -0.875 . . . . 0.0 110.481 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -149.97 158.32 27.62 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 108.831 -1.707 . . . . 0.0 108.831 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.08 -168.26 27.98 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.651 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -123.55 153.79 40.13 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.654 -0.909 . . . . 0.0 109.501 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.33 154.23 41.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.073 -1.017 . . . . 0.0 111.484 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -98.58 144.44 27.89 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.6 t -112.47 134.74 53.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.013 -1.055 . . . . 0.0 112.299 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -138.12 124.05 20.1 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 137' ' ' VAL . . . -139.04 155.55 47.87 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 120.857 -1.152 . . . . 0.0 112.027 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -78.27 120.24 22.77 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.54 -29.24 10.72 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -113.75 97.77 6.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.607 -0.937 . . . . 0.0 109.247 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 70.6 mtm -67.43 -47.85 69.0 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.301 -0.875 . . . . 0.0 111.329 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -55.51 131.3 45.77 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.39 -0.819 . . . . 0.0 111.694 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -82.42 155.1 24.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.747 -0.595 . . . . 0.0 109.632 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.4 mtm -131.3 166.18 21.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.274 -0.891 . . . . 0.0 111.224 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 46' ' ' THR . . . -92.97 153.23 21.38 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.54 121.85 2.92 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.114 -1.517 . . . . 0.0 111.021 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -111.5 129.6 55.99 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -137.93 126.53 23.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.937 -1.102 . . . . 0.0 111.558 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.9 mt -123.5 129.7 51.6 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.9 pttt -136.27 148.18 47.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.81 -1.181 . . . . 0.0 112.281 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -111.29 137.46 49.0 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -120.37 135.26 55.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 111.1 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -121.57 138.33 54.36 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -138.1 146.91 43.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.179 -0.951 . . . . 0.0 109.915 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 110.131 179.941 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 N--CA 1.483 0.867 0 N-CA-C 111.112 -0.38 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 20.4 tp -111.18 76.48 0.98 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.176 -0.953 . . . . 0.0 110.15 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.76 177.19 26.65 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 120.051 -1.071 . . . . 0.0 110.445 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.0 t -131.61 140.15 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.673 -0.898 . . . . 0.0 108.982 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.3 pt -121.66 147.59 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.96 -1.087 . . . . 0.0 111.386 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.96 129.75 8.8 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.1 t -136.91 142.86 42.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.169 -1.195 . . . . 0.0 111.765 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -115.35 139.85 49.64 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.9 m -130.42 136.16 48.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.17 -0.956 . . . . 0.0 110.169 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -134.74 111.1 9.68 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.349 -0.844 . . . . 0.0 109.171 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 60.3 m -112.84 138.32 49.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.432 -0.793 . . . . 0.0 109.388 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -138.11 160.52 39.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.09 -1.006 . . . . 0.0 110.532 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.4 mttt . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 110.127 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -121.8 93.15 3.91 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.331 -0.856 . . . . 0.0 111.182 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -98.24 150.86 21.07 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -158.5 132.84 3.23 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 118.195 -1.955 . . . . 0.0 111.631 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 46.8 pt -98.54 138.56 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 9.5 t -153.22 147.57 25.86 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.576 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.0 151.15 34.05 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.24 165.79 36.77 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.513 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -75.76 170.49 20.07 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.798 1.42 . . . . 0.0 110.655 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.39 140.62 24.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.603 -0.685 . . . . 0.0 109.452 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -123.17 141.47 51.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.331 -0.856 . . . . 0.0 110.558 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 . . . . . 0 N--CA 1.489 1.499 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.034 179.244 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.944 0 CA-C-O 121.656 0.741 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.6 t -138.22 155.35 48.74 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.633 -0.667 . . . . 0.0 109.618 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.7 tt -129.05 137.87 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.065 -1.022 . . . . 0.0 110.363 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -146.95 162.27 39.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.406 -0.809 . . . . 0.0 111.425 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.2 164.31 12.79 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.7 m -141.75 134.82 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -1.175 . . . . 0.0 111.53 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 66' ' ' THR . 7.2 p -138.76 148.34 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 178.65 -179.76 48.66 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.687 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.417 ' O ' ' HA2' ' A' ' 64' ' ' GLY . 57.0 t -118.64 142.02 35.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.335 0.588 . . . . 0.0 110.702 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.94 144.26 17.1 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -116.55 129.82 56.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.129 -1.219 . . . . 0.0 110.11 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -118.26 113.52 2.64 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.465 -1.021 . . . . 0.0 110.653 -179.724 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -113.08 154.78 26.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.329 -0.857 . . . . 0.0 110.11 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -143.46 153.51 24.9 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -96.58 139.54 32.51 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -1.15 . . . . 0.0 110.735 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.9 p -124.94 159.99 29.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.532 -0.73 . . . . 0.0 110.424 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -160.25 155.67 25.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.442 -0.786 . . . . 0.0 109.854 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.3 -169.77 39.24 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.497 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.77 165.15 20.92 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.602 -0.94 . . . . 0.0 108.905 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -152.75 -178.92 27.87 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.4 tp -139.54 147.37 41.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.371 -1.076 . . . . 0.0 110.22 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -99.11 141.72 31.52 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.087 -1.008 . . . . 0.0 109.157 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -148.2 148.64 30.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.303 -0.873 . . . . 0.0 110.868 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.425 ' HB2' ' HA ' ' A' ' 122' ' ' ALA . 0.8 OUTLIER 170.72 134.7 0.07 OUTLIER Pre-proline 0 N--CA 1.506 2.327 0 O-C-N 121.764 -0.585 . . . . 0.0 111.306 178.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -88.03 47.11 1.29 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.541 1.285 . . . . 0.0 109.484 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.3 mtt -141.71 139.45 32.91 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.424 -0.797 . . . . 0.0 109.044 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.77 -47.04 79.61 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -104.13 5.5 35.1 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.822 -1.174 . . . . 0.0 112.703 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.3 t -118.77 136.45 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.769 -1.207 . . . . 0.0 109.935 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.425 ' HA ' ' HB2' ' A' ' 116' ' ' ASN . . . -142.92 139.49 30.76 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.406 -0.917 . . . . 0.0 112.308 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.32 153.36 24.02 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -145.9 140.24 26.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.76 -1.212 . . . . 0.0 110.648 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.417 ' HB2' ' CZ2' ' A' ' 140' ' ' TRP . 49.1 p90 -132.07 142.74 49.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 0.0 109.391 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.9 t -146.51 149.42 33.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.375 -0.828 . . . . 0.0 111.231 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -118.12 126.57 52.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.698 -0.626 . . . . 0.0 109.428 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -137.35 136.42 37.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.456 -0.777 . . . . 0.0 110.593 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -112.18 130.09 56.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.42 -0.8 . . . . 0.0 109.765 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.0 m -122.1 147.59 45.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.295 -0.878 . . . . 0.0 110.436 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -135.78 130.53 34.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.499 -0.751 . . . . 0.0 110.23 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 88.4 mt -119.17 67.22 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.567 -0.708 . . . . 0.0 109.707 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 66.45 -60.74 0.32 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.672 -0.642 . . . . 0.0 111.388 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.2 p -124.65 5.73 8.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.067 -1.021 . . . . 0.0 111.69 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 51.2 t -126.52 133.35 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.934 -1.104 . . . . 0.0 110.798 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -132.22 115.87 16.23 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.443 ' HA ' ' CB ' ' A' ' 14' ' ' ALA . 32.0 t -110.76 145.51 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.131 -0.981 . . . . 0.0 111.121 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.84 117.85 2.58 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 107.684 -2.167 . . . . 0.0 107.684 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 10.2 t -134.14 151.96 51.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -1.184 . . . . 0.0 112.028 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.417 ' CZ2' ' HB2' ' A' ' 125' ' ' PHE . 60.5 t-105 -112.04 133.93 53.9 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.3 pt -115.91 147.17 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.068 -1.02 . . . . 0.0 111.319 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -147.49 136.92 22.61 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -162.96 -159.08 10.13 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 118.986 -1.578 . . . . 0.0 111.605 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.3 p -104.57 166.99 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 122.065 -0.667 . . . . 0.0 110.654 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -154.32 138.97 6.46 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -132.18 153.99 50.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.543 -0.975 . . . . 0.0 109.765 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -125.29 121.17 33.23 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.307 -0.87 . . . . 0.0 111.101 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 73.6 t80 . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.495 -0.753 . . . . 0.0 110.13 179.894 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 120.965 0.412 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -126.28 147.63 49.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -0.879 . . . . 0.0 109.153 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.0 p -135.12 152.47 51.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.067 -1.021 . . . . 0.0 110.431 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -112.24 135.77 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 37.1 m -155.31 128.22 8.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 110.642 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.86 173.37 45.06 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.86 -137.52 3.42 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -143.26 160.02 41.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.485 -1.009 . . . . 0.0 109.888 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.58 145.34 30.07 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.626 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -113.49 144.87 42.1 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.4 p -146.47 153.63 40.65 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.607 -1.237 . . . . 0.0 112.617 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -83.11 151.34 25.79 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -127.03 100.37 6.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.943 -1.098 . . . . 0.0 111.341 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -79.78 117.48 20.7 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.04 -13.21 58.95 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -107.68 178.04 4.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.118 -1.225 . . . . 0.0 110.294 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 94.3 mmm -57.75 -51.68 68.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.459 -0.776 . . . . 0.0 112.041 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -169.82 -148.62 0.07 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.694 -1.254 . . . . 0.0 110.747 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mttt -81.06 154.3 26.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.076 -1.015 . . . . 0.0 110.761 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 62.5 mtt -129.94 167.59 17.98 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.416 -0.803 . . . . 0.0 110.662 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 46' ' ' THR . . . -98.12 158.97 20.66 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.251 -1.939 . . . . 0.0 108.251 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.08 121.29 1.38 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.275 -1.44 . . . . 0.0 110.757 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -108.52 134.92 50.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.644 -0.916 . . . . 0.0 109.127 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -139.02 129.38 25.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.157 -0.964 . . . . 0.0 112.112 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.5 tp -121.85 127.59 50.69 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 21.3 mttt -129.24 144.66 51.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.656 -1.277 . . . . 0.0 111.748 -177.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -112.24 140.69 46.74 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -123.54 137.76 54.7 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.095 -1.003 . . . . 0.0 111.938 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -122.04 138.25 54.51 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -141.33 150.02 41.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.135 -0.978 . . . . 0.0 110.401 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 0.0 109.683 179.626 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo . . . . . 0 N--CA 1.482 0.838 0 N-CA-C 111.022 -0.414 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.5 tt -91.3 119.56 31.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.359 -0.838 . . . . 0.0 110.043 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.35 135.46 8.79 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.885 -1.15 . . . . 0.0 110.485 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -131.21 135.86 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.421 HD13 ' CD1' ' A' ' 80' ' ' TYR . 72.9 mt -125.32 141.92 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.922 -1.111 . . . . 0.0 111.455 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.81 141.07 15.15 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 106.998 -2.441 . . . . 0.0 106.998 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.416 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 42.7 t -137.53 141.18 41.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.886 -1.361 . . . . 0.0 112.649 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -122.97 134.13 54.35 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.8 m -131.03 136.93 48.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.031 . . . . 0.0 110.693 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -129.94 110.42 11.67 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 96.9 m -115.03 140.01 49.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.369 -0.832 . . . . 0.0 109.588 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -141.15 163.85 31.84 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.104 -0.997 . . . . 0.0 110.446 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 tttm . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.485 -0.759 . . . . 0.0 109.932 179.357 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.099 0.476 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.426 ' HB2' ' HB ' ' A' ' 46' ' ' THR . 50.9 m-85 -113.81 114.12 25.86 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.703 0.763 . . . . 0.0 111.22 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -98.08 145.17 26.81 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -150.54 128.79 2.73 Favored Glycine 0 N--CA 1.485 1.904 0 C-N-CA 118.502 -1.808 . . . . 0.0 110.932 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 78.2 mt -99.1 134.77 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 61.4 m -152.03 142.1 22.21 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.512 -1.275 . . . . 0.0 112.216 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.87 148.84 34.4 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -157.15 160.38 30.4 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.593 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.41 165.09 31.4 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.875 1.461 . . . . 0.0 110.646 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.97 137.42 31.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.489 -0.757 . . . . 0.0 109.823 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -125.23 143.48 50.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.582 -0.698 . . . . 0.0 110.927 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.4 ttt-85 . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.644 -0.66 . . . . 0.0 109.605 178.915 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.032 0.444 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.4 m -124.41 151.31 44.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.425 -0.797 . . . . 0.0 110.634 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.418 HD12 HG22 ' A' ' 79' ' ' ILE . 76.7 mt -119.46 136.85 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 109.176 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.421 ' CD1' HD13 ' A' ' 40' ' ' ILE . 38.6 m-85 -129.26 148.69 51.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.85 . . . . 0.0 111.145 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.28 159.28 19.84 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 109' ' ' TYR . 27.0 m -143.77 134.66 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.326 . . . . 0.0 112.164 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 66' ' ' THR . 61.9 t -134.85 144.63 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 178.78 -176.9 48.27 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 118.326 -1.892 . . . . 0.0 111.522 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.458 ' CG1' ' CZ ' ' A' ' 87' ' ' TYR . 52.8 t -121.9 144.27 31.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-O 121.652 0.739 . . . . 0.0 110.583 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . -99.14 135.84 12.36 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.458 ' CZ ' ' CG1' ' A' ' 85' ' ' VAL . 88.5 m-85 -127.86 132.13 49.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.067 -1.255 . . . . 0.0 110.189 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.79 127.95 6.72 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 27.8 pttt . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.416 -1.049 . . . . 0.0 110.488 -179.96 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 54.7 t0 . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 45.9 p90 -134.96 170.16 16.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.083 -1.011 . . . . 0.0 111.871 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -154.18 178.03 31.26 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -99.11 142.15 30.96 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.115 -1.227 . . . . 0.0 110.862 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.1 m -121.65 150.55 41.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.446 -0.784 . . . . 0.0 110.159 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 43.2 p90 -158.34 152.98 24.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.393 -0.817 . . . . 0.0 110.037 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 169.67 -176.63 43.5 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.584 -1.294 . . . . 0.0 110.65 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.99 163.46 11.37 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.681 -0.894 . . . . 0.0 109.091 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -159.71 -171.4 25.52 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.45 155.83 49.9 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.302 -1.116 . . . . 0.0 110.141 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 124' ' ' ASP . 40.8 tt0 -120.63 142.55 49.32 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.163 -0.961 . . . . 0.0 110.228 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -118.56 160.82 21.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.552 -0.718 . . . . 0.0 109.586 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -118.05 72.1 8.79 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.223 -0.923 . . . . 0.0 111.349 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 122' ' ' ALA . 44.8 Cg_endo -72.51 -12.29 26.97 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.582 1.306 . . . . 0.0 110.064 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.429 ' HB2' ' CG1' ' A' ' 121' ' ' VAL . 88.0 mtp -142.89 144.15 32.34 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.29 -51.57 69.36 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -90.59 3.03 55.24 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.768 -1.207 . . . . 0.0 113.04 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 118' ' ' MET . 8.8 p -152.78 119.44 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 120.714 -1.241 . . . . 0.0 111.348 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.44 ' HA ' ' HD2' ' A' ' 117' ' ' PRO . . . -110.75 167.45 10.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.904 . . . . 0.0 109.934 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 23.4 tp -112.91 149.74 32.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.251 -0.906 . . . . 0.0 109.338 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 52.6 t0 -137.05 139.75 41.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.041 -1.037 . . . . 0.0 109.534 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -133.87 132.16 40.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 0.0 109.092 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.7 p -145.47 164.72 30.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.17 -0.956 . . . . 0.0 111.058 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -114.31 132.63 56.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.595 -0.69 . . . . 0.0 109.429 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -133.17 135.24 45.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.298 -0.877 . . . . 0.0 110.817 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -130.18 147.99 51.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 109.742 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.1 t -139.1 141.09 38.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.338 -0.851 . . . . 0.0 110.495 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -129.11 129.19 44.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.366 -0.834 . . . . 0.0 109.868 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.484 ' HB ' ' CG2' ' A' ' 135' ' ' VAL . 83.5 mt -125.48 54.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.534 -0.729 . . . . 0.0 109.671 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 74.2 mtp180 61.52 -55.99 0.11 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 132' ' ' ILE . 0.4 OUTLIER -105.47 -14.7 15.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.98 -1.075 . . . . 0.0 111.617 -178.429 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.484 ' CG2' ' HB ' ' A' ' 132' ' ' ILE . 32.8 m -137.17 140.21 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 118.396 -1.322 . . . . 0.0 112.111 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -133.71 119.09 18.88 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.9 t -112.77 146.39 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.077 -1.014 . . . . 0.0 110.758 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -117.12 123.8 5.92 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 107.312 -2.315 . . . . 0.0 107.312 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.9 t -126.19 152.55 45.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.065 -1.256 . . . . 0.0 112.469 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.436 ' N ' ' CD1' ' A' ' 140' ' ' TRP . 56.4 m95 -111.69 137.45 49.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 76.7 mt -115.08 134.78 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.01 -1.056 . . . . 0.0 111.463 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.58 128.74 16.67 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -159.42 -157.98 8.87 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 118.985 -1.578 . . . . 0.0 111.789 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 6' ' ' THR . 7.2 p -111.45 163.13 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 122.135 -0.627 . . . . 0.0 110.555 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -140.54 131.44 5.0 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -129.38 145.64 51.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.465 -1.021 . . . . 0.0 109.893 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -127.81 119.89 26.66 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.395 -0.816 . . . . 0.0 111.046 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.3 t80 . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.461 -0.774 . . . . 0.0 110.085 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.6 p . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.14 0.495 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.1 p -112.49 161.12 17.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.436 -0.79 . . . . 0.0 109.17 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.6 m -136.43 139.99 42.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.119 -0.988 . . . . 0.0 110.59 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 p -126.38 142.84 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.423 HG22 ' CA ' ' A' ' 145' ' ' GLY . 29.4 p -152.17 138.75 18.7 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 25' ' ' ASN . . . -134.24 155.27 21.79 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.95 -163.32 28.43 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -137.35 161.44 36.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.652 -0.911 . . . . 0.0 109.356 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.06 153.69 41.01 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.644 -1.223 . . . . 0.0 112.145 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -112.5 137.77 50.23 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.4 m -121.23 145.54 47.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.991 -1.068 . . . . 0.0 112.633 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -130.2 139.39 50.84 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.426 ' CB ' ' CG2' ' A' ' 137' ' ' VAL . . . -145.9 148.32 32.69 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.774 -1.204 . . . . 0.0 112.11 -177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -78.93 123.56 27.38 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.09 -24.07 25.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.694 -1.763 . . . . 0.0 108.694 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.405 ' NE2' ' CG1' ' A' ' 135' ' ' VAL . 48.4 mt-30 -112.75 141.03 47.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.337 -1.096 . . . . 0.0 109.492 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.0 mtm -98.02 -67.17 0.86 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.29 -0.881 . . . . 0.0 110.572 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 -49.03 122.92 6.36 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.521 -0.737 . . . . 0.0 112.088 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -75.83 164.44 26.23 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.533 -0.729 . . . . 0.0 109.932 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 68.3 mtm -121.02 146.8 46.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.287 -0.883 . . . . 0.0 111.58 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -142.94 124.71 2.41 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -151.36 -160.06 9.24 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.124 -1.512 . . . . 0.0 110.883 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -121.31 154.59 36.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.744 -0.856 . . . . 0.0 110.064 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.41 ' O ' ' HA2' ' A' ' 7' ' ' GLY . 57.7 t30 -134.73 130.84 36.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.451 -0.781 . . . . 0.0 111.515 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.7 mt -111.87 155.13 24.13 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.431 ' CG ' ' CG2' ' A' ' 40' ' ' ILE . 17.4 ttpt -148.81 132.6 16.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.642 -1.286 . . . . 0.0 110.209 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -133.93 136.7 44.42 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.43 ' CB ' HG12 ' A' ' 40' ' ' ILE . 36.8 ptt180 -142.81 150.78 40.41 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.792 -1.163 . . . . 0.0 112.581 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -116.96 138.11 51.77 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -139.45 145.88 39.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.282 -0.886 . . . . 0.0 109.862 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.933 . . . . 0.0 109.652 179.946 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo . . . . . 0 N--CA 1.481 0.765 0 N-CA-C 111.146 -0.367 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.0 mt -108.64 73.13 0.85 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.242 -0.911 . . . . 0.0 110.137 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.83 -179.01 33.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -130.23 144.39 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.623 -0.928 . . . . 0.0 108.948 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.431 ' CG2' ' CG ' ' A' ' 27' ' ' LYS . 62.5 mt -118.38 143.62 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.965 -1.085 . . . . 0.0 110.876 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -124.25 122.64 4.87 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 76.6 p -139.38 144.98 38.41 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.147 -1.208 . . . . 0.0 111.451 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.85 148.25 44.28 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.53 -0.731 . . . . 0.0 109.948 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.9 m -129.73 138.72 51.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.244 -0.91 . . . . 0.0 110.376 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -137.57 110.91 7.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 108.933 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.3 p -122.54 160.34 25.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.489 -0.757 . . . . 0.0 110.457 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -127.4 165.84 19.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.468 -0.77 . . . . 0.0 110.411 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.706 -0.621 . . . . 0.0 110.487 179.784 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -119.7 127.72 53.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.166 -0.959 . . . . 0.0 111.529 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.475 ' CB ' ' CZ ' ' A' ' 87' ' ' TYR . 97.8 m-85 -116.1 136.2 53.24 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.733 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.76 112.22 0.6 Allowed Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.552 -1.309 . . . . 0.0 110.183 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.453 HG23 HD12 ' A' ' 65' ' ' ILE . 77.8 mt -101.49 135.85 36.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.472 ' CG2' ' HB ' ' A' ' 82' ' ' VAL . 12.6 m -150.65 140.2 21.56 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.836 -1.146 . . . . 0.0 111.111 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.71 151.56 30.68 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.54 171.92 40.15 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.388 -1.386 . . . . 0.0 110.6 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.04 161.79 43.72 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.964 1.507 . . . . 0.0 110.995 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -140.47 137.28 33.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.672 -0.643 . . . . 0.0 109.577 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -116.38 124.01 49.0 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.915 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.631 -0.668 . . . . 0.0 109.642 179.145 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 121.535 0.684 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 91.0 p -121.58 159.49 26.3 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.7 mt -124.87 136.29 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.922 -1.111 . . . . 0.0 110.551 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -145.65 158.92 43.79 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.912 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.72 176.89 24.29 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.472 ' HB ' ' CG2' ' A' ' 66' ' ' THR . 34.9 m -147.89 131.36 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.32 -1.106 . . . . 0.0 110.545 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 66' ' ' THR . 11.2 p -145.87 151.42 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.29 -0.881 . . . . 0.0 109.89 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 160.88 -153.18 23.98 Favored Glycine 0 N--CA 1.481 1.655 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.452 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.8 p -128.85 142.24 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 122.204 1.002 . . . . 0.0 112.861 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.98 126.52 6.02 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.475 ' CZ ' ' CB ' ' A' ' 63' ' ' TYR . 46.5 p90 -151.71 162.41 41.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.007 -1.29 . . . . 0.0 110.8 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.47 152.92 21.38 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.788 -0.831 . . . . 0.0 109.626 179.545 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.412 ' O ' ' CG1' ' A' ' 132' ' ' ILE . 43.2 p90 -127.04 169.73 13.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.279 -0.888 . . . . 0.0 110.602 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -156.12 177.19 33.3 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -96.2 137.4 35.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.327 -1.102 . . . . 0.0 110.054 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.7 m -114.89 154.55 28.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.584 -0.697 . . . . 0.0 110.985 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 37.3 p90 -158.03 154.09 27.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.687 -0.633 . . . . 0.0 109.656 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 159.68 -169.45 35.71 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.525 -1.321 . . . . 0.0 110.607 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.82 165.07 28.35 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.689 -0.889 . . . . 0.0 109.338 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -152.26 -177.05 25.55 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.442 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -143.59 147.33 34.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.387 -1.066 . . . . 0.0 110.346 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 124' ' ' ASP . 48.7 tt0 -114.15 148.85 36.57 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.229 -0.919 . . . . 0.0 110.697 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.442 ' CZ ' ' CD1' ' A' ' 113' ' ' LEU . 91.6 m-85 -117.99 164.13 15.55 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.653 -0.654 . . . . 0.0 110.213 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -118.81 80.94 18.21 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 0.0 110.32 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.34 -14.48 42.9 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.589 1.31 . . . . 0.0 111.341 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.524 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 79.9 mtp -148.93 -177.58 5.88 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.189 -0.944 . . . . 0.0 108.485 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -69.39 -41.62 76.21 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.748 -0.595 . . . . 0.0 110.948 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -118.08 12.57 13.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.093 -1.004 . . . . 0.0 111.928 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 20.4 t -114.03 137.18 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.92 -1.112 . . . . 0.0 109.94 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -137.7 135.59 36.59 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.45 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . 0.403 HD21 ' CE2' ' A' ' 125' ' ' PHE . 19.3 tp -110.78 147.01 35.35 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 65.2 t0 -144.68 143.7 30.86 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.483 -1.385 . . . . 0.0 111.206 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.403 ' CE2' HD21 ' A' ' 123' ' ' LEU . 98.7 m-85 -119.02 142.06 48.15 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.3 t -134.26 139.63 45.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.0 111.263 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -118.67 111.03 18.0 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -141.89 143.76 33.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.556 -0.715 . . . . 0.0 110.596 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -137.09 151.93 49.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.442 -0.786 . . . . 0.0 109.761 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.0 t -126.52 138.65 53.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.834 . . . . 0.0 110.367 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -136.78 137.57 39.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.402 -0.811 . . . . 0.0 111.151 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 134' ' ' SER . 6.7 tp -134.23 63.59 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.908 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 69.5 mtp85 59.91 -59.59 0.06 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 132' ' ' ILE . 56.5 p -95.49 -18.63 20.5 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.112 -0.992 . . . . 0.0 111.793 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.405 ' CG1' ' NE2' ' A' ' 17' ' ' GLN . 47.4 t -128.85 134.26 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 118.682 -1.207 . . . . 0.0 111.729 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -131.32 112.28 12.61 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.426 ' CG2' ' CB ' ' A' ' 14' ' ' ALA . 21.4 t -117.18 145.28 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.957 -1.089 . . . . 0.0 110.195 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -130.11 114.09 1.59 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.5 t -139.07 154.22 48.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.255 -1.144 . . . . 0.0 111.453 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 43.9 p90 -126.24 146.83 49.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.605 -0.685 . . . . 0.0 109.8 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 72.6 mt -112.4 141.42 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.329 -0.857 . . . . 0.0 110.666 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.79 145.23 31.56 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.437 -0.789 . . . . 0.0 109.895 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -177.2 -139.38 3.27 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.203 -1.475 . . . . 0.0 111.715 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.7 m -114.25 176.78 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 122.035 -0.685 . . . . 0.0 110.838 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.423 ' CA ' HG22 ' A' ' 6' ' ' THR . . . -162.42 144.56 9.78 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.33 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -129.8 157.39 42.35 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.842 -0.799 . . . . 0.0 109.263 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 32.1 mtp-105 -123.26 122.94 39.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.091 -1.006 . . . . 0.0 111.244 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 67.7 t80 . . . . . 0 N--CA 1.498 1.944 0 O-C-N 121.461 -0.774 . . . . 0.0 110.514 -179.898 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 65.3 p . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.2 m -119.8 144.21 47.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -0.866 . . . . 0.0 109.418 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.6 m -136.98 142.37 42.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.579 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.0 141.48 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.822 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 87.6 m -156.37 130.38 8.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.562 -0.711 . . . . 0.0 109.593 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -164.27 176.23 40.23 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.322 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.73 -125.94 1.05 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -147.06 162.0 39.69 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.478 -1.013 . . . . 0.0 109.528 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.29 142.8 30.67 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.59 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -125.07 143.9 50.68 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -147.47 149.23 32.27 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.266 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.414 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 52.7 t0 -74.98 148.87 39.56 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.406 ' CB ' ' HB2' ' A' ' 17' ' ' GLN . . . -125.15 100.52 6.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.804 -1.185 . . . . 0.0 111.578 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -79.58 115.06 18.98 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.51 -15.89 45.32 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.406 ' HB2' ' CB ' ' A' ' 14' ' ' ALA . 89.9 mt-30 -106.08 171.87 7.11 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.104 -1.233 . . . . 0.0 109.825 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 89.3 mtp -56.52 -49.84 73.57 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.332 -0.855 . . . . 0.0 111.659 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -162.43 -155.7 0.37 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.698 -1.251 . . . . 0.0 110.435 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -84.25 166.92 17.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.334 -0.854 . . . . 0.0 111.005 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.6 mtt -126.03 167.9 14.69 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.442 -0.787 . . . . 0.0 110.918 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.46 128.44 2.93 Favored Glycine 0 N--CA 1.502 3.049 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.392 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -145.92 -167.29 12.49 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.295 -1.431 . . . . 0.0 111.033 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -122.13 161.73 22.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.855 -0.791 . . . . 0.0 109.494 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.412 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 25.3 p-10 -148.61 135.66 20.08 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.227 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.4 mt -113.76 150.37 33.51 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 80.2 mttt -136.46 142.08 43.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.508 -1.37 . . . . 0.0 110.511 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.46 123.82 44.98 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.439 ' CG ' HG12 ' A' ' 40' ' ' ILE . 45.9 ttp180 -123.17 143.56 49.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.147 -0.97 . . . . 0.0 112.123 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -112.81 133.69 54.69 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -142.77 153.86 43.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.396 -0.815 . . . . 0.0 109.912 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 0.0 110.185 179.718 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 CA--C 1.537 0.627 0 N-CA-C 109.913 -0.841 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.5 119.81 33.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.534 -0.729 . . . . 0.0 110.004 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -121.89 134.75 10.04 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.7 t -130.48 132.86 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.336 -1.097 . . . . 0.0 108.921 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.439 HG12 ' CG ' ' A' ' 29' ' ' ARG . 72.4 mt -120.3 139.45 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.742 -1.224 . . . . 0.0 110.818 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.98 117.78 4.37 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 107.703 -2.159 . . . . 0.0 107.703 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.415 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 48.3 t -123.84 141.68 51.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.144 -1.21 . . . . 0.0 112.503 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.05 142.18 49.08 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.5 m -130.91 139.14 50.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.004 -1.06 . . . . 0.0 110.902 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -136.69 110.65 8.24 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.6 p -121.69 157.83 30.04 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.464 -0.773 . . . . 0.0 109.989 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -118.31 155.38 30.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -0.853 . . . . 0.0 110.237 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.1 tttt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.872 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -121.55 112.79 18.93 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.197 -0.94 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -98.42 140.3 32.89 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.07 117.7 0.95 Allowed Glycine 0 N--CA 1.486 2.01 0 C-N-CA 119.168 -1.491 . . . . 0.0 110.337 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.4 tt -112.03 134.97 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 70.9 m -151.7 141.68 22.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.812 -1.18 . . . . 0.0 111.712 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 40' ' ' ILE . . . -147.58 150.05 33.72 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.86 170.59 40.7 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.751 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.07 172.47 15.88 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 123.955 1.503 . . . . 0.0 110.741 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.62 141.55 24.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.482 -0.762 . . . . 0.0 109.741 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -127.19 146.17 50.5 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.611 -0.68 . . . . 0.0 110.77 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.518 -0.739 . . . . 0.0 109.927 179.271 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 121.357 0.599 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.9 t -138.13 150.06 46.48 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.522 -0.736 . . . . 0.0 109.72 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.6 tt -133.55 138.04 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.999 -1.063 . . . . 0.0 109.973 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -147.89 158.15 43.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.158 -0.963 . . . . 0.0 111.635 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -107.08 161.01 13.92 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 107.919 -2.072 . . . . 0.0 107.919 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.0 m -142.58 146.81 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.093 -1.239 . . . . 0.0 111.96 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 66' ' ' THR . 26.8 m -138.15 152.26 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.85 177.5 48.12 Favored Glycine 0 N--CA 1.479 1.548 0 C-N-CA 118.876 -1.63 . . . . 0.0 110.734 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.442 ' CG1' ' CZ ' ' A' ' 87' ' ' TYR . 48.7 t -122.3 135.78 61.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-O 121.738 0.78 . . . . 0.0 111.002 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . -103.4 133.97 11.67 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.442 ' CZ ' ' CG1' ' A' ' 85' ' ' VAL . 91.5 m-85 -117.09 146.1 43.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.153 -1.204 . . . . 0.0 110.47 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.32 116.84 3.26 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.7 mttp . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.516 -0.991 . . . . 0.0 109.963 179.775 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 52.6 t0 . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 38.6 p90 -132.04 170.34 15.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 111.436 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . 0.407 ' N ' HD12 ' A' ' 132' ' ' ILE . . . -160.03 -177.46 33.14 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -106.64 150.14 26.52 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.965 -1.315 . . . . 0.0 111.634 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 96.4 p -128.86 161.57 29.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.716 -0.615 . . . . 0.0 110.108 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -155.68 148.52 24.26 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.379 -0.825 . . . . 0.0 109.802 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 175.0 -175.36 47.07 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.468 -1.349 . . . . 0.0 110.827 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.67 159.51 9.99 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.609 -0.936 . . . . 0.0 109.022 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.48 -174.75 30.69 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.31 162.02 36.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.22 -1.165 . . . . 0.0 111.059 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -107.68 144.49 34.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.523 -0.735 . . . . 0.0 109.537 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . 0.447 ' CZ ' ' CE2' ' A' ' 125' ' ' PHE . 46.2 p90 -152.23 151.85 31.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.457 -0.777 . . . . 0.0 110.302 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 115' ' ' PHE . 0.2 OUTLIER 166.75 142.34 0.05 OUTLIER Pre-proline 0 N--CA 1.509 2.493 0 O-C-N 121.776 -0.577 . . . . 0.0 111.013 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -88.51 47.96 1.29 Allowed 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.491 1.259 . . . . 0.0 109.155 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 95.6 mmm -142.26 135.25 28.63 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 121.401 -0.812 . . . . 0.0 108.94 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.08 -42.3 99.61 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.813 -0.554 . . . . 0.0 112.44 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -106.58 5.55 29.18 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.721 -1.237 . . . . 0.0 112.922 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.92 136.42 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.715 -1.241 . . . . 0.0 110.506 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -145.44 129.98 17.91 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.577 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.6 mt -111.95 150.67 30.2 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -148.76 156.1 41.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.653 -1.279 . . . . 0.0 112.42 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.447 ' CE2' ' CZ ' ' A' ' 115' ' ' PHE . 34.2 m-85 -123.64 141.41 52.04 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.545 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.2 m -138.98 147.75 42.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.382 -0.824 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -117.97 124.23 47.69 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -133.58 138.25 45.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.264 -0.898 . . . . 0.0 111.416 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -119.68 128.61 53.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.639 -0.663 . . . . 0.0 109.537 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.9 m -122.31 146.34 47.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.287 -0.883 . . . . 0.0 110.626 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -129.39 125.18 36.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.432 -0.793 . . . . 0.0 110.117 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.433 ' HB ' ' HB ' ' A' ' 135' ' ' VAL . 14.7 mm -113.87 63.44 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 66.23 -60.04 0.32 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.406 -0.809 . . . . 0.0 111.349 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -125.68 9.23 7.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.057 -1.027 . . . . 0.0 111.16 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' A' ' 132' ' ' ILE . 43.9 t -124.77 132.88 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.182 -0.949 . . . . 0.0 110.678 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -131.54 111.78 12.06 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' A' ' 13' ' ' ASP . 88.1 t -115.24 145.13 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 110.799 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -107.47 103.9 2.02 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 107.116 -2.394 . . . . 0.0 107.116 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.2 m -104.9 136.85 43.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -1.069 . . . . 0.0 112.105 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -114.22 134.34 54.99 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.435 HD12 HG23 ' A' ' 141' ' ' ILE . 75.1 mt -116.05 132.55 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 110.52 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.0 143.06 31.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.479 -0.763 . . . . 0.0 109.425 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -174.77 -146.71 5.83 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 118.709 -1.71 . . . . 0.0 112.151 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.1 m -118.47 175.69 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.289 0.566 . . . . 0.0 111.075 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -157.36 139.84 6.7 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.98 157.37 45.36 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.598 -0.942 . . . . 0.0 109.837 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -131.9 121.33 23.85 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.271 -0.893 . . . . 0.0 111.065 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.403 -0.81 . . . . 0.0 110.29 -179.874 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.4 p . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.9 p -112.44 145.82 39.49 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.36 -0.838 . . . . 0.0 109.68 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.8 m -136.98 139.18 41.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.857 . . . . 0.0 110.634 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.05 142.25 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.571 -0.705 . . . . 0.0 109.846 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.8 m -156.42 130.52 8.56 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.44 -0.788 . . . . 0.0 110.123 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.411 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -165.66 171.6 40.91 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.61 -136.36 2.3 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -132.76 158.54 42.16 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.549 -0.971 . . . . 0.0 109.108 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.39 142.3 29.22 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.286 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -111.54 145.8 38.45 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.8 t -146.35 151.22 37.14 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.411 -1.316 . . . . 0.0 112.914 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -100.92 150.64 22.65 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 137' ' ' VAL . . . -134.12 116.3 15.26 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.787 -1.196 . . . . 0.0 111.823 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -67.03 117.14 8.68 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.59 -14.18 38.82 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . 0.426 ' HB2' ' CB ' ' A' ' 14' ' ' ALA . 87.6 mt-30 -114.59 156.62 24.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.348 -1.09 . . . . 0.0 109.356 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 70.1 mtm -100.51 -75.52 0.58 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.206 -0.933 . . . . 0.0 111.613 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -57.46 132.04 51.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.366 -0.834 . . . . 0.0 111.553 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -63.6 169.07 4.17 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.663 . . . . 0.0 110.237 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 90.1 mtp -128.15 166.7 18.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.279 -0.888 . . . . 0.0 111.44 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 46' ' ' THR . . . -124.86 178.94 16.34 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 107.904 -2.079 . . . . 0.0 107.904 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.94 148.27 9.19 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 118.57 -1.776 . . . . 0.0 111.89 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -109.24 133.68 52.72 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.411 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 76.1 m-20 -120.85 128.4 52.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.201 -0.937 . . . . 0.0 111.852 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.0 tp -121.58 133.53 55.0 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 22.7 mttt -136.08 146.71 47.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.313 -1.492 . . . . 0.0 111.44 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -115.96 129.46 56.4 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -128.57 134.32 48.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.15 -0.969 . . . . 0.0 112.106 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -125.06 139.95 53.33 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.592 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -142.04 150.26 41.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.144 -0.973 . . . . 0.0 110.278 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.368 -0.833 . . . . 0.0 109.662 -179.931 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo . . . . . 0 N--CA 1.481 0.784 0 N-CA-C 111.061 -0.4 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.05 76.27 7.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.318 -0.864 . . . . 0.0 110.203 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.67 132.85 11.74 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.67 129.26 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.359 -1.083 . . . . 0.0 108.925 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.0 tt -132.11 144.75 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.893 . . . . 0.0 111.431 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.58 148.21 16.38 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.428 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 42.3 t -138.72 141.53 38.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.272 . . . . 0.0 111.891 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -125.49 138.31 53.98 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 t -134.62 145.78 48.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.974 -1.079 . . . . 0.0 111.216 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -127.99 111.38 13.48 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 87.1 m -119.24 141.9 48.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.692 -0.63 . . . . 0.0 110.68 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -148.75 179.63 7.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.843 . . . . 0.0 110.075 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 mttp . . . . . 0 N--CA 1.494 1.735 0 O-C-N 121.437 -0.789 . . . . 0.0 109.99 179.898 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 . . . . . 0 N--CA 1.494 1.756 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -110.33 118.41 36.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.217 -0.927 . . . . 0.0 110.748 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.403 ' CD2' ' CE2' ' A' ' 87' ' ' TYR . 46.6 t80 -98.44 139.66 33.85 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.73 122.27 1.4 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 118.969 -1.586 . . . . 0.0 110.987 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.7 pt -112.85 138.0 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 1.3 p -153.57 144.29 22.62 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.584 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.26 153.59 35.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.473 -0.767 . . . . 0.0 109.27 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.85 174.15 43.43 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.536 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.8 167.69 25.88 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.891 1.469 . . . . 0.0 110.846 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.51 141.7 25.04 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.412 -0.805 . . . . 0.0 110.404 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -120.5 131.56 54.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.503 -0.748 . . . . 0.0 110.503 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.657 -0.652 . . . . 0.0 110.391 179.361 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.98 0 CA-C-O 121.123 0.487 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 24.6 m -115.5 146.14 41.97 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.357 -0.839 . . . . 0.0 109.364 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.0 mt -131.31 138.44 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.149 -0.969 . . . . 0.0 111.234 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -142.25 157.22 45.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.492 -0.755 . . . . 0.0 110.461 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.51 164.2 13.5 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.9 t -139.24 132.79 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -1.158 . . . . 0.0 111.086 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 66' ' ' THR . 26.7 m -141.89 151.95 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 164.24 -161.42 34.42 Favored Glycine 0 N--CA 1.48 1.572 0 C-N-CA 119.157 -1.497 . . . . 0.0 110.755 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.414 HG12 ' CD1' ' A' ' 107' ' ' PHE . 33.8 m -130.16 162.87 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 122.226 1.013 . . . . 0.0 112.651 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.07 137.84 7.9 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.403 ' CE2' ' CD2' ' A' ' 63' ' ' TYR . 13.9 p90 -150.82 163.94 37.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.081 -1.246 . . . . 0.0 110.701 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -119.36 141.28 15.61 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.4 tttt . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.826 -0.808 . . . . 0.0 109.942 179.914 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -133.04 169.44 16.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.256 -0.902 . . . . 0.0 110.912 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -163.03 -175.75 34.38 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . 0.414 ' CD1' HG12 ' A' ' 85' ' ' VAL . 98.8 m-85 -112.03 155.28 24.07 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.186 -1.185 . . . . 0.0 110.655 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 97.6 p -129.86 160.92 32.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.491 -0.755 . . . . 0.0 110.646 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . 0.407 ' CD1' HG12 ' A' ' 83' ' ' VAL . 65.7 t80 -155.26 148.03 24.35 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.439 -0.788 . . . . 0.0 109.673 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 175.82 -176.77 47.59 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.602 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.88 160.0 9.94 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.713 -0.875 . . . . 0.0 108.707 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -152.47 -179.1 27.77 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 78' ' ' SER . 5.3 mp -126.68 160.1 31.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.453 -1.027 . . . . 0.0 110.002 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.403 ' NE2' ' HB1' ' A' ' 122' ' ' ALA . 36.5 tt0 -106.65 140.65 39.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.81 -1.181 . . . . 0.0 108.057 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -124.65 165.19 18.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.372 -0.83 . . . . 0.0 111.518 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.84 88.94 0.1 OUTLIER Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.865 -0.522 . . . . 0.0 109.927 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.96 125.49 12.63 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.734 1.386 . . . . 0.0 110.398 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.417 ' CB ' ' HB ' ' A' ' 121' ' ' VAL . 95.5 mmm -145.21 163.25 35.0 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.13 -49.08 77.31 Favored 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.688 -0.632 . . . . 0.0 110.401 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -134.17 25.26 3.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.274 -0.891 . . . . 0.0 111.349 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.417 ' HB ' ' CB ' ' A' ' 118' ' ' MET . 48.2 t -127.11 139.66 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.95 -1.094 . . . . 0.0 109.964 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 144' ' ' VAL . . . -154.81 137.7 15.41 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.785 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 77.7 mt -121.65 143.62 49.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -149.45 153.25 37.0 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 118.246 -1.381 . . . . 0.0 112.395 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.31 140.14 53.08 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.6 t -143.62 149.23 37.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -0.977 . . . . 0.0 111.181 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -104.9 123.41 47.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.637 -0.665 . . . . 0.0 109.368 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -137.36 142.84 41.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.634 -0.666 . . . . 0.0 110.481 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -138.5 156.88 47.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.52 -0.738 . . . . 0.0 109.765 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.2 t -133.33 143.53 49.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.385 -0.822 . . . . 0.0 110.53 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -124.59 127.73 47.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.563 -0.71 . . . . 0.0 109.761 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.45 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 85.1 mt -121.17 39.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 68.5 mtt180 63.64 -55.13 0.21 Allowed 'General case' 0 N--CA 1.503 2.207 0 O-C-N 122.03 -0.419 . . . . 0.0 111.578 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 132' ' ' ILE . 66.5 p -99.93 -24.14 14.73 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.121 -0.987 . . . . 0.0 110.398 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 56.1 t -126.51 132.39 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.246 -0.909 . . . . 0.0 110.732 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -132.55 113.19 12.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 109.02 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 61.3 t -117.54 146.4 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.937 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -115.78 114.62 3.17 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 27.8 m -109.03 140.56 42.39 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.209 -1.171 . . . . 0.0 112.322 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -109.01 136.75 48.03 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 46.4 pt -124.14 147.06 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.98 -1.075 . . . . 0.0 111.654 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -154.43 139.6 17.48 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -168.59 -153.21 8.12 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 118.695 -1.717 . . . . 0.0 112.072 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 34.5 m -116.97 177.64 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 122.236 -0.567 . . . . 0.0 110.738 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -156.4 140.21 7.06 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.485 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -130.34 152.31 49.88 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.578 -0.954 . . . . 0.0 109.654 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -128.04 120.68 27.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.206 -0.934 . . . . 0.0 110.81 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.5 t80 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.48 -0.763 . . . . 0.0 110.205 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.6 p . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.5 m -116.44 145.21 43.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.9 . . . . 0.0 109.453 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 57.9 m -136.21 142.0 44.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.895 . . . . 0.0 110.673 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.42 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 14.7 p -128.61 141.39 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.655 -0.653 . . . . 0.0 109.571 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.8 m -156.68 133.07 9.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.51 -0.744 . . . . 0.0 109.815 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -166.23 173.47 41.73 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.156 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.85 -128.23 1.19 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -118.35 152.77 35.17 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.406 -1.055 . . . . 0.0 109.866 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.02 116.52 22.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 110.688 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -110.62 142.71 42.11 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.407 ' HB2' ' CB ' ' A' ' 139' ' ' THR . 25.3 t -148.49 145.35 27.9 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.42 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -73.3 150.86 41.6 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -127.94 90.52 3.11 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.959 -1.096 . . . . 0.0 112.046 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -80.91 116.09 20.71 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.87 -14.41 60.22 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -100.83 172.75 6.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.018 -1.283 . . . . 0.0 110.463 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 88.0 mtp -57.55 -49.39 76.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.432 -0.792 . . . . 0.0 112.11 -178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -164.55 -158.26 0.41 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.771 -1.206 . . . . 0.0 110.655 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -77.68 159.98 28.78 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.437 -0.79 . . . . 0.0 110.304 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 85.9 mtp -126.75 163.98 22.35 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.26 -0.9 . . . . 0.0 111.083 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.96 126.02 2.42 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -142.75 -171.78 13.53 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.567 -1.302 . . . . 0.0 110.771 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.48 146.62 40.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.636 -0.92 . . . . 0.0 109.988 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.418 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 51.2 t-20 -130.85 127.85 39.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.831 . . . . 0.0 110.997 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.83 141.62 47.85 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 31.9 mttm -130.8 144.86 51.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.419 -1.425 . . . . 0.0 110.501 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -122.75 124.46 43.41 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.408 ' CG ' HG12 ' A' ' 40' ' ' ILE . 59.0 ttt180 -122.74 142.72 50.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.147 -0.971 . . . . 0.0 111.953 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -114.07 137.23 51.99 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -138.44 152.01 47.95 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.4 -0.813 . . . . 0.0 109.61 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.045 -1.034 . . . . 0.0 109.93 179.773 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 CA--C 1.541 0.844 0 N-CA-C 110.547 -0.597 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.1 tp -94.48 120.35 34.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.843 -0.536 . . . . 0.0 110.909 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.49 134.19 9.57 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.4 t -130.8 135.13 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.341 -1.094 . . . . 0.0 109.044 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.408 HG12 ' CG ' ' A' ' 29' ' ' ARG . 73.5 mt -119.87 140.59 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.855 -1.153 . . . . 0.0 110.936 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.43 125.63 6.68 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 107.758 -2.137 . . . . 0.0 107.758 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.442 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 92.7 p -134.02 144.98 49.03 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.012 -1.287 . . . . 0.0 112.577 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -125.54 140.27 52.89 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 m -132.34 142.42 49.32 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.912 -1.117 . . . . 0.0 111.402 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -131.79 109.67 10.3 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.1 m -122.1 145.62 47.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.467 -0.771 . . . . 0.0 110.733 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -147.32 167.6 23.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.288 -0.882 . . . . 0.0 110.275 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.4 mttp . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.439 -0.788 . . . . 0.0 109.976 179.742 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 120.883 0.373 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -125.02 117.6 24.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.384 -0.822 . . . . 0.0 110.851 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -109.78 139.11 45.21 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.58 125.93 2.1 Favored Glycine 0 N--CA 1.485 1.957 0 C-N-CA 119.094 -1.527 . . . . 0.0 110.292 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.7 tt -108.43 137.59 39.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -151.41 140.19 20.84 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.018 -1.073 . . . . 0.0 111.126 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 40' ' ' ILE . . . -156.34 152.07 27.15 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.36 178.32 43.13 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.601 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.26 169.23 21.21 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 O-C-N 123.949 1.5 . . . . 0.0 110.638 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.93 145.89 21.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.586 -0.696 . . . . 0.0 110.028 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -120.99 141.18 50.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.655 -0.653 . . . . 0.0 109.948 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.499 -0.75 . . . . 0.0 110.263 179.909 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.367 0 CA-C-O 121.447 0.641 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.6 m -125.83 148.74 49.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.542 -0.724 . . . . 0.0 109.8 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.1 mt -123.41 137.17 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.151 -0.968 . . . . 0.0 110.474 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -146.9 166.19 27.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.367 -0.833 . . . . 0.0 110.878 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.41 162.15 19.73 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.26 141.07 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -1.108 . . . . 0.0 111.232 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 66' ' ' THR . 36.0 m -142.63 151.44 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 160.36 -149.34 18.62 Favored Glycine 0 N--CA 1.483 1.772 0 C-N-CA 119.265 -1.445 . . . . 0.0 110.953 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.4 HG23 ' CZ ' ' A' ' 87' ' ' TYR . 11.1 p -133.04 144.29 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 122.459 1.123 . . . . 0.0 113.567 -177.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.2 137.68 14.46 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.411 ' CE1' ' CB ' ' A' ' 105' ' ' TYR . 90.0 m-85 -120.65 143.56 48.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.141 -1.211 . . . . 0.0 110.796 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -125.02 114.59 2.22 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.0 tptm . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.491 -1.005 . . . . 0.0 110.253 -179.725 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 52.4 t0 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.024 0.44 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.411 ' CB ' ' CE1' ' A' ' 87' ' ' TYR . 43.4 p90 -127.6 168.83 14.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.275 -0.89 . . . . 0.0 110.305 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -159.83 -175.86 31.27 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -103.38 144.71 31.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.134 -1.215 . . . . 0.0 111.333 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.0 m -118.08 150.33 39.51 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 110.059 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -154.63 146.57 23.52 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.452 -0.78 . . . . 0.0 109.978 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.91 -176.27 42.55 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.016 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.81 162.89 32.43 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.46 -178.07 24.12 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.289 -1.434 . . . . 0.0 110.221 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.2 tp -139.51 149.39 43.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.609 -0.936 . . . . 0.0 109.923 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 124' ' ' ASP . 13.7 pt20 -127.06 151.81 48.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.185 -0.947 . . . . 0.0 109.824 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -156.88 161.19 39.68 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.359 -0.838 . . . . 0.0 110.883 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER 172.77 140.36 0.13 Allowed Pre-proline 0 N--CA 1.504 2.266 0 O-C-N 121.643 -0.661 . . . . 0.0 111.323 179.251 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -88.37 50.6 1.7 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.581 1.306 . . . . 0.0 109.011 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.415 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 86.6 mtp -146.25 140.58 26.63 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.527 -0.733 . . . . 0.0 109.068 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.48 -39.46 91.95 Favored 'General case' 0 C--N 1.292 -1.914 0 O-C-N 121.781 -0.574 . . . . 0.0 112.423 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -115.46 13.6 16.5 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.665 -1.272 . . . . 0.0 112.631 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 47.1 t -123.94 136.28 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.781 -1.199 . . . . 0.0 109.787 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.48 ' HA ' ' HB2' ' A' ' 116' ' ' ASN . . . -153.3 138.15 17.11 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.643 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.1 mt -103.13 153.1 20.67 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 52.5 t0 -143.97 136.52 26.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.569 -1.332 . . . . 0.0 110.361 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -128.71 142.28 51.06 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.6 t -145.91 155.74 43.07 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.132 -0.98 . . . . 0.0 111.375 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -107.14 119.27 38.91 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -131.96 144.32 50.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 110.9 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -141.26 155.0 46.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.577 -0.702 . . . . 0.0 109.609 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 29.3 t -142.46 141.3 32.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.397 -0.814 . . . . 0.0 110.294 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 -129.42 133.35 47.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.472 -0.768 . . . . 0.0 109.87 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 134' ' ' SER . 24.6 pt -125.15 48.76 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 76.7 mtt85 60.59 -56.62 0.08 Allowed 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 132' ' ' ILE . 53.4 m -92.18 -21.67 20.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 111.006 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.438 ' HB ' HG12 ' A' ' 132' ' ' ILE . 37.6 t -135.12 137.55 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.646 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -132.74 113.69 13.27 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.0 m -121.33 149.19 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.234 -0.916 . . . . 0.0 110.835 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -114.28 129.35 8.68 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . 0.407 ' CB ' ' HB2' ' A' ' 12' ' ' SER . 14.7 t -126.31 143.9 51.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -1.134 . . . . 0.0 112.263 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -123.06 140.89 52.55 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.6 pt -120.5 149.94 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.122 -0.986 . . . . 0.0 111.187 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -150.07 140.08 21.99 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -173.53 -146.3 5.47 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 118.783 -1.675 . . . . 0.0 111.906 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.4 m -118.77 179.87 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 122.229 -0.571 . . . . 0.0 110.908 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 5' ' ' VAL . . . -160.84 143.61 9.11 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.899 -1.143 . . . . 0.0 110.729 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -132.73 156.12 47.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.655 -0.909 . . . . 0.0 109.726 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 46.3 ptt85 -133.96 123.85 25.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.346 -0.846 . . . . 0.0 111.268 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.8 p90 . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.346 -0.846 . . . . 0.0 110.397 179.939 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 48.5 m . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.0 p -117.34 144.31 45.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 109.751 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.7 m -135.83 140.21 44.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.418 -0.801 . . . . 0.0 110.505 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -115.18 138.31 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.6 m -156.34 132.54 9.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.237 -0.914 . . . . 0.0 110.023 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.99 171.95 38.89 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.82 -148.43 7.91 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -139.36 159.86 41.17 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.442 -1.034 . . . . 0.0 109.85 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.67 147.07 31.58 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.838 -1.145 . . . . 0.0 111.628 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -99.19 138.16 36.68 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.5 m -119.73 145.13 46.82 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.193 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -136.69 141.09 43.09 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.427 ' CB ' ' CG2' ' A' ' 137' ' ' VAL . . . -153.96 149.52 27.34 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 120.411 -1.431 . . . . 0.0 112.482 -177.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -79.32 128.03 32.82 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.6 -28.29 14.77 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -114.02 157.26 22.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.457 -1.025 . . . . 0.0 110.212 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . 0.411 ' O ' ' HB2' ' A' ' 19' ' ' ASN . 64.8 mtt -121.46 171.33 8.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.442 -0.786 . . . . 0.0 110.29 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 18' ' ' MET . 18.2 m120 61.7 115.97 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.631 -0.668 . . . . 0.0 110.511 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -65.95 164.09 15.8 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.578 -0.701 . . . . 0.0 110.305 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 87.2 mtp -126.19 165.75 18.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.46 -0.775 . . . . 0.0 110.713 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.1 123.37 1.83 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.73 -172.67 12.74 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.153 -1.498 . . . . 0.0 110.754 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -119.0 148.6 42.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.804 -0.821 . . . . 0.0 108.999 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -125.59 134.65 51.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 111.265 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.2 mt -113.27 147.72 37.02 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 26.5 mttt -147.89 137.34 22.37 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.63 -1.294 . . . . 0.0 110.979 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -119.84 130.9 55.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.459 -0.776 . . . . 0.0 108.928 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -132.27 140.27 48.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.14 -0.975 . . . . 0.0 111.878 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -119.0 133.3 55.91 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -141.97 142.75 32.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.199 -0.938 . . . . 0.0 110.459 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.419 -0.8 . . . . 0.0 109.879 179.557 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 N--CA 1.481 0.759 0 N-CA-C 111.183 -0.353 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 28.1 tp -116.59 84.72 2.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.26 -0.9 . . . . 0.0 110.595 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.74 -175.83 24.8 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.02 147.04 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.488 -1.007 . . . . 0.0 109.342 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 67' ' ' ALA . 16.5 tt -135.75 146.64 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.239 -0.913 . . . . 0.0 111.451 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 27' ' ' LYS . . . -115.73 151.16 18.49 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.5 t -140.35 142.27 35.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.075 -1.25 . . . . 0.0 111.788 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -129.95 138.67 50.99 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.4 t -134.04 148.55 51.09 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.95 -1.094 . . . . 0.0 111.677 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -141.59 114.37 8.48 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.3 p -122.11 159.73 26.53 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.418 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -142.35 170.9 14.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.747 . . . . 0.0 110.418 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.0 pttt . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.398 -0.814 . . . . 0.0 110.305 179.847 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -110.48 117.53 33.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.779 . . . . 0.0 110.98 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.498 ' HB2' ' HB2' ' A' ' 87' ' ' TYR . 86.4 m-85 -113.62 135.08 54.31 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.098 0.475 . . . . 0.0 109.776 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.01 126.8 2.52 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.547 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.404 ' CG2' HG23 ' A' ' 85' ' ' VAL . 14.0 tt -122.03 134.63 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 1.1 p -149.71 143.79 25.68 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.668 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 40' ' ' ILE . . . -141.23 150.09 42.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.685 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.84 168.24 40.58 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.65 176.97 8.1 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.788 1.415 . . . . 0.0 110.681 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.49 147.99 21.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.476 -0.765 . . . . 0.0 110.847 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -118.49 134.81 54.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.429 -0.795 . . . . 0.0 109.646 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.5 ttt-85 . . . . . 0 N--CA 1.496 1.86 0 O-C-N 121.456 -0.777 . . . . 0.0 110.765 -179.485 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.103 0.477 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.7 t -95.77 142.44 28.05 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.492 -0.755 . . . . 0.0 109.8 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.0 tt -132.62 144.43 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.361 -0.837 . . . . 0.0 110.451 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -142.96 153.98 43.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -0.812 . . . . 0.0 110.882 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.48 161.79 21.42 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 110' ' ' GLY . 47.3 t -134.45 132.77 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.119 -1.224 . . . . 0.0 111.467 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 66' ' ' THR . 60.5 t -137.29 145.59 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 170.7 -166.39 39.59 Favored Glycine 0 N--CA 1.477 1.412 0 C-N-CA 118.537 -1.792 . . . . 0.0 111.337 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.457 HG11 ' CE2' ' A' ' 105' ' ' TYR . 33.2 m -133.84 177.07 7.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 121.838 0.827 . . . . 0.0 111.529 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.39 145.05 15.67 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.498 ' HB2' ' HB2' ' A' ' 63' ' ' TYR . 99.2 m-85 -126.06 132.49 51.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.201 -1.176 . . . . 0.0 109.732 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.06 129.02 9.15 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.3 tttt . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.594 -0.945 . . . . 0.0 109.676 179.695 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.457 ' CE2' HG11 ' A' ' 85' ' ' VAL . 39.4 t80 -81.69 131.0 35.25 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.108 -0.995 . . . . 0.0 111.443 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -117.96 -164.13 13.02 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -140.8 148.86 41.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.443 -1.033 . . . . 0.0 109.917 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.7 m -136.6 143.57 43.65 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.198 -0.939 . . . . 0.0 110.858 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -151.7 141.38 21.8 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.449 -0.782 . . . . 0.0 110.014 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 82' ' ' VAL . . . 174.87 -176.07 47.04 Favored Glycine 0 N--CA 1.497 2.727 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.451 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -169.2 161.23 10.13 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.458 -1.025 . . . . 0.0 109.0 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -156.06 -174.89 26.42 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.303 -1.427 . . . . 0.0 109.946 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.01 162.42 23.49 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.43 -1.041 . . . . 0.0 110.069 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -119.21 131.85 55.87 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.862 -1.148 . . . . 0.0 109.04 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -129.28 129.2 44.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.293 -0.879 . . . . 0.0 110.629 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -177.34 150.69 0.86 Allowed Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.331 -0.855 . . . . 0.0 110.471 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -77.01 -77.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.577 1.304 . . . . 0.0 110.131 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.404 ' HB2' HG23 ' A' ' 121' ' ' VAL . 89.0 mtp -47.22 119.17 2.47 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.435 1.112 . . . . 0.0 110.596 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.5 -10.43 7.82 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.437 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -92.06 -4.06 54.93 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.531 -1.356 . . . . 0.0 110.743 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 118' ' ' MET . 34.1 m -128.28 161.1 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -0.875 . . . . 0.0 110.51 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -156.11 138.64 14.98 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.685 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.3 tp -119.68 132.31 55.64 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 49.5 p30 -143.85 156.72 44.56 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.088 -1.445 . . . . 0.0 113.797 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.414 ' CE1' ' HB3' ' A' ' 142' ' ' ALA . 95.6 m-85 -124.51 134.86 52.88 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.2 t -138.45 142.82 39.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 111.016 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.44 ' CD1' ' CZ2' ' A' ' 140' ' ' TRP . 81.0 t80 -109.23 127.54 54.33 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -142.14 147.39 36.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.526 -0.734 . . . . 0.0 110.41 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -112.22 135.14 53.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.547 -0.72 . . . . 0.0 110.106 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.7 m -128.4 143.61 51.02 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.608 -0.682 . . . . 0.0 109.315 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 39.5 ptt180 -147.06 144.7 29.29 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.81 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.443 ' O ' ' N ' ' A' ' 134' ' ' SER . 44.8 mm -122.67 90.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.57 -0.706 . . . . 0.0 110.031 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 51.7 mtt180 61.75 -66.45 0.07 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.667 -0.645 . . . . 0.0 112.385 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 132' ' ' ILE . 32.2 p -125.86 20.84 7.68 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.033 -1.042 . . . . 0.0 110.96 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 131' ' ' ARG . 61.5 t -124.57 133.94 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 119.261 -0.975 . . . . 0.0 111.024 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -129.3 111.89 13.32 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.427 ' CG2' ' CB ' ' A' ' 14' ' ' ALA . 18.6 t -113.15 144.2 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.807 -1.183 . . . . 0.0 111.276 -177.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -117.12 107.12 1.52 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.125 -2.39 . . . . 0.0 107.125 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.5 m -121.81 142.33 50.33 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -1.13 . . . . 0.0 112.051 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.44 ' CZ2' ' CD1' ' A' ' 127' ' ' TYR . 89.3 m95 -105.63 135.51 46.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.3 pt -119.53 150.5 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.147 -0.97 . . . . 0.0 111.312 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.414 ' HB3' ' CE1' ' A' ' 125' ' ' PHE . . . -151.66 139.03 19.42 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -164.23 -157.71 9.65 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 118.92 -1.61 . . . . 0.0 111.745 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.8 m -117.38 173.71 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 122.135 -0.626 . . . . 0.0 110.385 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -152.41 138.75 6.59 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.699 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -127.04 147.35 50.15 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.582 -0.952 . . . . 0.0 109.357 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -129.22 122.89 30.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.133 -0.979 . . . . 0.0 111.046 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 69.0 t80 . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.466 -0.771 . . . . 0.0 110.2 179.862 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 93.8 m . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 120.546 0.212 . . . . 0.0 110.818 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 82.8 p -149.4 154.39 38.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.867 -1.145 . . . . 0.0 109.779 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.2 m -136.11 137.69 41.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.418 -0.801 . . . . 0.0 110.06 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.0 t -106.79 138.05 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 47.6 m -156.58 133.59 10.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.217 -0.927 . . . . 0.0 110.367 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.35 176.12 44.72 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.09 -120.85 0.78 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 27.1 t80 -139.46 158.92 43.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.482 -1.01 . . . . 0.0 109.228 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.2 117.4 14.5 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.143 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -106.76 144.63 33.13 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.3 p -150.12 154.08 37.46 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.342 -178.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -77.22 154.32 33.17 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.436 ' CB ' ' HB2' ' A' ' 17' ' ' GLN . . . -125.76 98.57 5.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.099 -1.001 . . . . 0.0 111.821 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -80.13 115.68 19.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.396 -0.815 . . . . 0.0 108.802 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.51 -14.09 59.43 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.436 ' HB2' ' CB ' ' A' ' 14' ' ' ALA . 96.6 mt-30 -115.05 160.03 20.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.439 -1.036 . . . . 0.0 109.402 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.1 ttm -98.99 137.96 36.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 111.052 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.6 t30 64.63 138.59 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.541 -0.724 . . . . 0.0 111.099 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -69.17 177.79 2.59 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.613 -0.679 . . . . 0.0 110.128 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 68.9 mtm -129.16 169.91 14.2 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.343 -0.848 . . . . 0.0 110.724 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -152.68 128.94 2.61 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -136.09 177.28 19.67 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.78 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -108.54 139.99 42.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.709 -0.877 . . . . 0.0 109.785 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -121.4 125.68 47.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.43 -0.794 . . . . 0.0 111.394 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.1 tp -119.94 135.08 55.04 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.422 ' HD2' ' CD1' ' A' ' 40' ' ' ILE . 24.8 ttpt -138.91 144.98 39.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.489 -1.382 . . . . 0.0 111.754 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -110.34 145.18 37.93 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.6 ttm-85 -128.74 146.72 50.81 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.186 -0.946 . . . . 0.0 111.78 -178.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -136.21 133.86 37.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.736 -0.603 . . . . 0.0 109.412 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -141.06 153.91 45.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.154 -0.966 . . . . 0.0 110.131 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -111.16 135.65 51.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 0.0 110.0 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -58.55 -24.97 61.95 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.582 -0.699 . . . . 0.0 110.772 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -60.39 -42.07 95.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.293 -0.88 . . . . 0.0 110.994 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.3 m -143.75 169.68 9.92 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.198 -0.939 . . . . 0.0 110.567 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -83.26 45.36 1.84 Allowed 'Trans proline' 0 C--N 1.314 -1.24 0 O-C-N 123.604 1.318 . . . . 0.0 111.045 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.0 tp -92.02 125.27 36.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.262 -0.899 . . . . 0.0 110.043 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -133.71 134.4 7.44 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.57 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.41 131.8 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.422 ' CD1' ' HD2' ' A' ' 27' ' ' LYS . 33.0 pt -127.0 145.63 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.895 -1.128 . . . . 0.0 112.041 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.6 120.18 4.32 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.0 t -125.18 144.47 50.43 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.191 -1.182 . . . . 0.0 111.657 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -114.57 144.41 43.43 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.3 m -131.61 138.61 48.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.925 -1.11 . . . . 0.0 110.883 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.4 ' CE2' ' OE2' ' A' ' 47' ' ' GLU . 60.7 t80 -133.19 109.6 9.55 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.9 m -123.07 143.82 49.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.395 -0.816 . . . . 0.0 111.147 -178.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' OE2' ' CE2' ' A' ' 45' ' ' TYR . 93.9 mt-10 -137.82 165.34 26.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.406 -0.809 . . . . 0.0 110.316 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -70.68 145.41 50.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.539 -0.726 . . . . 0.0 109.719 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.5 m -58.57 148.9 27.11 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.336 -0.853 . . . . 0.0 110.449 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -129.59 157.28 42.52 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.536 -0.727 . . . . 0.0 110.225 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.1 p -106.24 161.56 14.42 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.428 -0.795 . . . . 0.0 109.954 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.23 -35.49 77.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.427 -0.796 . . . . 0.0 110.192 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.9 p -63.47 -26.08 68.56 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.432 -0.792 . . . . 0.0 110.17 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.5 m -62.65 155.8 25.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.43 -0.794 . . . . 0.0 110.403 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.72 -162.19 17.54 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -95.54 10.17 37.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.539 -0.977 . . . . 0.0 110.642 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -85.38 145.52 27.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 0.0 110.308 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -113.64 119.74 38.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.394 -0.817 . . . . 0.0 109.852 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -53.3 -91.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.32 -0.862 . . . . 0.0 110.689 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -113.36 162.03 16.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.812 -1.18 . . . . 0.0 110.854 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -122.76 154.15 38.55 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.513 -0.742 . . . . 0.0 110.0 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -120.38 100.82 7.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.249 -0.907 . . . . 0.0 111.011 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -102.81 142.56 33.74 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.77 158.06 27.66 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 118.63 -1.748 . . . . 0.0 111.173 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.3 pt -121.79 137.17 56.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 65.3 p -150.21 139.59 21.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 110.919 -179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.29 155.09 24.21 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.0 175.25 42.86 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.414 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.21 165.73 31.51 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.93 1.489 . . . . 0.0 110.538 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.65 140.68 26.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.487 -0.758 . . . . 0.0 110.079 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -123.66 143.75 50.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.543 -0.723 . . . . 0.0 109.978 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -96.6 125.7 41.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.542 -0.724 . . . . 0.0 110.962 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 78.5 mt -127.6 115.95 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 53.6 -178.72 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.506 -0.746 . . . . 0.0 109.951 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.44 ' OD1' ' CE3' ' A' ' 76' ' ' TRP . 53.1 p30 -91.43 10.37 27.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.289 -0.882 . . . . 0.0 111.284 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.44 ' CE3' ' OD1' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -140.85 22.86 2.28 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.092 -1.005 . . . . 0.0 111.102 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -150.04 122.25 8.35 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.089 -1.007 . . . . 0.0 111.332 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.2 m -134.93 147.33 49.76 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.591 -0.693 . . . . 0.0 109.573 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.464 HD12 HG22 ' A' ' 79' ' ' ILE . 43.5 pt -129.8 138.72 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.01 -1.056 . . . . 0.0 110.607 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 40.6 p90 -147.47 167.91 23.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.448 -0.782 . . . . 0.0 111.202 -179.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.83 164.95 21.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.7 m -135.87 135.48 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -1.112 . . . . 0.0 110.7 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.5 p -141.05 147.83 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 159.18 -149.94 20.16 Favored Glycine 0 N--CA 1.477 1.426 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.442 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.411 HG13 ' CD1' ' A' ' 107' ' ' PHE . 34.1 m -135.5 -172.72 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.527 1.156 . . . . 0.0 113.272 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.09 152.18 23.04 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -123.82 133.8 53.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -1.166 . . . . 0.0 109.916 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -116.2 113.23 2.78 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -101.39 116.76 33.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.622 -0.928 . . . . 0.0 109.492 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -123.48 148.74 45.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.663 -0.648 . . . . 0.0 110.353 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 51.27 45.04 28.48 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.39 -0.819 . . . . 0.0 110.784 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.1 m -80.7 130.3 35.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.298 -0.876 . . . . 0.0 110.195 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 15.0 t -140.2 152.86 46.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.443 -0.786 . . . . 0.0 110.507 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.68 -31.43 72.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.455 -0.778 . . . . 0.0 110.181 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -81.53 164.03 51.42 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.464 -0.773 . . . . 0.0 110.265 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.26 145.76 61.09 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.6 1.316 . . . . 0.0 110.449 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.8 p -101.91 16.57 25.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.457 -0.777 . . . . 0.0 110.667 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 59.1 17.71 5.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.351 -0.843 . . . . 0.0 111.017 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -119.71 144.82 47.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.18 -0.95 . . . . 0.0 109.891 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -56.9 -44.33 82.25 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.256 -0.902 . . . . 0.0 110.224 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -176.47 150.87 0.91 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.441 -0.787 . . . . 0.0 110.488 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 45.7 m -139.04 122.53 17.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.283 -0.886 . . . . 0.0 109.996 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.5 t -154.75 135.42 13.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.296 -0.877 . . . . 0.0 110.685 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -120.85 116.11 24.55 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.408 -0.808 . . . . 0.0 109.177 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 48.5 p90 -136.17 170.78 15.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.075 -1.016 . . . . 0.0 111.778 -178.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -157.56 -178.0 31.2 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.411 ' CD1' HG13 ' A' ' 85' ' ' VAL . 99.4 m-85 -108.25 152.41 24.65 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.033 -1.275 . . . . 0.0 110.876 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -125.51 153.9 42.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.414 -0.804 . . . . 0.0 110.515 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 64.1 t80 -154.83 146.75 23.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.465 -0.772 . . . . 0.0 109.868 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 169.03 -178.23 42.39 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.841 179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -165.16 165.88 19.45 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.695 -0.885 . . . . 0.0 108.915 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -155.94 -173.74 24.91 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -136.8 155.44 49.82 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.352 -1.087 . . . . 0.0 110.072 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.4 tt0 -115.73 141.87 47.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.178 -0.951 . . . . 0.0 109.564 179.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -146.12 150.02 35.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.41 -0.806 . . . . 0.0 110.438 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.432 ' HB2' ' HA ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER 175.66 138.43 0.19 Allowed Pre-proline 0 N--CA 1.503 2.178 0 O-C-N 121.65 -0.656 . . . . 0.0 111.553 179.413 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -88.69 48.09 1.26 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.576 1.303 . . . . 0.0 109.168 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.433 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 86.5 mtp -147.15 137.01 23.13 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.459 -0.776 . . . . 0.0 108.945 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.43 -38.19 89.14 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.778 -0.576 . . . . 0.0 112.43 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -109.26 7.81 25.44 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.67 -1.269 . . . . 0.0 112.66 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.433 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 60.8 t -122.45 138.69 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.739 -1.226 . . . . 0.0 110.063 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.432 ' HA ' ' HB2' ' A' ' 116' ' ' ASN . . . -146.45 139.18 25.34 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.386 -0.926 . . . . 0.0 112.338 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.8 tp -122.13 135.58 54.81 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 53.0 p30 -139.06 153.8 48.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.458 -1.401 . . . . 0.0 112.167 -179.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -124.44 138.94 54.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.804 -0.56 . . . . 0.0 109.616 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.1 p -146.2 157.22 43.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.843 . . . . 0.0 110.191 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -133.82 143.1 48.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.519 -0.738 . . . . 0.0 110.342 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -150.98 143.86 24.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.509 -0.744 . . . . 0.0 110.164 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -113.78 146.61 39.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.403 -0.811 . . . . 0.0 109.97 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.5 t -129.18 139.61 51.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.44 -0.787 . . . . 0.0 110.246 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.3 ttp85 -127.98 127.89 44.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.475 -0.766 . . . . 0.0 109.837 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 89.5 mt -119.15 56.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.668 -0.645 . . . . 0.0 109.56 -179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 17.6 ttm180 66.05 -57.26 0.35 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.884 -0.51 . . . . 0.0 111.647 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.07 -7.32 11.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.085 -1.009 . . . . 0.0 111.401 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.9 t -119.64 130.82 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.967 -1.083 . . . . 0.0 110.653 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -133.44 114.01 13.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.561 -0.712 . . . . 0.0 109.242 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.5 m -124.65 149.3 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 110.506 -179.21 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.89 103.65 2.34 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.126 -1.989 . . . . 0.0 108.126 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 24.3 m -111.03 145.49 38.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.42 -1.047 . . . . 0.0 111.765 -178.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 60.2 p-90 -132.1 145.37 51.36 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.434 HG21 HD12 ' A' ' 141' ' ' ILE . 75.4 mt -117.35 131.11 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.252 -0.905 . . . . 0.0 110.175 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -149.27 145.54 27.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.44 -0.787 . . . . 0.0 110.185 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -177.09 -128.71 1.17 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.381 -1.39 . . . . 0.0 111.163 -179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.2 m -117.87 171.51 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.861 -0.788 . . . . 0.0 111.383 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -148.81 135.56 5.48 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -130.46 149.56 52.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.576 -0.956 . . . . 0.0 109.394 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -131.89 122.38 25.57 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.261 -0.899 . . . . 0.0 111.478 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.494 -0.754 . . . . 0.0 110.181 -179.986 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.936 0.398 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.7 t -128.08 144.85 51.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.903 . . . . 0.0 109.793 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 146' ' ' TYR . 26.9 m -136.01 136.31 40.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.873 . . . . 0.0 109.996 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -107.69 139.37 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.579 -0.701 . . . . 0.0 109.26 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 51.5 m -154.8 129.66 9.39 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.08 -1.012 . . . . 0.0 110.323 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -164.12 169.05 38.85 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.56 -130.4 1.34 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -127.3 158.24 37.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.45 -1.029 . . . . 0.0 109.763 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.79 116.5 16.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 111.066 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -113.75 142.36 46.15 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 59.1 p -153.63 154.6 34.5 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.695 -178.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.409 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 88.5 m-20 -93.85 153.15 18.42 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.59 119.16 17.0 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.775 -1.203 . . . . 0.0 111.878 -178.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -71.17 119.88 15.94 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.03 -15.25 44.09 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -115.79 156.44 26.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.603 -0.939 . . . . 0.0 109.138 178.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 65.6 mtt -96.24 -77.69 0.48 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.09 -1.006 . . . . 0.0 110.985 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -66.06 134.45 52.89 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.372 -0.83 . . . . 0.0 110.962 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -68.8 178.5 2.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.525 -0.734 . . . . 0.0 110.103 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.3 mtm -124.05 163.29 21.73 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.273 -0.892 . . . . 0.0 110.69 -179.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.94 125.68 2.02 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -143.0 -159.34 7.9 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.523 -178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 51.3 p90 -129.19 161.16 30.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.537 -0.978 . . . . 0.0 110.047 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.433 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 45.5 t-20 -141.34 132.26 26.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.46 -0.775 . . . . 0.0 111.359 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.0 tp -118.62 141.15 48.87 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 47.3 mttt -134.86 146.72 49.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.403 -1.436 . . . . 0.0 111.26 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -115.91 138.97 50.68 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 53.2 ttt-85 -129.5 143.04 50.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.202 -0.936 . . . . 0.0 111.817 -178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -134.15 133.0 40.5 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -142.99 149.99 39.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.169 -0.957 . . . . 0.0 110.48 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -104.18 132.57 50.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.337 -0.852 . . . . 0.0 109.462 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -57.23 -24.48 54.93 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.391 -0.818 . . . . 0.0 111.013 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -60.02 -40.0 87.77 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.324 -0.86 . . . . 0.0 110.964 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.6 m -141.38 169.52 11.19 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.209 -0.932 . . . . 0.0 110.702 -179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -84.52 41.97 1.08 Allowed 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.637 1.335 . . . . 0.0 111.142 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -87.77 98.97 11.75 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.941 . . . . 0.0 110.11 179.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -107.98 131.66 10.71 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.78 129.36 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.558 -0.966 . . . . 0.0 108.721 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.452 ' CD1' ' CD1' ' A' ' 80' ' ' TYR . 77.8 mt -123.55 142.57 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.101 -0.999 . . . . 0.0 111.339 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.431 ' O ' ' HA ' ' A' ' 27' ' ' LYS . . . -109.46 145.45 16.76 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 107.086 -2.406 . . . . 0.0 107.086 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.401 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 34.7 t -139.71 142.46 36.86 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 118.969 1.384 . . . . 0.0 112.174 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -123.42 137.83 54.72 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.6 m -132.03 140.07 48.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.823 -1.173 . . . . 0.0 111.074 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 75.6 t80 -134.33 110.28 9.37 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.2 m -119.48 146.5 45.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.525 -0.734 . . . . 0.0 110.276 -178.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -124.6 158.96 31.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.114 -0.991 . . . . 0.0 110.416 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.8 pttt -127.43 150.3 49.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.549 -0.72 . . . . 0.0 110.485 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.1 t -123.04 139.66 53.84 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.436 -0.79 . . . . 0.0 110.154 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 47.0 mtm105 -128.36 152.21 48.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.432 -0.793 . . . . 0.0 110.335 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.5 m 51.52 46.11 27.01 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.449 -0.782 . . . . 0.0 110.767 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 51.23 -156.22 0.13 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.476 -0.765 . . . . 0.0 110.831 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.6 t 55.1 173.43 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.38 -0.825 . . . . 0.0 110.574 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 84.8 p -142.22 161.01 39.11 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.393 -0.817 . . . . 0.0 110.201 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.46 49.59 19.02 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -60.06 147.85 37.8 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.354 -1.086 . . . . 0.0 110.296 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -62.0 -26.69 68.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.518 -0.739 . . . . 0.0 110.336 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -59.16 -39.03 81.2 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.304 -0.873 . . . . 0.0 109.998 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 44.5 mttt 54.32 53.28 11.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.522 -0.736 . . . . 0.0 110.733 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -84.49 133.96 34.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.472 -0.768 . . . . 0.0 109.637 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -122.89 155.84 35.87 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.386 -0.821 . . . . 0.0 110.427 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -114.08 126.91 55.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.346 -0.846 . . . . 0.0 110.88 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.499 ' CD2' ' CE1' ' A' ' 87' ' ' TYR . 97.8 m-85 -110.38 137.06 48.6 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.802 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.28 115.02 0.74 Allowed Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.411 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 76.5 mt -104.53 136.14 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.47 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 3.3 p -151.23 139.33 20.12 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.291 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.94 151.6 33.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.08 165.14 37.54 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.34 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -74.07 172.7 15.43 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.858 1.451 . . . . 0.0 110.741 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.43 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . . . -144.34 138.91 28.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.587 -0.696 . . . . 0.0 109.675 179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -120.79 135.86 55.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.439 -0.788 . . . . 0.0 110.779 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.1 ttp85 -108.89 87.85 2.59 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.024 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 42.7 pt -95.19 -31.04 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.426 -0.796 . . . . 0.0 109.526 179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -132.89 128.83 37.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.654 -0.654 . . . . 0.0 109.504 179.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -58.01 -34.23 69.81 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.213 -0.929 . . . . 0.0 110.154 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -59.28 -36.02 74.79 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.648 -0.658 . . . . 0.0 111.434 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.19 155.14 42.49 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.996 -1.065 . . . . 0.0 111.82 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 49.7 m -126.75 161.48 28.06 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.697 -0.627 . . . . 0.0 109.526 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.3 mt -118.01 136.67 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.002 -1.061 . . . . 0.0 110.222 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.452 ' CD1' ' CD1' ' A' ' 40' ' ' ILE . 85.7 m-85 -132.58 154.16 50.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.685 -0.634 . . . . 0.0 110.284 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.13 163.06 21.11 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.1 m -136.32 132.06 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.094 -1.239 . . . . 0.0 111.281 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.47 ' O ' ' HA ' ' A' ' 66' ' ' THR . 59.5 t -140.74 145.31 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 160.87 -149.02 17.77 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 119.346 -1.407 . . . . 0.0 110.848 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.3 m -127.21 158.19 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.315 1.055 . . . . 0.0 112.977 -177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.421 ' HA2' ' O ' ' A' ' 63' ' ' TYR . . . -140.57 130.69 4.67 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.499 ' CE1' ' CD2' ' A' ' 63' ' ' TYR . 43.6 p90 -151.89 164.2 37.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.002 -1.293 . . . . 0.0 111.242 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.32 154.58 20.4 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -129.03 139.63 51.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.825 -0.809 . . . . 0.0 110.332 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -115.08 154.14 29.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.787 -0.571 . . . . 0.0 110.132 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -117.54 103.47 10.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.378 -0.826 . . . . 0.0 110.116 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 70.7 p -131.57 157.82 42.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.445 -0.784 . . . . 0.0 110.265 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 94' ' ' GLU . 70.6 p -128.3 159.85 34.0 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.447 -0.783 . . . . 0.0 110.317 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.408 ' O ' ' O ' ' A' ' 93' ' ' THR . 77.9 mm-40 55.5 114.09 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.435 0.636 . . . . 0.0 111.177 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.7 m-85 -119.12 98.89 50.89 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.198 -0.939 . . . . 0.0 110.217 179.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -77.22 -64.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.43 1.226 . . . . 0.0 110.322 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.2 t -145.69 143.43 29.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.284 -0.885 . . . . 0.0 110.023 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 46.05 -168.89 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.544 -0.722 . . . . 0.0 111.18 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.0 mttm 56.27 51.46 11.61 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.466 -0.771 . . . . 0.0 110.477 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -54.97 -30.68 59.62 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.415 -0.803 . . . . 0.0 110.603 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 55.16 46.53 23.71 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.402 -0.811 . . . . 0.0 110.305 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -94.89 -176.35 3.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.597 -0.69 . . . . 0.0 110.179 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.0 m -103.17 157.12 17.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.536 -0.727 . . . . 0.0 109.832 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -134.96 141.25 46.21 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.317 -0.864 . . . . 0.0 110.018 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.471 ' CD2' ' CB ' ' A' ' 87' ' ' TYR . 85.9 m-85 -114.85 162.52 16.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.172 -0.955 . . . . 0.0 111.042 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -160.94 -176.86 33.51 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -116.02 156.78 25.71 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.017 -1.284 . . . . 0.0 111.398 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.9 m -124.58 154.9 39.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.53 -0.731 . . . . 0.0 110.417 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -153.06 145.19 23.83 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.421 -0.799 . . . . 0.0 109.907 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 171.47 -177.59 44.25 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.908 179.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.28 163.47 13.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.653 -0.91 . . . . 0.0 108.949 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -157.33 -172.05 24.07 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.58 -1.295 . . . . 0.0 109.93 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 19.6 tp -130.74 152.44 50.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.467 -1.019 . . . . 0.0 109.673 179.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -118.52 149.39 41.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.998 -1.064 . . . . 0.0 109.771 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -115.36 154.96 28.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.51 -0.744 . . . . 0.0 109.705 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -113.94 64.09 1.2 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.844 . . . . 0.0 111.279 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.69 -14.26 36.05 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.436 1.23 . . . . 0.0 109.904 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.429 ' HB2' ' CG2' ' A' ' 121' ' ' VAL . 64.9 mtt -145.4 139.87 27.24 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -60.92 -38.69 86.65 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.69 -0.631 . . . . 0.0 112.209 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 46.2 p-10 -94.94 -3.73 48.08 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.777 -1.202 . . . . 0.0 112.745 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.46 HG13 ' CE1' ' A' ' 146' ' ' TYR . 30.1 m -150.42 121.46 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 120.809 -1.182 . . . . 0.0 111.604 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -117.78 154.66 31.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.502 -0.749 . . . . 0.0 109.249 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.0 mt -113.3 144.45 42.71 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.114 -0.991 . . . . 0.0 109.776 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 48.7 p30 -138.79 151.04 46.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.139 -0.975 . . . . 0.0 111.267 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -133.01 141.64 48.39 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.2 p -145.91 164.44 31.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.238 -0.914 . . . . 0.0 111.159 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -112.42 127.87 56.15 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -127.47 132.13 50.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.239 -0.913 . . . . 0.0 111.262 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -123.28 127.04 47.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.607 -0.683 . . . . 0.0 109.282 178.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.6 t -130.35 143.73 50.95 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.198 -0.939 . . . . 0.0 110.742 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 65.2 mtm180 -124.04 129.68 51.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.591 -0.693 . . . . 0.0 109.718 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.427 HD11 HG22 ' A' ' 132' ' ' ILE . 17.3 mm -114.74 63.1 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 66.42 -59.96 0.33 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.562 -0.711 . . . . 0.0 111.224 -179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 51.6 p -124.38 6.66 8.36 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.062 -1.024 . . . . 0.0 111.394 -179.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.1 t -125.87 133.34 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.124 -0.985 . . . . 0.0 110.646 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -131.44 112.27 12.53 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.409 ' CG1' ' O ' ' A' ' 13' ' ' ASP . 55.5 t -119.18 146.28 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.151 -0.968 . . . . 0.0 110.742 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -109.5 107.34 2.35 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.0 m -109.78 139.58 44.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.328 -1.101 . . . . 0.0 112.02 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -111.49 142.16 44.12 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.7 mm -112.65 129.6 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.115 -0.991 . . . . 0.0 110.659 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -137.96 128.61 26.7 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.52 -0.738 . . . . 0.0 109.027 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -164.73 -158.04 10.05 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 118.715 -1.707 . . . . 0.0 112.13 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 8.9 p -110.82 170.02 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 122.211 -0.582 . . . . 0.0 110.221 -179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -142.15 134.95 6.38 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.932 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.46 ' CE1' HG13 ' A' ' 121' ' ' VAL . 83.3 m-85 -122.86 138.5 54.63 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.3 ttt-85 -126.74 121.21 31.36 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.936 -1.103 . . . . 0.0 111.108 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 55.8 t80 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.51 -0.744 . . . . 0.0 110.224 -179.883 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 70.0 p . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.9 p -109.19 152.31 25.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 0.0 109.531 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.8 m -135.34 138.66 43.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 110.52 179.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.7 t -115.76 136.52 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.548 -0.72 . . . . 0.0 109.333 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 85.2 m -154.01 129.59 9.96 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.272 -0.892 . . . . 0.0 110.247 179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -165.48 172.5 41.03 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.65 -132.14 1.64 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -143.55 161.94 37.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.485 -1.009 . . . . 0.0 109.688 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.03 136.03 28.0 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.679 -1.208 . . . . 0.0 112.131 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -107.32 125.53 51.29 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.5 m -126.94 148.55 50.05 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.808 -177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.422 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 52.5 t0 -95.55 152.22 18.62 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 137' ' ' VAL . . . -135.83 122.95 21.56 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.697 -1.201 . . . . 0.0 111.837 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -73.31 116.4 13.81 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.3 -30.87 8.94 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -115.07 99.02 7.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.644 -0.915 . . . . 0.0 109.052 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 65.1 mtt -62.33 -40.22 95.67 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.411 -0.806 . . . . 0.0 111.146 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -57.77 119.83 7.35 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.264 -0.898 . . . . 0.0 111.228 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -71.41 162.43 29.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.617 -0.677 . . . . 0.0 109.704 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 66.7 mtm -127.19 157.66 39.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.205 -0.935 . . . . 0.0 111.463 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.429 ' N ' HG22 ' A' ' 46' ' ' THR . . . -142.39 124.08 2.33 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -137.84 -174.41 13.36 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.501 -178.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . 0.457 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . 99.2 m-85 -122.97 160.51 26.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.7 -0.882 . . . . 0.0 110.157 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.403 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 34.4 t-20 -140.8 131.71 26.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.543 -0.723 . . . . 0.0 111.101 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.39 132.85 54.09 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.462 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 74.6 mttt -131.3 145.4 51.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.639 -1.288 . . . . 0.0 111.595 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -116.24 132.19 56.73 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -125.16 138.85 54.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.104 -0.997 . . . . 0.0 112.149 -178.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -119.5 138.82 52.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -149.2 163.71 36.86 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.973 . . . . 0.0 110.858 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -113.07 130.16 56.26 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -58.12 -25.75 61.77 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.4 -0.813 . . . . 0.0 110.767 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -61.31 -38.0 85.26 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.406 -0.809 . . . . 0.0 111.091 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.8 p -134.38 166.69 27.35 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.22 -0.925 . . . . 0.0 110.774 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -87.17 33.25 0.43 Allowed 'Trans proline' 0 C--N 1.316 -1.157 0 O-C-N 123.719 1.379 . . . . 0.0 111.085 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.0 mt -88.87 139.45 30.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.251 -0.906 . . . . 0.0 109.817 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -148.56 140.3 8.19 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.538 -1.315 . . . . 0.0 111.039 -179.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.68 129.71 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.1 tt -129.13 143.58 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.977 -1.077 . . . . 0.0 111.322 -178.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.8 135.67 12.95 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.462 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 61.1 p -130.26 142.71 50.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.125 -1.221 . . . . 0.0 111.759 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -126.22 135.34 51.47 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.9 t -135.77 148.31 48.73 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.645 -1.222 . . . . 0.0 111.498 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.457 ' CE1' ' HB2' ' A' ' 24' ' ' PHE . 42.7 p90 -141.88 111.43 6.56 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 22' ' ' GLY . 73.4 m -121.97 137.02 54.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 110.672 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 85.5 tt0 -155.63 164.33 38.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.585 -0.697 . . . . 0.0 109.566 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.4 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 29.2 tttp -68.69 143.16 54.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.865 . . . . 0.0 109.795 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.2 t -82.97 141.92 31.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.36 -0.838 . . . . 0.0 110.519 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -125.04 159.07 32.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.534 -0.728 . . . . 0.0 110.252 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.5 p -75.47 164.45 26.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.392 -0.817 . . . . 0.0 109.813 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.13 96.73 0.84 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.417 -0.802 . . . . 0.0 110.202 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.4 m -126.31 152.08 46.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.632 -0.668 . . . . 0.0 110.16 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.7 m -56.79 -33.45 66.67 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.325 -0.859 . . . . 0.0 110.132 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -101.13 102.53 2.43 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -58.27 -40.74 82.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.448 -1.031 . . . . 0.0 110.623 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.0 t80 48.07 92.64 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.516 -0.74 . . . . 0.0 110.922 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -107.82 111.93 24.32 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.256 -0.902 . . . . 0.0 110.73 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -72.52 -100.37 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.332 -0.855 . . . . 0.0 109.951 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -103.23 143.03 33.17 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.669 -1.269 . . . . 0.0 110.571 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -119.04 149.18 42.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.478 -0.764 . . . . 0.0 109.682 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 71.9 t80 -112.89 90.17 3.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.431 -0.793 . . . . 0.0 110.589 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -116.92 141.35 48.35 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.48 168.58 38.19 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.027 -2.035 . . . . 0.0 112.298 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.431 HD13 HG22 ' A' ' 65' ' ' ILE . 49.8 pt -105.68 140.55 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 114.48 -0.86 . . . . 0.0 109.246 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -150.87 141.55 22.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 110.619 -179.809 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.94 154.55 29.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 108.946 179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.46 163.61 37.05 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.493 -1.336 . . . . 0.0 110.276 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.38 173.06 14.41 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.91 1.479 . . . . 0.0 110.679 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.437 ' HB2' ' CE1' ' A' ' 80' ' ' TYR . . . -141.11 136.5 31.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.811 -0.556 . . . . 0.0 109.617 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 93.8 m-85 -126.28 145.78 50.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.698 -0.626 . . . . 0.0 110.67 -179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -98.13 87.89 4.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.492 -0.755 . . . . 0.0 109.554 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.3 tt -66.65 -33.83 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.459 -0.776 . . . . 0.0 110.847 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -155.61 172.95 17.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.465 -0.772 . . . . 0.0 110.145 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 -65.69 146.89 54.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.511 -0.743 . . . . 0.0 109.975 179.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.8 m-90 53.35 23.4 3.27 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.384 -0.823 . . . . 0.0 110.883 -179.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.5 129.51 18.5 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.0 110.194 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m -139.34 155.07 47.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.335 -0.853 . . . . 0.0 110.565 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.409 ' CG2' ' CD2' ' A' ' 113' ' ' LEU . 50.6 pt -121.14 144.35 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.331 -0.856 . . . . 0.0 109.716 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 70' ' ' ALA . 93.6 m-85 -132.41 154.44 49.83 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.328 -0.857 . . . . 0.0 111.169 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.87 162.66 17.81 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.137 -1.985 . . . . 0.0 108.137 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.2 m -142.66 132.63 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.96 -1.318 . . . . 0.0 111.683 -179.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 66' ' ' THR . 33.0 m -142.99 150.66 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 158.12 -151.06 22.16 Favored Glycine 0 N--CA 1.479 1.553 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.049 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 12.4 p -129.59 144.62 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.488 1.137 . . . . 0.0 113.502 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.41 149.62 19.19 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.41 ' CE2' ' HB2' ' A' ' 89' ' ' LYS . 66.4 t80 -126.67 129.47 48.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.002 -1.293 . . . . 0.0 111.577 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -109.56 113.51 3.67 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 107.934 -2.066 . . . . 0.0 107.934 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.41 ' HB2' ' CE2' ' A' ' 87' ' ' TYR . 36.3 tttp -111.68 126.26 54.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.493 -1.004 . . . . 0.0 111.609 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -115.23 135.41 54.19 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 59.0 105.66 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.273 -0.892 . . . . 0.0 110.226 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 9.6 t -56.36 -39.44 72.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.454 -0.779 . . . . 0.0 110.896 -179.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 42.1 m -72.44 130.86 41.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.376 -0.828 . . . . 0.0 110.279 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -125.71 155.32 41.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.516 -0.74 . . . . 0.0 110.073 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -83.58 146.0 49.07 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.417 -0.802 . . . . 0.0 109.918 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.442 ' O ' ' CD2' ' A' ' 98' ' ' TYR . 44.1 Cg_endo -70.55 128.65 15.59 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.539 1.284 . . . . 0.0 110.531 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.4 p 43.29 25.34 0.06 Allowed 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.708 -0.62 . . . . 0.0 112.298 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.442 ' CD2' ' O ' ' A' ' 96' ' ' PRO . 21.3 m-85 -135.63 144.99 46.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.112 -0.993 . . . . 0.0 110.46 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.3 mttt 56.19 46.8 20.68 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.562 -0.711 . . . . 0.0 110.58 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -57.3 -21.43 34.76 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.464 -0.772 . . . . 0.0 110.708 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -83.62 17.98 2.06 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.293 -0.879 . . . . 0.0 111.896 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.6 m -60.99 -33.74 73.71 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.962 -1.086 . . . . 0.0 109.804 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.7 p -116.3 160.29 20.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.633 -0.667 . . . . 0.0 109.59 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 47.6 t0 -134.84 154.23 51.72 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.309 -0.869 . . . . 0.0 110.44 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -112.03 156.69 21.78 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.376 -0.827 . . . . 0.0 110.601 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -144.25 161.54 27.91 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -97.63 145.8 25.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.927 -1.337 . . . . 0.0 110.937 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.0 t -122.46 148.65 44.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.482 -0.761 . . . . 0.0 110.3 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 66.6 t80 -154.01 145.67 23.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.494 -0.754 . . . . 0.0 109.661 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 171.84 -178.9 43.85 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.906 179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -167.2 163.7 15.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.818 -0.813 . . . . 0.0 108.812 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -156.06 -173.32 24.5 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.409 ' CD2' ' CG2' ' A' ' 79' ' ' ILE . 76.3 mt -128.44 152.85 47.75 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.373 -1.075 . . . . 0.0 109.278 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -119.53 140.97 49.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.818 -1.176 . . . . 0.0 109.971 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -117.35 161.1 20.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.508 -0.745 . . . . 0.0 110.061 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.96 86.59 42.1 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.464 -0.773 . . . . 0.0 110.459 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.4 -7.39 20.81 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.664 1.35 . . . . 0.0 111.535 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.529 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 80.0 mtp -149.95 175.66 11.47 Favored 'General case' 0 C--N 1.311 -1.077 0 O-C-N 121.056 -1.027 . . . . 0.0 108.452 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.88 -39.7 95.27 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.807 -0.558 . . . . 0.0 110.993 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -121.99 18.16 10.9 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.201 -0.937 . . . . 0.0 112.2 -178.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.529 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 21.3 t -118.46 139.38 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.933 -1.105 . . . . 0.0 109.729 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.34 137.48 32.4 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.736 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.445 ' N ' ' CD2' ' A' ' 123' ' ' LEU . 4.4 mm? -112.29 152.24 28.73 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -145.49 139.42 26.81 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.719 -1.238 . . . . 0.0 110.736 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -124.7 126.24 45.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 109.179 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -130.64 151.46 51.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.32 -0.863 . . . . 0.0 111.178 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -113.97 126.87 55.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.597 -0.689 . . . . 0.0 109.187 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -137.74 152.31 49.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.339 -0.85 . . . . 0.0 111.172 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -138.63 147.89 43.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 0.0 109.405 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 51.1 m -134.62 145.96 49.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.197 -0.939 . . . . 0.0 110.822 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -132.54 128.55 37.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.489 -0.757 . . . . 0.0 109.828 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 91.4 mt -119.8 59.26 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.47 -0.769 . . . . 0.0 109.709 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 93.2 mtt-85 64.65 -57.46 0.26 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.908 -0.495 . . . . 0.0 111.912 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 44.0 p -117.69 -3.29 11.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.959 -1.088 . . . . 0.0 111.539 -179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.4 t -124.72 131.44 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.025 -1.047 . . . . 0.0 110.457 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -131.53 111.52 11.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.345 -0.847 . . . . 0.0 109.16 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 59.0 t -119.29 145.88 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.93 . . . . 0.0 110.525 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -107.18 120.27 6.12 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 107.813 -2.115 . . . . 0.0 107.813 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 59.3 m -118.29 137.25 53.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.232 -1.158 . . . . 0.0 111.9 -178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -114.44 140.15 48.93 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.429 HD13 HG23 ' A' ' 141' ' ' ILE . 73.7 mt -113.66 133.1 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.103 -0.998 . . . . 0.0 110.903 -179.275 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.81 133.93 22.77 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -170.5 -146.0 4.97 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.041 -1.552 . . . . 0.0 111.503 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.8 m -117.32 177.03 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 122.113 -0.639 . . . . 0.0 111.142 -178.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -153.26 138.58 6.39 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -134.65 153.4 52.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.571 -0.958 . . . . 0.0 109.714 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -133.82 122.03 22.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.368 -0.833 . . . . 0.0 110.986 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 65.8 t80 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.474 -0.766 . . . . 0.0 110.216 -179.662 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 66.3 p . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.004 0.43 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.6 t -124.16 137.64 54.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.427 -0.796 . . . . 0.0 109.728 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 66.1 m -137.84 145.48 42.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.788 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.6 p -126.4 140.36 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.607 -0.683 . . . . 0.0 109.705 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 88.9 m -156.45 130.61 8.59 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.301 -0.875 . . . . 0.0 110.481 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -149.97 158.32 27.62 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 108.831 -1.707 . . . . 0.0 108.831 179.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.08 -168.26 27.98 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.651 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -123.55 153.79 40.13 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.654 -0.909 . . . . 0.0 109.501 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.33 154.23 41.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.073 -1.017 . . . . 0.0 111.484 -179.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -98.58 144.44 27.89 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.6 t -112.47 134.74 53.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.013 -1.055 . . . . 0.0 112.299 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -138.12 124.05 20.1 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.443 ' CB ' ' HA ' ' A' ' 137' ' ' VAL . . . -139.04 155.55 47.87 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 120.857 -1.152 . . . . 0.0 112.027 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -78.27 120.24 22.77 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.54 -29.24 10.72 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -113.75 97.77 6.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.607 -0.937 . . . . 0.0 109.247 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 70.6 mtm -67.43 -47.85 69.0 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.301 -0.875 . . . . 0.0 111.329 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -55.51 131.3 45.77 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.39 -0.819 . . . . 0.0 111.694 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -82.42 155.1 24.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.747 -0.595 . . . . 0.0 109.632 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 73.4 mtm -131.3 166.18 21.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.274 -0.891 . . . . 0.0 111.224 -179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 46' ' ' THR . . . -92.97 153.23 21.38 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.54 121.85 2.92 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.114 -1.517 . . . . 0.0 111.021 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -111.5 129.6 55.99 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -137.93 126.53 23.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.937 -1.102 . . . . 0.0 111.558 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 81.9 mt -123.5 129.7 51.6 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.9 pttt -136.27 148.18 47.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.81 -1.181 . . . . 0.0 112.281 -178.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -111.29 137.46 49.0 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.5 ttt180 -120.37 135.26 55.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 111.1 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -121.57 138.33 54.36 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -138.1 146.91 43.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.179 -0.951 . . . . 0.0 109.915 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -104.4 138.94 40.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 110.131 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -54.16 -27.34 33.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.621 -0.674 . . . . 0.0 111.76 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -60.82 -42.35 97.51 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.105 -0.997 . . . . 0.0 111.458 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.01 168.48 11.99 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.963 -1.085 . . . . 0.0 110.839 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -86.38 40.29 0.71 Allowed 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.714 1.376 . . . . 0.0 111.112 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 20.4 tp -111.18 76.48 0.98 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.176 -0.953 . . . . 0.0 110.15 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.76 177.19 26.65 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 120.051 -1.071 . . . . 0.0 110.445 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.0 t -131.61 140.15 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.673 -0.898 . . . . 0.0 108.982 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 41.3 pt -121.66 147.59 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.96 -1.087 . . . . 0.0 111.386 -179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.96 129.75 8.8 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.1 t -136.91 142.86 42.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.169 -1.195 . . . . 0.0 111.765 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -115.35 139.85 49.64 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.9 m -130.42 136.16 48.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.17 -0.956 . . . . 0.0 110.169 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -134.74 111.1 9.68 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.349 -0.844 . . . . 0.0 109.171 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 60.3 m -112.84 138.32 49.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.432 -0.793 . . . . 0.0 109.388 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -138.11 160.52 39.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.09 -1.006 . . . . 0.0 110.532 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -85.26 143.98 28.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 110.127 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.9 t -69.92 151.39 45.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.458 -0.776 . . . . 0.0 109.597 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -61.4 133.22 55.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.358 -0.839 . . . . 0.0 110.26 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 38.4 m -132.09 148.8 52.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.524 -0.735 . . . . 0.0 109.872 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.58 -29.21 67.79 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.346 -0.846 . . . . 0.0 110.157 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 29.9 t -125.78 142.59 51.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.551 -0.718 . . . . 0.0 110.504 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.9 m 49.52 25.75 1.49 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.539 -0.726 . . . . 0.0 111.427 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -125.57 -66.87 0.18 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -51.41 -32.91 28.13 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.457 -1.026 . . . . 0.0 111.148 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -119.03 161.17 20.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.287 -0.883 . . . . 0.0 111.07 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 54.3 t30 57.54 34.9 25.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.632 -0.667 . . . . 0.0 110.73 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -78.0 142.25 38.39 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.305 -0.872 . . . . 0.0 110.4 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -111.35 161.26 16.25 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.412 -0.805 . . . . 0.0 110.443 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -122.62 151.84 41.06 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.347 -0.845 . . . . 0.0 109.845 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -121.8 93.15 3.91 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.331 -0.856 . . . . 0.0 111.182 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -98.24 150.86 21.07 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.417 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -158.5 132.84 3.23 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 118.195 -1.955 . . . . 0.0 111.631 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 46.8 pt -98.54 138.56 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 9.5 t -153.22 147.57 25.86 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.576 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.0 151.15 34.05 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.24 165.79 36.77 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.513 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -75.76 170.49 20.07 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.798 1.42 . . . . 0.0 110.655 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.39 140.62 24.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.603 -0.685 . . . . 0.0 109.452 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -123.17 141.47 51.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.331 -0.856 . . . . 0.0 110.558 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -108.88 85.31 2.07 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.034 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 mm -72.98 -46.37 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.426 -0.796 . . . . 0.0 109.064 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -140.46 147.76 40.12 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -58.26 -34.09 70.12 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.152 -0.968 . . . . 0.0 110.196 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -60.71 -35.61 76.76 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.611 -0.681 . . . . 0.0 111.819 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -143.93 159.81 41.92 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.973 -1.079 . . . . 0.0 111.891 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 26.6 t -138.22 155.35 48.74 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.633 -0.667 . . . . 0.0 109.618 179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.7 tt -129.05 137.87 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.065 -1.022 . . . . 0.0 110.363 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -146.95 162.27 39.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.406 -0.809 . . . . 0.0 111.425 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.2 164.31 12.79 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.7 m -141.75 134.82 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -1.175 . . . . 0.0 111.53 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 66' ' ' THR . 7.2 p -138.76 148.34 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 178.65 -179.76 48.66 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.687 -179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.417 ' O ' ' HA2' ' A' ' 64' ' ' GLY . 57.0 t -118.64 142.02 35.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.335 0.588 . . . . 0.0 110.702 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.94 144.26 17.1 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -116.55 129.82 56.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.129 -1.219 . . . . 0.0 110.11 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -118.26 113.52 2.64 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -114.79 136.77 52.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.465 -1.021 . . . . 0.0 110.653 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -139.39 158.54 43.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.546 -0.721 . . . . 0.0 109.927 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -95.55 134.38 38.48 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.354 -0.841 . . . . 0.0 110.392 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -139.15 157.45 45.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.487 -0.758 . . . . 0.0 110.382 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.8 t -108.1 -1.26 20.55 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.472 -0.768 . . . . 0.0 110.911 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.29 -32.35 73.07 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.27 -0.893 . . . . 0.0 110.474 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -118.98 100.25 50.77 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.432 -0.793 . . . . 0.0 110.404 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.8 141.17 53.27 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.463 1.244 . . . . 0.0 110.259 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.7 p 47.1 -176.46 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.261 0.553 . . . . 0.0 111.218 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.419 ' CD2' ' O ' ' A' ' 98' ' ' TYR . 60.7 t80 46.9 66.08 1.08 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.457 -0.777 . . . . 0.0 110.888 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -65.89 -37.22 85.53 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.267 -0.895 . . . . 0.0 110.044 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.3 t30 56.78 18.35 3.73 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.503 -0.748 . . . . 0.0 111.084 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 47.34 42.88 14.6 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.24 -0.912 . . . . 0.0 111.31 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 7.2 t -68.78 111.84 5.13 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.215 -0.928 . . . . 0.0 110.657 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.2 p -142.16 160.72 39.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.402 -0.811 . . . . 0.0 110.314 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -93.2 143.22 26.47 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.472 -0.768 . . . . 0.0 109.93 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -113.08 154.78 26.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.329 -0.857 . . . . 0.0 110.11 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -143.46 153.51 24.9 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -96.58 139.54 32.51 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -1.15 . . . . 0.0 110.735 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.9 p -124.94 159.99 29.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.532 -0.73 . . . . 0.0 110.424 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 41.1 p90 -160.25 155.67 25.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.442 -0.786 . . . . 0.0 109.854 179.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 164.3 -169.77 39.24 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.497 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.77 165.15 20.92 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.602 -0.94 . . . . 0.0 108.905 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -152.75 -178.92 27.87 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.4 tp -139.54 147.37 41.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.371 -1.076 . . . . 0.0 110.22 -179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -99.11 141.72 31.52 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.087 -1.008 . . . . 0.0 109.157 179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -148.2 148.64 30.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.303 -0.873 . . . . 0.0 110.868 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.425 ' HB2' ' HA ' ' A' ' 122' ' ' ALA . 0.8 OUTLIER 170.72 134.7 0.07 OUTLIER Pre-proline 0 N--CA 1.506 2.327 0 O-C-N 121.764 -0.585 . . . . 0.0 111.306 178.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -88.03 47.11 1.29 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.541 1.285 . . . . 0.0 109.484 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 65.3 mtt -141.71 139.45 32.91 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.424 -0.797 . . . . 0.0 109.044 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.77 -47.04 79.61 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -104.13 5.5 35.1 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.822 -1.174 . . . . 0.0 112.703 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 59.3 t -118.77 136.45 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.769 -1.207 . . . . 0.0 109.935 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.425 ' HA ' ' HB2' ' A' ' 116' ' ' ASN . . . -142.92 139.49 30.76 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.406 -0.917 . . . . 0.0 112.308 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -109.32 153.36 24.02 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -145.9 140.24 26.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.76 -1.212 . . . . 0.0 110.648 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.417 ' HB2' ' CZ2' ' A' ' 140' ' ' TRP . 49.1 p90 -132.07 142.74 49.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 0.0 109.391 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 28.9 t -146.51 149.42 33.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.375 -0.828 . . . . 0.0 111.231 -179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -118.12 126.57 52.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.698 -0.626 . . . . 0.0 109.428 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -137.35 136.42 37.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.456 -0.777 . . . . 0.0 110.593 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -112.18 130.09 56.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.42 -0.8 . . . . 0.0 109.765 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.0 m -122.1 147.59 45.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.295 -0.878 . . . . 0.0 110.436 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 42.5 ptt85 -135.78 130.53 34.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.499 -0.751 . . . . 0.0 110.23 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 88.4 mt -119.17 67.22 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.567 -0.708 . . . . 0.0 109.707 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 41.4 ttm180 66.45 -60.74 0.32 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.672 -0.642 . . . . 0.0 111.388 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.2 p -124.65 5.73 8.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.067 -1.021 . . . . 0.0 111.69 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 51.2 t -126.52 133.35 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.934 -1.104 . . . . 0.0 110.798 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -132.22 115.87 16.23 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.443 ' HA ' ' CB ' ' A' ' 14' ' ' ALA . 32.0 t -110.76 145.51 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.131 -0.981 . . . . 0.0 111.121 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.84 117.85 2.58 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 107.684 -2.167 . . . . 0.0 107.684 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 10.2 t -134.14 151.96 51.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -1.184 . . . . 0.0 112.028 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.417 ' CZ2' ' HB2' ' A' ' 125' ' ' PHE . 60.5 t-105 -112.04 133.93 53.9 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.3 pt -115.91 147.17 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.068 -1.02 . . . . 0.0 111.319 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -147.49 136.92 22.61 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -162.96 -159.08 10.13 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 118.986 -1.578 . . . . 0.0 111.605 -178.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 9.3 p -104.57 166.99 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 122.065 -0.667 . . . . 0.0 110.654 -179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -154.32 138.97 6.46 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -132.18 153.99 50.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.543 -0.975 . . . . 0.0 109.765 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -125.29 121.17 33.23 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.307 -0.87 . . . . 0.0 111.101 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 73.6 t80 . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.495 -0.753 . . . . 0.0 110.13 179.894 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 120.965 0.412 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -126.28 147.63 49.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -0.879 . . . . 0.0 109.153 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 19.0 p -135.12 152.47 51.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.067 -1.021 . . . . 0.0 110.431 179.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -112.24 135.77 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 37.1 m -155.31 128.22 8.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 110.642 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.86 173.37 45.06 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.86 -137.52 3.42 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 45.5 p90 -143.26 160.02 41.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.485 -1.009 . . . . 0.0 109.888 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.58 145.34 30.07 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.626 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -113.49 144.87 42.1 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.4 p -146.47 153.63 40.65 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.607 -1.237 . . . . 0.0 112.617 -178.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -83.11 151.34 25.79 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -127.03 100.37 6.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.943 -1.098 . . . . 0.0 111.341 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -79.78 117.48 20.7 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.04 -13.21 58.95 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -107.68 178.04 4.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.118 -1.225 . . . . 0.0 110.294 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 94.3 mmm -57.75 -51.68 68.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.459 -0.776 . . . . 0.0 112.041 -178.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 19.7 t30 -169.82 -148.62 0.07 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.694 -1.254 . . . . 0.0 110.747 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mttt -81.06 154.3 26.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.076 -1.015 . . . . 0.0 110.761 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 62.5 mtt -129.94 167.59 17.98 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.416 -0.803 . . . . 0.0 110.662 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.449 ' O ' ' HA ' ' A' ' 46' ' ' THR . . . -98.12 158.97 20.66 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.251 -1.939 . . . . 0.0 108.251 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -147.08 121.29 1.38 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.275 -1.44 . . . . 0.0 110.757 -179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -108.52 134.92 50.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.644 -0.916 . . . . 0.0 109.127 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -139.02 129.38 25.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.157 -0.964 . . . . 0.0 112.112 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.5 tp -121.85 127.59 50.69 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 21.3 mttt -129.24 144.66 51.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.656 -1.277 . . . . 0.0 111.748 -177.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -112.24 140.69 46.74 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -123.54 137.76 54.7 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.095 -1.003 . . . . 0.0 111.938 -178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -122.04 138.25 54.51 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -141.33 150.02 41.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.135 -0.978 . . . . 0.0 110.401 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -106.19 135.94 46.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 0.0 109.683 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -62.1 -22.85 66.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.581 -0.699 . . . . 0.0 110.646 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -61.16 -43.3 99.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.344 -0.847 . . . . 0.0 111.041 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.3 m -140.88 170.31 9.72 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.17 -0.956 . . . . 0.0 110.617 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -83.86 41.39 1.03 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.608 1.32 . . . . 0.0 111.022 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.5 tt -91.3 119.56 31.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.359 -0.838 . . . . 0.0 110.043 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -127.35 135.46 8.79 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.885 -1.15 . . . . 0.0 110.485 -179.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -131.21 135.86 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.421 HD13 ' CD1' ' A' ' 80' ' ' TYR . 72.9 mt -125.32 141.92 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.922 -1.111 . . . . 0.0 111.455 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.81 141.07 15.15 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 106.998 -2.441 . . . . 0.0 106.998 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.416 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 42.7 t -137.53 141.18 41.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.886 -1.361 . . . . 0.0 112.649 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -122.97 134.13 54.35 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.8 m -131.03 136.93 48.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.031 . . . . 0.0 110.693 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -129.94 110.42 11.67 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 96.9 m -115.03 140.01 49.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.369 -0.832 . . . . 0.0 109.588 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -141.15 163.85 31.84 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.104 -0.997 . . . . 0.0 110.446 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 21.4 tttm -73.6 134.98 43.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.485 -0.759 . . . . 0.0 109.932 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.5 p -79.43 145.52 33.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.416 -0.803 . . . . 0.0 109.934 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -144.74 161.79 38.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.403 -0.811 . . . . 0.0 110.049 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 41.7 m -56.64 -38.63 72.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.348 -0.845 . . . . 0.0 109.837 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 50.81 28.25 3.55 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.437 -0.789 . . . . 0.0 111.118 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 86.7 p -60.43 -36.56 78.47 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.291 -0.881 . . . . 0.0 109.868 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 97.7 p -80.99 -24.69 37.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.457 -0.777 . . . . 0.0 110.184 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.42 178.57 37.96 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -90.17 125.07 35.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.582 -0.952 . . . . 0.0 110.349 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -111.91 139.17 47.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.374 -0.829 . . . . 0.0 110.366 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -123.25 41.86 3.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.479 -0.763 . . . . 0.0 110.322 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -46.33 -75.58 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.634 -0.666 . . . . 0.0 111.11 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -106.67 146.13 31.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.223 -0.923 . . . . 0.0 110.477 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -143.9 165.04 28.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.408 -0.808 . . . . 0.0 110.475 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.426 ' HB2' ' HB ' ' A' ' 46' ' ' THR . 50.9 m-85 -113.81 114.12 25.86 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.703 0.763 . . . . 0.0 111.22 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -98.08 145.17 26.81 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -150.54 128.79 2.73 Favored Glycine 0 N--CA 1.485 1.904 0 C-N-CA 118.502 -1.808 . . . . 0.0 110.932 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 78.2 mt -99.1 134.77 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.533 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 61.4 m -152.03 142.1 22.21 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.512 -1.275 . . . . 0.0 112.216 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.87 148.84 34.4 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -157.15 160.38 30.4 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.593 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.41 165.09 31.4 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.875 1.461 . . . . 0.0 110.646 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -141.97 137.42 31.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.489 -0.757 . . . . 0.0 109.823 179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -125.23 143.48 50.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.582 -0.698 . . . . 0.0 110.927 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.4 ttt-85 -109.83 119.87 40.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.644 -0.66 . . . . 0.0 109.605 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.2 mm -99.52 -88.09 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.285 -0.885 . . . . 0.0 110.865 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -153.11 173.73 15.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.071 -1.018 . . . . 0.0 110.47 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 53.05 44.27 30.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.451 -0.781 . . . . 0.0 110.887 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 95.9 m95 50.7 24.93 1.86 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.421 -0.8 . . . . 0.0 110.92 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.99 129.89 36.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.291 -0.881 . . . . 0.0 109.896 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.4 m -124.41 151.31 44.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.425 -0.797 . . . . 0.0 110.634 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.418 HD12 HG22 ' A' ' 79' ' ' ILE . 76.7 mt -119.46 136.85 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 109.176 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.421 ' CD1' HD13 ' A' ' 40' ' ' ILE . 38.6 m-85 -129.26 148.69 51.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.85 . . . . 0.0 111.145 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.28 159.28 19.84 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' A' ' 109' ' ' TYR . 27.0 m -143.77 134.66 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.326 . . . . 0.0 112.164 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.533 ' O ' ' HA ' ' A' ' 66' ' ' THR . 61.9 t -134.85 144.63 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 178.78 -176.9 48.27 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 118.326 -1.892 . . . . 0.0 111.522 -179.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.458 ' CG1' ' CZ ' ' A' ' 87' ' ' TYR . 52.8 t -121.9 144.27 31.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-O 121.652 0.739 . . . . 0.0 110.583 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . -99.14 135.84 12.36 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.458 ' CZ ' ' CG1' ' A' ' 85' ' ' VAL . 88.5 m-85 -127.86 132.13 49.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.067 -1.255 . . . . 0.0 110.189 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.79 127.95 6.72 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 27.8 pttt -133.37 150.91 51.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.416 -1.049 . . . . 0.0 110.488 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -146.71 -179.12 6.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.634 -0.666 . . . . 0.0 110.205 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 54.99 169.88 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.52 -0.737 . . . . 0.0 110.904 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.6 t -128.02 170.03 13.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.285 -0.884 . . . . 0.0 110.395 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 2.1 m 56.91 179.14 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.411 -0.805 . . . . 0.0 110.192 -179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 53.15 48.87 21.23 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.298 -0.876 . . . . 0.0 110.407 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -65.75 126.62 92.04 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.48 -0.762 . . . . 0.0 110.373 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.81 164.41 35.65 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.551 1.29 . . . . 0.0 110.517 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.0 t -57.47 -172.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.41 -0.806 . . . . 0.0 110.24 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -56.04 -43.81 78.19 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.284 -0.885 . . . . 0.0 110.444 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.8 tptp -53.27 -32.95 51.12 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.323 -0.86 . . . . 0.0 110.76 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 55.64 53.52 9.48 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.395 -0.815 . . . . 0.0 110.845 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -53.24 -35.99 60.58 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.171 -0.956 . . . . 0.0 110.106 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 51.6 m -59.28 -24.6 63.38 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.539 -0.725 . . . . 0.0 110.333 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.5 p -92.35 165.05 13.27 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.434 -0.791 . . . . 0.0 110.083 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -133.21 135.31 44.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.489 -0.757 . . . . 0.0 109.458 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 45.9 p90 -134.96 170.16 16.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.083 -1.011 . . . . 0.0 111.871 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -154.18 178.03 31.26 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -99.11 142.15 30.96 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.115 -1.227 . . . . 0.0 110.862 -179.079 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.1 m -121.65 150.55 41.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.446 -0.784 . . . . 0.0 110.159 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.433 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 43.2 p90 -158.34 152.98 24.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.393 -0.817 . . . . 0.0 110.037 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 169.67 -176.63 43.5 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.584 -1.294 . . . . 0.0 110.65 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.99 163.46 11.37 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.681 -0.894 . . . . 0.0 109.091 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -159.71 -171.4 25.52 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.45 155.83 49.9 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.302 -1.116 . . . . 0.0 110.141 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 124' ' ' ASP . 40.8 tt0 -120.63 142.55 49.32 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.163 -0.961 . . . . 0.0 110.228 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -118.56 160.82 21.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.552 -0.718 . . . . 0.0 109.586 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -118.05 72.1 8.79 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.223 -0.923 . . . . 0.0 111.349 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.44 ' HD2' ' HA ' ' A' ' 122' ' ' ALA . 44.8 Cg_endo -72.51 -12.29 26.97 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.582 1.306 . . . . 0.0 110.064 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.429 ' HB2' ' CG1' ' A' ' 121' ' ' VAL . 88.0 mtp -142.89 144.15 32.34 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.29 -51.57 69.36 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -90.59 3.03 55.24 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.768 -1.207 . . . . 0.0 113.04 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 118' ' ' MET . 8.8 p -152.78 119.44 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 120.714 -1.241 . . . . 0.0 111.348 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.44 ' HA ' ' HD2' ' A' ' 117' ' ' PRO . . . -110.75 167.45 10.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.904 . . . . 0.0 109.934 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 23.4 tp -112.91 149.74 32.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.251 -0.906 . . . . 0.0 109.338 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 52.6 t0 -137.05 139.75 41.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.041 -1.037 . . . . 0.0 109.534 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -133.87 132.16 40.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 0.0 109.092 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.7 p -145.47 164.72 30.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.17 -0.956 . . . . 0.0 111.058 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -114.31 132.63 56.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.595 -0.69 . . . . 0.0 109.429 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -133.17 135.24 45.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.298 -0.877 . . . . 0.0 110.817 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -130.18 147.99 51.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 109.742 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.1 t -139.1 141.09 38.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.338 -0.851 . . . . 0.0 110.495 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.1 mtm180 -129.11 129.19 44.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.366 -0.834 . . . . 0.0 109.868 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.484 ' HB ' ' CG2' ' A' ' 135' ' ' VAL . 83.5 mt -125.48 54.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.534 -0.729 . . . . 0.0 109.671 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 74.2 mtp180 61.52 -55.99 0.11 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 132' ' ' ILE . 0.4 OUTLIER -105.47 -14.7 15.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.98 -1.075 . . . . 0.0 111.617 -178.429 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.484 ' CG2' ' HB ' ' A' ' 132' ' ' ILE . 32.8 m -137.17 140.21 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 118.396 -1.322 . . . . 0.0 112.111 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -133.71 119.09 18.88 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 63.9 t -112.77 146.39 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.077 -1.014 . . . . 0.0 110.758 -178.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -117.12 123.8 5.92 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 107.312 -2.315 . . . . 0.0 107.312 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.9 t -126.19 152.55 45.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.065 -1.256 . . . . 0.0 112.469 -177.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.436 ' N ' ' CD1' ' A' ' 140' ' ' TRP . 56.4 m95 -111.69 137.45 49.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 76.7 mt -115.08 134.78 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.01 -1.056 . . . . 0.0 111.463 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.58 128.74 16.67 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -159.42 -157.98 8.87 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 118.985 -1.578 . . . . 0.0 111.789 -178.661 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 6' ' ' THR . 7.2 p -111.45 163.13 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 122.135 -0.627 . . . . 0.0 110.555 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -140.54 131.44 5.0 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -129.38 145.64 51.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.465 -1.021 . . . . 0.0 109.893 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -127.81 119.89 26.66 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.395 -0.816 . . . . 0.0 111.046 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.3 t80 . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.461 -0.774 . . . . 0.0 110.085 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.6 p . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.14 0.495 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.1 p -112.49 161.12 17.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.436 -0.79 . . . . 0.0 109.17 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 36.6 m -136.43 139.99 42.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.119 -0.988 . . . . 0.0 110.59 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 13.3 p -126.38 142.84 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.423 HG22 ' CA ' ' A' ' 145' ' ' GLY . 29.4 p -152.17 138.75 18.7 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 25' ' ' ASN . . . -134.24 155.27 21.79 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.95 -163.32 28.43 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -137.35 161.44 36.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.652 -0.911 . . . . 0.0 109.356 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.06 153.69 41.01 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.644 -1.223 . . . . 0.0 112.145 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -112.5 137.77 50.23 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.4 m -121.23 145.54 47.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.991 -1.068 . . . . 0.0 112.633 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -130.2 139.39 50.84 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.426 ' CB ' ' CG2' ' A' ' 137' ' ' VAL . . . -145.9 148.32 32.69 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.774 -1.204 . . . . 0.0 112.11 -177.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -78.93 123.56 27.38 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.09 -24.07 25.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.694 -1.763 . . . . 0.0 108.694 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.405 ' NE2' ' CG1' ' A' ' 135' ' ' VAL . 48.4 mt-30 -112.75 141.03 47.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.337 -1.096 . . . . 0.0 109.492 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.0 mtm -98.02 -67.17 0.86 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.29 -0.881 . . . . 0.0 110.572 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 -49.03 122.92 6.36 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.521 -0.737 . . . . 0.0 112.088 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -75.83 164.44 26.23 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.533 -0.729 . . . . 0.0 109.932 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 68.3 mtm -121.02 146.8 46.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.287 -0.883 . . . . 0.0 111.58 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -142.94 124.71 2.41 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -151.36 -160.06 9.24 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.124 -1.512 . . . . 0.0 110.883 -178.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -121.31 154.59 36.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.744 -0.856 . . . . 0.0 110.064 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.41 ' O ' ' HA2' ' A' ' 7' ' ' GLY . 57.7 t30 -134.73 130.84 36.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.451 -0.781 . . . . 0.0 111.515 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.7 mt -111.87 155.13 24.13 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' CG ' ' CG2' ' A' ' 40' ' ' ILE . 17.4 ttpt -148.81 132.6 16.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.642 -1.286 . . . . 0.0 110.209 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -133.93 136.7 44.42 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.43 ' CB ' HG12 ' A' ' 40' ' ' ILE . 36.8 ptt180 -142.81 150.78 40.41 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.792 -1.163 . . . . 0.0 112.581 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -116.96 138.11 51.77 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -139.45 145.88 39.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.282 -0.886 . . . . 0.0 109.862 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -98.62 131.43 44.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.933 . . . . 0.0 109.652 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -53.4 -24.25 11.92 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.543 -0.723 . . . . 0.0 111.657 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -60.35 -44.37 95.63 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.164 -0.96 . . . . 0.0 110.897 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.4 m -140.77 161.84 52.03 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.118 -0.989 . . . . 0.0 110.851 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -87.87 34.59 0.41 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.747 1.393 . . . . 0.0 111.146 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.0 mt -108.64 73.13 0.85 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.242 -0.911 . . . . 0.0 110.137 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.83 -179.01 33.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -130.23 144.39 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.623 -0.928 . . . . 0.0 108.948 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.431 ' CG2' ' CG ' ' A' ' 27' ' ' LYS . 62.5 mt -118.38 143.62 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.965 -1.085 . . . . 0.0 110.876 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -124.25 122.64 4.87 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 76.6 p -139.38 144.98 38.41 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.147 -1.208 . . . . 0.0 111.451 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.85 148.25 44.28 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.53 -0.731 . . . . 0.0 109.948 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.9 m -129.73 138.72 51.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.244 -0.91 . . . . 0.0 110.376 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -137.57 110.91 7.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 108.933 178.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.3 p -122.54 160.34 25.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.489 -0.757 . . . . 0.0 110.457 -179.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -127.4 165.84 19.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.468 -0.77 . . . . 0.0 110.411 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -73.29 147.55 44.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.706 -0.621 . . . . 0.0 110.487 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.5 p -64.77 158.13 25.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.508 -0.745 . . . . 0.0 109.959 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 -146.68 165.5 29.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.363 -0.836 . . . . 0.0 110.767 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.3 p -105.21 171.89 7.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.49 -0.756 . . . . 0.0 110.2 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.07 -32.22 67.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.481 -0.762 . . . . 0.0 110.48 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.5 m -62.19 157.49 19.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.354 -0.841 . . . . 0.0 109.802 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.0 m -57.41 -43.33 83.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.354 -0.841 . . . . 0.0 110.354 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 48.29 -104.89 0.1 OUTLIER Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 53.97 40.86 32.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.639 -0.918 . . . . 0.0 111.014 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -63.15 -42.49 99.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.299 -0.875 . . . . 0.0 109.656 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -168.63 83.14 0.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.587 -0.696 . . . . 0.0 109.154 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -70.74 127.24 31.97 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.406 -0.809 . . . . 0.0 111.329 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -104.04 163.16 12.57 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -119.67 152.87 36.43 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.044 -1.035 . . . . 0.0 109.811 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -119.7 127.72 53.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.166 -0.959 . . . . 0.0 111.529 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.475 ' CB ' ' CZ ' ' A' ' 87' ' ' TYR . 97.8 m-85 -116.1 136.2 53.24 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.733 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.76 112.22 0.6 Allowed Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.552 -1.309 . . . . 0.0 110.183 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.453 HG23 HD12 ' A' ' 65' ' ' ILE . 77.8 mt -101.49 135.85 36.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.472 ' CG2' ' HB ' ' A' ' 82' ' ' VAL . 12.6 m -150.65 140.2 21.56 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.836 -1.146 . . . . 0.0 111.111 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.71 151.56 30.68 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -164.54 171.92 40.15 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.388 -1.386 . . . . 0.0 110.6 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.04 161.79 43.72 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.964 1.507 . . . . 0.0 110.995 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -140.47 137.28 33.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.672 -0.643 . . . . 0.0 109.577 179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -116.38 124.01 49.0 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.915 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -109.91 130.74 55.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.631 -0.668 . . . . 0.0 109.642 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 15.6 tt -170.26 -39.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.413 -0.804 . . . . 0.0 110.162 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -106.78 124.08 49.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.511 -0.743 . . . . 0.0 110.011 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.04 -31.92 69.28 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.451 -0.781 . . . . 0.0 110.13 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -54.12 -42.63 69.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.504 -0.748 . . . . 0.0 111.272 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -169.36 165.06 10.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.105 -0.997 . . . . 0.0 111.564 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 91.0 p -121.58 159.49 26.3 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.7 mt -124.87 136.29 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.922 -1.111 . . . . 0.0 110.551 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.5 p90 -145.65 158.92 43.79 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.912 179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -103.72 176.89 24.29 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.472 ' HB ' ' CG2' ' A' ' 66' ' ' THR . 34.9 m -147.89 131.36 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.32 -1.106 . . . . 0.0 110.545 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 66' ' ' THR . 11.2 p -145.87 151.42 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.29 -0.881 . . . . 0.0 109.89 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 160.88 -153.18 23.98 Favored Glycine 0 N--CA 1.481 1.655 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.452 179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.8 p -128.85 142.24 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 122.204 1.002 . . . . 0.0 112.861 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.98 126.52 6.02 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.475 ' CZ ' ' CB ' ' A' ' 63' ' ' TYR . 46.5 p90 -151.71 162.41 41.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.007 -1.29 . . . . 0.0 110.8 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.47 152.92 21.38 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -99.7 126.56 45.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.788 -0.831 . . . . 0.0 109.626 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -124.23 160.43 27.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.751 -0.593 . . . . 0.0 110.319 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 54.63 52.17 12.67 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.413 -0.805 . . . . 0.0 110.892 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.4 p -73.7 160.26 31.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.353 -0.842 . . . . 0.0 109.952 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 9.3 t -89.51 156.88 18.35 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.397 -0.814 . . . . 0.0 110.415 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.3 -31.85 72.51 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.545 -0.722 . . . . 0.0 110.276 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -90.4 152.71 45.8 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.82 . . . . 0.0 110.077 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.91 129.46 16.4 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.507 1.267 . . . . 0.0 110.604 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.0 p 41.88 38.61 1.05 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.755 -0.591 . . . . 0.0 111.784 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 72.5 t80 -59.0 -42.77 90.88 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.333 -0.855 . . . . 0.0 110.269 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -138.93 178.56 7.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.408 -0.807 . . . . 0.0 110.09 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -69.19 103.29 1.88 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.381 -0.824 . . . . 0.0 109.781 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -69.41 148.6 49.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.532 -0.73 . . . . 0.0 110.362 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.6 m -119.54 135.14 54.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.535 -0.728 . . . . 0.0 110.001 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.2 m -130.21 148.25 52.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.515 -0.741 . . . . 0.0 110.227 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -88.06 129.7 35.21 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.457 -0.777 . . . . 0.0 109.73 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.412 ' O ' ' CG1' ' A' ' 132' ' ' ILE . 43.2 p90 -127.04 169.73 13.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.279 -0.888 . . . . 0.0 110.602 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -156.12 177.19 33.3 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -96.2 137.4 35.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.327 -1.102 . . . . 0.0 110.054 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.7 m -114.89 154.55 28.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.584 -0.697 . . . . 0.0 110.985 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.416 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 37.3 p90 -158.03 154.09 27.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.687 -0.633 . . . . 0.0 109.656 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 159.68 -169.45 35.71 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.525 -1.321 . . . . 0.0 110.607 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.82 165.07 28.35 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.689 -0.889 . . . . 0.0 109.338 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -152.26 -177.05 25.55 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.442 ' CD1' ' CZ ' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -143.59 147.33 34.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.387 -1.066 . . . . 0.0 110.346 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.401 ' HA ' ' HA ' ' A' ' 124' ' ' ASP . 48.7 tt0 -114.15 148.85 36.57 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.229 -0.919 . . . . 0.0 110.697 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.442 ' CZ ' ' CD1' ' A' ' 113' ' ' LEU . 91.6 m-85 -117.99 164.13 15.55 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.653 -0.654 . . . . 0.0 110.213 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -118.81 80.94 18.21 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 0.0 110.32 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.34 -14.48 42.9 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.589 1.31 . . . . 0.0 111.341 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.524 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 79.9 mtp -148.93 -177.58 5.88 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.189 -0.944 . . . . 0.0 108.485 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -69.39 -41.62 76.21 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.748 -0.595 . . . . 0.0 110.948 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -118.08 12.57 13.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.093 -1.004 . . . . 0.0 111.928 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.524 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 20.4 t -114.03 137.18 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.92 -1.112 . . . . 0.0 109.94 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -137.7 135.59 36.59 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.45 -179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . 0.403 HD21 ' CE2' ' A' ' 125' ' ' PHE . 19.3 tp -110.78 147.01 35.35 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 65.2 t0 -144.68 143.7 30.86 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.483 -1.385 . . . . 0.0 111.206 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.403 ' CE2' HD21 ' A' ' 123' ' ' LEU . 98.7 m-85 -119.02 142.06 48.15 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.3 t -134.26 139.63 45.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.0 111.263 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -118.67 111.03 18.0 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -141.89 143.76 33.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.556 -0.715 . . . . 0.0 110.596 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -137.09 151.93 49.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.442 -0.786 . . . . 0.0 109.761 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.0 t -126.52 138.65 53.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.834 . . . . 0.0 110.367 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 76.5 mtp180 -136.78 137.57 39.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.402 -0.811 . . . . 0.0 111.151 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.492 ' O ' ' N ' ' A' ' 134' ' ' SER . 6.7 tp -134.23 63.59 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.908 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 69.5 mtp85 59.91 -59.59 0.06 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 132' ' ' ILE . 56.5 p -95.49 -18.63 20.5 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.112 -0.992 . . . . 0.0 111.793 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.405 ' CG1' ' NE2' ' A' ' 17' ' ' GLN . 47.4 t -128.85 134.26 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 118.682 -1.207 . . . . 0.0 111.729 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -131.32 112.28 12.61 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.426 ' CG2' ' CB ' ' A' ' 14' ' ' ALA . 21.4 t -117.18 145.28 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.957 -1.089 . . . . 0.0 110.195 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -130.11 114.09 1.59 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.5 t -139.07 154.22 48.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.255 -1.144 . . . . 0.0 111.453 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 43.9 p90 -126.24 146.83 49.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.605 -0.685 . . . . 0.0 109.8 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 72.6 mt -112.4 141.42 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.329 -0.857 . . . . 0.0 110.666 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.79 145.23 31.56 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.437 -0.789 . . . . 0.0 109.895 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -177.2 -139.38 3.27 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.203 -1.475 . . . . 0.0 111.715 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.7 m -114.25 176.78 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 122.035 -0.685 . . . . 0.0 110.838 -178.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.423 ' CA ' HG22 ' A' ' 6' ' ' THR . . . -162.42 144.56 9.78 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.33 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -129.8 157.39 42.35 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.842 -0.799 . . . . 0.0 109.263 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 32.1 mtp-105 -123.26 122.94 39.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.091 -1.006 . . . . 0.0 111.244 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 67.7 t80 . . . . . 0 N--CA 1.498 1.944 0 O-C-N 121.461 -0.774 . . . . 0.0 110.514 -179.898 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 65.3 p . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.2 m -119.8 144.21 47.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -0.866 . . . . 0.0 109.418 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.6 m -136.98 142.37 42.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.579 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.4 m -123.0 141.48 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.822 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 87.6 m -156.37 130.38 8.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.562 -0.711 . . . . 0.0 109.593 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -164.27 176.23 40.23 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.322 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.73 -125.94 1.05 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -147.06 162.0 39.69 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.478 -1.013 . . . . 0.0 109.528 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.29 142.8 30.67 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.59 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -125.07 143.9 50.68 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -147.47 149.23 32.27 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.266 -178.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.414 ' O ' ' CG1' ' A' ' 137' ' ' VAL . 52.7 t0 -74.98 148.87 39.56 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.406 ' CB ' ' HB2' ' A' ' 17' ' ' GLN . . . -125.15 100.52 6.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.804 -1.185 . . . . 0.0 111.578 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -79.58 115.06 18.98 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.51 -15.89 45.32 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.406 ' HB2' ' CB ' ' A' ' 14' ' ' ALA . 89.9 mt-30 -106.08 171.87 7.11 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.104 -1.233 . . . . 0.0 109.825 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 89.3 mtp -56.52 -49.84 73.57 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.332 -0.855 . . . . 0.0 111.659 -178.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 47.4 p-10 -162.43 -155.7 0.37 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.698 -1.251 . . . . 0.0 110.435 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -84.25 166.92 17.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.334 -0.854 . . . . 0.0 111.005 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.6 mtt -126.03 167.9 14.69 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.442 -0.787 . . . . 0.0 110.918 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.46 128.44 2.93 Favored Glycine 0 N--CA 1.502 3.049 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.392 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -145.92 -167.29 12.49 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.295 -1.431 . . . . 0.0 111.033 -178.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -122.13 161.73 22.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.855 -0.791 . . . . 0.0 109.494 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.412 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 25.3 p-10 -148.61 135.66 20.08 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.227 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.4 mt -113.76 150.37 33.51 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.415 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 80.2 mttt -136.46 142.08 43.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.508 -1.37 . . . . 0.0 110.511 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.46 123.82 44.98 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.439 ' CG ' HG12 ' A' ' 40' ' ' ILE . 45.9 ttp180 -123.17 143.56 49.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.147 -0.97 . . . . 0.0 112.123 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -112.81 133.69 54.69 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -142.77 153.86 43.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.396 -0.815 . . . . 0.0 109.912 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -98.21 -173.72 2.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 0.0 110.185 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.87 -38.24 90.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.605 -0.684 . . . . 0.0 110.411 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -98.28 18.42 16.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.432 -0.792 . . . . 0.0 111.217 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.9 m 34.46 56.02 1.91 Allowed Pre-proline 0 N--CA 1.505 2.315 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 179.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -87.96 -70.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 122.991 0.995 . . . . 0.0 109.913 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.5 119.81 33.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.534 -0.729 . . . . 0.0 110.004 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -121.89 134.75 10.04 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.7 t -130.48 132.86 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.336 -1.097 . . . . 0.0 108.921 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.439 HG12 ' CG ' ' A' ' 29' ' ' ARG . 72.4 mt -120.3 139.45 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.742 -1.224 . . . . 0.0 110.818 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -112.98 117.78 4.37 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 107.703 -2.159 . . . . 0.0 107.703 178.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.415 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 48.3 t -123.84 141.68 51.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.144 -1.21 . . . . 0.0 112.503 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.05 142.18 49.08 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.5 m -130.91 139.14 50.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.004 -1.06 . . . . 0.0 110.902 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -136.69 110.65 8.24 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 44.6 p -121.69 157.83 30.04 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.464 -0.773 . . . . 0.0 109.989 -179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -118.31 155.38 30.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -0.853 . . . . 0.0 110.237 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 18.1 tttt -93.02 135.43 34.19 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.2 t -109.72 140.67 43.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.332 -0.855 . . . . 0.0 110.655 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -125.26 140.39 52.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.629 -0.669 . . . . 0.0 109.875 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 81.1 p -66.68 -40.62 88.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.392 -0.817 . . . . 0.0 110.058 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.96 -32.86 69.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.486 -0.759 . . . . 0.0 110.216 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.8 m 52.78 21.29 1.87 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.475 -0.766 . . . . 0.0 111.099 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 82.5 p -81.28 -18.17 46.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.238 -0.914 . . . . 0.0 110.568 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -92.8 46.42 2.5 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -57.78 -40.44 79.86 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.301 -1.117 . . . . 0.0 109.944 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -70.28 -21.42 62.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.655 -0.653 . . . . 0.0 110.229 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -94.94 33.53 1.49 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.394 -0.816 . . . . 0.0 110.441 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.9 pttt -59.58 125.55 24.09 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.36 -0.837 . . . . 0.0 110.438 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -97.9 160.27 14.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.439 -0.788 . . . . 0.0 110.052 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -128.53 152.17 48.6 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.319 -0.863 . . . . 0.0 109.983 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -121.55 112.79 18.93 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.197 -0.94 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 49.0 t80 -98.42 140.3 32.89 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.07 117.7 0.95 Allowed Glycine 0 N--CA 1.486 2.01 0 C-N-CA 119.168 -1.491 . . . . 0.0 110.337 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 14.4 tt -112.03 134.97 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.514 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 70.9 m -151.7 141.68 22.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.812 -1.18 . . . . 0.0 111.712 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.422 ' HA ' ' O ' ' A' ' 40' ' ' ILE . . . -147.58 150.05 33.72 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.86 170.59 40.7 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.751 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.07 172.47 15.88 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 123.955 1.503 . . . . 0.0 110.741 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.62 141.55 24.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.482 -0.762 . . . . 0.0 109.741 179.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -127.19 146.17 50.5 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.611 -0.68 . . . . 0.0 110.77 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -106.0 131.65 53.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.518 -0.739 . . . . 0.0 109.927 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 79.4 mt -121.24 108.14 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.465 -0.772 . . . . 0.0 109.255 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.8 t30 53.86 42.22 31.8 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.599 -0.688 . . . . 0.0 110.072 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 77' ' ' ALA . 91.6 m-20 50.8 -175.22 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.502 -0.748 . . . . 0.0 110.788 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 99.0 m95 55.47 -84.79 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.755 -0.591 . . . . 0.0 111.389 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 75' ' ' ASP . . . -65.61 141.52 58.38 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.126 -0.984 . . . . 0.0 111.123 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.9 t -138.13 150.06 46.48 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.522 -0.736 . . . . 0.0 109.72 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.6 tt -133.55 138.04 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.999 -1.063 . . . . 0.0 109.973 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -147.89 158.15 43.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.158 -0.963 . . . . 0.0 111.635 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -107.08 161.01 13.92 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 107.919 -2.072 . . . . 0.0 107.919 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 35.0 m -142.58 146.81 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.093 -1.239 . . . . 0.0 111.96 -179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.514 ' O ' ' HA ' ' A' ' 66' ' ' THR . 26.8 m -138.15 152.26 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -179.85 177.5 48.12 Favored Glycine 0 N--CA 1.479 1.548 0 C-N-CA 118.876 -1.63 . . . . 0.0 110.734 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.442 ' CG1' ' CZ ' ' A' ' 87' ' ' TYR . 48.7 t -122.3 135.78 61.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-O 121.738 0.78 . . . . 0.0 111.002 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . -103.4 133.97 11.67 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.442 ' CZ ' ' CG1' ' A' ' 85' ' ' VAL . 91.5 m-85 -117.09 146.1 43.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.153 -1.204 . . . . 0.0 110.47 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.32 116.84 3.26 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -103.2 113.01 26.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.516 -0.991 . . . . 0.0 109.963 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -125.09 157.1 37.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.826 -0.546 . . . . 0.0 110.069 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -72.55 142.77 48.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.353 -0.842 . . . . 0.0 109.642 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.3 t -132.06 164.42 26.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.355 -0.841 . . . . 0.0 110.767 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 43.5 m -55.4 -34.17 64.15 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.547 -0.72 . . . . 0.0 110.355 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 57.34 107.04 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.677 -0.639 . . . . 0.0 110.83 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -61.31 147.18 87.75 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.386 -0.822 . . . . 0.0 109.981 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.13 -20.66 37.52 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.513 1.27 . . . . 0.0 110.974 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 49.5 m -124.41 143.71 50.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.283 -0.886 . . . . 0.0 110.854 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.414 ' CD2' ' O ' ' A' ' 98' ' ' TYR . 55.9 t80 51.49 64.59 1.78 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.512 -0.742 . . . . 0.0 111.105 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -67.31 134.28 51.26 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.333 -0.855 . . . . 0.0 110.542 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.404 ' OD1' ' CE2' ' A' ' 98' ' ' TYR . 84.5 m-20 -111.35 120.43 42.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.458 -0.776 . . . . 0.0 109.88 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -89.5 111.15 21.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.4 -0.812 . . . . 0.0 110.621 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.8 t -141.16 153.71 45.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.42 -0.8 . . . . 0.0 110.505 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.2 m -130.01 147.97 51.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.434 -0.791 . . . . 0.0 110.192 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -80.13 125.2 29.51 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.299 -0.876 . . . . 0.0 109.781 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.443 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 38.6 p90 -132.04 170.34 15.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 111.436 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.407 ' N ' HD12 ' A' ' 132' ' ' ILE . . . -160.03 -177.46 33.14 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -106.64 150.14 26.52 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.965 -1.315 . . . . 0.0 111.634 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 96.4 p -128.86 161.57 29.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.716 -0.615 . . . . 0.0 110.108 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -155.68 148.52 24.26 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.379 -0.825 . . . . 0.0 109.802 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 175.0 -175.36 47.07 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.468 -1.349 . . . . 0.0 110.827 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.67 159.51 9.99 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.609 -0.936 . . . . 0.0 109.022 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.48 -174.75 30.69 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.31 162.02 36.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.22 -1.165 . . . . 0.0 111.059 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -107.68 144.49 34.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.523 -0.735 . . . . 0.0 109.537 179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . 0.447 ' CZ ' ' CE2' ' A' ' 125' ' ' PHE . 46.2 p90 -152.23 151.85 31.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.457 -0.777 . . . . 0.0 110.302 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 115' ' ' PHE . 0.2 OUTLIER 166.75 142.34 0.05 OUTLIER Pre-proline 0 N--CA 1.509 2.493 0 O-C-N 121.776 -0.577 . . . . 0.0 111.013 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -88.51 47.96 1.29 Allowed 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.491 1.259 . . . . 0.0 109.155 177.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 95.6 mmm -142.26 135.25 28.63 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 121.401 -0.812 . . . . 0.0 108.94 -179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.08 -42.3 99.61 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.813 -0.554 . . . . 0.0 112.44 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -106.58 5.55 29.18 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.721 -1.237 . . . . 0.0 112.922 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 48.4 t -119.92 136.42 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.715 -1.241 . . . . 0.0 110.506 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -145.44 129.98 17.91 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.577 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 80.6 mt -111.95 150.67 30.2 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 54.1 p30 -148.76 156.1 41.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.653 -1.279 . . . . 0.0 112.42 -179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.447 ' CE2' ' CZ ' ' A' ' 115' ' ' PHE . 34.2 m-85 -123.64 141.41 52.04 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.545 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.2 m -138.98 147.75 42.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.382 -0.824 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -117.97 124.23 47.69 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -133.58 138.25 45.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.264 -0.898 . . . . 0.0 111.416 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -119.68 128.61 53.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.639 -0.663 . . . . 0.0 109.537 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.9 m -122.31 146.34 47.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.287 -0.883 . . . . 0.0 110.626 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -129.39 125.18 36.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.432 -0.793 . . . . 0.0 110.117 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.433 ' HB ' ' HB ' ' A' ' 135' ' ' VAL . 14.7 mm -113.87 63.44 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.9 ttt180 66.23 -60.04 0.32 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.406 -0.809 . . . . 0.0 111.349 -179.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -125.68 9.23 7.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.057 -1.027 . . . . 0.0 111.16 -179.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.433 ' HB ' ' HB ' ' A' ' 132' ' ' ILE . 43.9 t -124.77 132.88 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.182 -0.949 . . . . 0.0 110.678 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -131.54 111.78 12.06 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.414 ' CG1' ' O ' ' A' ' 13' ' ' ASP . 88.1 t -115.24 145.13 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 110.799 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -107.47 103.9 2.02 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 107.116 -2.394 . . . . 0.0 107.116 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 53.2 m -104.9 136.85 43.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -1.069 . . . . 0.0 112.105 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -114.22 134.34 54.99 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.435 HD12 HG23 ' A' ' 141' ' ' ILE . 75.1 mt -116.05 132.55 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 110.52 -179.362 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.0 143.06 31.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.479 -0.763 . . . . 0.0 109.425 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -174.77 -146.71 5.83 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 118.709 -1.71 . . . . 0.0 112.151 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.1 m -118.47 175.69 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.289 0.566 . . . . 0.0 111.075 -178.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -157.36 139.84 6.7 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -132.98 157.37 45.36 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.598 -0.942 . . . . 0.0 109.837 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -131.9 121.33 23.85 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.271 -0.893 . . . . 0.0 111.065 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.403 -0.81 . . . . 0.0 110.29 -179.874 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.4 p . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.9 p -112.44 145.82 39.49 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.36 -0.838 . . . . 0.0 109.68 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 91.8 m -136.98 139.18 41.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.857 . . . . 0.0 110.634 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.05 142.25 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.571 -0.705 . . . . 0.0 109.846 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 62.8 m -156.42 130.52 8.56 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.44 -0.788 . . . . 0.0 110.123 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.411 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -165.66 171.6 40.91 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.61 -136.36 2.3 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -132.76 158.54 42.16 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.549 -0.971 . . . . 0.0 109.108 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.39 142.3 29.22 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.286 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -111.54 145.8 38.45 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.8 t -146.35 151.22 37.14 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.411 -1.316 . . . . 0.0 112.914 -177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 86.5 m-20 -100.92 150.64 22.65 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.452 ' HA ' ' HA ' ' A' ' 137' ' ' VAL . . . -134.12 116.3 15.26 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.787 -1.196 . . . . 0.0 111.823 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -67.03 117.14 8.68 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.59 -14.18 38.82 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . 0.426 ' HB2' ' CB ' ' A' ' 14' ' ' ALA . 87.6 mt-30 -114.59 156.62 24.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.348 -1.09 . . . . 0.0 109.356 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 70.1 mtm -100.51 -75.52 0.58 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.206 -0.933 . . . . 0.0 111.613 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -57.46 132.04 51.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.366 -0.834 . . . . 0.0 111.553 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -63.6 169.07 4.17 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.663 . . . . 0.0 110.237 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 90.1 mtp -128.15 166.7 18.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.279 -0.888 . . . . 0.0 111.44 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.43 ' O ' ' HA ' ' A' ' 46' ' ' THR . . . -124.86 178.94 16.34 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 107.904 -2.079 . . . . 0.0 107.904 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.94 148.27 9.19 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 118.57 -1.776 . . . . 0.0 111.89 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -109.24 133.68 52.72 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.411 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 76.1 m-20 -120.85 128.4 52.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.201 -0.937 . . . . 0.0 111.852 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 25.0 tp -121.58 133.53 55.0 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 22.7 mttt -136.08 146.71 47.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.313 -1.492 . . . . 0.0 111.44 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -115.96 129.46 56.4 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 56.2 ttp180 -128.57 134.32 48.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.15 -0.969 . . . . 0.0 112.106 -178.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 99.4 m-85 -125.06 139.95 53.33 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.592 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -142.04 150.26 41.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.144 -0.973 . . . . 0.0 110.278 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -99.85 132.68 45.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.368 -0.833 . . . . 0.0 109.662 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -56.71 -24.15 47.32 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.481 -0.762 . . . . 0.0 111.226 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -60.61 -40.56 92.3 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.273 -0.892 . . . . 0.0 110.946 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -140.43 166.92 19.92 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.226 -0.921 . . . . 0.0 110.559 -179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -84.61 42.1 1.1 Allowed 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.722 1.38 . . . . 0.0 111.061 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.05 76.27 7.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.318 -0.864 . . . . 0.0 110.203 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.67 132.85 11.74 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 35.6 m -132.67 129.26 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.359 -1.083 . . . . 0.0 108.925 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.0 tt -132.11 144.75 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.893 . . . . 0.0 111.431 -178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.58 148.21 16.38 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.428 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 42.3 t -138.72 141.53 38.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.272 . . . . 0.0 111.891 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -125.49 138.31 53.98 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 t -134.62 145.78 48.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.974 -1.079 . . . . 0.0 111.216 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -127.99 111.38 13.48 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.43 ' HA ' ' O ' ' A' ' 22' ' ' GLY . 87.1 m -119.24 141.9 48.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.692 -0.63 . . . . 0.0 110.68 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -148.75 179.63 7.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.843 . . . . 0.0 110.075 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -72.93 154.74 40.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.437 -0.789 . . . . 0.0 109.99 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 m -57.74 156.93 7.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.455 -0.778 . . . . 0.0 110.448 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -55.62 148.82 15.15 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.456 -0.778 . . . . 0.0 110.69 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.4 p -114.88 168.71 9.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.499 -0.75 . . . . 0.0 110.098 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.67 -30.08 67.09 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.454 -0.779 . . . . 0.0 110.318 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -58.36 -35.73 72.4 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.433 -0.792 . . . . 0.0 110.243 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.5 p 47.33 40.84 11.36 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.583 -0.698 . . . . 0.0 111.156 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.51 178.29 51.52 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.412 ' OD1' ' CD2' ' A' ' 57' ' ' TYR . 53.3 p30 -90.67 11.15 23.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.456 -1.026 . . . . 0.0 111.104 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.412 ' CD2' ' OD1' ' A' ' 56' ' ' ASP . 34.5 m-85 -113.0 144.51 42.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.151 -0.968 . . . . 0.0 110.09 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -114.66 15.79 17.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.482 -0.762 . . . . 0.0 110.453 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.5 tttp 53.33 -88.72 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.439 -0.788 . . . . 0.0 110.989 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -105.07 143.1 33.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.918 -1.114 . . . . 0.0 110.468 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -121.4 154.77 36.07 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.479 -0.763 . . . . 0.0 109.538 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -110.33 118.41 36.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.217 -0.927 . . . . 0.0 110.748 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.403 ' CD2' ' CE2' ' A' ' 87' ' ' TYR . 46.6 t80 -98.44 139.66 33.85 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.73 122.27 1.4 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 118.969 -1.586 . . . . 0.0 110.987 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 43.7 pt -112.85 138.0 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.531 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 1.3 p -153.57 144.29 22.62 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.584 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -151.26 153.59 35.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.473 -0.767 . . . . 0.0 109.27 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.85 174.15 43.43 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.536 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.8 167.69 25.88 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.891 1.469 . . . . 0.0 110.846 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.51 141.7 25.04 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.412 -0.805 . . . . 0.0 110.404 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -120.5 131.56 54.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.503 -0.748 . . . . 0.0 110.503 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -111.32 143.69 41.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.657 -0.652 . . . . 0.0 110.391 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 80.4 mt 54.07 22.88 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.397 -0.814 . . . . 0.0 110.639 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -89.67 116.32 27.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.154 -0.966 . . . . 0.0 110.086 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 51.62 -92.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.575 -0.703 . . . . 0.0 110.638 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -130.31 139.73 50.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.804 -1.185 . . . . 0.0 110.407 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 48.76 -166.91 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.384 -0.822 . . . . 0.0 111.139 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.445 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 24.6 m -115.5 146.14 41.97 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.357 -0.839 . . . . 0.0 109.364 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.0 mt -131.31 138.44 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.149 -0.969 . . . . 0.0 111.234 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -142.25 157.22 45.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.492 -0.755 . . . . 0.0 110.461 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.51 164.2 13.5 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 48.9 t -139.24 132.79 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -1.158 . . . . 0.0 111.086 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 66' ' ' THR . 26.7 m -141.89 151.95 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 164.24 -161.42 34.42 Favored Glycine 0 N--CA 1.48 1.572 0 C-N-CA 119.157 -1.497 . . . . 0.0 110.755 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.414 HG12 ' CD1' ' A' ' 107' ' ' PHE . 33.8 m -130.16 162.87 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 122.226 1.013 . . . . 0.0 112.651 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.07 137.84 7.9 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.403 ' CE2' ' CD2' ' A' ' 63' ' ' TYR . 13.9 p90 -150.82 163.94 37.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.081 -1.246 . . . . 0.0 110.701 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -119.36 141.28 15.61 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -134.01 140.9 47.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.826 -0.808 . . . . 0.0 109.942 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -99.64 131.98 45.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -0.876 . . . . 0.0 110.13 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -93.22 19.36 8.17 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.45 -0.781 . . . . 0.0 110.83 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.6 p -71.33 158.59 36.07 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.282 -0.886 . . . . 0.0 110.058 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 45.6 m -57.78 -40.03 78.87 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.441 -0.787 . . . . 0.0 110.451 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 86.3 tt0 56.14 164.72 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.553 -0.717 . . . . 0.0 110.675 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -58.03 166.49 2.0 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.279 -0.888 . . . . 0.0 110.221 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.67 -15.73 51.61 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.635 1.334 . . . . 0.0 110.583 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.1 t -128.62 155.54 44.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.362 -0.836 . . . . 0.0 109.721 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 98' ' ' TYR . 31.7 p90 -137.33 149.03 46.75 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.304 -0.872 . . . . 0.0 110.918 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -89.69 4.61 49.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.581 -0.699 . . . . 0.0 110.571 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 30.6 t30 59.13 36.24 23.98 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.26 -0.9 . . . . 0.0 110.276 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -131.67 3.56 4.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.489 -0.757 . . . . 0.0 110.843 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 74.9 p -78.03 -28.11 48.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.169 -0.957 . . . . 0.0 110.589 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.7 m -83.63 151.01 25.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.417 -0.802 . . . . 0.0 110.475 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -134.84 136.92 42.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.528 -0.733 . . . . 0.0 109.73 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 43.2 p90 -133.04 169.44 16.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.256 -0.902 . . . . 0.0 110.912 -179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -163.03 -175.75 34.38 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.414 ' CD1' HG12 ' A' ' 85' ' ' VAL . 98.8 m-85 -112.03 155.28 24.07 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.186 -1.185 . . . . 0.0 110.655 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 97.6 p -129.86 160.92 32.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.491 -0.755 . . . . 0.0 110.646 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . 0.407 ' CD1' HG12 ' A' ' 83' ' ' VAL . 65.7 t80 -155.26 148.03 24.35 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.439 -0.788 . . . . 0.0 109.673 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 175.82 -176.77 47.59 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.602 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.88 160.0 9.94 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.713 -0.875 . . . . 0.0 108.707 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -152.47 -179.1 27.77 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.445 ' HA ' ' O ' ' A' ' 78' ' ' SER . 5.3 mp -126.68 160.1 31.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.453 -1.027 . . . . 0.0 110.002 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.403 ' NE2' ' HB1' ' A' ' 122' ' ' ALA . 36.5 tt0 -106.65 140.65 39.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.81 -1.181 . . . . 0.0 108.057 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -124.65 165.19 18.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.372 -0.83 . . . . 0.0 111.518 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.84 88.94 0.1 OUTLIER Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.865 -0.522 . . . . 0.0 109.927 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.96 125.49 12.63 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.734 1.386 . . . . 0.0 110.398 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.417 ' CB ' ' HB ' ' A' ' 121' ' ' VAL . 95.5 mmm -145.21 163.25 35.0 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.13 -49.08 77.31 Favored 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.688 -0.632 . . . . 0.0 110.401 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -134.17 25.26 3.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.274 -0.891 . . . . 0.0 111.349 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.417 ' HB ' ' CB ' ' A' ' 118' ' ' MET . 48.2 t -127.11 139.66 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.95 -1.094 . . . . 0.0 109.964 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.405 ' O ' ' HA ' ' A' ' 144' ' ' VAL . . . -154.81 137.7 15.41 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.785 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 77.7 mt -121.65 143.62 49.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -149.45 153.25 37.0 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 118.246 -1.381 . . . . 0.0 112.395 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.31 140.14 53.08 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.6 t -143.62 149.23 37.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -0.977 . . . . 0.0 111.181 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -104.9 123.41 47.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.637 -0.665 . . . . 0.0 109.368 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -137.36 142.84 41.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.634 -0.666 . . . . 0.0 110.481 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -138.5 156.88 47.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.52 -0.738 . . . . 0.0 109.765 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.2 t -133.33 143.53 49.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.385 -0.822 . . . . 0.0 110.53 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -124.59 127.73 47.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.563 -0.71 . . . . 0.0 109.761 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.45 ' O ' ' HB2' ' A' ' 133' ' ' ARG . 85.1 mt -121.17 39.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 68.5 mtt180 63.64 -55.13 0.21 Allowed 'General case' 0 N--CA 1.503 2.207 0 O-C-N 122.03 -0.419 . . . . 0.0 111.578 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 132' ' ' ILE . 66.5 p -99.93 -24.14 14.73 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.121 -0.987 . . . . 0.0 110.398 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 56.1 t -126.51 132.39 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.246 -0.909 . . . . 0.0 110.732 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -132.55 113.19 12.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 109.02 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 14' ' ' ALA . 61.3 t -117.54 146.4 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.937 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -115.78 114.62 3.17 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 27.8 m -109.03 140.56 42.39 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.209 -1.171 . . . . 0.0 112.322 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 41.6 m95 -109.01 136.75 48.03 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 46.4 pt -124.14 147.06 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.98 -1.075 . . . . 0.0 111.654 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -154.43 139.6 17.48 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -168.59 -153.21 8.12 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 118.695 -1.717 . . . . 0.0 112.072 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.405 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 34.5 m -116.97 177.64 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 122.236 -0.567 . . . . 0.0 110.738 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -156.4 140.21 7.06 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.485 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -130.34 152.31 49.88 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.578 -0.954 . . . . 0.0 109.654 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -128.04 120.68 27.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.206 -0.934 . . . . 0.0 110.81 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.5 t80 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.48 -0.763 . . . . 0.0 110.205 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.6 p . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.5 m -116.44 145.21 43.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.9 . . . . 0.0 109.453 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 57.9 m -136.21 142.0 44.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.895 . . . . 0.0 110.673 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.42 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 14.7 p -128.61 141.39 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.655 -0.653 . . . . 0.0 109.571 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.8 m -156.68 133.07 9.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.51 -0.744 . . . . 0.0 109.815 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -166.23 173.47 41.73 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.156 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.85 -128.23 1.19 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -118.35 152.77 35.17 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.406 -1.055 . . . . 0.0 109.866 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.02 116.52 22.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 110.688 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -110.62 142.71 42.11 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.407 ' HB2' ' CB ' ' A' ' 139' ' ' THR . 25.3 t -148.49 145.35 27.9 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.42 -178.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -73.3 150.86 41.6 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -127.94 90.52 3.11 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.959 -1.096 . . . . 0.0 112.046 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -80.91 116.09 20.71 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.87 -14.41 60.22 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -100.83 172.75 6.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.018 -1.283 . . . . 0.0 110.463 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 88.0 mtp -57.55 -49.39 76.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.432 -0.792 . . . . 0.0 112.11 -178.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -164.55 -158.26 0.41 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.771 -1.206 . . . . 0.0 110.655 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -77.68 159.98 28.78 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.437 -0.79 . . . . 0.0 110.304 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 85.9 mtp -126.75 163.98 22.35 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.26 -0.9 . . . . 0.0 111.083 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.96 126.02 2.42 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -142.75 -171.78 13.53 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.567 -1.302 . . . . 0.0 110.771 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.48 146.62 40.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.636 -0.92 . . . . 0.0 109.988 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.418 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 51.2 t-20 -130.85 127.85 39.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.831 . . . . 0.0 110.997 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -115.83 141.62 47.85 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.442 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 31.9 mttm -130.8 144.86 51.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.419 -1.425 . . . . 0.0 110.501 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -122.75 124.46 43.41 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.408 ' CG ' HG12 ' A' ' 40' ' ' ILE . 59.0 ttt180 -122.74 142.72 50.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.147 -0.971 . . . . 0.0 111.953 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -114.07 137.23 51.99 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -138.44 152.01 47.95 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.4 -0.813 . . . . 0.0 109.61 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -96.21 178.22 5.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.045 -1.034 . . . . 0.0 109.93 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.11 -37.0 78.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.385 -0.822 . . . . 0.0 110.425 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -90.97 12.16 20.53 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.431 -0.793 . . . . 0.0 111.338 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 13.4 p 38.79 51.81 3.3 Favored Pre-proline 0 N--CA 1.503 2.178 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -94.66 -66.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 122.882 0.938 . . . . 0.0 110.547 179.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.1 tp -94.48 120.35 34.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.843 -0.536 . . . . 0.0 110.909 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.49 134.19 9.57 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.4 t -130.8 135.13 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.341 -1.094 . . . . 0.0 109.044 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.408 HG12 ' CG ' ' A' ' 29' ' ' ARG . 73.5 mt -119.87 140.59 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.855 -1.153 . . . . 0.0 110.936 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.43 125.63 6.68 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 107.758 -2.137 . . . . 0.0 107.758 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.442 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 92.7 p -134.02 144.98 49.03 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.012 -1.287 . . . . 0.0 112.577 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -125.54 140.27 52.89 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 m -132.34 142.42 49.32 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.912 -1.117 . . . . 0.0 111.402 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -131.79 109.67 10.3 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 9.1 m -122.1 145.62 47.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.467 -0.771 . . . . 0.0 110.733 -178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -147.32 167.6 23.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.288 -0.882 . . . . 0.0 110.275 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -94.21 140.54 29.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.439 -0.788 . . . . 0.0 109.976 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.3 t -124.77 134.72 52.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.418 -0.801 . . . . 0.0 110.506 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 50.5 mtm-85 -144.1 159.39 42.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.496 -0.752 . . . . 0.0 110.055 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.1 m -114.54 133.33 55.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.415 -0.803 . . . . 0.0 110.077 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.96 157.59 36.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.44 -0.788 . . . . 0.0 110.195 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.3 p -62.07 -24.06 66.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.421 -0.8 . . . . 0.0 110.256 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.9 t -102.32 150.88 22.88 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.405 -0.81 . . . . 0.0 110.3 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.417 ' HA2' ' CE2' ' A' ' 57' ' ' TYR . . . -91.75 20.68 40.52 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -81.98 112.05 18.71 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.144 -1.209 . . . . 0.0 110.146 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.417 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 91.5 m-85 -126.53 150.89 48.52 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.471 -0.768 . . . . 0.0 110.64 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -59.03 -29.84 67.57 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.536 -0.727 . . . . 0.0 109.884 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 63.32 39.65 9.29 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.65 -0.657 . . . . 0.0 110.527 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -84.35 153.58 23.38 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.314 -0.866 . . . . 0.0 109.438 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -136.4 157.72 46.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.169 -0.957 . . . . 0.0 110.261 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -125.02 117.6 24.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.384 -0.822 . . . . 0.0 110.851 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -109.78 139.11 45.21 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.58 125.93 2.1 Favored Glycine 0 N--CA 1.485 1.957 0 C-N-CA 119.094 -1.527 . . . . 0.0 110.292 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 16.7 tt -108.43 137.59 39.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.487 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -151.41 140.19 20.84 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.018 -1.073 . . . . 0.0 111.126 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.4 ' HA ' ' O ' ' A' ' 40' ' ' ILE . . . -156.34 152.07 27.15 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.36 178.32 43.13 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.601 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.26 169.23 21.21 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 O-C-N 123.949 1.5 . . . . 0.0 110.638 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.93 145.89 21.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.586 -0.696 . . . . 0.0 110.028 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -120.99 141.18 50.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.655 -0.653 . . . . 0.0 109.948 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 -108.05 126.84 53.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.499 -0.75 . . . . 0.0 110.263 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.413 HD11 HG22 ' A' ' 73' ' ' ILE . 46.8 mm -124.43 115.16 43.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.3 t30 59.34 177.63 0.08 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.377 -0.827 . . . . 0.0 109.86 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -57.36 -36.69 71.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.412 -0.805 . . . . 0.0 111.198 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . 0.419 ' O ' ' CB ' ' A' ' 77' ' ' ALA . 11.3 m0 -119.18 175.43 5.8 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.246 -0.909 . . . . 0.0 110.885 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.419 ' CB ' ' O ' ' A' ' 76' ' ' TRP . . . 72.3 95.4 0.07 Allowed 'General case' 0 N--CA 1.506 2.367 0 CA-C-O 121.447 0.641 . . . . 0.0 111.045 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.6 m -125.83 148.74 49.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.542 -0.724 . . . . 0.0 109.8 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 81.1 mt -123.41 137.17 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.151 -0.968 . . . . 0.0 110.474 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -146.9 166.19 27.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.367 -0.833 . . . . 0.0 110.878 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.41 162.15 19.73 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.26 141.07 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -1.108 . . . . 0.0 111.232 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.487 ' O ' ' HA ' ' A' ' 66' ' ' THR . 36.0 m -142.63 151.44 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 160.36 -149.34 18.62 Favored Glycine 0 N--CA 1.483 1.772 0 C-N-CA 119.265 -1.445 . . . . 0.0 110.953 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.4 HG23 ' CZ ' ' A' ' 87' ' ' TYR . 11.1 p -133.04 144.29 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 122.459 1.123 . . . . 0.0 113.567 -177.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.2 137.68 14.46 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.411 ' CE1' ' CB ' ' A' ' 105' ' ' TYR . 90.0 m-85 -120.65 143.56 48.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.141 -1.211 . . . . 0.0 110.796 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -125.02 114.59 2.22 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -101.74 121.08 41.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.491 -1.005 . . . . 0.0 110.253 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -119.89 146.69 45.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.536 -0.728 . . . . 0.0 110.254 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -59.0 -36.65 75.27 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.404 -0.81 . . . . 0.0 110.53 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 2.2 m 59.66 154.96 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.504 -0.747 . . . . 0.0 110.432 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 77.7 p -109.74 12.33 24.14 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.32 -0.862 . . . . 0.0 110.936 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.09 143.03 53.13 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.123 -0.986 . . . . 0.0 110.285 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -60.31 151.16 69.5 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.398 -0.814 . . . . 0.0 110.292 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.4 -21.53 40.68 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.624 1.328 . . . . 0.0 111.05 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.448 ' CG2' ' CE2' ' A' ' 98' ' ' TYR . 31.0 m -59.38 -43.77 92.86 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.119 -0.988 . . . . 0.0 110.389 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . 0.448 ' CE2' ' CG2' ' A' ' 97' ' ' THR . 86.9 m-85 -130.34 142.43 50.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.473 -0.767 . . . . 0.0 110.446 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt 55.21 66.51 1.21 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.394 -0.817 . . . . 0.0 110.697 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -53.33 -39.73 64.3 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.27 -0.893 . . . . 0.0 110.538 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -170.13 137.52 1.56 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.375 -0.828 . . . . 0.0 110.18 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.0 t -138.41 154.31 48.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.364 -0.835 . . . . 0.0 110.623 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 88.9 p -130.8 154.99 47.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.435 -0.791 . . . . 0.0 110.121 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 52.4 t0 -110.27 148.56 31.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.391 -0.818 . . . . 0.0 110.194 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.411 ' CB ' ' CE1' ' A' ' 87' ' ' TYR . 43.4 p90 -127.6 168.83 14.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.275 -0.89 . . . . 0.0 110.305 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -159.83 -175.86 31.27 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -103.38 144.71 31.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.134 -1.215 . . . . 0.0 111.333 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.0 m -118.08 150.33 39.51 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 110.059 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -154.63 146.57 23.52 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.452 -0.78 . . . . 0.0 109.978 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.91 -176.27 42.55 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.016 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -160.81 162.89 32.43 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.46 -178.07 24.12 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.289 -1.434 . . . . 0.0 110.221 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 20.2 tp -139.51 149.39 43.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.609 -0.936 . . . . 0.0 109.923 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 124' ' ' ASP . 13.7 pt20 -127.06 151.81 48.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.185 -0.947 . . . . 0.0 109.824 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -156.88 161.19 39.68 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.359 -0.838 . . . . 0.0 110.883 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER 172.77 140.36 0.13 Allowed Pre-proline 0 N--CA 1.504 2.266 0 O-C-N 121.643 -0.661 . . . . 0.0 111.323 179.251 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -88.37 50.6 1.7 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.581 1.306 . . . . 0.0 109.011 177.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.415 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 86.6 mtp -146.25 140.58 26.63 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.527 -0.733 . . . . 0.0 109.068 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.48 -39.46 91.95 Favored 'General case' 0 C--N 1.292 -1.914 0 O-C-N 121.781 -0.574 . . . . 0.0 112.423 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -115.46 13.6 16.5 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.665 -1.272 . . . . 0.0 112.631 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.415 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 47.1 t -123.94 136.28 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.781 -1.199 . . . . 0.0 109.787 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.48 ' HA ' ' HB2' ' A' ' 116' ' ' ASN . . . -153.3 138.15 17.11 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.643 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.1 mt -103.13 153.1 20.67 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.432 ' HA ' ' HA ' ' A' ' 114' ' ' GLN . 52.5 t0 -143.97 136.52 26.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.569 -1.332 . . . . 0.0 110.361 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -128.71 142.28 51.06 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.6 t -145.91 155.74 43.07 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.132 -0.98 . . . . 0.0 111.375 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -107.14 119.27 38.91 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -131.96 144.32 50.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 110.9 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -141.26 155.0 46.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.577 -0.702 . . . . 0.0 109.609 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 29.3 t -142.46 141.3 32.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.397 -0.814 . . . . 0.0 110.294 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 -129.42 133.35 47.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.472 -0.768 . . . . 0.0 109.87 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.489 ' O ' ' N ' ' A' ' 134' ' ' SER . 24.6 pt -125.15 48.76 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 76.7 mtt85 60.59 -56.62 0.08 Allowed 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.489 ' N ' ' O ' ' A' ' 132' ' ' ILE . 53.4 m -92.18 -21.67 20.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 111.006 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.438 ' HB ' HG12 ' A' ' 132' ' ' ILE . 37.6 t -135.12 137.55 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.646 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -132.74 113.69 13.27 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 34.0 m -121.33 149.19 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.234 -0.916 . . . . 0.0 110.835 -178.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -114.28 129.35 8.68 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . 0.407 ' CB ' ' HB2' ' A' ' 12' ' ' SER . 14.7 t -126.31 143.9 51.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -1.134 . . . . 0.0 112.263 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -123.06 140.89 52.55 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.6 pt -120.5 149.94 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.122 -0.986 . . . . 0.0 111.187 -179.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -150.07 140.08 21.99 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -173.53 -146.3 5.47 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 118.783 -1.675 . . . . 0.0 111.906 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 35.4 m -118.77 179.87 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 122.229 -0.571 . . . . 0.0 110.908 -178.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 5' ' ' VAL . . . -160.84 143.61 9.11 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.899 -1.143 . . . . 0.0 110.729 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -132.73 156.12 47.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.655 -0.909 . . . . 0.0 109.726 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 46.3 ptt85 -133.96 123.85 25.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.346 -0.846 . . . . 0.0 111.268 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.8 p90 . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.346 -0.846 . . . . 0.0 110.397 179.939 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 48.5 m . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.0 p -117.34 144.31 45.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 109.751 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 56.7 m -135.83 140.21 44.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.418 -0.801 . . . . 0.0 110.505 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -115.18 138.31 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.6 m -156.34 132.54 9.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.237 -0.914 . . . . 0.0 110.023 179.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.99 171.95 38.89 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.82 -148.43 7.91 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.2 p90 -139.36 159.86 41.17 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.442 -1.034 . . . . 0.0 109.85 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -145.67 147.07 31.58 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.838 -1.145 . . . . 0.0 111.628 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -99.19 138.16 36.68 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 43.5 m -119.73 145.13 46.82 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.193 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -136.69 141.09 43.09 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.427 ' CB ' ' CG2' ' A' ' 137' ' ' VAL . . . -153.96 149.52 27.34 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 120.411 -1.431 . . . . 0.0 112.482 -177.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -79.32 128.03 32.82 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.6 -28.29 14.77 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -114.02 157.26 22.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.457 -1.025 . . . . 0.0 110.212 179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . 0.411 ' O ' ' HB2' ' A' ' 19' ' ' ASN . 64.8 mtt -121.46 171.33 8.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.442 -0.786 . . . . 0.0 110.29 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 18' ' ' MET . 18.2 m120 61.7 115.97 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.631 -0.668 . . . . 0.0 110.511 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -65.95 164.09 15.8 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.578 -0.701 . . . . 0.0 110.305 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 87.2 mtp -126.19 165.75 18.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.46 -0.775 . . . . 0.0 110.713 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.1 123.37 1.83 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -135.73 -172.67 12.74 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.153 -1.498 . . . . 0.0 110.754 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -119.0 148.6 42.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.804 -0.821 . . . . 0.0 108.999 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 -125.59 134.65 51.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 111.265 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.2 mt -113.27 147.72 37.02 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 26.5 mttt -147.89 137.34 22.37 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.63 -1.294 . . . . 0.0 110.979 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -119.84 130.9 55.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.459 -0.776 . . . . 0.0 108.928 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 14.2 ttp180 -132.27 140.27 48.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.14 -0.975 . . . . 0.0 111.878 -179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -119.0 133.3 55.91 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -141.97 142.75 32.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.199 -0.938 . . . . 0.0 110.459 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -104.5 129.74 52.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.419 -0.8 . . . . 0.0 109.879 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -54.35 -22.49 12.3 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.565 -0.709 . . . . 0.0 111.657 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -60.64 -36.09 77.81 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.238 -0.914 . . . . 0.0 110.686 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.3 m -145.51 160.39 45.01 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.151 -0.968 . . . . 0.0 110.539 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -88.11 33.99 0.4 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.695 1.366 . . . . 0.0 111.183 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 28.1 tp -116.59 84.72 2.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.26 -0.9 . . . . 0.0 110.595 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.74 -175.83 24.8 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.02 147.04 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.488 -1.007 . . . . 0.0 109.342 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.42 ' O ' ' HA ' ' A' ' 67' ' ' ALA . 16.5 tt -135.75 146.64 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.239 -0.913 . . . . 0.0 111.451 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 27' ' ' LYS . . . -115.73 151.16 18.49 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.5 t -140.35 142.27 35.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.075 -1.25 . . . . 0.0 111.788 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -129.95 138.67 50.99 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.4 t -134.04 148.55 51.09 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.95 -1.094 . . . . 0.0 111.677 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -141.59 114.37 8.48 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 32.3 p -122.11 159.73 26.53 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.418 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -142.35 170.9 14.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.747 . . . . 0.0 110.418 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -128.99 155.48 45.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.398 -0.814 . . . . 0.0 110.305 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.1 m -96.71 156.42 16.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.49 -0.756 . . . . 0.0 110.185 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.3 ptt-85 -141.35 161.1 38.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.431 -0.793 . . . . 0.0 110.542 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.2 m -120.92 142.55 49.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.432 -0.793 . . . . 0.0 110.11 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 53' ' ' SER . . . -60.1 142.68 53.77 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.456 -0.778 . . . . 0.0 110.144 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 52' ' ' ALA . 0.6 OUTLIER 60.09 132.44 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.557 -0.715 . . . . 0.0 110.435 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 m 52.41 64.47 1.84 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.176 -0.953 . . . . 0.0 110.324 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.17 -171.06 36.76 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -65.47 130.17 42.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.332 -1.099 . . . . 0.0 110.155 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -85.0 -15.83 42.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.479 -0.763 . . . . 0.0 111.042 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.0 p-10 -126.68 -164.28 1.32 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.262 -0.899 . . . . 0.0 110.784 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -143.97 117.01 8.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.519 -0.738 . . . . 0.0 109.482 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.401 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 84.2 m-20 -98.41 148.45 23.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.354 -0.842 . . . . 0.0 111.169 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -109.77 145.52 36.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.613 -0.679 . . . . 0.0 109.752 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.4 t80 -110.48 117.53 33.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.779 . . . . 0.0 110.98 -179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.498 ' HB2' ' HB2' ' A' ' 87' ' ' TYR . 86.4 m-85 -113.62 135.08 54.31 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.098 0.475 . . . . 0.0 109.776 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.01 126.8 2.52 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.547 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.404 ' CG2' HG23 ' A' ' 85' ' ' VAL . 14.0 tt -122.03 134.63 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.564 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 1.1 p -149.71 143.79 25.68 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.668 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 40' ' ' ILE . . . -141.23 150.09 42.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.685 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -167.84 168.24 40.58 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.65 176.97 8.1 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.788 1.415 . . . . 0.0 110.681 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -157.49 147.99 21.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.476 -0.765 . . . . 0.0 110.847 179.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -118.49 134.81 54.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.429 -0.795 . . . . 0.0 109.646 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.5 ttt-85 -68.97 150.93 47.16 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.456 -0.777 . . . . 0.0 110.765 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 15.0 tt -63.83 82.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 121.486 0.66 . . . . 0.0 110.116 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -55.6 -33.92 64.39 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.521 -0.737 . . . . 0.0 110.52 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -164.08 -39.37 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.413 -0.804 . . . . 0.0 110.717 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 18.2 m0 -93.85 -69.77 0.73 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.29 -0.881 . . . . 0.0 110.854 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -160.56 172.06 17.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.333 -0.854 . . . . 0.0 110.521 -179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.7 t -95.77 142.44 28.05 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.492 -0.755 . . . . 0.0 109.8 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.0 tt -132.62 144.43 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.361 -0.837 . . . . 0.0 110.451 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -142.96 153.98 43.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -0.812 . . . . 0.0 110.882 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.48 161.79 21.42 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 110' ' ' GLY . 47.3 t -134.45 132.77 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.119 -1.224 . . . . 0.0 111.467 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.564 ' O ' ' HA ' ' A' ' 66' ' ' THR . 60.5 t -137.29 145.59 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 170.7 -166.39 39.59 Favored Glycine 0 N--CA 1.477 1.412 0 C-N-CA 118.537 -1.792 . . . . 0.0 111.337 179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.457 HG11 ' CE2' ' A' ' 105' ' ' TYR . 33.2 m -133.84 177.07 7.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 121.838 0.827 . . . . 0.0 111.529 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.39 145.05 15.67 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.498 ' HB2' ' HB2' ' A' ' 63' ' ' TYR . 99.2 m-85 -126.06 132.49 51.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.201 -1.176 . . . . 0.0 109.732 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.06 129.02 9.15 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 26.3 tttt -127.15 132.91 50.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.594 -0.945 . . . . 0.0 109.676 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -131.79 165.85 22.87 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.441 -0.787 . . . . 0.0 110.467 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -104.85 147.01 28.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.526 -0.733 . . . . 0.0 110.358 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.5 m -84.58 152.39 23.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.529 -0.732 . . . . 0.0 110.079 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 40.8 m -57.27 144.34 36.0 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.44 -0.787 . . . . 0.0 110.156 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 56.27 171.47 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.503 -0.748 . . . . 0.0 110.209 -179.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.14 115.17 13.0 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.375 -0.828 . . . . 0.0 110.444 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.87 -19.86 35.04 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 123.482 1.254 . . . . 0.0 110.803 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 68.5 p 45.42 28.18 0.45 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.572 -0.705 . . . . 0.0 111.257 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -135.84 134.65 39.09 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.371 -0.831 . . . . 0.0 109.662 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 101' ' ' ASP . 99.1 mttt -55.12 -40.94 71.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.387 -0.821 . . . . 0.0 110.976 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 49.5 -90.29 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.538 -0.726 . . . . 0.0 111.191 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 99' ' ' LYS . 84.7 m-20 53.57 46.76 25.42 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.852 -1.155 . . . . 0.0 110.848 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.2 p -125.24 143.07 51.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.338 -0.851 . . . . 0.0 110.218 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.4 m -136.03 152.63 51.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.44 -0.788 . . . . 0.0 110.352 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -83.27 131.12 35.1 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.395 -0.816 . . . . 0.0 109.571 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.457 ' CE2' HG11 ' A' ' 85' ' ' VAL . 39.4 t80 -81.69 131.0 35.25 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.108 -0.995 . . . . 0.0 111.443 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -117.96 -164.13 13.02 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -140.8 148.86 41.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.443 -1.033 . . . . 0.0 109.917 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.7 m -136.6 143.57 43.65 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.198 -0.939 . . . . 0.0 110.858 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -151.7 141.38 21.8 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.449 -0.782 . . . . 0.0 110.014 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 82' ' ' VAL . . . 174.87 -176.07 47.04 Favored Glycine 0 N--CA 1.497 2.727 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.451 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -169.2 161.23 10.13 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.458 -1.025 . . . . 0.0 109.0 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -156.06 -174.89 26.42 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.303 -1.427 . . . . 0.0 109.946 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -124.01 162.42 23.49 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.43 -1.041 . . . . 0.0 110.069 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 75.2 mt-30 -119.21 131.85 55.87 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.862 -1.148 . . . . 0.0 109.04 179.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -129.28 129.2 44.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.293 -0.879 . . . . 0.0 110.629 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -177.34 150.69 0.86 Allowed Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.331 -0.855 . . . . 0.0 110.471 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -77.01 -77.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.577 1.304 . . . . 0.0 110.131 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.404 ' HB2' HG23 ' A' ' 121' ' ' VAL . 89.0 mtp -47.22 119.17 2.47 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.435 1.112 . . . . 0.0 110.596 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.5 -10.43 7.82 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.437 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -92.06 -4.06 54.93 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.531 -1.356 . . . . 0.0 110.743 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . 0.404 HG23 ' HB2' ' A' ' 118' ' ' MET . 34.1 m -128.28 161.1 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -0.875 . . . . 0.0 110.51 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -156.11 138.64 14.98 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.685 179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.3 tp -119.68 132.31 55.64 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 49.5 p30 -143.85 156.72 44.56 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.088 -1.445 . . . . 0.0 113.797 -177.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.414 ' CE1' ' HB3' ' A' ' 142' ' ' ALA . 95.6 m-85 -124.51 134.86 52.88 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 31.2 t -138.45 142.82 39.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 111.016 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.44 ' CD1' ' CZ2' ' A' ' 140' ' ' TRP . 81.0 t80 -109.23 127.54 54.33 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -142.14 147.39 36.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.526 -0.734 . . . . 0.0 110.41 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -112.22 135.14 53.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.547 -0.72 . . . . 0.0 110.106 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.7 m -128.4 143.61 51.02 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.608 -0.682 . . . . 0.0 109.315 179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 39.5 ptt180 -147.06 144.7 29.29 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.81 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.443 ' O ' ' N ' ' A' ' 134' ' ' SER . 44.8 mm -122.67 90.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.57 -0.706 . . . . 0.0 110.031 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 51.7 mtt180 61.75 -66.45 0.07 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.667 -0.645 . . . . 0.0 112.385 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 132' ' ' ILE . 32.2 p -125.86 20.84 7.68 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.033 -1.042 . . . . 0.0 110.96 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.511 ' O ' ' HA ' ' A' ' 131' ' ' ARG . 61.5 t -124.57 133.94 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 119.261 -0.975 . . . . 0.0 111.024 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -129.3 111.89 13.32 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.427 ' CG2' ' CB ' ' A' ' 14' ' ' ALA . 18.6 t -113.15 144.2 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.807 -1.183 . . . . 0.0 111.276 -177.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -117.12 107.12 1.52 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.125 -2.39 . . . . 0.0 107.125 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 90.5 m -121.81 142.33 50.33 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -1.13 . . . . 0.0 112.051 -177.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.44 ' CZ2' ' CD1' ' A' ' 127' ' ' TYR . 89.3 m95 -105.63 135.51 46.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 49.3 pt -119.53 150.5 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.147 -0.97 . . . . 0.0 111.312 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.414 ' HB3' ' CE1' ' A' ' 125' ' ' PHE . . . -151.66 139.03 19.42 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -164.23 -157.71 9.65 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 118.92 -1.61 . . . . 0.0 111.745 -178.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 34.8 m -117.38 173.71 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 122.135 -0.626 . . . . 0.0 110.385 -179.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -152.41 138.75 6.59 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.699 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -127.04 147.35 50.15 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.582 -0.952 . . . . 0.0 109.357 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -129.22 122.89 30.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.133 -0.979 . . . . 0.0 111.046 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 69.0 t80 . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.466 -0.771 . . . . 0.0 110.2 179.862 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 3' ' ' SER . 93.8 m . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 120.546 0.212 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.416 ' N ' HG22 ' A' ' 2' ' ' THR . 82.8 p -149.4 154.39 38.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.867 -1.145 . . . . 0.0 109.779 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.646 HG23 ' O ' ' A' ' 146' ' ' TYR . 27.2 m -136.11 137.69 41.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.418 -0.801 . . . . 0.0 110.06 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.421 HG23 ' HE2' ' A' ' 148' ' ' PHE . 58.0 t -106.79 138.05 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 144' ' ' VAL . 47.6 m -156.58 133.59 10.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.217 -0.927 . . . . 0.0 110.367 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.35 176.12 44.72 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.09 -120.85 0.78 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.404 ' CE2' ' HA3' ' A' ' 22' ' ' GLY . 27.1 t80 -139.46 158.92 43.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.482 -1.01 . . . . 0.0 109.228 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.2 117.4 14.5 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.143 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -106.76 144.63 33.13 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.426 ' HB3' HG23 ' A' ' 139' ' ' THR . 54.3 p -150.12 154.08 37.46 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.342 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -77.22 154.32 33.17 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.917 ' HB1' ' HB2' ' A' ' 17' ' ' GLN . . . -125.76 98.57 5.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.099 -1.001 . . . . 0.0 111.821 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -80.13 115.68 19.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.396 -0.815 . . . . 0.0 108.802 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.51 -14.09 59.43 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.917 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 96.6 mt-30 -115.05 160.03 20.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.439 -1.036 . . . . 0.0 109.402 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.1 ttm -98.99 137.96 36.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 111.052 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.6 t30 64.63 138.59 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.541 -0.724 . . . . 0.0 111.099 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -69.17 177.79 2.59 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.613 -0.679 . . . . 0.0 110.128 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.753 ' HB3' HG22 ' A' ' 46' ' ' THR . 68.9 mtm -129.16 169.91 14.2 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.343 -0.848 . . . . 0.0 110.724 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.79 ' C ' HG23 ' A' ' 46' ' ' THR . . . -152.68 128.94 2.61 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 45' ' ' TYR . . . -136.09 177.28 19.67 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.78 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -108.54 139.99 42.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.709 -0.877 . . . . 0.0 109.785 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.444 ' ND2' ' OG ' ' A' ' 42' ' ' SER . 25.3 t30 -121.4 125.68 47.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.43 -0.794 . . . . 0.0 111.394 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.1 tp -119.94 135.08 55.04 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.699 ' HD2' HD12 ' A' ' 40' ' ' ILE . 24.8 ttpt -138.91 144.98 39.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.489 -1.382 . . . . 0.0 111.754 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -110.34 145.18 37.93 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.529 ' HG3' HG22 ' A' ' 40' ' ' ILE . 20.6 ttm-85 -128.74 146.72 50.81 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.186 -0.946 . . . . 0.0 111.78 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -136.21 133.86 37.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.736 -0.603 . . . . 0.0 109.412 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -141.06 153.91 45.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.154 -0.966 . . . . 0.0 110.131 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 0.0 110.0 179.734 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo . . . . . 0 N--CA 1.483 0.862 0 N-CA-C 111.045 -0.406 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.0 tp -92.02 125.27 36.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.262 -0.899 . . . . 0.0 110.043 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.55 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . -133.71 134.4 7.44 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.57 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.41 131.8 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.699 HD12 ' HD2' ' A' ' 27' ' ' LYS . 33.0 pt -127.0 145.63 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.895 -1.128 . . . . 0.0 112.041 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.6 120.18 4.32 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.444 ' OG ' ' ND2' ' A' ' 25' ' ' ASN . 15.0 t -125.18 144.47 50.43 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.191 -1.182 . . . . 0.0 111.657 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -114.57 144.41 43.43 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.3 m -131.61 138.61 48.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.925 -1.11 . . . . 0.0 110.883 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.403 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 60.7 t80 -133.19 109.6 9.55 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.79 HG23 ' C ' ' A' ' 22' ' ' GLY . 27.9 m -123.07 143.82 49.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.395 -0.816 . . . . 0.0 111.147 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.4 ' OE2' ' CE2' ' A' ' 45' ' ' TYR . 93.9 mt-10 -137.82 165.34 26.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.406 -0.809 . . . . 0.0 110.316 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 tttt . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.539 -0.726 . . . . 0.0 109.719 179.459 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 . . . . . 0 N--CA 1.495 1.814 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -120.38 100.82 7.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.249 -0.907 . . . . 0.0 111.011 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -102.81 142.56 33.74 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.77 158.06 27.66 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 118.63 -1.748 . . . . 0.0 111.173 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.476 ' C ' HG23 ' A' ' 66' ' ' THR . 44.3 pt -121.79 137.17 56.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.476 HG23 ' C ' ' A' ' 65' ' ' ILE . 65.3 p -150.21 139.59 21.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 110.919 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.767 ' O ' HG12 ' A' ' 83' ' ' VAL . . . -160.29 155.09 24.21 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.0 175.25 42.86 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.414 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 44.9 Cg_endo -71.21 165.73 31.51 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.93 1.489 . . . . 0.0 110.538 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.55 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -146.65 140.68 26.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.487 -0.758 . . . . 0.0 110.079 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -123.66 143.75 50.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.543 -0.723 . . . . 0.0 109.978 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.542 -0.724 . . . . 0.0 110.962 -179.311 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.344 0.593 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.2 m -134.93 147.33 49.76 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.591 -0.693 . . . . 0.0 109.573 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.5 pt -129.8 138.72 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.01 -1.056 . . . . 0.0 110.607 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.43 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 40.6 p90 -147.47 167.91 23.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.448 -0.782 . . . . 0.0 111.202 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.83 164.95 21.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 110' ' ' GLY . 34.7 m -135.87 135.48 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -1.112 . . . . 0.0 110.7 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 67' ' ' ALA . 10.5 p -141.05 147.83 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 159.18 -149.94 20.16 Favored Glycine 0 N--CA 1.477 1.426 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.442 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.46 HG22 ' CG1' ' A' ' 65' ' ' ILE . 34.1 m -135.5 -172.72 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.527 1.156 . . . . 0.0 113.272 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.09 152.18 23.04 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -123.82 133.8 53.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -1.166 . . . . 0.0 109.916 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -116.2 113.23 2.78 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.2 mttt . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.622 -0.928 . . . . 0.0 109.492 179.541 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.9 t0 . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.844 ' O ' HG23 ' A' ' 132' ' ' ILE . 48.5 p90 -136.17 170.78 15.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.075 -1.016 . . . . 0.0 111.778 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -157.56 -178.0 31.2 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.419 ' CD1' HG12 ' A' ' 85' ' ' VAL . 99.4 m-85 -108.25 152.41 24.65 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.033 -1.275 . . . . 0.0 110.876 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -125.51 153.9 42.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.414 -0.804 . . . . 0.0 110.515 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 64.1 t80 -154.83 146.75 23.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.465 -0.772 . . . . 0.0 109.868 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.508 ' O ' HG22 ' A' ' 82' ' ' VAL . . . 169.03 -178.23 42.39 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.841 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 80' ' ' TYR . . . -165.16 165.88 19.45 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.695 -0.885 . . . . 0.0 108.915 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -155.94 -173.74 24.91 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -136.8 155.44 49.82 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.352 -1.087 . . . . 0.0 110.072 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.679 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 30.4 tt0 -115.73 141.87 47.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.178 -0.951 . . . . 0.0 109.564 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -146.12 150.02 35.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.41 -0.806 . . . . 0.0 110.438 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.448 ' HB2' ' HA ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER 175.66 138.43 0.19 Allowed Pre-proline 0 N--CA 1.503 2.178 0 O-C-N 121.65 -0.656 . . . . 0.0 111.553 179.413 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 116' ' ' ASN . 52.5 Cg_endo -88.69 48.09 1.26 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.576 1.303 . . . . 0.0 109.168 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.475 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 86.5 mtp -147.15 137.01 23.13 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.459 -0.776 . . . . 0.0 108.945 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.43 -38.19 89.14 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.778 -0.576 . . . . 0.0 112.43 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -109.26 7.81 25.44 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.67 -1.269 . . . . 0.0 112.66 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 60.8 t -122.45 138.69 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.739 -1.226 . . . . 0.0 110.063 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.679 ' HB1' ' CD ' ' A' ' 114' ' ' GLN . . . -146.45 139.18 25.34 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.386 -0.926 . . . . 0.0 112.338 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 143' ' ' GLY . 13.8 tp -122.13 135.58 54.81 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' HB3' ' CB ' ' A' ' 114' ' ' GLN . 53.0 p30 -139.06 153.8 48.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.458 -1.401 . . . . 0.0 112.167 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -124.44 138.94 54.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.804 -0.56 . . . . 0.0 109.616 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.1 p -146.2 157.22 43.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.843 . . . . 0.0 110.191 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -133.82 143.1 48.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.519 -0.738 . . . . 0.0 110.342 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -150.98 143.86 24.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.509 -0.744 . . . . 0.0 110.164 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -113.78 146.61 39.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.403 -0.811 . . . . 0.0 109.97 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.5 t -129.18 139.61 51.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.44 -0.787 . . . . 0.0 110.246 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.3 ttp85 -127.98 127.89 44.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.475 -0.766 . . . . 0.0 109.837 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.844 HG23 ' O ' ' A' ' 105' ' ' TYR . 89.5 mt -119.15 56.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.668 -0.645 . . . . 0.0 109.56 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.455 ' HB3' ' O ' ' A' ' 132' ' ' ILE . 17.6 ttm180 66.05 -57.26 0.35 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.884 -0.51 . . . . 0.0 111.647 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.07 -7.32 11.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.085 -1.009 . . . . 0.0 111.401 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.498 HG11 ' NE2' ' A' ' 17' ' ' GLN . 48.9 t -119.64 130.82 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.967 -1.083 . . . . 0.0 110.653 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -133.44 114.01 13.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.561 -0.712 . . . . 0.0 109.242 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.897 HG12 ' HA ' ' A' ' 14' ' ' ALA . 31.5 m -124.65 149.3 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 110.506 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.89 103.65 2.34 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.126 -1.989 . . . . 0.0 108.126 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.426 HG23 ' HB3' ' A' ' 12' ' ' SER . 24.3 m -111.03 145.49 38.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.42 -1.047 . . . . 0.0 111.765 -178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.601 ' HZ3' ' HB3' ' A' ' 142' ' ' ALA . 60.2 p-90 -132.1 145.37 51.36 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 75.4 mt -117.35 131.11 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.252 -0.905 . . . . 0.0 110.175 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.601 ' HB3' ' HZ3' ' A' ' 140' ' ' TRP . . . -149.27 145.54 27.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.44 -0.787 . . . . 0.0 110.185 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.818 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -177.09 -128.71 1.17 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.381 -1.39 . . . . 0.0 111.163 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.7 ' O ' HG23 ' A' ' 6' ' ' THR . 35.2 m -117.87 171.51 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.861 -0.788 . . . . 0.0 111.383 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 122' ' ' ALA . . . -148.81 135.56 5.48 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.646 ' O ' HG23 ' A' ' 4' ' ' THR . 64.8 t80 -130.46 149.56 52.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.576 -0.956 . . . . 0.0 109.394 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -131.89 122.38 25.57 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.261 -0.899 . . . . 0.0 111.478 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.421 ' HE2' HG23 ' A' ' 5' ' ' VAL . 95.9 m-85 . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.494 -0.754 . . . . 0.0 110.181 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.936 0.398 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.7 t -128.08 144.85 51.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.903 . . . . 0.0 109.793 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 146' ' ' TYR . 26.9 m -136.01 136.31 40.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.873 . . . . 0.0 109.996 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -107.69 139.37 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.579 -0.701 . . . . 0.0 109.26 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 144' ' ' VAL . 51.5 m -154.8 129.66 9.39 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.08 -1.012 . . . . 0.0 110.323 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -164.12 169.05 38.85 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.56 -130.4 1.34 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -127.3 158.24 37.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.45 -1.029 . . . . 0.0 109.763 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.79 116.5 16.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 111.066 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -113.75 142.36 46.15 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.428 ' HB2' HG12 ' A' ' 137' ' ' VAL . 59.1 p -153.63 154.6 34.5 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.695 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.746 ' O ' HG13 ' A' ' 137' ' ' VAL . 88.5 m-20 -93.85 153.15 18.42 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.759 ' CB ' HG22 ' A' ' 137' ' ' VAL . . . -135.59 119.16 17.0 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.775 -1.203 . . . . 0.0 111.878 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -71.17 119.88 15.94 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.03 -15.25 44.09 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.663 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 91.6 mt-30 -115.79 156.44 26.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.603 -0.939 . . . . 0.0 109.138 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 65.6 mtt -96.24 -77.69 0.48 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.09 -1.006 . . . . 0.0 110.985 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -66.06 134.45 52.89 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.372 -0.83 . . . . 0.0 110.962 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -68.8 178.5 2.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.525 -0.734 . . . . 0.0 110.103 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.628 ' HB3' HG22 ' A' ' 46' ' ' THR . 64.3 mtm -124.05 163.29 21.73 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.273 -0.892 . . . . 0.0 110.69 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.66 ' C ' HG23 ' A' ' 46' ' ' THR . . . -149.94 125.68 2.02 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.55 ' N ' HG23 ' A' ' 46' ' ' THR . . . -143.0 -159.34 7.9 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.523 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' A' ' 45' ' ' TYR . 51.3 p90 -129.19 161.16 30.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.537 -0.978 . . . . 0.0 110.047 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.433 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 45.5 t-20 -141.34 132.26 26.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.46 -0.775 . . . . 0.0 111.359 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.0 tp -118.62 141.15 48.87 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 47.3 mttt -134.86 146.72 49.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.403 -1.436 . . . . 0.0 111.26 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -115.91 138.97 50.68 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.516 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 53.2 ttt-85 -129.5 143.04 50.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.202 -0.936 . . . . 0.0 111.817 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -134.15 133.0 40.5 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -142.99 149.99 39.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.169 -0.957 . . . . 0.0 110.48 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.337 -0.852 . . . . 0.0 109.462 179.663 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo . . . . . 0 N--CA 1.483 0.88 0 N-CA-C 111.142 -0.369 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 37' ' ' LEU . 2.7 mm? -87.77 98.97 11.75 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.941 . . . . 0.0 110.11 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 69' ' ' PRO . . . -107.98 131.66 10.71 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.78 129.36 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.558 -0.966 . . . . 0.0 108.721 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.452 ' CD1' ' CD1' ' A' ' 80' ' ' TYR . 77.8 mt -123.55 142.57 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.101 -0.999 . . . . 0.0 111.339 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 27' ' ' LYS . . . -109.46 145.45 16.76 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 107.086 -2.406 . . . . 0.0 107.086 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.406 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 34.7 t -139.71 142.46 36.86 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 118.969 1.384 . . . . 0.0 112.174 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -123.42 137.83 54.72 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.6 m -132.03 140.07 48.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.823 -1.173 . . . . 0.0 111.074 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.438 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 75.6 t80 -134.33 110.28 9.37 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.66 HG23 ' C ' ' A' ' 22' ' ' GLY . 4.2 m -119.48 146.5 45.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.525 -0.734 . . . . 0.0 110.276 -178.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -124.6 158.96 31.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.114 -0.991 . . . . 0.0 110.416 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 47.8 pttt . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.549 -0.72 . . . . 0.0 110.485 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 120.981 0.419 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -114.08 126.91 55.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.346 -0.846 . . . . 0.0 110.88 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.499 ' CD2' ' CE1' ' A' ' 87' ' ' TYR . 97.8 m-85 -110.38 137.06 48.6 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.802 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.28 115.02 0.74 Allowed Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.411 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.481 ' O ' HG23 ' A' ' 66' ' ' THR . 76.5 mt -104.53 136.14 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 3.3 p -151.23 139.33 20.12 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.291 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.94 151.6 33.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.08 165.14 37.54 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.34 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 48.2 Cg_endo -74.07 172.7 15.43 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.858 1.451 . . . . 0.0 110.741 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.34 138.91 28.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.587 -0.696 . . . . 0.0 109.675 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -120.79 135.86 55.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.439 -0.788 . . . . 0.0 110.779 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.1 ttp85 . . . . . 0 N--CA 1.491 1.581 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.024 179.394 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 121.606 0.717 . . . . 0.0 111.82 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.804 ' O ' HD12 ' A' ' 113' ' ' LEU . 49.7 m -126.75 161.48 28.06 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.697 -0.627 . . . . 0.0 109.526 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.3 mt -118.01 136.67 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.002 -1.061 . . . . 0.0 110.222 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.452 ' CD1' ' CD1' ' A' ' 40' ' ' ILE . 85.7 m-85 -132.58 154.16 50.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.685 -0.634 . . . . 0.0 110.284 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.13 163.06 21.11 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.528 HG22 ' C ' ' A' ' 110' ' ' GLY . 34.1 m -136.32 132.06 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.094 -1.239 . . . . 0.0 111.281 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 66' ' ' THR . 59.5 t -140.74 145.31 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 160.87 -149.02 17.77 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 119.346 -1.407 . . . . 0.0 110.848 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 33.3 m -127.21 158.19 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.315 1.055 . . . . 0.0 112.977 -177.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.628 ' O ' HD12 ' A' ' 132' ' ' ILE . . . -140.57 130.69 4.67 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.499 ' CE1' ' CD2' ' A' ' 63' ' ' TYR . 43.6 p90 -151.89 164.2 37.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.002 -1.293 . . . . 0.0 111.242 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.32 154.58 20.4 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.8 tttp . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.825 -0.809 . . . . 0.0 110.332 -179.843 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.486 ' CG ' HG22 ' A' ' 132' ' ' ILE . 56.2 t0 . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.471 ' CD2' ' CB ' ' A' ' 87' ' ' TYR . 85.9 m-85 -114.85 162.52 16.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.172 -0.955 . . . . 0.0 111.042 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.677 ' HA3' HD13 ' A' ' 132' ' ' ILE . . . -160.94 -176.86 33.51 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 99.0 m-85 -116.02 156.78 25.71 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.017 -1.284 . . . . 0.0 111.398 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.9 m -124.58 154.9 39.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.53 -0.731 . . . . 0.0 110.417 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -153.06 145.19 23.83 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.421 -0.799 . . . . 0.0 109.907 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.528 ' C ' HG22 ' A' ' 82' ' ' VAL . . . 171.47 -177.59 44.25 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.908 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.28 163.47 13.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.653 -0.91 . . . . 0.0 108.949 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -157.33 -172.05 24.07 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.58 -1.295 . . . . 0.0 109.93 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 78' ' ' SER . 19.6 tp -130.74 152.44 50.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.467 -1.019 . . . . 0.0 109.673 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.4 ' CB ' ' HB3' ' A' ' 124' ' ' ASP . 51.3 tt0 -118.52 149.39 41.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.998 -1.064 . . . . 0.0 109.771 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.66 ' O ' ' HB1' ' A' ' 122' ' ' ALA . 99.5 m-85 -115.36 154.96 28.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.51 -0.744 . . . . 0.0 109.705 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -113.94 64.09 1.2 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.844 . . . . 0.0 111.279 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.69 -14.26 36.05 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.436 1.23 . . . . 0.0 109.904 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.603 ' HB2' HG23 ' A' ' 121' ' ' VAL . 64.9 mtt -145.4 139.87 27.24 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -60.92 -38.69 86.65 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.69 -0.631 . . . . 0.0 112.209 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.485 ' OD1' HG22 ' A' ' 121' ' ' VAL . 46.2 p-10 -94.94 -3.73 48.08 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.777 -1.202 . . . . 0.0 112.745 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.603 HG23 ' HB2' ' A' ' 118' ' ' MET . 30.1 m -150.42 121.46 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 120.809 -1.182 . . . . 0.0 111.604 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.66 ' HB1' ' O ' ' A' ' 115' ' ' PHE . . . -117.78 154.66 31.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.502 -0.749 . . . . 0.0 109.249 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.0 mt -113.3 144.45 42.71 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.114 -0.991 . . . . 0.0 109.776 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 114' ' ' GLN . 48.7 p30 -138.79 151.04 46.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.139 -0.975 . . . . 0.0 111.267 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -133.01 141.64 48.39 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.2 p -145.91 164.44 31.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.238 -0.914 . . . . 0.0 111.159 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -112.42 127.87 56.15 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -127.47 132.13 50.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.239 -0.913 . . . . 0.0 111.262 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -123.28 127.04 47.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.607 -0.683 . . . . 0.0 109.282 178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.6 t -130.35 143.73 50.95 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.198 -0.939 . . . . 0.0 110.742 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.4 ' O ' ' HA3' ' A' ' 106' ' ' GLY . 65.2 mtm180 -124.04 129.68 51.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.591 -0.693 . . . . 0.0 109.718 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.677 HD13 ' HA3' ' A' ' 106' ' ' GLY . 17.3 mm -114.74 63.1 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.429 ' HB3' ' O ' ' A' ' 132' ' ' ILE . 50.8 ttp180 66.42 -59.96 0.33 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.562 -0.711 . . . . 0.0 111.224 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 132' ' ' ILE . 51.6 p -124.38 6.66 8.36 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.062 -1.024 . . . . 0.0 111.394 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.422 ' HB ' ' HB ' ' A' ' 132' ' ' ILE . 47.1 t -125.87 133.34 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.124 -0.985 . . . . 0.0 110.646 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -131.44 112.27 12.53 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.759 HG22 ' CB ' ' A' ' 14' ' ' ALA . 55.5 t -119.18 146.28 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.151 -0.968 . . . . 0.0 110.742 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -109.5 107.34 2.35 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.413 HG23 ' HB3' ' A' ' 12' ' ' SER . 26.0 m -109.78 139.58 44.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.328 -1.101 . . . . 0.0 112.02 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -111.49 142.16 44.12 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.7 mm -112.65 129.6 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.115 -0.991 . . . . 0.0 110.659 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -137.96 128.61 26.7 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.52 -0.738 . . . . 0.0 109.027 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -164.73 -158.04 10.05 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 118.715 -1.707 . . . . 0.0 112.13 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 6' ' ' THR . 8.9 p -110.82 170.02 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 122.211 -0.582 . . . . 0.0 110.221 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.486 ' N ' HG22 ' A' ' 144' ' ' VAL . . . -142.15 134.95 6.38 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.932 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.606 ' O ' HG23 ' A' ' 4' ' ' THR . 83.3 m-85 -122.86 138.5 54.63 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.3 ttt-85 -126.74 121.21 31.36 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.936 -1.103 . . . . 0.0 111.108 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 55.8 t80 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.51 -0.744 . . . . 0.0 110.224 -179.883 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 70.0 p . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.9 p -109.19 152.31 25.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 0.0 109.531 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 146' ' ' TYR . 36.8 m -135.34 138.66 43.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 110.52 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.7 t -115.76 136.52 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.548 -0.72 . . . . 0.0 109.333 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 144' ' ' VAL . 85.2 m -154.01 129.59 9.96 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.272 -0.892 . . . . 0.0 110.247 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -165.48 172.5 41.03 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.65 -132.14 1.64 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 40.7 p90 -143.55 161.94 37.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.485 -1.009 . . . . 0.0 109.688 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.03 136.03 28.0 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.679 -1.208 . . . . 0.0 112.131 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -107.32 125.53 51.29 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.644 ' OG ' HG23 ' A' ' 139' ' ' THR . 10.5 m -126.94 148.55 50.05 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.808 -177.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.756 ' O ' HG13 ' A' ' 137' ' ' VAL . 52.5 t0 -95.55 152.22 18.62 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.867 ' CB ' HG22 ' A' ' 137' ' ' VAL . . . -135.83 122.95 21.56 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.697 -1.201 . . . . 0.0 111.837 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -73.31 116.4 13.81 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.3 -30.87 8.94 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.423 ' HB3' ' CB ' ' A' ' 14' ' ' ALA . 63.6 tt0 -115.07 99.02 7.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.644 -0.915 . . . . 0.0 109.052 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 65.1 mtt -62.33 -40.22 95.67 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.411 -0.806 . . . . 0.0 111.146 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -57.77 119.83 7.35 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.264 -0.898 . . . . 0.0 111.228 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -71.41 162.43 29.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.617 -0.677 . . . . 0.0 109.704 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.862 ' HB3' HG22 ' A' ' 46' ' ' THR . 66.7 mtm -127.19 157.66 39.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.205 -0.935 . . . . 0.0 111.463 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.824 ' C ' HG23 ' A' ' 46' ' ' THR . . . -142.39 124.08 2.33 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.625 ' N ' HG23 ' A' ' 46' ' ' THR . . . -137.84 -174.41 13.36 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.501 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.466 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . 99.2 m-85 -122.97 160.51 26.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.7 -0.882 . . . . 0.0 110.157 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.403 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 34.4 t-20 -140.8 131.71 26.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.543 -0.723 . . . . 0.0 111.101 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.704 HD13 ' N ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -123.39 132.85 54.09 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.704 ' N ' HD13 ' A' ' 26' ' ' LEU . 74.6 mttt -131.3 145.4 51.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.639 -1.288 . . . . 0.0 111.595 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.514 ' CE2' HD12 ' A' ' 26' ' ' LEU . 97.9 m-85 -116.24 132.19 56.73 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.461 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 44.8 ttt180 -125.16 138.85 54.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.104 -0.997 . . . . 0.0 112.149 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -119.5 138.82 52.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -149.2 163.71 36.86 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.973 . . . . 0.0 110.858 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.166 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 N--CA 1.48 0.728 0 N-CA-C 111.085 -0.39 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.0 mt -88.87 139.45 30.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.251 -0.906 . . . . 0.0 109.817 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . -148.56 140.3 8.19 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.538 -1.315 . . . . 0.0 111.039 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.68 129.71 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.462 HD11 ' CB ' ' A' ' 27' ' ' LYS . 17.1 tt -129.13 143.58 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.977 -1.077 . . . . 0.0 111.322 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.8 135.67 12.95 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.466 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 61.1 p -130.26 142.71 50.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.125 -1.221 . . . . 0.0 111.759 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -126.22 135.34 51.47 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 14.9 t -135.77 148.31 48.73 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.645 -1.222 . . . . 0.0 111.498 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.466 ' CE1' ' HB2' ' A' ' 24' ' ' PHE . 42.7 p90 -141.88 111.43 6.56 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.862 HG22 ' HB3' ' A' ' 21' ' ' MET . 73.4 m -121.97 137.02 54.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 110.672 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 85.5 tt0 -155.63 164.33 38.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.585 -0.697 . . . . 0.0 109.566 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.41 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 29.2 tttp . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.865 . . . . 0.0 109.795 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.406 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 71.9 t80 -112.89 90.17 3.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.431 -0.793 . . . . 0.0 110.589 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 44' ' ' THR . 69.2 t80 -116.92 141.35 48.35 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.48 168.58 38.19 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.027 -2.035 . . . . 0.0 112.298 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.659 HG12 HG12 ' A' ' 85' ' ' VAL . 49.8 pt -105.68 140.55 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 114.48 -0.86 . . . . 0.0 109.246 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -150.87 141.55 22.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 110.619 -179.809 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.58 ' O ' HG22 ' A' ' 83' ' ' VAL . . . -156.94 154.55 29.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 108.946 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.46 163.61 37.05 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.493 -1.336 . . . . 0.0 110.276 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.38 173.06 14.41 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.91 1.479 . . . . 0.0 110.679 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.501 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -141.11 136.5 31.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.811 -0.556 . . . . 0.0 109.617 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . 0.552 ' HB2' HD11 ' A' ' 79' ' ' ILE . 93.8 m-85 -126.28 145.78 50.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.698 -0.626 . . . . 0.0 110.67 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.492 -0.755 . . . . 0.0 109.554 179.058 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.057 0.456 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m -139.34 155.07 47.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.335 -0.853 . . . . 0.0 110.565 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.843 HG22 ' CD2' ' A' ' 113' ' ' LEU . 50.6 pt -121.14 144.35 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.331 -0.856 . . . . 0.0 109.716 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -132.41 154.44 49.83 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.328 -0.857 . . . . 0.0 111.169 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.87 162.66 17.81 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.137 -1.985 . . . . 0.0 108.137 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.839 HG21 ' OE2' ' A' ' 128' ' ' GLU . 35.2 m -142.66 132.63 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.96 -1.318 . . . . 0.0 111.683 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 67' ' ' ALA . 33.0 m -142.99 150.66 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 158.12 -151.06 22.16 Favored Glycine 0 N--CA 1.479 1.553 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.049 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.659 HG12 HG12 ' A' ' 65' ' ' ILE . 12.4 p -129.59 144.62 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.488 1.137 . . . . 0.0 113.502 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.41 149.62 19.19 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.41 ' CE2' ' HB2' ' A' ' 89' ' ' LYS . 66.4 t80 -126.67 129.47 48.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.002 -1.293 . . . . 0.0 111.577 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -109.56 113.51 3.67 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 107.934 -2.066 . . . . 0.0 107.934 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.41 ' HB2' ' CE2' ' A' ' 87' ' ' TYR . 36.3 tttp . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.493 -1.004 . . . . 0.0 111.609 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.67 ' OD2' HG22 ' A' ' 132' ' ' ILE . 47.6 t0 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.044 0.45 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -112.03 156.69 21.78 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.376 -0.827 . . . . 0.0 110.601 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -144.25 161.54 27.91 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -97.63 145.8 25.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.927 -1.337 . . . . 0.0 110.937 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.0 t -122.46 148.65 44.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.482 -0.761 . . . . 0.0 110.3 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.558 ' CD1' HG12 ' A' ' 83' ' ' VAL . 66.6 t80 -154.01 145.67 23.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.494 -0.754 . . . . 0.0 109.661 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.465 ' O ' HG22 ' A' ' 82' ' ' VAL . . . 171.84 -178.9 43.85 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.906 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -167.2 163.7 15.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.818 -0.813 . . . . 0.0 108.812 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -156.06 -173.32 24.5 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.843 ' CD2' HG22 ' A' ' 79' ' ' ILE . 76.3 mt -128.44 152.85 47.75 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.373 -1.075 . . . . 0.0 109.278 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -119.53 140.97 49.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.818 -1.176 . . . . 0.0 109.971 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -117.35 161.1 20.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.508 -0.745 . . . . 0.0 110.061 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.96 86.59 42.1 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.464 -0.773 . . . . 0.0 110.459 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.623 ' HG3' HD23 ' A' ' 123' ' ' LEU . 43.8 Cg_endo -69.4 -7.39 20.81 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.664 1.35 . . . . 0.0 111.535 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.556 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 80.0 mtp -149.95 175.66 11.47 Favored 'General case' 0 C--N 1.311 -1.077 0 O-C-N 121.056 -1.027 . . . . 0.0 108.452 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.88 -39.7 95.27 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.807 -0.558 . . . . 0.0 110.993 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.469 ' OD1' HG23 ' A' ' 121' ' ' VAL . 48.0 p-10 -121.99 18.16 10.9 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.201 -0.937 . . . . 0.0 112.2 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 21.3 t -118.46 139.38 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.933 -1.105 . . . . 0.0 109.729 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.651 ' C ' HD22 ' A' ' 123' ' ' LEU . . . -141.34 137.48 32.4 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.736 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.651 HD22 ' C ' ' A' ' 122' ' ' ALA . 4.4 mm? -112.29 152.24 28.73 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -145.49 139.42 26.81 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.719 -1.238 . . . . 0.0 110.736 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -124.7 126.24 45.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 109.179 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -130.64 151.46 51.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.32 -0.863 . . . . 0.0 111.178 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -113.97 126.87 55.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.597 -0.689 . . . . 0.0 109.187 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.839 ' OE2' HG21 ' A' ' 82' ' ' VAL . 94.8 mt-10 -137.74 152.31 49.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.339 -0.85 . . . . 0.0 111.172 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -138.63 147.89 43.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 0.0 109.405 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 51.1 m -134.62 145.96 49.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.197 -0.939 . . . . 0.0 110.822 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -132.54 128.55 37.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.489 -0.757 . . . . 0.0 109.828 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.67 HG22 ' OD2' ' A' ' 104' ' ' ASP . 91.4 mt -119.8 59.26 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.47 -0.769 . . . . 0.0 109.709 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 93.2 mtt-85 64.65 -57.46 0.26 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.908 -0.495 . . . . 0.0 111.912 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 132' ' ' ILE . 44.0 p -117.69 -3.29 11.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.959 -1.088 . . . . 0.0 111.539 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.4 t -124.72 131.44 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.025 -1.047 . . . . 0.0 110.457 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -131.53 111.52 11.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.345 -0.847 . . . . 0.0 109.16 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.867 HG22 ' CB ' ' A' ' 14' ' ' ALA . 59.0 t -119.29 145.88 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.93 . . . . 0.0 110.525 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -107.18 120.27 6.12 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 107.813 -2.115 . . . . 0.0 107.813 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.644 HG23 ' OG ' ' A' ' 12' ' ' SER . 59.3 m -118.29 137.25 53.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.232 -1.158 . . . . 0.0 111.9 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -114.44 140.15 48.93 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.7 mt -113.66 133.1 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.103 -0.998 . . . . 0.0 110.903 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.81 133.93 22.77 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.571 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -170.5 -146.0 4.97 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.041 -1.552 . . . . 0.0 111.503 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.79 ' O ' HG23 ' A' ' 6' ' ' THR . 34.8 m -117.32 177.03 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 122.113 -0.639 . . . . 0.0 111.142 -178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -153.26 138.58 6.39 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.635 ' O ' HG23 ' A' ' 4' ' ' THR . 69.8 t80 -134.65 153.4 52.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.571 -0.958 . . . . 0.0 109.714 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -133.82 122.03 22.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.368 -0.833 . . . . 0.0 110.986 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 65.8 t80 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.474 -0.766 . . . . 0.0 110.216 -179.662 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 66.3 p . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.004 0.43 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.6 t -124.16 137.64 54.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.427 -0.796 . . . . 0.0 109.728 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.853 HG23 ' O ' ' A' ' 146' ' ' TYR . 66.1 m -137.84 145.48 42.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.788 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.6 p -126.4 140.36 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.607 -0.683 . . . . 0.0 109.705 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.814 HG23 ' O ' ' A' ' 144' ' ' VAL . 88.9 m -156.45 130.61 8.59 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.301 -0.875 . . . . 0.0 110.481 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.486 ' HA3' HD23 ' A' ' 26' ' ' LEU . . . -149.97 158.32 27.62 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 108.831 -1.707 . . . . 0.0 108.831 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.08 -168.26 27.98 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.651 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -123.55 153.79 40.13 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.654 -0.909 . . . . 0.0 109.501 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.632 ' HB2' HG22 ' A' ' 141' ' ' ILE . . . -146.33 154.23 41.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.073 -1.017 . . . . 0.0 111.484 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -98.58 144.44 27.89 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.6 t -112.47 134.74 53.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.013 -1.055 . . . . 0.0 112.299 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -138.12 124.05 20.1 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.887 ' HB2' HG22 ' A' ' 137' ' ' VAL . . . -139.04 155.55 47.87 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 120.857 -1.152 . . . . 0.0 112.027 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -78.27 120.24 22.77 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.54 -29.24 10.72 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -113.75 97.77 6.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.607 -0.937 . . . . 0.0 109.247 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 70.6 mtm -67.43 -47.85 69.0 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.301 -0.875 . . . . 0.0 111.329 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -55.51 131.3 45.77 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.39 -0.819 . . . . 0.0 111.694 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -82.42 155.1 24.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.747 -0.595 . . . . 0.0 109.632 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.522 ' HB3' HG22 ' A' ' 46' ' ' THR . 73.4 mtm -131.3 166.18 21.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.274 -0.891 . . . . 0.0 111.224 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.805 ' O ' HG23 ' A' ' 46' ' ' THR . . . -92.97 153.23 21.38 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.54 121.85 2.92 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.114 -1.517 . . . . 0.0 111.021 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -111.5 129.6 55.99 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -137.93 126.53 23.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.937 -1.102 . . . . 0.0 111.558 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.486 HD23 ' HA3' ' A' ' 7' ' ' GLY . 81.9 mt -123.5 129.7 51.6 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HB3' ' CB ' ' A' ' 42' ' ' SER . 19.9 pttt -136.27 148.18 47.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.81 -1.181 . . . . 0.0 112.281 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -111.29 137.46 49.0 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.613 ' HA ' HG22 ' A' ' 40' ' ' ILE . 49.5 ttt180 -120.37 135.26 55.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 111.1 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -121.57 138.33 54.36 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -138.1 146.91 43.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.179 -0.951 . . . . 0.0 109.915 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 110.131 179.941 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 N--CA 1.483 0.867 0 N-CA-C 111.112 -0.38 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 20.4 tp -111.18 76.48 0.98 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.176 -0.953 . . . . 0.0 110.15 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.76 177.19 26.65 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 120.051 -1.071 . . . . 0.0 110.445 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.0 t -131.61 140.15 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.673 -0.898 . . . . 0.0 108.982 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.613 HG22 ' HA ' ' A' ' 29' ' ' ARG . 41.3 pt -121.66 147.59 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.96 -1.087 . . . . 0.0 111.386 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.96 129.75 8.8 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.527 ' O ' HG22 ' A' ' 66' ' ' THR . 32.1 t -136.91 142.86 42.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.169 -1.195 . . . . 0.0 111.765 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -115.35 139.85 49.64 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.9 m -130.42 136.16 48.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.17 -0.956 . . . . 0.0 110.169 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -134.74 111.1 9.68 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.349 -0.844 . . . . 0.0 109.171 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.805 HG23 ' O ' ' A' ' 22' ' ' GLY . 60.3 m -112.84 138.32 49.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.432 -0.793 . . . . 0.0 109.388 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -138.11 160.52 39.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.09 -1.006 . . . . 0.0 110.532 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.4 mttt . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 110.127 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.441 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 70.5 t80 -121.8 93.15 3.91 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.331 -0.856 . . . . 0.0 111.182 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -98.24 150.86 21.07 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -158.5 132.84 3.23 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 118.195 -1.955 . . . . 0.0 111.631 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.447 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 46.8 pt -98.54 138.56 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 42' ' ' SER . 9.5 t -153.22 147.57 25.86 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.576 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.726 ' O ' HG12 ' A' ' 83' ' ' VAL . . . -149.0 151.15 34.05 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.24 165.79 36.77 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.513 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -75.76 170.49 20.07 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.798 1.42 . . . . 0.0 110.655 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.39 140.62 24.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.603 -0.685 . . . . 0.0 109.452 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -123.17 141.47 51.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.331 -0.856 . . . . 0.0 110.558 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 . . . . . 0 N--CA 1.489 1.499 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.034 179.244 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.944 0 CA-C-O 121.656 0.741 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.773 ' O ' HD12 ' A' ' 113' ' ' LEU . 26.6 t -138.22 155.35 48.74 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.633 -0.667 . . . . 0.0 109.618 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.7 tt -129.05 137.87 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.065 -1.022 . . . . 0.0 110.363 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -146.95 162.27 39.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.406 -0.809 . . . . 0.0 111.425 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.2 164.31 12.79 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.587 HG22 ' C ' ' A' ' 110' ' ' GLY . 34.7 m -141.75 134.82 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -1.175 . . . . 0.0 111.53 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 67' ' ' ALA . 7.2 p -138.76 148.34 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 178.65 -179.76 48.66 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.687 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.446 ' O ' ' HA2' ' A' ' 64' ' ' GLY . 57.0 t -118.64 142.02 35.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.335 0.588 . . . . 0.0 110.702 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.94 144.26 17.1 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -116.55 129.82 56.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.129 -1.219 . . . . 0.0 110.11 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -118.26 113.52 2.64 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.465 -1.021 . . . . 0.0 110.653 -179.724 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -113.08 154.78 26.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.329 -0.857 . . . . 0.0 110.11 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 85' ' ' VAL . . . -143.46 153.51 24.9 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -96.58 139.54 32.51 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -1.15 . . . . 0.0 110.735 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.9 p -124.94 159.99 29.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.532 -0.73 . . . . 0.0 110.424 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 41.1 p90 -160.25 155.67 25.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.442 -0.786 . . . . 0.0 109.854 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.587 ' C ' HG22 ' A' ' 82' ' ' VAL . . . 164.3 -169.77 39.24 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.497 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.77 165.15 20.92 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.602 -0.94 . . . . 0.0 108.905 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -152.75 -178.92 27.87 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.773 HD12 ' O ' ' A' ' 78' ' ' SER . 15.4 tp -139.54 147.37 41.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.371 -1.076 . . . . 0.0 110.22 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 93.1 mt-30 -99.11 141.72 31.52 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.087 -1.008 . . . . 0.0 109.157 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -148.2 148.64 30.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.303 -0.873 . . . . 0.0 110.868 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.593 ' OD1' HD23 ' A' ' 123' ' ' LEU . 0.8 OUTLIER 170.72 134.7 0.07 OUTLIER Pre-proline 0 N--CA 1.506 2.327 0 O-C-N 121.764 -0.585 . . . . 0.0 111.306 178.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -88.03 47.11 1.29 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.541 1.285 . . . . 0.0 109.484 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.437 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 65.3 mtt -141.71 139.45 32.91 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.424 -0.797 . . . . 0.0 109.044 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.77 -47.04 79.61 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -104.13 5.5 35.1 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.822 -1.174 . . . . 0.0 112.703 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.546 HG12 ' ND2' ' A' ' 116' ' ' ASN . 59.3 t -118.77 136.45 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.769 -1.207 . . . . 0.0 109.935 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 145' ' ' GLY . . . -142.92 139.49 30.76 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.406 -0.917 . . . . 0.0 112.308 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.835 HD13 ' O ' ' A' ' 143' ' ' GLY . 3.7 mm? -109.32 153.36 24.02 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -145.9 140.24 26.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.76 -1.212 . . . . 0.0 110.648 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 113' ' ' LEU . 49.1 p90 -132.07 142.74 49.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 0.0 109.391 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.636 ' HB3' HD11 ' A' ' 141' ' ' ILE . 28.9 t -146.51 149.42 33.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.375 -0.828 . . . . 0.0 111.231 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -118.12 126.57 52.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.698 -0.626 . . . . 0.0 109.428 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -137.35 136.42 37.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.456 -0.777 . . . . 0.0 110.593 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -112.18 130.09 56.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.42 -0.8 . . . . 0.0 109.765 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.0 m -122.1 147.59 45.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.295 -0.878 . . . . 0.0 110.436 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 42.5 ptt85 -135.78 130.53 34.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.499 -0.751 . . . . 0.0 110.23 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 132' ' ' ILE . 88.4 mt -119.17 67.22 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.567 -0.708 . . . . 0.0 109.707 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 132' ' ' ILE . 41.4 ttm180 66.45 -60.74 0.32 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.672 -0.642 . . . . 0.0 111.388 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.2 p -124.65 5.73 8.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.067 -1.021 . . . . 0.0 111.69 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 131' ' ' ARG . 51.2 t -126.52 133.35 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.934 -1.104 . . . . 0.0 110.798 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -132.22 115.87 16.23 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.887 HG22 ' HB2' ' A' ' 14' ' ' ALA . 32.0 t -110.76 145.51 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.131 -0.981 . . . . 0.0 111.121 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.84 117.85 2.58 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 107.684 -2.167 . . . . 0.0 107.684 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 10.2 t -134.14 151.96 51.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -1.184 . . . . 0.0 112.028 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' A' ' 125' ' ' PHE . 60.5 t-105 -112.04 133.93 53.9 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.636 HD11 ' HB3' ' A' ' 126' ' ' SER . 49.3 pt -115.91 147.17 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.068 -1.02 . . . . 0.0 111.319 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -147.49 136.92 22.61 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.835 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -162.96 -159.08 10.13 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 118.986 -1.578 . . . . 0.0 111.605 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.814 ' O ' HG23 ' A' ' 6' ' ' THR . 9.3 p -104.57 166.99 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 122.065 -0.667 . . . . 0.0 110.654 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.606 ' O ' ' HB3' ' A' ' 122' ' ' ALA . . . -154.32 138.97 6.46 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.853 ' O ' HG23 ' A' ' 4' ' ' THR . 68.4 t80 -132.18 153.99 50.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.543 -0.975 . . . . 0.0 109.765 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -125.29 121.17 33.23 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.307 -0.87 . . . . 0.0 111.101 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 73.6 t80 . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.495 -0.753 . . . . 0.0 110.13 179.894 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 120.965 0.412 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -126.28 147.63 49.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -0.879 . . . . 0.0 109.153 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.474 ' OG1' ' HB3' ' A' ' 29' ' ' ARG . 19.0 p -135.12 152.47 51.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.067 -1.021 . . . . 0.0 110.431 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -112.24 135.77 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 37.1 m -155.31 128.22 8.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 110.642 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.86 173.37 45.06 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.86 -137.52 3.42 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 45.5 p90 -143.26 160.02 41.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.485 -1.009 . . . . 0.0 109.888 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.58 145.34 30.07 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.626 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -113.49 144.87 42.1 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.441 ' HB3' ' CB ' ' A' ' 139' ' ' THR . 54.4 p -146.47 153.63 40.65 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.607 -1.237 . . . . 0.0 112.617 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.883 ' O ' HG13 ' A' ' 137' ' ' VAL . 88.7 m-20 -83.11 151.34 25.79 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.736 ' HB1' ' HB2' ' A' ' 17' ' ' GLN . . . -127.03 100.37 6.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.943 -1.098 . . . . 0.0 111.341 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -79.78 117.48 20.7 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.04 -13.21 58.95 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.736 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 89.2 mt-30 -107.68 178.04 4.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.118 -1.225 . . . . 0.0 110.294 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.401 ' CB ' ' HE3' ' A' ' 48' ' ' LYS . 94.3 mmm -57.75 -51.68 68.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.459 -0.776 . . . . 0.0 112.041 -178.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.531 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 19.7 t30 -169.82 -148.62 0.07 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.694 -1.254 . . . . 0.0 110.747 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mttt -81.06 154.3 26.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.076 -1.015 . . . . 0.0 110.761 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 62.5 mtt -129.94 167.59 17.98 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.416 -0.803 . . . . 0.0 110.662 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.816 ' O ' HG23 ' A' ' 46' ' ' THR . . . -98.12 158.97 20.66 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.251 -1.939 . . . . 0.0 108.251 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 9' ' ' TYR . . . -147.08 121.29 1.38 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.275 -1.44 . . . . 0.0 110.757 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -108.52 134.92 50.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.644 -0.916 . . . . 0.0 109.127 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -139.02 129.38 25.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.157 -0.964 . . . . 0.0 112.112 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.438 HD21 ' OH ' ' A' ' 28' ' ' TYR . 25.5 tp -121.85 127.59 50.69 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . 21.3 mttt -129.24 144.66 51.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.656 -1.277 . . . . 0.0 111.748 -177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.438 ' OH ' HD21 ' A' ' 26' ' ' LEU . 98.8 m-85 -112.24 140.69 46.74 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.474 ' HB3' ' OG1' ' A' ' 4' ' ' THR . 14.2 ttp180 -123.54 137.76 54.7 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.095 -1.003 . . . . 0.0 111.938 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -122.04 138.25 54.51 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -141.33 150.02 41.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.135 -0.978 . . . . 0.0 110.401 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 0.0 109.683 179.626 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo . . . . . 0 N--CA 1.482 0.838 0 N-CA-C 111.022 -0.414 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.481 ' C ' HD23 ' A' ' 37' ' ' LEU . 8.5 tt -91.3 119.56 31.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.359 -0.838 . . . . 0.0 110.043 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . -127.35 135.46 8.79 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.885 -1.15 . . . . 0.0 110.485 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -131.21 135.86 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.532 HD11 ' CD1' ' A' ' 80' ' ' TYR . 72.9 mt -125.32 141.92 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.922 -1.111 . . . . 0.0 111.455 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.81 141.07 15.15 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 106.998 -2.441 . . . . 0.0 106.998 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.415 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 42.7 t -137.53 141.18 41.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.886 -1.361 . . . . 0.0 112.649 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -122.97 134.13 54.35 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.8 m -131.03 136.93 48.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.031 . . . . 0.0 110.693 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -129.94 110.42 11.67 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 22' ' ' GLY . 96.9 m -115.03 140.01 49.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.369 -0.832 . . . . 0.0 109.588 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -141.15 163.85 31.84 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.104 -0.997 . . . . 0.0 110.446 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HE3' ' CB ' ' A' ' 18' ' ' MET . 21.4 tttm . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.485 -0.759 . . . . 0.0 109.932 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.099 0.476 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.464 ' HB2' ' HB ' ' A' ' 46' ' ' THR . 50.9 m-85 -113.81 114.12 25.86 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.703 0.763 . . . . 0.0 111.22 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.411 ' HB3' ' HB2' ' A' ' 87' ' ' TYR . 68.4 t80 -98.08 145.17 26.81 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -150.54 128.79 2.73 Favored Glycine 0 N--CA 1.485 1.904 0 C-N-CA 118.502 -1.808 . . . . 0.0 110.932 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.45 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 78.2 mt -99.1 134.77 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.749 HG23 ' O ' ' A' ' 83' ' ' VAL . 61.4 m -152.03 142.1 22.21 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.512 -1.275 . . . . 0.0 112.216 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.87 148.84 34.4 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -157.15 160.38 30.4 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.593 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 49.7 Cg_endo -75.41 165.09 31.4 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.875 1.461 . . . . 0.0 110.646 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.444 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -141.97 137.42 31.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.489 -0.757 . . . . 0.0 109.823 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -125.23 143.48 50.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.582 -0.698 . . . . 0.0 110.927 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.4 ttt-85 . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.644 -0.66 . . . . 0.0 109.605 178.915 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.032 0.444 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.4 m -124.41 151.31 44.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.425 -0.797 . . . . 0.0 110.634 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.7 mt -119.46 136.85 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 109.176 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.532 ' CD1' HD11 ' A' ' 40' ' ' ILE . 38.6 m-85 -129.26 148.69 51.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.85 . . . . 0.0 111.145 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.28 159.28 19.84 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 110' ' ' GLY . 27.0 m -143.77 134.66 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.326 . . . . 0.0 112.164 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.749 ' O ' HG23 ' A' ' 66' ' ' THR . 61.9 t -134.85 144.63 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 178.78 -176.9 48.27 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 118.326 -1.892 . . . . 0.0 111.522 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.458 ' CG1' ' CZ ' ' A' ' 87' ' ' TYR . 52.8 t -121.9 144.27 31.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-O 121.652 0.739 . . . . 0.0 110.583 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.14 135.84 12.36 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.458 ' CZ ' ' CG1' ' A' ' 85' ' ' VAL . 88.5 m-85 -127.86 132.13 49.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.067 -1.255 . . . . 0.0 110.189 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.79 127.95 6.72 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 27.8 pttt . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.416 -1.049 . . . . 0.0 110.488 -179.96 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 54.7 t0 . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.727 ' O ' HG23 ' A' ' 132' ' ' ILE . 45.9 p90 -134.96 170.16 16.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.083 -1.011 . . . . 0.0 111.871 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.424 ' HA3' HG12 ' A' ' 132' ' ' ILE . . . -154.18 178.03 31.26 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.415 ' CZ ' HG13 ' A' ' 83' ' ' VAL . 68.3 t80 -99.11 142.15 30.96 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.115 -1.227 . . . . 0.0 110.862 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.1 m -121.65 150.55 41.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.446 -0.784 . . . . 0.0 110.159 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 43.2 p90 -158.34 152.98 24.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.393 -0.817 . . . . 0.0 110.037 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.558 ' O ' HG22 ' A' ' 82' ' ' VAL . . . 169.67 -176.63 43.5 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.584 -1.294 . . . . 0.0 110.65 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.99 163.46 11.37 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.681 -0.894 . . . . 0.0 109.091 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -159.71 -171.4 25.52 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.45 155.83 49.9 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.302 -1.116 . . . . 0.0 110.141 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -120.63 142.55 49.32 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.163 -0.961 . . . . 0.0 110.228 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.67 ' O ' ' HB1' ' A' ' 122' ' ' ALA . 47.7 t80 -118.56 160.82 21.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.552 -0.718 . . . . 0.0 109.586 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -118.05 72.1 8.79 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.223 -0.923 . . . . 0.0 111.349 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.489 ' HD2' ' HA ' ' A' ' 122' ' ' ALA . 44.8 Cg_endo -72.51 -12.29 26.97 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.582 1.306 . . . . 0.0 110.064 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.599 ' HB2' HG13 ' A' ' 121' ' ' VAL . 88.0 mtp -142.89 144.15 32.34 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.29 -51.57 69.36 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -90.59 3.03 55.24 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.768 -1.207 . . . . 0.0 113.04 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.758 HG23 HG23 ' A' ' 144' ' ' VAL . 8.8 p -152.78 119.44 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 120.714 -1.241 . . . . 0.0 111.348 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.67 ' HB1' ' O ' ' A' ' 115' ' ' PHE . . . -110.75 167.45 10.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.904 . . . . 0.0 109.934 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 143' ' ' GLY . 23.4 tp -112.91 149.74 32.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.251 -0.906 . . . . 0.0 109.338 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -137.05 139.75 41.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.041 -1.037 . . . . 0.0 109.534 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -133.87 132.16 40.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 0.0 109.092 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.7 p -145.47 164.72 30.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.17 -0.956 . . . . 0.0 111.058 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -114.31 132.63 56.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.595 -0.69 . . . . 0.0 109.429 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -133.17 135.24 45.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.298 -0.877 . . . . 0.0 110.817 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -130.18 147.99 51.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 109.742 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.1 t -139.1 141.09 38.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.338 -0.851 . . . . 0.0 110.495 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.409 ' O ' ' HA3' ' A' ' 106' ' ' GLY . 63.1 mtm180 -129.11 129.19 44.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.366 -0.834 . . . . 0.0 109.868 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.727 HG23 ' O ' ' A' ' 105' ' ' TYR . 83.5 mt -125.48 54.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.534 -0.729 . . . . 0.0 109.671 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 74.2 mtp180 61.52 -55.99 0.11 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 132' ' ' ILE . 0.4 OUTLIER -105.47 -14.7 15.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.98 -1.075 . . . . 0.0 111.617 -178.429 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.499 ' CG2' ' HB ' ' A' ' 132' ' ' ILE . 32.8 m -137.17 140.21 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 118.396 -1.322 . . . . 0.0 112.111 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -133.71 119.09 18.88 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 13' ' ' ASP . 63.9 t -112.77 146.39 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.077 -1.014 . . . . 0.0 110.758 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -117.12 123.8 5.92 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 107.312 -2.315 . . . . 0.0 107.312 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.441 ' CB ' ' HB3' ' A' ' 12' ' ' SER . 14.9 t -126.19 152.55 45.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.065 -1.256 . . . . 0.0 112.469 -177.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 140' ' ' TRP . 56.4 m95 -111.69 137.45 49.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 76.7 mt -115.08 134.78 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.01 -1.056 . . . . 0.0 111.463 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.58 128.74 16.67 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.427 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -159.42 -157.98 8.87 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 118.985 -1.578 . . . . 0.0 111.789 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.758 HG23 HG23 ' A' ' 121' ' ' VAL . 7.2 p -111.45 163.13 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 122.135 -0.627 . . . . 0.0 110.555 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.42 ' N ' HG22 ' A' ' 144' ' ' VAL . . . -140.54 131.44 5.0 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -129.38 145.64 51.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.465 -1.021 . . . . 0.0 109.893 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -127.81 119.89 26.66 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.395 -0.816 . . . . 0.0 111.046 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.3 t80 . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.461 -0.774 . . . . 0.0 110.085 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.6 p . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.14 0.495 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.1 p -112.49 161.12 17.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.436 -0.79 . . . . 0.0 109.17 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.595 HG21 HH21 ' A' ' 29' ' ' ARG . 36.6 m -136.43 139.99 42.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.119 -0.988 . . . . 0.0 110.59 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.403 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 13.3 p -126.38 142.84 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.477 HG22 ' CA ' ' A' ' 145' ' ' GLY . 29.4 p -152.17 138.75 18.7 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 25' ' ' ASN . . . -134.24 155.27 21.79 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 24' ' ' PHE . . . -175.95 -163.32 28.43 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -137.35 161.44 36.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.652 -0.911 . . . . 0.0 109.356 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.06 153.69 41.01 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.644 -1.223 . . . . 0.0 112.145 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -112.5 137.77 50.23 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.4 m -121.23 145.54 47.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.991 -1.068 . . . . 0.0 112.633 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -130.2 139.39 50.84 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.898 ' CB ' HG22 ' A' ' 137' ' ' VAL . . . -145.9 148.32 32.69 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.774 -1.204 . . . . 0.0 112.11 -177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -78.93 123.56 27.38 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.09 -24.07 25.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.694 -1.763 . . . . 0.0 108.694 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -112.75 141.03 47.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.337 -1.096 . . . . 0.0 109.492 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.0 mtm -98.02 -67.17 0.86 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.29 -0.881 . . . . 0.0 110.572 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 -49.03 122.92 6.36 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.521 -0.737 . . . . 0.0 112.088 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -75.83 164.44 26.23 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.533 -0.729 . . . . 0.0 109.932 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 68.3 mtm -121.02 146.8 46.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.287 -0.883 . . . . 0.0 111.58 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -142.94 124.71 2.41 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.692 ' HA3' HG22 ' A' ' 46' ' ' THR . . . -151.36 -160.06 9.24 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.124 -1.512 . . . . 0.0 110.883 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 99.1 m-85 -121.31 154.59 36.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.744 -0.856 . . . . 0.0 110.064 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.533 ' ND2' HD13 ' A' ' 141' ' ' ILE . 57.7 t30 -134.73 130.84 36.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.451 -0.781 . . . . 0.0 111.515 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.7 mt -111.87 155.13 24.13 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.733 ' HD2' HG21 ' A' ' 40' ' ' ILE . 17.4 ttpt -148.81 132.6 16.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.642 -1.286 . . . . 0.0 110.209 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -133.93 136.7 44.42 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.595 HH21 HG21 ' A' ' 4' ' ' THR . 36.8 ptt180 -142.81 150.78 40.41 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.792 -1.163 . . . . 0.0 112.581 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -116.96 138.11 51.77 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -139.45 145.88 39.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.282 -0.886 . . . . 0.0 109.862 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.933 . . . . 0.0 109.652 179.946 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo . . . . . 0 N--CA 1.481 0.765 0 N-CA-C 111.146 -0.367 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.0 mt -108.64 73.13 0.85 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.242 -0.911 . . . . 0.0 110.137 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.83 -179.01 33.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -130.23 144.39 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.623 -0.928 . . . . 0.0 108.948 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.733 HG21 ' HD2' ' A' ' 27' ' ' LYS . 62.5 mt -118.38 143.62 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.965 -1.085 . . . . 0.0 110.876 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -124.25 122.64 4.87 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 76.6 p -139.38 144.98 38.41 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.147 -1.208 . . . . 0.0 111.451 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.85 148.25 44.28 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.53 -0.731 . . . . 0.0 109.948 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.9 m -129.73 138.72 51.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.244 -0.91 . . . . 0.0 110.376 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.414 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 68.7 t80 -137.57 110.91 7.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 108.933 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.692 HG22 ' HA3' ' A' ' 23' ' ' GLY . 30.3 p -122.54 160.34 25.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.489 -0.757 . . . . 0.0 110.457 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -127.4 165.84 19.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.468 -0.77 . . . . 0.0 110.411 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.706 -0.621 . . . . 0.0 110.487 179.784 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -119.7 127.72 53.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.166 -0.959 . . . . 0.0 111.529 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.475 ' CB ' ' CZ ' ' A' ' 87' ' ' TYR . 97.8 m-85 -116.1 136.2 53.24 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.733 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.76 112.22 0.6 Allowed Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.552 -1.309 . . . . 0.0 110.183 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.496 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 77.8 mt -101.49 135.85 36.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 12.6 m -150.65 140.2 21.56 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.836 -1.146 . . . . 0.0 111.111 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.86 ' O ' HG12 ' A' ' 83' ' ' VAL . . . -152.71 151.56 30.68 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 81' ' ' GLY . . . -164.54 171.92 40.15 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.388 -1.386 . . . . 0.0 110.6 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.04 161.79 43.72 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.964 1.507 . . . . 0.0 110.995 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.717 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -140.47 137.28 33.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.672 -0.643 . . . . 0.0 109.577 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -116.38 124.01 49.0 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.915 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.631 -0.668 . . . . 0.0 109.642 179.145 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 121.535 0.684 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 91.0 p -121.58 159.49 26.3 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.7 mt -124.87 136.29 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.922 -1.111 . . . . 0.0 110.551 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.408 ' HB2' ' CD1' ' A' ' 40' ' ' ILE . 43.5 p90 -145.65 158.92 43.79 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.912 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.46 ' C ' HG13 ' A' ' 82' ' ' VAL . . . -103.72 176.89 24.29 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.748 HG22 ' C ' ' A' ' 110' ' ' GLY . 34.9 m -147.89 131.36 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.32 -1.106 . . . . 0.0 110.545 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.86 HG12 ' O ' ' A' ' 67' ' ' ALA . 11.2 p -145.87 151.42 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.29 -0.881 . . . . 0.0 109.89 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 160.88 -153.18 23.98 Favored Glycine 0 N--CA 1.481 1.655 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.452 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.8 p -128.85 142.24 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 122.204 1.002 . . . . 0.0 112.861 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.98 126.52 6.02 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.475 ' CZ ' ' CB ' ' A' ' 63' ' ' TYR . 46.5 p90 -151.71 162.41 41.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.007 -1.29 . . . . 0.0 110.8 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.47 152.92 21.38 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.788 -0.831 . . . . 0.0 109.626 179.545 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.457 ' CB ' ' HB3' ' A' ' 87' ' ' TYR . 43.2 p90 -127.04 169.73 13.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.279 -0.888 . . . . 0.0 110.602 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.54 ' HA2' HD13 ' A' ' 132' ' ' ILE . . . -156.12 177.19 33.3 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -96.2 137.4 35.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.327 -1.102 . . . . 0.0 110.054 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.7 m -114.89 154.55 28.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.584 -0.697 . . . . 0.0 110.985 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 37.3 p90 -158.03 154.09 27.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.687 -0.633 . . . . 0.0 109.656 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.748 ' C ' HG22 ' A' ' 82' ' ' VAL . . . 159.68 -169.45 35.71 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.525 -1.321 . . . . 0.0 110.607 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.82 165.07 28.35 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.689 -0.889 . . . . 0.0 109.338 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -152.26 -177.05 25.55 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.717 HD12 ' CZ ' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -143.59 147.33 34.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.387 -1.066 . . . . 0.0 110.346 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -114.15 148.85 36.57 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.229 -0.919 . . . . 0.0 110.697 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.717 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 91.6 m-85 -117.99 164.13 15.55 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.653 -0.654 . . . . 0.0 110.213 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -118.81 80.94 18.21 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 0.0 110.32 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.34 -14.48 42.9 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.589 1.31 . . . . 0.0 111.341 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.551 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 79.9 mtp -148.93 -177.58 5.88 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.189 -0.944 . . . . 0.0 108.485 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -69.39 -41.62 76.21 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.748 -0.595 . . . . 0.0 110.948 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -118.08 12.57 13.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.093 -1.004 . . . . 0.0 111.928 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 20.4 t -114.03 137.18 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.92 -1.112 . . . . 0.0 109.94 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 145' ' ' GLY . . . -137.7 135.59 36.59 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.45 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.84 HD12 ' O ' ' A' ' 143' ' ' GLY . 19.3 tp -110.78 147.01 35.35 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -144.68 143.7 30.86 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.483 -1.385 . . . . 0.0 111.206 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.439 ' CZ ' HD21 ' A' ' 123' ' ' LEU . 98.7 m-85 -119.02 142.06 48.15 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.3 t -134.26 139.63 45.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.0 111.263 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -118.67 111.03 18.0 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -141.89 143.76 33.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.556 -0.715 . . . . 0.0 110.596 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -137.09 151.93 49.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.442 -0.786 . . . . 0.0 109.761 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.0 t -126.52 138.65 53.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.834 . . . . 0.0 110.367 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 76.5 mtp180 -136.78 137.57 39.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.402 -0.811 . . . . 0.0 111.151 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.607 ' O ' HG23 ' A' ' 132' ' ' ILE . 6.7 tp -134.23 63.59 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.908 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 69.5 mtp85 59.91 -59.59 0.06 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 132' ' ' ILE . 56.5 p -95.49 -18.63 20.5 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.112 -0.992 . . . . 0.0 111.793 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.529 ' HB ' HG22 ' A' ' 132' ' ' ILE . 47.4 t -128.85 134.26 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 118.682 -1.207 . . . . 0.0 111.729 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -131.32 112.28 12.61 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.898 HG22 ' CB ' ' A' ' 14' ' ' ALA . 21.4 t -117.18 145.28 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.957 -1.089 . . . . 0.0 110.195 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -130.11 114.09 1.59 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.5 t -139.07 154.22 48.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.255 -1.144 . . . . 0.0 111.453 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 43.9 p90 -126.24 146.83 49.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.605 -0.685 . . . . 0.0 109.8 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.533 HD13 ' ND2' ' A' ' 25' ' ' ASN . 72.6 mt -112.4 141.42 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.329 -0.857 . . . . 0.0 110.666 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.79 145.23 31.56 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.437 -0.789 . . . . 0.0 109.895 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.84 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -177.2 -139.38 3.27 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.203 -1.475 . . . . 0.0 111.715 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 35.7 m -114.25 176.78 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 122.035 -0.685 . . . . 0.0 110.838 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.626 ' O ' ' HB3' ' A' ' 122' ' ' ALA . . . -162.42 144.56 9.78 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.33 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -129.8 157.39 42.35 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.842 -0.799 . . . . 0.0 109.263 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 32.1 mtp-105 -123.26 122.94 39.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.091 -1.006 . . . . 0.0 111.244 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 67.7 t80 . . . . . 0 N--CA 1.498 1.944 0 O-C-N 121.461 -0.774 . . . . 0.0 110.514 -179.898 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 65.3 p . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.2 m -119.8 144.21 47.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -0.866 . . . . 0.0 109.418 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.772 HG23 ' O ' ' A' ' 146' ' ' TYR . 76.6 m -136.98 142.37 42.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.579 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.414 ' C ' ' HG1' ' A' ' 6' ' ' THR . 34.4 m -123.0 141.48 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.822 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.793 HG23 ' O ' ' A' ' 144' ' ' VAL . 87.6 m -156.37 130.38 8.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.562 -0.711 . . . . 0.0 109.593 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -164.27 176.23 40.23 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.322 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.73 -125.94 1.05 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -147.06 162.0 39.69 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.478 -1.013 . . . . 0.0 109.528 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.29 142.8 30.67 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.59 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -125.07 143.9 50.68 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.628 ' OG ' HG23 ' A' ' 139' ' ' THR . 1.0 OUTLIER -147.47 149.23 32.27 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.266 -178.122 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.87 ' O ' HG13 ' A' ' 137' ' ' VAL . 52.7 t0 -74.98 148.87 39.56 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.719 ' HB1' ' HB2' ' A' ' 17' ' ' GLN . . . -125.15 100.52 6.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.804 -1.185 . . . . 0.0 111.578 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -79.58 115.06 18.98 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.51 -15.89 45.32 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.719 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 89.9 mt-30 -106.08 171.87 7.11 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.104 -1.233 . . . . 0.0 109.825 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.41 ' CG ' ' HE2' ' A' ' 48' ' ' LYS . 89.3 mtp -56.52 -49.84 73.57 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.332 -0.855 . . . . 0.0 111.659 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.541 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 47.4 p-10 -162.43 -155.7 0.37 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.698 -1.251 . . . . 0.0 110.435 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -84.25 166.92 17.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.334 -0.854 . . . . 0.0 111.005 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.6 mtt -126.03 167.9 14.69 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.442 -0.787 . . . . 0.0 110.918 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.46 128.44 2.93 Favored Glycine 0 N--CA 1.502 3.049 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.392 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.71 ' HA3' HG22 ' A' ' 46' ' ' THR . . . -145.92 -167.29 12.49 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.295 -1.431 . . . . 0.0 111.033 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -122.13 161.73 22.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.855 -0.791 . . . . 0.0 109.494 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.412 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 25.3 p-10 -148.61 135.66 20.08 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.227 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.4 mt -113.76 150.37 33.51 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 80.2 mttt -136.46 142.08 43.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.508 -1.37 . . . . 0.0 110.511 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.46 123.82 44.98 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.528 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 45.9 ttp180 -123.17 143.56 49.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.147 -0.97 . . . . 0.0 112.123 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -112.81 133.69 54.69 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -142.77 153.86 43.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.396 -0.815 . . . . 0.0 109.912 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 0.0 110.185 179.718 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 CA--C 1.537 0.627 0 N-CA-C 109.913 -0.841 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.5 119.81 33.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.534 -0.729 . . . . 0.0 110.004 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . -121.89 134.75 10.04 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.7 t -130.48 132.86 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.336 -1.097 . . . . 0.0 108.921 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.466 HG12 ' CG ' ' A' ' 29' ' ' ARG . 72.4 mt -120.3 139.45 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.742 -1.224 . . . . 0.0 110.818 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 27' ' ' LYS . . . -112.98 117.78 4.37 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 107.703 -2.159 . . . . 0.0 107.703 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.421 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 48.3 t -123.84 141.68 51.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.144 -1.21 . . . . 0.0 112.503 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.05 142.18 49.08 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.5 m -130.91 139.14 50.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.004 -1.06 . . . . 0.0 110.902 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -136.69 110.65 8.24 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.71 HG22 ' HA3' ' A' ' 23' ' ' GLY . 44.6 p -121.69 157.83 30.04 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.464 -0.773 . . . . 0.0 109.989 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -118.31 155.38 30.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -0.853 . . . . 0.0 110.237 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.41 ' HE2' ' CG ' ' A' ' 18' ' ' MET . 18.1 tttt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -121.55 112.79 18.93 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.197 -0.94 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.421 ' HB3' ' HB2' ' A' ' 87' ' ' TYR . 49.0 t80 -98.42 140.3 32.89 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.07 117.7 0.95 Allowed Glycine 0 N--CA 1.486 2.01 0 C-N-CA 119.168 -1.491 . . . . 0.0 110.337 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.44 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 14.4 tt -112.03 134.97 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 83' ' ' VAL . 70.9 m -151.7 141.68 22.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.812 -1.18 . . . . 0.0 111.712 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.543 ' O ' HG22 ' A' ' 83' ' ' VAL . . . -147.58 150.05 33.72 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.86 170.59 40.7 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.751 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 48.1 Cg_endo -74.07 172.47 15.88 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 123.955 1.503 . . . . 0.0 110.741 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.61 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -148.62 141.55 24.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.482 -0.762 . . . . 0.0 109.741 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -127.19 146.17 50.5 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.611 -0.68 . . . . 0.0 110.77 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.518 -0.739 . . . . 0.0 109.927 179.271 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 121.357 0.599 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.9 t -138.13 150.06 46.48 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.522 -0.736 . . . . 0.0 109.72 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.6 tt -133.55 138.04 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.999 -1.063 . . . . 0.0 109.973 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -147.89 158.15 43.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.158 -0.963 . . . . 0.0 111.635 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -107.08 161.01 13.92 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 107.919 -2.072 . . . . 0.0 107.919 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 110' ' ' GLY . 35.0 m -142.58 146.81 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.093 -1.239 . . . . 0.0 111.96 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.736 ' O ' HG23 ' A' ' 66' ' ' THR . 26.8 m -138.15 152.26 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . -179.85 177.5 48.12 Favored Glycine 0 N--CA 1.479 1.548 0 C-N-CA 118.876 -1.63 . . . . 0.0 110.734 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.442 ' CG1' ' CZ ' ' A' ' 87' ' ' TYR . 48.7 t -122.3 135.78 61.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-O 121.738 0.78 . . . . 0.0 111.002 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . -103.4 133.97 11.67 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.442 ' CZ ' ' CG1' ' A' ' 85' ' ' VAL . 91.5 m-85 -117.09 146.1 43.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.153 -1.204 . . . . 0.0 110.47 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.32 116.84 3.26 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.7 mttp . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.516 -0.991 . . . . 0.0 109.963 179.775 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 52.6 t0 . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 38.6 p90 -132.04 170.34 15.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 111.436 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.709 ' HA3' HD13 ' A' ' 132' ' ' ILE . . . -160.03 -177.46 33.14 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -106.64 150.14 26.52 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.965 -1.315 . . . . 0.0 111.634 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 96.4 p -128.86 161.57 29.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.716 -0.615 . . . . 0.0 110.108 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -155.68 148.52 24.26 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.379 -0.825 . . . . 0.0 109.802 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.78 ' O ' HG22 ' A' ' 82' ' ' VAL . . . 175.0 -175.36 47.07 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.468 -1.349 . . . . 0.0 110.827 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.67 159.51 9.99 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.609 -0.936 . . . . 0.0 109.022 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.48 -174.75 30.69 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.31 162.02 36.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.22 -1.165 . . . . 0.0 111.059 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.5 ' HG2' ' HB3' ' A' ' 124' ' ' ASP . 91.3 mt-30 -107.68 144.49 34.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.523 -0.735 . . . . 0.0 109.537 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . 0.447 ' CZ ' ' CE2' ' A' ' 125' ' ' PHE . 46.2 p90 -152.23 151.85 31.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.457 -0.777 . . . . 0.0 110.302 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 115' ' ' PHE . 0.9 OUTLIER 166.75 142.34 0.05 OUTLIER Pre-proline 0 N--CA 1.509 2.493 0 O-C-N 121.776 -0.577 . . . . 0.0 111.013 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 116' ' ' ASN . 52.0 Cg_endo -88.51 47.96 1.29 Allowed 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.491 1.259 . . . . 0.0 109.155 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.438 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 95.6 mmm -142.26 135.25 28.63 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 121.401 -0.812 . . . . 0.0 108.94 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.08 -42.3 99.61 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.813 -0.554 . . . . 0.0 112.44 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -106.58 5.55 29.18 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.721 -1.237 . . . . 0.0 112.922 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 48.4 t -119.92 136.42 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.715 -1.241 . . . . 0.0 110.506 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 116' ' ' ASN . . . -145.44 129.98 17.91 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.577 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 144' ' ' VAL . 80.6 mt -111.95 150.67 30.2 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.5 ' HB3' ' HG2' ' A' ' 114' ' ' GLN . 54.1 p30 -148.76 156.1 41.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.653 -1.279 . . . . 0.0 112.42 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . 0.447 ' CE2' ' CZ ' ' A' ' 115' ' ' PHE . 34.2 m-85 -123.64 141.41 52.04 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.545 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.2 m -138.98 147.75 42.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.382 -0.824 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -117.97 124.23 47.69 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -133.58 138.25 45.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.264 -0.898 . . . . 0.0 111.416 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -119.68 128.61 53.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.639 -0.663 . . . . 0.0 109.537 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.9 m -122.31 146.34 47.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.287 -0.883 . . . . 0.0 110.626 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -129.39 125.18 36.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.432 -0.793 . . . . 0.0 110.117 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.709 HD13 ' HA3' ' A' ' 106' ' ' GLY . 14.7 mm -113.87 63.44 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.456 ' HB3' ' O ' ' A' ' 132' ' ' ILE . 22.9 ttt180 66.23 -60.04 0.32 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.406 -0.809 . . . . 0.0 111.349 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 132' ' ' ILE . 0.6 OUTLIER -125.68 9.23 7.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.057 -1.027 . . . . 0.0 111.16 -179.6 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.562 HG11 ' NE2' ' A' ' 17' ' ' GLN . 43.9 t -124.77 132.88 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.182 -0.949 . . . . 0.0 110.678 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -131.54 111.78 12.06 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 13' ' ' ASP . 88.1 t -115.24 145.13 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 110.799 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -107.47 103.9 2.02 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 107.116 -2.394 . . . . 0.0 107.116 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.628 HG23 ' OG ' ' A' ' 12' ' ' SER . 53.2 m -104.9 136.85 43.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -1.069 . . . . 0.0 112.105 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -114.22 134.34 54.99 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 75.1 mt -116.05 132.55 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 110.52 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.0 143.06 31.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.479 -0.763 . . . . 0.0 109.425 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -174.77 -146.71 5.83 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 118.709 -1.71 . . . . 0.0 112.151 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.793 ' O ' HG23 ' A' ' 6' ' ' THR . 34.1 m -118.47 175.69 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.289 0.566 . . . . 0.0 111.075 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -157.36 139.84 6.7 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.772 ' O ' HG23 ' A' ' 4' ' ' THR . 97.7 m-85 -132.98 157.37 45.36 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.598 -0.942 . . . . 0.0 109.837 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -131.9 121.33 23.85 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.271 -0.893 . . . . 0.0 111.065 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.403 -0.81 . . . . 0.0 110.29 -179.874 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.4 p . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.9 p -112.44 145.82 39.49 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.36 -0.838 . . . . 0.0 109.68 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.71 HG21 ' CZ ' ' A' ' 29' ' ' ARG . 91.8 m -136.98 139.18 41.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.857 . . . . 0.0 110.634 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.05 142.25 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.571 -0.705 . . . . 0.0 109.846 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.785 HG23 ' O ' ' A' ' 144' ' ' VAL . 62.8 m -156.42 130.52 8.56 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.44 -0.788 . . . . 0.0 110.123 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.411 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -165.66 171.6 40.91 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.61 -136.36 2.3 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -132.76 158.54 42.16 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.549 -0.971 . . . . 0.0 109.108 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.469 ' HB1' ' O ' ' A' ' 140' ' ' TRP . . . -145.39 142.3 29.22 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.286 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -111.54 145.8 38.45 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.614 ' HB2' HG23 ' A' ' 139' ' ' THR . 19.8 t -146.35 151.22 37.14 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.411 -1.316 . . . . 0.0 112.914 -177.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.712 ' O ' HG13 ' A' ' 137' ' ' VAL . 86.5 m-20 -100.92 150.64 22.65 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.743 ' HB3' ' HB2' ' A' ' 17' ' ' GLN . . . -134.12 116.3 15.26 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.787 -1.196 . . . . 0.0 111.823 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -67.03 117.14 8.68 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.59 -14.18 38.82 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.743 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 87.6 mt-30 -114.59 156.62 24.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.348 -1.09 . . . . 0.0 109.356 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 70.1 mtm -100.51 -75.52 0.58 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.206 -0.933 . . . . 0.0 111.613 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -57.46 132.04 51.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.366 -0.834 . . . . 0.0 111.553 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -63.6 169.07 4.17 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.663 . . . . 0.0 110.237 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 90.1 mtp -128.15 166.7 18.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.279 -0.888 . . . . 0.0 111.44 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.814 ' O ' HG23 ' A' ' 46' ' ' THR . . . -124.86 178.94 16.34 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 107.904 -2.079 . . . . 0.0 107.904 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.94 148.27 9.19 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 118.57 -1.776 . . . . 0.0 111.89 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -109.24 133.68 52.72 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.411 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 76.1 m-20 -120.85 128.4 52.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.201 -0.937 . . . . 0.0 111.852 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.579 HD21 ' OH ' ' A' ' 28' ' ' TYR . 25.0 tp -121.58 133.53 55.0 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.43 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 22.7 mttt -136.08 146.71 47.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.313 -1.492 . . . . 0.0 111.44 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . 0.579 ' OH ' HD21 ' A' ' 26' ' ' LEU . 97.4 m-85 -115.96 129.46 56.4 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.71 ' CZ ' HG21 ' A' ' 4' ' ' THR . 56.2 ttp180 -128.57 134.32 48.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.15 -0.969 . . . . 0.0 112.106 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . 0.468 ' O ' HG22 ' A' ' 39' ' ' VAL . 99.4 m-85 -125.06 139.95 53.33 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.592 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -142.04 150.26 41.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.144 -0.973 . . . . 0.0 110.278 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.368 -0.833 . . . . 0.0 109.662 -179.931 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo . . . . . 0 N--CA 1.481 0.784 0 N-CA-C 111.061 -0.4 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.05 76.27 7.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.318 -0.864 . . . . 0.0 110.203 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 69' ' ' PRO . . . -79.67 132.85 11.74 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 30' ' ' TYR . 35.6 m -132.67 129.26 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.359 -1.083 . . . . 0.0 108.925 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 17.0 tt -132.11 144.75 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.893 . . . . 0.0 111.431 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.58 148.21 16.38 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.43 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 42.3 t -138.72 141.53 38.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.272 . . . . 0.0 111.891 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -125.49 138.31 53.98 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 t -134.62 145.78 48.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.974 -1.079 . . . . 0.0 111.216 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -127.99 111.38 13.48 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.814 HG23 ' O ' ' A' ' 22' ' ' GLY . 87.1 m -119.24 141.9 48.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.692 -0.63 . . . . 0.0 110.68 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -148.75 179.63 7.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.843 . . . . 0.0 110.075 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 mttp . . . . . 0 N--CA 1.494 1.735 0 O-C-N 121.437 -0.789 . . . . 0.0 109.99 179.898 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 . . . . . 0 N--CA 1.494 1.756 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -110.33 118.41 36.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.217 -0.927 . . . . 0.0 110.748 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.465 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 46.6 t80 -98.44 139.66 33.85 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.73 122.27 1.4 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 118.969 -1.586 . . . . 0.0 110.987 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.581 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 43.7 pt -112.85 138.0 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 1.3 p -153.57 144.29 22.62 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.584 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.617 ' O ' HG22 ' A' ' 83' ' ' VAL . . . -151.26 153.59 35.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.473 -0.767 . . . . 0.0 109.27 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.85 174.15 43.43 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.536 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 45.9 Cg_endo -71.8 167.69 25.88 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.891 1.469 . . . . 0.0 110.846 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -148.51 141.7 25.04 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.412 -0.805 . . . . 0.0 110.404 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -120.5 131.56 54.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.503 -0.748 . . . . 0.0 110.503 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.657 -0.652 . . . . 0.0 110.391 179.361 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.78 ' HB1' ' O ' ' A' ' 114' ' ' GLN . . . . . . . . 0 N--CA 1.499 1.98 0 CA-C-O 121.123 0.487 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 24.6 m -115.5 146.14 41.97 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.357 -0.839 . . . . 0.0 109.364 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.0 mt -131.31 138.44 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.149 -0.969 . . . . 0.0 111.234 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -142.25 157.22 45.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.492 -0.755 . . . . 0.0 110.461 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.51 164.2 13.5 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.519 HG13 ' HB ' ' A' ' 66' ' ' THR . 48.9 t -139.24 132.79 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -1.158 . . . . 0.0 111.086 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 67' ' ' ALA . 26.7 m -141.89 151.95 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.581 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 164.24 -161.42 34.42 Favored Glycine 0 N--CA 1.48 1.572 0 C-N-CA 119.157 -1.497 . . . . 0.0 110.755 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.554 HG22 ' CG1' ' A' ' 65' ' ' ILE . 33.8 m -130.16 162.87 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 122.226 1.013 . . . . 0.0 112.651 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.07 137.84 7.9 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.465 ' CE2' ' HB3' ' A' ' 63' ' ' TYR . 13.9 p90 -150.82 163.94 37.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.081 -1.246 . . . . 0.0 110.701 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -119.36 141.28 15.61 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.4 tttt . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.826 -0.808 . . . . 0.0 109.942 179.914 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.896 ' O ' HG23 ' A' ' 132' ' ' ILE . 43.2 p90 -133.04 169.44 16.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.256 -0.902 . . . . 0.0 110.912 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -163.03 -175.75 34.38 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.432 ' CD1' HG12 ' A' ' 85' ' ' VAL . 98.8 m-85 -112.03 155.28 24.07 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.186 -1.185 . . . . 0.0 110.655 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 97.6 p -129.86 160.92 32.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.491 -0.755 . . . . 0.0 110.646 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.561 ' CD1' HG12 ' A' ' 83' ' ' VAL . 65.7 t80 -155.26 148.03 24.35 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.439 -0.788 . . . . 0.0 109.673 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 175.82 -176.77 47.59 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.602 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.88 160.0 9.94 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.713 -0.875 . . . . 0.0 108.707 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.433 ' C ' HD12 ' A' ' 113' ' ' LEU . . . -152.47 -179.1 27.77 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 113' ' ' LEU . 5.3 mp -126.68 160.1 31.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.453 -1.027 . . . . 0.0 110.002 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.78 ' O ' ' HB1' ' A' ' 77' ' ' ALA . 36.5 tt0 -106.65 140.65 39.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.81 -1.181 . . . . 0.0 108.057 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -124.65 165.19 18.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.372 -0.83 . . . . 0.0 111.518 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.84 88.94 0.1 OUTLIER Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.865 -0.522 . . . . 0.0 109.927 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.96 125.49 12.63 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.734 1.386 . . . . 0.0 110.398 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.43 ' CB ' ' HB ' ' A' ' 121' ' ' VAL . 95.5 mmm -145.21 163.25 35.0 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.13 -49.08 77.31 Favored 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.688 -0.632 . . . . 0.0 110.401 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -134.17 25.26 3.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.274 -0.891 . . . . 0.0 111.349 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.43 ' HB ' ' CB ' ' A' ' 118' ' ' MET . 48.2 t -127.11 139.66 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.95 -1.094 . . . . 0.0 109.964 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.715 ' HB1' ' CD ' ' A' ' 114' ' ' GLN . . . -154.81 137.7 15.41 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.785 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' A' ' 144' ' ' VAL . 77.7 mt -121.65 143.62 49.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -149.45 153.25 37.0 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 118.246 -1.381 . . . . 0.0 112.395 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.31 140.14 53.08 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.6 t -143.62 149.23 37.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -0.977 . . . . 0.0 111.181 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -104.9 123.41 47.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.637 -0.665 . . . . 0.0 109.368 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -137.36 142.84 41.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.634 -0.666 . . . . 0.0 110.481 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -138.5 156.88 47.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.52 -0.738 . . . . 0.0 109.765 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.2 t -133.33 143.53 49.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.385 -0.822 . . . . 0.0 110.53 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -124.59 127.73 47.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.563 -0.71 . . . . 0.0 109.761 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.896 HG23 ' O ' ' A' ' 105' ' ' TYR . 85.1 mt -121.17 39.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 68.5 mtt180 63.64 -55.13 0.21 Allowed 'General case' 0 N--CA 1.503 2.207 0 O-C-N 122.03 -0.419 . . . . 0.0 111.578 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 132' ' ' ILE . 66.5 p -99.93 -24.14 14.73 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.121 -0.987 . . . . 0.0 110.398 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 56.1 t -126.51 132.39 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.246 -0.909 . . . . 0.0 110.732 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -132.55 113.19 12.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 109.02 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.712 HG22 ' CB ' ' A' ' 14' ' ' ALA . 61.3 t -117.54 146.4 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.937 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -115.78 114.62 3.17 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.614 HG23 ' HB2' ' A' ' 12' ' ' SER . 27.8 m -109.03 140.56 42.39 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.209 -1.171 . . . . 0.0 112.322 -178.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.469 ' O ' ' HB1' ' A' ' 10' ' ' ALA . 41.6 m95 -109.01 136.75 48.03 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 46.4 pt -124.14 147.06 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.98 -1.075 . . . . 0.0 111.654 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -154.43 139.6 17.48 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -168.59 -153.21 8.12 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 118.695 -1.717 . . . . 0.0 112.072 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.785 ' O ' HG23 ' A' ' 6' ' ' THR . 34.5 m -116.97 177.64 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 122.236 -0.567 . . . . 0.0 110.738 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -156.4 140.21 7.06 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.485 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -130.34 152.31 49.88 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.578 -0.954 . . . . 0.0 109.654 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -128.04 120.68 27.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.206 -0.934 . . . . 0.0 110.81 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.5 t80 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.48 -0.763 . . . . 0.0 110.205 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.6 p . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.5 m -116.44 145.21 43.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.9 . . . . 0.0 109.453 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 29' ' ' ARG . 57.9 m -136.21 142.0 44.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.895 . . . . 0.0 110.673 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.435 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 14.7 p -128.61 141.39 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.655 -0.653 . . . . 0.0 109.571 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 144' ' ' VAL . 71.8 m -156.68 133.07 9.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.51 -0.744 . . . . 0.0 109.815 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -166.23 173.47 41.73 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.156 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.85 -128.23 1.19 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -118.35 152.77 35.17 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.406 -1.055 . . . . 0.0 109.866 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.02 116.52 22.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 110.688 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -110.62 142.71 42.11 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.3 t -148.49 145.35 27.9 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.42 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -73.3 150.86 41.6 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.899 ' HB1' ' HB2' ' A' ' 17' ' ' GLN . . . -127.94 90.52 3.11 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.959 -1.096 . . . . 0.0 112.046 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -80.91 116.09 20.71 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.87 -14.41 60.22 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.899 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 93.2 mt-30 -100.83 172.75 6.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.018 -1.283 . . . . 0.0 110.463 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 88.0 mtp -57.55 -49.39 76.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.432 -0.792 . . . . 0.0 112.11 -178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -164.55 -158.26 0.41 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.771 -1.206 . . . . 0.0 110.655 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -77.68 159.98 28.78 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.437 -0.79 . . . . 0.0 110.304 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.733 ' HB3' HG22 ' A' ' 46' ' ' THR . 85.9 mtp -126.75 163.98 22.35 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.26 -0.9 . . . . 0.0 111.083 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.736 ' C ' HG23 ' A' ' 46' ' ' THR . . . -145.96 126.02 2.42 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.573 ' N ' HG23 ' A' ' 46' ' ' THR . . . -142.75 -171.78 13.53 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.567 -1.302 . . . . 0.0 110.771 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.48 146.62 40.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.636 -0.92 . . . . 0.0 109.988 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.418 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 51.2 t-20 -130.85 127.85 39.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.831 . . . . 0.0 110.997 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.794 HD13 ' N ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -115.83 141.62 47.85 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.592 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.794 ' N ' HD13 ' A' ' 26' ' ' LEU . 31.9 mttm -130.8 144.86 51.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.419 -1.425 . . . . 0.0 110.501 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -122.75 124.46 43.41 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.47 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 59.0 ttt180 -122.74 142.72 50.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.147 -0.971 . . . . 0.0 111.953 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -114.07 137.23 51.99 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -138.44 152.01 47.95 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.4 -0.813 . . . . 0.0 109.61 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.045 -1.034 . . . . 0.0 109.93 179.773 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 CA--C 1.541 0.844 0 N-CA-C 110.547 -0.597 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.1 tp -94.48 120.35 34.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.843 -0.536 . . . . 0.0 110.909 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.49 134.19 9.57 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.4 t -130.8 135.13 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.341 -1.094 . . . . 0.0 109.044 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.525 HD12 ' HB2' ' A' ' 80' ' ' TYR . 73.5 mt -119.87 140.59 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.855 -1.153 . . . . 0.0 110.936 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.43 125.63 6.68 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 107.758 -2.137 . . . . 0.0 107.758 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.45 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 92.7 p -134.02 144.98 49.03 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.012 -1.287 . . . . 0.0 112.577 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -125.54 140.27 52.89 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 m -132.34 142.42 49.32 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.912 -1.117 . . . . 0.0 111.402 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.417 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 78.3 t80 -131.79 109.67 10.3 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.736 HG23 ' C ' ' A' ' 22' ' ' GLY . 9.1 m -122.1 145.62 47.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.467 -0.771 . . . . 0.0 110.733 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -147.32 167.6 23.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.288 -0.882 . . . . 0.0 110.275 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.4 mttp . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.439 -0.788 . . . . 0.0 109.976 179.742 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 120.883 0.373 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -125.02 117.6 24.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.384 -0.822 . . . . 0.0 110.851 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' A' ' 87' ' ' TYR . 95.5 m-85 -109.78 139.11 45.21 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.58 125.93 2.1 Favored Glycine 0 N--CA 1.485 1.957 0 C-N-CA 119.094 -1.527 . . . . 0.0 110.292 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.578 ' CG2' HG12 ' A' ' 85' ' ' VAL . 16.7 tt -108.43 137.59 39.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -151.41 140.19 20.84 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.018 -1.073 . . . . 0.0 111.126 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.793 ' O ' HG22 ' A' ' 83' ' ' VAL . . . -156.34 152.07 27.15 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.36 178.32 43.13 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.601 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.26 169.23 21.21 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 O-C-N 123.949 1.5 . . . . 0.0 110.638 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.93 145.89 21.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.586 -0.696 . . . . 0.0 110.028 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -120.99 141.18 50.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.655 -0.653 . . . . 0.0 109.948 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.499 -0.75 . . . . 0.0 110.263 179.909 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.367 0 CA-C-O 121.447 0.641 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.806 ' O ' HD12 ' A' ' 113' ' ' LEU . 50.6 m -125.83 148.74 49.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.542 -0.724 . . . . 0.0 109.8 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.58 HG12 HD13 ' A' ' 113' ' ' LEU . 81.1 mt -123.41 137.17 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.151 -0.968 . . . . 0.0 110.474 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.525 ' HB2' HD12 ' A' ' 40' ' ' ILE . 39.7 p90 -146.9 166.19 27.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.367 -0.833 . . . . 0.0 110.878 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.41 162.15 19.73 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.409 ' HB ' ' HB ' ' A' ' 66' ' ' THR . 34.6 m -135.26 141.07 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -1.108 . . . . 0.0 111.232 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 67' ' ' ALA . 36.0 m -142.63 151.44 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 160.36 -149.34 18.62 Favored Glycine 0 N--CA 1.483 1.772 0 C-N-CA 119.265 -1.445 . . . . 0.0 110.953 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.578 HG12 ' CG2' ' A' ' 65' ' ' ILE . 11.1 p -133.04 144.29 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 122.459 1.123 . . . . 0.0 113.567 -177.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.2 137.68 14.46 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.525 ' CE2' HG13 ' A' ' 85' ' ' VAL . 90.0 m-85 -120.65 143.56 48.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.141 -1.211 . . . . 0.0 110.796 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -125.02 114.59 2.22 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.0 tptm . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.491 -1.005 . . . . 0.0 110.253 -179.725 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.527 ' HB3' HD12 ' A' ' 132' ' ' ILE . 52.4 t0 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.024 0.44 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.453 ' HB3' ' CD1' ' A' ' 87' ' ' TYR . 43.4 p90 -127.6 168.83 14.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.275 -0.89 . . . . 0.0 110.305 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.682 ' HA3' HG22 ' A' ' 132' ' ' ILE . . . -159.83 -175.86 31.27 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -103.38 144.71 31.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.134 -1.215 . . . . 0.0 111.333 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.0 m -118.08 150.33 39.51 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 110.059 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -154.63 146.57 23.52 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.452 -0.78 . . . . 0.0 109.978 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.91 -176.27 42.55 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.016 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 80' ' ' TYR . . . -160.81 162.89 32.43 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.46 -178.07 24.12 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.289 -1.434 . . . . 0.0 110.221 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.806 HD12 ' O ' ' A' ' 78' ' ' SER . 20.2 tp -139.51 149.39 43.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.609 -0.936 . . . . 0.0 109.923 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -127.06 151.81 48.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.185 -0.947 . . . . 0.0 109.824 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -156.88 161.19 39.68 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.359 -0.838 . . . . 0.0 110.883 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . 0.489 ' HB2' ' HA ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER 172.77 140.36 0.13 Allowed Pre-proline 0 N--CA 1.504 2.266 0 O-C-N 121.643 -0.661 . . . . 0.0 111.323 179.251 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 116' ' ' ASN . 52.2 Cg_endo -88.37 50.6 1.7 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.581 1.306 . . . . 0.0 109.011 177.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.457 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 86.6 mtp -146.25 140.58 26.63 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.527 -0.733 . . . . 0.0 109.068 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.48 -39.46 91.95 Favored 'General case' 0 C--N 1.292 -1.914 0 O-C-N 121.781 -0.574 . . . . 0.0 112.423 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -115.46 13.6 16.5 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.665 -1.272 . . . . 0.0 112.631 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 47.1 t -123.94 136.28 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.781 -1.199 . . . . 0.0 109.787 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.489 ' HA ' ' HB2' ' A' ' 116' ' ' ASN . . . -153.3 138.15 17.11 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.643 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.1 mt -103.13 153.1 20.67 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 142' ' ' ALA . 52.5 t0 -143.97 136.52 26.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.569 -1.332 . . . . 0.0 110.361 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -128.71 142.28 51.06 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.6 t -145.91 155.74 43.07 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.132 -0.98 . . . . 0.0 111.375 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -107.14 119.27 38.91 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.532 ' HB3' HG23 ' A' ' 139' ' ' THR . 84.5 tt0 -131.96 144.32 50.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 110.9 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -141.26 155.0 46.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.577 -0.702 . . . . 0.0 109.609 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 29.3 t -142.46 141.3 32.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.397 -0.814 . . . . 0.0 110.294 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 -129.42 133.35 47.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.472 -0.768 . . . . 0.0 109.87 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.682 HG22 ' HA3' ' A' ' 106' ' ' GLY . 24.6 pt -125.15 48.76 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 76.7 mtt85 60.59 -56.62 0.08 Allowed 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 132' ' ' ILE . 53.4 m -92.18 -21.67 20.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 111.006 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.468 ' HB ' HG12 ' A' ' 132' ' ' ILE . 37.6 t -135.12 137.55 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.646 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -132.74 113.69 13.27 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.847 HG12 ' HA ' ' A' ' 14' ' ' ALA . 34.0 m -121.33 149.19 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.234 -0.916 . . . . 0.0 110.835 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -114.28 129.35 8.68 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.532 HG23 ' HB3' ' A' ' 128' ' ' GLU . 14.7 t -126.31 143.9 51.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -1.134 . . . . 0.0 112.263 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -123.06 140.89 52.55 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.542 HD12 ' HE3' ' A' ' 27' ' ' LYS . 49.6 pt -120.5 149.94 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.122 -0.986 . . . . 0.0 111.187 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 124' ' ' ASP . . . -150.07 140.08 21.99 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -173.53 -146.3 5.47 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 118.783 -1.675 . . . . 0.0 111.906 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.784 ' O ' HG23 ' A' ' 6' ' ' THR . 35.4 m -118.77 179.87 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 122.229 -0.571 . . . . 0.0 110.908 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 5' ' ' VAL . . . -160.84 143.61 9.11 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.899 -1.143 . . . . 0.0 110.729 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -132.73 156.12 47.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.655 -0.909 . . . . 0.0 109.726 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 46.3 ptt85 -133.96 123.85 25.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.346 -0.846 . . . . 0.0 111.268 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.8 p90 . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.346 -0.846 . . . . 0.0 110.397 179.939 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 48.5 m . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.0 p -117.34 144.31 45.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 109.751 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 146' ' ' TYR . 56.7 m -135.83 140.21 44.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.418 -0.801 . . . . 0.0 110.505 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -115.18 138.31 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 144' ' ' VAL . 27.6 m -156.34 132.54 9.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.237 -0.914 . . . . 0.0 110.023 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.99 171.95 38.89 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.82 -148.43 7.91 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 46.2 p90 -139.36 159.86 41.17 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.442 -1.034 . . . . 0.0 109.85 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.829 ' HB2' HG22 ' A' ' 141' ' ' ILE . . . -145.67 147.07 31.58 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.838 -1.145 . . . . 0.0 111.628 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.89 ' O ' HG23 ' A' ' 139' ' ' THR . 94.5 mt-30 -99.19 138.16 36.68 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.404 ' HB3' HG11 ' A' ' 137' ' ' VAL . 43.5 m -119.73 145.13 46.82 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.193 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -136.69 141.09 43.09 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.894 ' CB ' HG22 ' A' ' 137' ' ' VAL . . . -153.96 149.52 27.34 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 120.411 -1.431 . . . . 0.0 112.482 -177.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -79.32 128.03 32.82 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.6 -28.29 14.77 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . 0.536 ' NE2' HG11 ' A' ' 135' ' ' VAL . 96.5 mt-30 -114.02 157.26 22.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.457 -1.025 . . . . 0.0 110.212 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . 0.406 ' O ' ' HB2' ' A' ' 19' ' ' ASN . 64.8 mtt -121.46 171.33 8.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.442 -0.786 . . . . 0.0 110.29 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 18' ' ' MET . 18.2 m120 61.7 115.97 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.631 -0.668 . . . . 0.0 110.511 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -65.95 164.09 15.8 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.578 -0.701 . . . . 0.0 110.305 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 87.2 mtp -126.19 165.75 18.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.46 -0.775 . . . . 0.0 110.713 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.1 123.37 1.83 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.709 ' HA3' HG22 ' A' ' 46' ' ' THR . . . -135.73 -172.67 12.74 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.153 -1.498 . . . . 0.0 110.754 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -119.0 148.6 42.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.804 -0.821 . . . . 0.0 108.999 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.405 ' ND2' ' HE2' ' A' ' 27' ' ' LYS . 44.9 t-20 -125.59 134.65 51.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 111.265 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.2 mt -113.27 147.72 37.02 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 26.5 mttt -147.89 137.34 22.37 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.63 -1.294 . . . . 0.0 110.979 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -119.84 130.9 55.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.459 -0.776 . . . . 0.0 108.928 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.414 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 14.2 ttp180 -132.27 140.27 48.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.14 -0.975 . . . . 0.0 111.878 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -119.0 133.3 55.91 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -141.97 142.75 32.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.199 -0.938 . . . . 0.0 110.459 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.419 -0.8 . . . . 0.0 109.879 179.557 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 N--CA 1.481 0.759 0 N-CA-C 111.183 -0.353 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 28.1 tp -116.59 84.72 2.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.26 -0.9 . . . . 0.0 110.595 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.74 -175.83 24.8 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.02 147.04 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.488 -1.007 . . . . 0.0 109.342 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.77 HG22 ' O ' ' A' ' 68' ' ' GLY . 16.5 tt -135.75 146.64 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.239 -0.913 . . . . 0.0 111.451 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 27' ' ' LYS . . . -115.73 151.16 18.49 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.5 t -140.35 142.27 35.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.075 -1.25 . . . . 0.0 111.788 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -129.95 138.67 50.99 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.4 t -134.04 148.55 51.09 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.95 -1.094 . . . . 0.0 111.677 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -141.59 114.37 8.48 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.709 HG22 ' HA3' ' A' ' 23' ' ' GLY . 32.3 p -122.11 159.73 26.53 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.418 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -142.35 170.9 14.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.747 . . . . 0.0 110.418 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.0 pttt . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.398 -0.814 . . . . 0.0 110.305 179.847 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.415 ' HB3' ' OG1' ' A' ' 46' ' ' THR . 69.4 t80 -110.48 117.53 33.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.779 . . . . 0.0 110.98 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' A' ' 87' ' ' TYR . 86.4 m-85 -113.62 135.08 54.31 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.098 0.475 . . . . 0.0 109.776 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.01 126.8 2.52 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.547 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.551 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 14.0 tt -122.03 134.63 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 1.1 p -149.71 143.79 25.68 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.668 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 40' ' ' ILE . . . -141.23 150.09 42.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.685 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.77 ' O ' HG22 ' A' ' 40' ' ' ILE . . . -167.84 168.24 40.58 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.65 176.97 8.1 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.788 1.415 . . . . 0.0 110.681 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.404 ' CB ' ' HD2' ' A' ' 29' ' ' ARG . . . -157.49 147.99 21.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.476 -0.765 . . . . 0.0 110.847 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -118.49 134.81 54.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.429 -0.795 . . . . 0.0 109.646 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.5 ttt-85 . . . . . 0 N--CA 1.496 1.86 0 O-C-N 121.456 -0.777 . . . . 0.0 110.765 -179.485 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.103 0.477 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 33.7 t -95.77 142.44 28.05 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.492 -0.755 . . . . 0.0 109.8 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.0 tt -132.62 144.43 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.361 -0.837 . . . . 0.0 110.451 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -142.96 153.98 43.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -0.812 . . . . 0.0 110.882 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.48 161.79 21.42 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 110' ' ' GLY . 47.3 t -134.45 132.77 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.119 -1.224 . . . . 0.0 111.467 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 66' ' ' THR . 60.5 t -137.29 145.59 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 170.7 -166.39 39.59 Favored Glycine 0 N--CA 1.477 1.412 0 C-N-CA 118.537 -1.792 . . . . 0.0 111.337 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.595 HG11 ' CE2' ' A' ' 105' ' ' TYR . 33.2 m -133.84 177.07 7.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 121.838 0.827 . . . . 0.0 111.529 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.39 145.05 15.67 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' A' ' 63' ' ' TYR . 99.2 m-85 -126.06 132.49 51.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.201 -1.176 . . . . 0.0 109.732 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.06 129.02 9.15 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.3 tttt . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.594 -0.945 . . . . 0.0 109.676 179.695 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.595 ' CE2' HG11 ' A' ' 85' ' ' VAL . 39.4 t80 -81.69 131.0 35.25 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.108 -0.995 . . . . 0.0 111.443 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . 0.714 ' HA3' HD13 ' A' ' 132' ' ' ILE . . . -117.96 -164.13 13.02 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 66.0 t80 -140.8 148.86 41.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.443 -1.033 . . . . 0.0 109.917 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.7 m -136.6 143.57 43.65 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.198 -0.939 . . . . 0.0 110.858 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 128' ' ' GLU . 69.2 t80 -151.7 141.38 21.8 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.449 -0.782 . . . . 0.0 110.014 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 82' ' ' VAL . . . 174.87 -176.07 47.04 Favored Glycine 0 N--CA 1.497 2.727 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.451 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -169.2 161.23 10.13 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.458 -1.025 . . . . 0.0 109.0 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -156.06 -174.89 26.42 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.303 -1.427 . . . . 0.0 109.946 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 78' ' ' SER . 0.5 OUTLIER -124.01 162.42 23.49 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.43 -1.041 . . . . 0.0 110.069 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . 0.537 ' HG2' ' HB3' ' A' ' 124' ' ' ASP . 75.2 mt-30 -119.21 131.85 55.87 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.862 -1.148 . . . . 0.0 109.04 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -129.28 129.2 44.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.293 -0.879 . . . . 0.0 110.629 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -177.34 150.69 0.86 Allowed Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.331 -0.855 . . . . 0.0 110.471 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -77.01 -77.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.577 1.304 . . . . 0.0 110.131 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' MET . . . . . 0.415 ' HB2' HG22 ' A' ' 121' ' ' VAL . 89.0 mtp -47.22 119.17 2.47 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.435 1.112 . . . . 0.0 110.596 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.5 -10.43 7.82 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.437 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -92.06 -4.06 54.93 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.531 -1.356 . . . . 0.0 110.743 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 118' ' ' MET . 34.1 m -128.28 161.1 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -0.875 . . . . 0.0 110.51 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 144' ' ' VAL . . . -156.11 138.64 14.98 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.685 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . 0.837 HD12 ' O ' ' A' ' 143' ' ' GLY . 18.3 tp -119.68 132.31 55.64 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.537 ' HB3' ' HG2' ' A' ' 114' ' ' GLN . 49.5 p30 -143.85 156.72 44.56 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.088 -1.445 . . . . 0.0 113.797 -177.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -124.51 134.86 52.88 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . 0.615 ' HB3' HD11 ' A' ' 141' ' ' ILE . 31.2 t -138.45 142.82 39.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 111.016 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.44 ' CD1' ' CZ2' ' A' ' 140' ' ' TRP . 81.0 t80 -109.23 127.54 54.33 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 109' ' ' TYR . 21.9 pt-20 -142.14 147.39 36.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.526 -0.734 . . . . 0.0 110.41 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -112.22 135.14 53.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.547 -0.72 . . . . 0.0 110.106 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 50.7 m -128.4 143.61 51.02 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.608 -0.682 . . . . 0.0 109.315 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 39.5 ptt180 -147.06 144.7 29.29 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.81 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.714 HD13 ' HA3' ' A' ' 106' ' ' GLY . 44.8 mm -122.67 90.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.57 -0.706 . . . . 0.0 110.031 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 51.7 mtt180 61.75 -66.45 0.07 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.667 -0.645 . . . . 0.0 112.385 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 132' ' ' ILE . 32.2 p -125.86 20.84 7.68 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.033 -1.042 . . . . 0.0 110.96 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.536 HG11 ' NE2' ' A' ' 17' ' ' GLN . 61.5 t -124.57 133.94 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 119.261 -0.975 . . . . 0.0 111.024 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -129.3 111.89 13.32 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.894 HG22 ' CB ' ' A' ' 14' ' ' ALA . 18.6 t -113.15 144.2 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.807 -1.183 . . . . 0.0 111.276 -177.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -117.12 107.12 1.52 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.125 -2.39 . . . . 0.0 107.125 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . 0.89 HG23 ' O ' ' A' ' 11' ' ' GLN . 90.5 m -121.81 142.33 50.33 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -1.13 . . . . 0.0 112.051 -177.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TRP . . . . . 0.44 ' CZ2' ' CD1' ' A' ' 127' ' ' TYR . 89.3 m95 -105.63 135.51 46.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.829 HG22 ' HB2' ' A' ' 10' ' ' ALA . 49.3 pt -119.53 150.5 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.147 -0.97 . . . . 0.0 111.312 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -151.66 139.03 19.42 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.837 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -164.23 -157.71 9.65 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 118.92 -1.61 . . . . 0.0 111.745 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.745 ' O ' HG23 ' A' ' 6' ' ' THR . 34.8 m -117.38 173.71 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 122.135 -0.626 . . . . 0.0 110.385 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 121' ' ' VAL . . . -152.41 138.75 6.59 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.699 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.71 ' O ' HG23 ' A' ' 4' ' ' THR . 84.7 m-85 -127.04 147.35 50.15 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.582 -0.952 . . . . 0.0 109.357 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -129.22 122.89 30.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.133 -0.979 . . . . 0.0 111.046 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 69.0 t80 . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.466 -0.771 . . . . 0.0 110.2 179.862 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 3' ' ' SER . 93.8 m . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 120.546 0.212 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.416 ' N ' HG22 ' A' ' 2' ' ' THR . 82.8 p -149.4 154.39 38.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.867 -1.145 . . . . 0.0 109.779 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.646 HG23 ' O ' ' A' ' 146' ' ' TYR . 27.2 m -136.11 137.69 41.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.418 -0.801 . . . . 0.0 110.06 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.421 HG23 ' HE2' ' A' ' 148' ' ' PHE . 58.0 t -106.79 138.05 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 144' ' ' VAL . 47.6 m -156.58 133.59 10.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.217 -0.927 . . . . 0.0 110.367 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.35 176.12 44.72 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.09 -120.85 0.78 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.404 ' CE2' ' HA3' ' A' ' 22' ' ' GLY . 27.1 t80 -139.46 158.92 43.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.482 -1.01 . . . . 0.0 109.228 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.2 117.4 14.5 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.143 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -106.76 144.63 33.13 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.426 ' HB3' HG23 ' A' ' 139' ' ' THR . 54.3 p -150.12 154.08 37.46 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.342 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -77.22 154.32 33.17 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.917 ' HB1' ' HB2' ' A' ' 17' ' ' GLN . . . -125.76 98.57 5.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.099 -1.001 . . . . 0.0 111.821 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -80.13 115.68 19.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.396 -0.815 . . . . 0.0 108.802 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.51 -14.09 59.43 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.917 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 96.6 mt-30 -115.05 160.03 20.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.439 -1.036 . . . . 0.0 109.402 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.1 ttm -98.99 137.96 36.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 111.052 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.6 t30 64.63 138.59 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.541 -0.724 . . . . 0.0 111.099 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -69.17 177.79 2.59 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.613 -0.679 . . . . 0.0 110.128 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.753 ' HB3' HG22 ' A' ' 46' ' ' THR . 68.9 mtm -129.16 169.91 14.2 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.343 -0.848 . . . . 0.0 110.724 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.79 ' C ' HG23 ' A' ' 46' ' ' THR . . . -152.68 128.94 2.61 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 45' ' ' TYR . . . -136.09 177.28 19.67 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.78 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -108.54 139.99 42.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.709 -0.877 . . . . 0.0 109.785 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.444 ' ND2' ' OG ' ' A' ' 42' ' ' SER . 25.3 t30 -121.4 125.68 47.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.43 -0.794 . . . . 0.0 111.394 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.1 tp -119.94 135.08 55.04 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.699 ' HD2' HD12 ' A' ' 40' ' ' ILE . 24.8 ttpt -138.91 144.98 39.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.489 -1.382 . . . . 0.0 111.754 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -110.34 145.18 37.93 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.529 ' HG3' HG22 ' A' ' 40' ' ' ILE . 20.6 ttm-85 -128.74 146.72 50.81 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.186 -0.946 . . . . 0.0 111.78 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -136.21 133.86 37.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.736 -0.603 . . . . 0.0 109.412 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -141.06 153.91 45.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.154 -0.966 . . . . 0.0 110.131 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -111.16 135.65 51.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 0.0 110.0 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -58.55 -24.97 61.95 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.582 -0.699 . . . . 0.0 110.772 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -60.39 -42.07 95.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.293 -0.88 . . . . 0.0 110.994 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.3 m -143.75 169.68 9.92 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.198 -0.939 . . . . 0.0 110.567 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -83.26 45.36 1.84 Allowed 'Trans proline' 0 C--N 1.314 -1.24 0 O-C-N 123.604 1.318 . . . . 0.0 111.045 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.0 tp -92.02 125.27 36.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.262 -0.899 . . . . 0.0 110.043 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.55 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . -133.71 134.4 7.44 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.57 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.41 131.8 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.699 HD12 ' HD2' ' A' ' 27' ' ' LYS . 33.0 pt -127.0 145.63 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.895 -1.128 . . . . 0.0 112.041 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.6 120.18 4.32 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.444 ' OG ' ' ND2' ' A' ' 25' ' ' ASN . 15.0 t -125.18 144.47 50.43 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.191 -1.182 . . . . 0.0 111.657 -178.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -114.57 144.41 43.43 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.3 m -131.61 138.61 48.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.925 -1.11 . . . . 0.0 110.883 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.403 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 60.7 t80 -133.19 109.6 9.55 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.79 HG23 ' C ' ' A' ' 22' ' ' GLY . 27.9 m -123.07 143.82 49.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.395 -0.816 . . . . 0.0 111.147 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' OE2' ' CE2' ' A' ' 45' ' ' TYR . 93.9 mt-10 -137.82 165.34 26.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.406 -0.809 . . . . 0.0 110.316 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -70.68 145.41 50.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.539 -0.726 . . . . 0.0 109.719 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.5 m -58.57 148.9 27.11 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.336 -0.853 . . . . 0.0 110.449 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -129.59 157.28 42.52 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.536 -0.727 . . . . 0.0 110.225 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.1 p -106.24 161.56 14.42 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.428 -0.795 . . . . 0.0 109.954 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.23 -35.49 77.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.427 -0.796 . . . . 0.0 110.192 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.9 p -63.47 -26.08 68.56 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.432 -0.792 . . . . 0.0 110.17 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.5 m -62.65 155.8 25.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.43 -0.794 . . . . 0.0 110.403 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.72 -162.19 17.54 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -95.54 10.17 37.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.539 -0.977 . . . . 0.0 110.642 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -85.38 145.52 27.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 0.0 110.308 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 11.3 t-20 -113.64 119.74 38.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.394 -0.817 . . . . 0.0 109.852 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -53.3 -91.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.32 -0.862 . . . . 0.0 110.689 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -113.36 162.03 16.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.812 -1.18 . . . . 0.0 110.854 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -122.76 154.15 38.55 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.513 -0.742 . . . . 0.0 110.0 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -120.38 100.82 7.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.249 -0.907 . . . . 0.0 111.011 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -102.81 142.56 33.74 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.77 158.06 27.66 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 118.63 -1.748 . . . . 0.0 111.173 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.476 ' C ' HG23 ' A' ' 66' ' ' THR . 44.3 pt -121.79 137.17 56.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.476 HG23 ' C ' ' A' ' 65' ' ' ILE . 65.3 p -150.21 139.59 21.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 110.919 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.767 ' O ' HG12 ' A' ' 83' ' ' VAL . . . -160.29 155.09 24.21 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.0 175.25 42.86 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.414 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 44.9 Cg_endo -71.21 165.73 31.51 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.93 1.489 . . . . 0.0 110.538 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.55 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -146.65 140.68 26.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.487 -0.758 . . . . 0.0 110.079 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -123.66 143.75 50.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.543 -0.723 . . . . 0.0 109.978 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -96.6 125.7 41.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.542 -0.724 . . . . 0.0 110.962 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 78.5 mt -127.6 115.95 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 53.6 -178.72 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.506 -0.746 . . . . 0.0 109.951 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.44 ' OD1' ' CE3' ' A' ' 76' ' ' TRP . 53.1 p30 -91.43 10.37 27.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.289 -0.882 . . . . 0.0 111.284 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.44 ' CE3' ' OD1' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -140.85 22.86 2.28 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.092 -1.005 . . . . 0.0 111.102 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -150.04 122.25 8.35 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.089 -1.007 . . . . 0.0 111.332 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.2 m -134.93 147.33 49.76 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.591 -0.693 . . . . 0.0 109.573 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.5 pt -129.8 138.72 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.01 -1.056 . . . . 0.0 110.607 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.43 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 40.6 p90 -147.47 167.91 23.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.448 -0.782 . . . . 0.0 111.202 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.83 164.95 21.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 110' ' ' GLY . 34.7 m -135.87 135.48 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -1.112 . . . . 0.0 110.7 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 67' ' ' ALA . 10.5 p -141.05 147.83 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 159.18 -149.94 20.16 Favored Glycine 0 N--CA 1.477 1.426 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.442 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.46 HG22 ' CG1' ' A' ' 65' ' ' ILE . 34.1 m -135.5 -172.72 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.527 1.156 . . . . 0.0 113.272 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.09 152.18 23.04 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -123.82 133.8 53.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -1.166 . . . . 0.0 109.916 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -116.2 113.23 2.78 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -101.39 116.76 33.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.622 -0.928 . . . . 0.0 109.492 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -123.48 148.74 45.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.663 -0.648 . . . . 0.0 110.353 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 51.27 45.04 28.48 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.39 -0.819 . . . . 0.0 110.784 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.1 m -80.7 130.3 35.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.298 -0.876 . . . . 0.0 110.195 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 95' ' ' TYR . 15.0 t -140.2 152.86 46.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.443 -0.786 . . . . 0.0 110.507 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.68 -31.43 72.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.455 -0.778 . . . . 0.0 110.181 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.581 ' O ' HG23 ' A' ' 93' ' ' THR . 7.0 m-85 -81.53 164.03 51.42 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.464 -0.773 . . . . 0.0 110.265 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.26 145.76 61.09 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.6 1.316 . . . . 0.0 110.449 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.8 p -101.91 16.57 25.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.457 -0.777 . . . . 0.0 110.667 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 59.1 17.71 5.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.351 -0.843 . . . . 0.0 111.017 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -119.71 144.82 47.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.18 -0.95 . . . . 0.0 109.891 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -56.9 -44.33 82.25 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.256 -0.902 . . . . 0.0 110.224 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -176.47 150.87 0.91 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.441 -0.787 . . . . 0.0 110.488 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 45.7 m -139.04 122.53 17.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.283 -0.886 . . . . 0.0 109.996 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.5 t -154.75 135.42 13.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.296 -0.877 . . . . 0.0 110.685 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -120.85 116.11 24.55 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.408 -0.808 . . . . 0.0 109.177 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.844 ' O ' HG23 ' A' ' 132' ' ' ILE . 48.5 p90 -136.17 170.78 15.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.075 -1.016 . . . . 0.0 111.778 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -157.56 -178.0 31.2 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.419 ' CD1' HG12 ' A' ' 85' ' ' VAL . 99.4 m-85 -108.25 152.41 24.65 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.033 -1.275 . . . . 0.0 110.876 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -125.51 153.9 42.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.414 -0.804 . . . . 0.0 110.515 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 64.1 t80 -154.83 146.75 23.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.465 -0.772 . . . . 0.0 109.868 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.508 ' O ' HG22 ' A' ' 82' ' ' VAL . . . 169.03 -178.23 42.39 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.841 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 80' ' ' TYR . . . -165.16 165.88 19.45 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.695 -0.885 . . . . 0.0 108.915 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -155.94 -173.74 24.91 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -136.8 155.44 49.82 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.352 -1.087 . . . . 0.0 110.072 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.679 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 30.4 tt0 -115.73 141.87 47.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.178 -0.951 . . . . 0.0 109.564 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -146.12 150.02 35.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.41 -0.806 . . . . 0.0 110.438 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.448 ' HB2' ' HA ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER 175.66 138.43 0.19 Allowed Pre-proline 0 N--CA 1.503 2.178 0 O-C-N 121.65 -0.656 . . . . 0.0 111.553 179.413 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 116' ' ' ASN . 52.5 Cg_endo -88.69 48.09 1.26 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.576 1.303 . . . . 0.0 109.168 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.475 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 86.5 mtp -147.15 137.01 23.13 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.459 -0.776 . . . . 0.0 108.945 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.43 -38.19 89.14 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.778 -0.576 . . . . 0.0 112.43 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -109.26 7.81 25.44 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.67 -1.269 . . . . 0.0 112.66 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 60.8 t -122.45 138.69 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.739 -1.226 . . . . 0.0 110.063 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.679 ' HB1' ' CD ' ' A' ' 114' ' ' GLN . . . -146.45 139.18 25.34 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.386 -0.926 . . . . 0.0 112.338 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 143' ' ' GLY . 13.8 tp -122.13 135.58 54.81 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' HB3' ' CB ' ' A' ' 114' ' ' GLN . 53.0 p30 -139.06 153.8 48.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.458 -1.401 . . . . 0.0 112.167 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -124.44 138.94 54.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.804 -0.56 . . . . 0.0 109.616 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.1 p -146.2 157.22 43.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.843 . . . . 0.0 110.191 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -133.82 143.1 48.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.519 -0.738 . . . . 0.0 110.342 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -150.98 143.86 24.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.509 -0.744 . . . . 0.0 110.164 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -113.78 146.61 39.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.403 -0.811 . . . . 0.0 109.97 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.5 t -129.18 139.61 51.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.44 -0.787 . . . . 0.0 110.246 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.3 ttp85 -127.98 127.89 44.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.475 -0.766 . . . . 0.0 109.837 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.844 HG23 ' O ' ' A' ' 105' ' ' TYR . 89.5 mt -119.15 56.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.668 -0.645 . . . . 0.0 109.56 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.455 ' HB3' ' O ' ' A' ' 132' ' ' ILE . 17.6 ttm180 66.05 -57.26 0.35 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.884 -0.51 . . . . 0.0 111.647 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.07 -7.32 11.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.085 -1.009 . . . . 0.0 111.401 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.498 HG11 ' NE2' ' A' ' 17' ' ' GLN . 48.9 t -119.64 130.82 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.967 -1.083 . . . . 0.0 110.653 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -133.44 114.01 13.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.561 -0.712 . . . . 0.0 109.242 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.897 HG12 ' HA ' ' A' ' 14' ' ' ALA . 31.5 m -124.65 149.3 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 110.506 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.89 103.65 2.34 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.126 -1.989 . . . . 0.0 108.126 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.426 HG23 ' HB3' ' A' ' 12' ' ' SER . 24.3 m -111.03 145.49 38.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.42 -1.047 . . . . 0.0 111.765 -178.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.601 ' HZ3' ' HB3' ' A' ' 142' ' ' ALA . 60.2 p-90 -132.1 145.37 51.36 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 75.4 mt -117.35 131.11 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.252 -0.905 . . . . 0.0 110.175 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.601 ' HB3' ' HZ3' ' A' ' 140' ' ' TRP . . . -149.27 145.54 27.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.44 -0.787 . . . . 0.0 110.185 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.818 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -177.09 -128.71 1.17 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.381 -1.39 . . . . 0.0 111.163 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.7 ' O ' HG23 ' A' ' 6' ' ' THR . 35.2 m -117.87 171.51 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.861 -0.788 . . . . 0.0 111.383 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 122' ' ' ALA . . . -148.81 135.56 5.48 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.646 ' O ' HG23 ' A' ' 4' ' ' THR . 64.8 t80 -130.46 149.56 52.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.576 -0.956 . . . . 0.0 109.394 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -131.89 122.38 25.57 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.261 -0.899 . . . . 0.0 111.478 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.421 ' HE2' HG23 ' A' ' 5' ' ' VAL . 95.9 m-85 . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.494 -0.754 . . . . 0.0 110.181 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.936 0.398 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.7 t -128.08 144.85 51.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.903 . . . . 0.0 109.793 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 146' ' ' TYR . 26.9 m -136.01 136.31 40.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.873 . . . . 0.0 109.996 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -107.69 139.37 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.579 -0.701 . . . . 0.0 109.26 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 144' ' ' VAL . 51.5 m -154.8 129.66 9.39 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.08 -1.012 . . . . 0.0 110.323 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -164.12 169.05 38.85 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.56 -130.4 1.34 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -127.3 158.24 37.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.45 -1.029 . . . . 0.0 109.763 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.79 116.5 16.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 111.066 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -113.75 142.36 46.15 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.428 ' HB2' HG12 ' A' ' 137' ' ' VAL . 59.1 p -153.63 154.6 34.5 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.695 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.746 ' O ' HG13 ' A' ' 137' ' ' VAL . 88.5 m-20 -93.85 153.15 18.42 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.759 ' CB ' HG22 ' A' ' 137' ' ' VAL . . . -135.59 119.16 17.0 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.775 -1.203 . . . . 0.0 111.878 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -71.17 119.88 15.94 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.03 -15.25 44.09 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.663 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 91.6 mt-30 -115.79 156.44 26.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.603 -0.939 . . . . 0.0 109.138 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 65.6 mtt -96.24 -77.69 0.48 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.09 -1.006 . . . . 0.0 110.985 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -66.06 134.45 52.89 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.372 -0.83 . . . . 0.0 110.962 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -68.8 178.5 2.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.525 -0.734 . . . . 0.0 110.103 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.628 ' HB3' HG22 ' A' ' 46' ' ' THR . 64.3 mtm -124.05 163.29 21.73 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.273 -0.892 . . . . 0.0 110.69 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.66 ' C ' HG23 ' A' ' 46' ' ' THR . . . -149.94 125.68 2.02 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.55 ' N ' HG23 ' A' ' 46' ' ' THR . . . -143.0 -159.34 7.9 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.523 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' A' ' 45' ' ' TYR . 51.3 p90 -129.19 161.16 30.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.537 -0.978 . . . . 0.0 110.047 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.433 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 45.5 t-20 -141.34 132.26 26.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.46 -0.775 . . . . 0.0 111.359 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.0 tp -118.62 141.15 48.87 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 47.3 mttt -134.86 146.72 49.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.403 -1.436 . . . . 0.0 111.26 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -115.91 138.97 50.68 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.516 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 53.2 ttt-85 -129.5 143.04 50.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.202 -0.936 . . . . 0.0 111.817 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -134.15 133.0 40.5 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -142.99 149.99 39.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.169 -0.957 . . . . 0.0 110.48 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -104.18 132.57 50.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.337 -0.852 . . . . 0.0 109.462 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -57.23 -24.48 54.93 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.391 -0.818 . . . . 0.0 111.013 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -60.02 -40.0 87.77 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.324 -0.86 . . . . 0.0 110.964 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.442 ' HB3' HD23 ' A' ' 37' ' ' LEU . 1.6 m -141.38 169.52 11.19 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.209 -0.932 . . . . 0.0 110.702 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -84.52 41.97 1.08 Allowed 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.637 1.335 . . . . 0.0 111.142 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 37' ' ' LEU . 2.7 mm? -87.77 98.97 11.75 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.941 . . . . 0.0 110.11 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 69' ' ' PRO . . . -107.98 131.66 10.71 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.78 129.36 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.558 -0.966 . . . . 0.0 108.721 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.452 ' CD1' ' CD1' ' A' ' 80' ' ' TYR . 77.8 mt -123.55 142.57 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.101 -0.999 . . . . 0.0 111.339 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 27' ' ' LYS . . . -109.46 145.45 16.76 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 107.086 -2.406 . . . . 0.0 107.086 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.406 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 34.7 t -139.71 142.46 36.86 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 118.969 1.384 . . . . 0.0 112.174 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -123.42 137.83 54.72 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.6 m -132.03 140.07 48.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.823 -1.173 . . . . 0.0 111.074 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.438 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 75.6 t80 -134.33 110.28 9.37 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.66 HG23 ' C ' ' A' ' 22' ' ' GLY . 4.2 m -119.48 146.5 45.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.525 -0.734 . . . . 0.0 110.276 -178.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -124.6 158.96 31.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.114 -0.991 . . . . 0.0 110.416 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 47.8 pttt -127.43 150.3 49.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.549 -0.72 . . . . 0.0 110.485 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.1 t -123.04 139.66 53.84 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.436 -0.79 . . . . 0.0 110.154 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 47.0 mtm105 -128.36 152.21 48.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.432 -0.793 . . . . 0.0 110.335 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.5 m 51.52 46.11 27.01 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.449 -0.782 . . . . 0.0 110.767 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 51.23 -156.22 0.13 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.476 -0.765 . . . . 0.0 110.831 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.6 t 55.1 173.43 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.38 -0.825 . . . . 0.0 110.574 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 84.8 p -142.22 161.01 39.11 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.393 -0.817 . . . . 0.0 110.201 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.46 49.59 19.02 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -60.06 147.85 37.8 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.354 -1.086 . . . . 0.0 110.296 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -62.0 -26.69 68.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.518 -0.739 . . . . 0.0 110.336 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -59.16 -39.03 81.2 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.304 -0.873 . . . . 0.0 109.998 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 44.5 mttt 54.32 53.28 11.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.522 -0.736 . . . . 0.0 110.733 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -84.49 133.96 34.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.472 -0.768 . . . . 0.0 109.637 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -122.89 155.84 35.87 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.386 -0.821 . . . . 0.0 110.427 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -114.08 126.91 55.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.346 -0.846 . . . . 0.0 110.88 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.499 ' CD2' ' CE1' ' A' ' 87' ' ' TYR . 97.8 m-85 -110.38 137.06 48.6 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.802 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.28 115.02 0.74 Allowed Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.411 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.481 ' O ' HG23 ' A' ' 66' ' ' THR . 76.5 mt -104.53 136.14 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 3.3 p -151.23 139.33 20.12 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.291 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.94 151.6 33.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.08 165.14 37.54 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.34 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 48.2 Cg_endo -74.07 172.7 15.43 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.858 1.451 . . . . 0.0 110.741 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.34 138.91 28.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.587 -0.696 . . . . 0.0 109.675 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -120.79 135.86 55.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.439 -0.788 . . . . 0.0 110.779 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.1 ttp85 -108.89 87.85 2.59 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.024 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 74' ' ' ASN . 42.7 pt -95.19 -31.04 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.426 -0.796 . . . . 0.0 109.526 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.408 ' N ' HG13 ' A' ' 73' ' ' ILE . 85.4 m-20 -132.89 128.83 37.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.654 -0.654 . . . . 0.0 109.504 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -58.01 -34.23 69.81 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.213 -0.929 . . . . 0.0 110.154 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -59.28 -36.02 74.79 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.648 -0.658 . . . . 0.0 111.434 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.19 155.14 42.49 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.996 -1.065 . . . . 0.0 111.82 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.804 ' O ' HD12 ' A' ' 113' ' ' LEU . 49.7 m -126.75 161.48 28.06 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.697 -0.627 . . . . 0.0 109.526 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.3 mt -118.01 136.67 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.002 -1.061 . . . . 0.0 110.222 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.452 ' CD1' ' CD1' ' A' ' 40' ' ' ILE . 85.7 m-85 -132.58 154.16 50.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.685 -0.634 . . . . 0.0 110.284 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.13 163.06 21.11 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.528 HG22 ' C ' ' A' ' 110' ' ' GLY . 34.1 m -136.32 132.06 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.094 -1.239 . . . . 0.0 111.281 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 66' ' ' THR . 59.5 t -140.74 145.31 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 160.87 -149.02 17.77 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 119.346 -1.407 . . . . 0.0 110.848 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 33.3 m -127.21 158.19 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.315 1.055 . . . . 0.0 112.977 -177.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.628 ' O ' HD12 ' A' ' 132' ' ' ILE . . . -140.57 130.69 4.67 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.499 ' CE1' ' CD2' ' A' ' 63' ' ' TYR . 43.6 p90 -151.89 164.2 37.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.002 -1.293 . . . . 0.0 111.242 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.32 154.58 20.4 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -129.03 139.63 51.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.825 -0.809 . . . . 0.0 110.332 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -115.08 154.14 29.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.787 -0.571 . . . . 0.0 110.132 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -117.54 103.47 10.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.378 -0.826 . . . . 0.0 110.116 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.522 ' HG1' ' HH ' ' A' ' 95' ' ' TYR . 70.7 p -131.57 157.82 42.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.445 -0.784 . . . . 0.0 110.265 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 94' ' ' GLU . 70.6 p -128.3 159.85 34.0 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.447 -0.783 . . . . 0.0 110.317 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.408 ' O ' ' O ' ' A' ' 93' ' ' THR . 77.9 mm-40 55.5 114.09 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.435 0.636 . . . . 0.0 111.177 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.522 ' HH ' ' HG1' ' A' ' 92' ' ' THR . 43.7 m-85 -119.12 98.89 50.89 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.198 -0.939 . . . . 0.0 110.217 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -77.22 -64.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.43 1.226 . . . . 0.0 110.322 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.2 t -145.69 143.43 29.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.284 -0.885 . . . . 0.0 110.023 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 46.05 -168.89 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.544 -0.722 . . . . 0.0 111.18 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.0 mttm 56.27 51.46 11.61 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.466 -0.771 . . . . 0.0 110.477 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -54.97 -30.68 59.62 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.415 -0.803 . . . . 0.0 110.603 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 55.16 46.53 23.71 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.402 -0.811 . . . . 0.0 110.305 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.532 HG22 ' H ' ' A' ' 103' ' ' SER . 0.9 OUTLIER -94.89 -176.35 3.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.597 -0.69 . . . . 0.0 110.179 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . 0.532 ' H ' HG22 ' A' ' 102' ' ' THR . 59.0 m -103.17 157.12 17.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.536 -0.727 . . . . 0.0 109.832 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.486 ' CG ' HG22 ' A' ' 132' ' ' ILE . 56.2 t0 -134.96 141.25 46.21 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.317 -0.864 . . . . 0.0 110.018 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.471 ' CD2' ' CB ' ' A' ' 87' ' ' TYR . 85.9 m-85 -114.85 162.52 16.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.172 -0.955 . . . . 0.0 111.042 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.677 ' HA3' HD13 ' A' ' 132' ' ' ILE . . . -160.94 -176.86 33.51 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 99.0 m-85 -116.02 156.78 25.71 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.017 -1.284 . . . . 0.0 111.398 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.9 m -124.58 154.9 39.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.53 -0.731 . . . . 0.0 110.417 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -153.06 145.19 23.83 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.421 -0.799 . . . . 0.0 109.907 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.528 ' C ' HG22 ' A' ' 82' ' ' VAL . . . 171.47 -177.59 44.25 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.908 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.28 163.47 13.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.653 -0.91 . . . . 0.0 108.949 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -157.33 -172.05 24.07 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.58 -1.295 . . . . 0.0 109.93 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 78' ' ' SER . 19.6 tp -130.74 152.44 50.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.467 -1.019 . . . . 0.0 109.673 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.4 ' CB ' ' HB3' ' A' ' 124' ' ' ASP . 51.3 tt0 -118.52 149.39 41.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.998 -1.064 . . . . 0.0 109.771 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.66 ' O ' ' HB1' ' A' ' 122' ' ' ALA . 99.5 m-85 -115.36 154.96 28.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.51 -0.744 . . . . 0.0 109.705 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -113.94 64.09 1.2 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.844 . . . . 0.0 111.279 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.69 -14.26 36.05 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.436 1.23 . . . . 0.0 109.904 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.603 ' HB2' HG23 ' A' ' 121' ' ' VAL . 64.9 mtt -145.4 139.87 27.24 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -60.92 -38.69 86.65 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.69 -0.631 . . . . 0.0 112.209 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.485 ' OD1' HG22 ' A' ' 121' ' ' VAL . 46.2 p-10 -94.94 -3.73 48.08 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.777 -1.202 . . . . 0.0 112.745 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.603 HG23 ' HB2' ' A' ' 118' ' ' MET . 30.1 m -150.42 121.46 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 120.809 -1.182 . . . . 0.0 111.604 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.66 ' HB1' ' O ' ' A' ' 115' ' ' PHE . . . -117.78 154.66 31.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.502 -0.749 . . . . 0.0 109.249 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.0 mt -113.3 144.45 42.71 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.114 -0.991 . . . . 0.0 109.776 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 114' ' ' GLN . 48.7 p30 -138.79 151.04 46.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.139 -0.975 . . . . 0.0 111.267 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -133.01 141.64 48.39 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.2 p -145.91 164.44 31.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.238 -0.914 . . . . 0.0 111.159 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -112.42 127.87 56.15 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -127.47 132.13 50.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.239 -0.913 . . . . 0.0 111.262 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -123.28 127.04 47.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.607 -0.683 . . . . 0.0 109.282 178.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.6 t -130.35 143.73 50.95 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.198 -0.939 . . . . 0.0 110.742 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.4 ' O ' ' HA3' ' A' ' 106' ' ' GLY . 65.2 mtm180 -124.04 129.68 51.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.591 -0.693 . . . . 0.0 109.718 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.677 HD13 ' HA3' ' A' ' 106' ' ' GLY . 17.3 mm -114.74 63.1 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.429 ' HB3' ' O ' ' A' ' 132' ' ' ILE . 50.8 ttp180 66.42 -59.96 0.33 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.562 -0.711 . . . . 0.0 111.224 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 132' ' ' ILE . 51.6 p -124.38 6.66 8.36 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.062 -1.024 . . . . 0.0 111.394 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.422 ' HB ' ' HB ' ' A' ' 132' ' ' ILE . 47.1 t -125.87 133.34 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.124 -0.985 . . . . 0.0 110.646 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -131.44 112.27 12.53 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.759 HG22 ' CB ' ' A' ' 14' ' ' ALA . 55.5 t -119.18 146.28 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.151 -0.968 . . . . 0.0 110.742 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -109.5 107.34 2.35 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.413 HG23 ' HB3' ' A' ' 12' ' ' SER . 26.0 m -109.78 139.58 44.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.328 -1.101 . . . . 0.0 112.02 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -111.49 142.16 44.12 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.7 mm -112.65 129.6 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.115 -0.991 . . . . 0.0 110.659 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -137.96 128.61 26.7 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.52 -0.738 . . . . 0.0 109.027 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -164.73 -158.04 10.05 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 118.715 -1.707 . . . . 0.0 112.13 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 6' ' ' THR . 8.9 p -110.82 170.02 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 122.211 -0.582 . . . . 0.0 110.221 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.486 ' N ' HG22 ' A' ' 144' ' ' VAL . . . -142.15 134.95 6.38 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.932 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.606 ' O ' HG23 ' A' ' 4' ' ' THR . 83.3 m-85 -122.86 138.5 54.63 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.3 ttt-85 -126.74 121.21 31.36 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.936 -1.103 . . . . 0.0 111.108 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 55.8 t80 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.51 -0.744 . . . . 0.0 110.224 -179.883 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 70.0 p . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.9 p -109.19 152.31 25.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 0.0 109.531 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 146' ' ' TYR . 36.8 m -135.34 138.66 43.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 110.52 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.7 t -115.76 136.52 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.548 -0.72 . . . . 0.0 109.333 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 144' ' ' VAL . 85.2 m -154.01 129.59 9.96 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.272 -0.892 . . . . 0.0 110.247 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -165.48 172.5 41.03 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.65 -132.14 1.64 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 40.7 p90 -143.55 161.94 37.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.485 -1.009 . . . . 0.0 109.688 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.03 136.03 28.0 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.679 -1.208 . . . . 0.0 112.131 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -107.32 125.53 51.29 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.644 ' OG ' HG23 ' A' ' 139' ' ' THR . 10.5 m -126.94 148.55 50.05 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.808 -177.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.756 ' O ' HG13 ' A' ' 137' ' ' VAL . 52.5 t0 -95.55 152.22 18.62 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.867 ' CB ' HG22 ' A' ' 137' ' ' VAL . . . -135.83 122.95 21.56 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.697 -1.201 . . . . 0.0 111.837 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -73.31 116.4 13.81 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.3 -30.87 8.94 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.423 ' HB3' ' CB ' ' A' ' 14' ' ' ALA . 63.6 tt0 -115.07 99.02 7.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.644 -0.915 . . . . 0.0 109.052 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 65.1 mtt -62.33 -40.22 95.67 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.411 -0.806 . . . . 0.0 111.146 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -57.77 119.83 7.35 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.264 -0.898 . . . . 0.0 111.228 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -71.41 162.43 29.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.617 -0.677 . . . . 0.0 109.704 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.862 ' HB3' HG22 ' A' ' 46' ' ' THR . 66.7 mtm -127.19 157.66 39.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.205 -0.935 . . . . 0.0 111.463 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.824 ' C ' HG23 ' A' ' 46' ' ' THR . . . -142.39 124.08 2.33 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.625 ' N ' HG23 ' A' ' 46' ' ' THR . . . -137.84 -174.41 13.36 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.501 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.466 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . 99.2 m-85 -122.97 160.51 26.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.7 -0.882 . . . . 0.0 110.157 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.403 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 34.4 t-20 -140.8 131.71 26.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.543 -0.723 . . . . 0.0 111.101 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.704 HD13 ' N ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -123.39 132.85 54.09 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.704 ' N ' HD13 ' A' ' 26' ' ' LEU . 74.6 mttt -131.3 145.4 51.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.639 -1.288 . . . . 0.0 111.595 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.514 ' CE2' HD12 ' A' ' 26' ' ' LEU . 97.9 m-85 -116.24 132.19 56.73 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.461 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 44.8 ttt180 -125.16 138.85 54.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.104 -0.997 . . . . 0.0 112.149 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -119.5 138.82 52.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -149.2 163.71 36.86 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.973 . . . . 0.0 110.858 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -113.07 130.16 56.26 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -58.12 -25.75 61.77 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.4 -0.813 . . . . 0.0 110.767 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -61.31 -38.0 85.26 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.406 -0.809 . . . . 0.0 111.091 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.8 p -134.38 166.69 27.35 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.22 -0.925 . . . . 0.0 110.774 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -87.17 33.25 0.43 Allowed 'Trans proline' 0 C--N 1.316 -1.157 0 O-C-N 123.719 1.379 . . . . 0.0 111.085 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.0 mt -88.87 139.45 30.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.251 -0.906 . . . . 0.0 109.817 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . -148.56 140.3 8.19 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.538 -1.315 . . . . 0.0 111.039 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.68 129.71 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.462 HD11 ' CB ' ' A' ' 27' ' ' LYS . 17.1 tt -129.13 143.58 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.977 -1.077 . . . . 0.0 111.322 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.8 135.67 12.95 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.466 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 61.1 p -130.26 142.71 50.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.125 -1.221 . . . . 0.0 111.759 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -126.22 135.34 51.47 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 14.9 t -135.77 148.31 48.73 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.645 -1.222 . . . . 0.0 111.498 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.466 ' CE1' ' HB2' ' A' ' 24' ' ' PHE . 42.7 p90 -141.88 111.43 6.56 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.862 HG22 ' HB3' ' A' ' 21' ' ' MET . 73.4 m -121.97 137.02 54.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 110.672 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 85.5 tt0 -155.63 164.33 38.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.585 -0.697 . . . . 0.0 109.566 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.41 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 29.2 tttp -68.69 143.16 54.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.865 . . . . 0.0 109.795 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.2 t -82.97 141.92 31.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.36 -0.838 . . . . 0.0 110.519 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -125.04 159.07 32.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.534 -0.728 . . . . 0.0 110.252 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.5 p -75.47 164.45 26.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.392 -0.817 . . . . 0.0 109.813 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.13 96.73 0.84 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.417 -0.802 . . . . 0.0 110.202 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.4 m -126.31 152.08 46.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.632 -0.668 . . . . 0.0 110.16 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.7 m -56.79 -33.45 66.67 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.325 -0.859 . . . . 0.0 110.132 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -101.13 102.53 2.43 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -58.27 -40.74 82.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.448 -1.031 . . . . 0.0 110.623 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.0 t80 48.07 92.64 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.516 -0.74 . . . . 0.0 110.922 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -107.82 111.93 24.32 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.256 -0.902 . . . . 0.0 110.73 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -72.52 -100.37 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.332 -0.855 . . . . 0.0 109.951 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -103.23 143.03 33.17 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.669 -1.269 . . . . 0.0 110.571 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -119.04 149.18 42.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.478 -0.764 . . . . 0.0 109.682 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.406 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 71.9 t80 -112.89 90.17 3.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.431 -0.793 . . . . 0.0 110.589 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 44' ' ' THR . 69.2 t80 -116.92 141.35 48.35 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.48 168.58 38.19 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.027 -2.035 . . . . 0.0 112.298 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.659 HG12 HG12 ' A' ' 85' ' ' VAL . 49.8 pt -105.68 140.55 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 114.48 -0.86 . . . . 0.0 109.246 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -150.87 141.55 22.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 110.619 -179.809 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.58 ' O ' HG22 ' A' ' 83' ' ' VAL . . . -156.94 154.55 29.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 108.946 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.46 163.61 37.05 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.493 -1.336 . . . . 0.0 110.276 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.38 173.06 14.41 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.91 1.479 . . . . 0.0 110.679 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.501 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -141.11 136.5 31.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.811 -0.556 . . . . 0.0 109.617 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.552 ' HB2' HD11 ' A' ' 79' ' ' ILE . 93.8 m-85 -126.28 145.78 50.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.698 -0.626 . . . . 0.0 110.67 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -98.13 87.89 4.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.492 -0.755 . . . . 0.0 109.554 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.3 tt -66.65 -33.83 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.459 -0.776 . . . . 0.0 110.847 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -155.61 172.95 17.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.465 -0.772 . . . . 0.0 110.145 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.455 ' HB3' ' CE3' ' A' ' 76' ' ' TRP . 85.9 m-20 -65.69 146.89 54.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.511 -0.743 . . . . 0.0 109.975 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.455 ' CE3' ' HB3' ' A' ' 75' ' ' ASP . 7.8 m-90 53.35 23.4 3.27 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.384 -0.823 . . . . 0.0 110.883 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.5 129.51 18.5 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.0 110.194 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m -139.34 155.07 47.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.335 -0.853 . . . . 0.0 110.565 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.843 HG22 ' CD2' ' A' ' 113' ' ' LEU . 50.6 pt -121.14 144.35 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.331 -0.856 . . . . 0.0 109.716 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -132.41 154.44 49.83 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.328 -0.857 . . . . 0.0 111.169 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.87 162.66 17.81 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.137 -1.985 . . . . 0.0 108.137 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.839 HG21 ' OE2' ' A' ' 128' ' ' GLU . 35.2 m -142.66 132.63 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.96 -1.318 . . . . 0.0 111.683 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 67' ' ' ALA . 33.0 m -142.99 150.66 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 158.12 -151.06 22.16 Favored Glycine 0 N--CA 1.479 1.553 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.049 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.659 HG12 HG12 ' A' ' 65' ' ' ILE . 12.4 p -129.59 144.62 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.488 1.137 . . . . 0.0 113.502 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.41 149.62 19.19 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.41 ' CE2' ' HB2' ' A' ' 89' ' ' LYS . 66.4 t80 -126.67 129.47 48.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.002 -1.293 . . . . 0.0 111.577 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -109.56 113.51 3.67 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 107.934 -2.066 . . . . 0.0 107.934 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.41 ' HB2' ' CE2' ' A' ' 87' ' ' TYR . 36.3 tttp -111.68 126.26 54.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.493 -1.004 . . . . 0.0 111.609 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -115.23 135.41 54.19 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 59.0 105.66 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.273 -0.892 . . . . 0.0 110.226 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.477 HG23 ' N ' ' A' ' 93' ' ' THR . 9.6 t -56.36 -39.44 72.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.454 -0.779 . . . . 0.0 110.896 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.477 ' N ' HG23 ' A' ' 92' ' ' THR . 42.1 m -72.44 130.86 41.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.376 -0.828 . . . . 0.0 110.279 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -125.71 155.32 41.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.516 -0.74 . . . . 0.0 110.073 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -83.58 146.0 49.07 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.417 -0.802 . . . . 0.0 109.918 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.442 ' O ' ' CD2' ' A' ' 98' ' ' TYR . 44.1 Cg_endo -70.55 128.65 15.59 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.539 1.284 . . . . 0.0 110.531 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.4 p 43.29 25.34 0.06 Allowed 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.708 -0.62 . . . . 0.0 112.298 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.442 ' CD2' ' O ' ' A' ' 96' ' ' PRO . 21.3 m-85 -135.63 144.99 46.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.112 -0.993 . . . . 0.0 110.46 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.3 mttt 56.19 46.8 20.68 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.562 -0.711 . . . . 0.0 110.58 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -57.3 -21.43 34.76 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.464 -0.772 . . . . 0.0 110.708 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -83.62 17.98 2.06 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.293 -0.879 . . . . 0.0 111.896 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.6 m -60.99 -33.74 73.71 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.962 -1.086 . . . . 0.0 109.804 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.7 p -116.3 160.29 20.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.633 -0.667 . . . . 0.0 109.59 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.67 ' OD2' HG22 ' A' ' 132' ' ' ILE . 47.6 t0 -134.84 154.23 51.72 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.309 -0.869 . . . . 0.0 110.44 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -112.03 156.69 21.78 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.376 -0.827 . . . . 0.0 110.601 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -144.25 161.54 27.91 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -97.63 145.8 25.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.927 -1.337 . . . . 0.0 110.937 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.0 t -122.46 148.65 44.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.482 -0.761 . . . . 0.0 110.3 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.558 ' CD1' HG12 ' A' ' 83' ' ' VAL . 66.6 t80 -154.01 145.67 23.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.494 -0.754 . . . . 0.0 109.661 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.465 ' O ' HG22 ' A' ' 82' ' ' VAL . . . 171.84 -178.9 43.85 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.906 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -167.2 163.7 15.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.818 -0.813 . . . . 0.0 108.812 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -156.06 -173.32 24.5 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.843 ' CD2' HG22 ' A' ' 79' ' ' ILE . 76.3 mt -128.44 152.85 47.75 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.373 -1.075 . . . . 0.0 109.278 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -119.53 140.97 49.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.818 -1.176 . . . . 0.0 109.971 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -117.35 161.1 20.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.508 -0.745 . . . . 0.0 110.061 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 76' ' ' TRP . 0.7 OUTLIER -120.96 86.59 42.1 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.464 -0.773 . . . . 0.0 110.459 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.623 ' HG3' HD23 ' A' ' 123' ' ' LEU . 43.8 Cg_endo -69.4 -7.39 20.81 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.664 1.35 . . . . 0.0 111.535 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.556 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 80.0 mtp -149.95 175.66 11.47 Favored 'General case' 0 C--N 1.311 -1.077 0 O-C-N 121.056 -1.027 . . . . 0.0 108.452 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.88 -39.7 95.27 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.807 -0.558 . . . . 0.0 110.993 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.469 ' OD1' HG23 ' A' ' 121' ' ' VAL . 48.0 p-10 -121.99 18.16 10.9 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.201 -0.937 . . . . 0.0 112.2 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 21.3 t -118.46 139.38 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.933 -1.105 . . . . 0.0 109.729 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.651 ' C ' HD22 ' A' ' 123' ' ' LEU . . . -141.34 137.48 32.4 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.736 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.651 HD22 ' C ' ' A' ' 122' ' ' ALA . 4.4 mm? -112.29 152.24 28.73 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -145.49 139.42 26.81 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.719 -1.238 . . . . 0.0 110.736 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -124.7 126.24 45.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 109.179 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -130.64 151.46 51.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.32 -0.863 . . . . 0.0 111.178 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -113.97 126.87 55.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.597 -0.689 . . . . 0.0 109.187 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.839 ' OE2' HG21 ' A' ' 82' ' ' VAL . 94.8 mt-10 -137.74 152.31 49.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.339 -0.85 . . . . 0.0 111.172 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -138.63 147.89 43.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 0.0 109.405 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 51.1 m -134.62 145.96 49.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.197 -0.939 . . . . 0.0 110.822 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -132.54 128.55 37.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.489 -0.757 . . . . 0.0 109.828 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.67 HG22 ' OD2' ' A' ' 104' ' ' ASP . 91.4 mt -119.8 59.26 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.47 -0.769 . . . . 0.0 109.709 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 93.2 mtt-85 64.65 -57.46 0.26 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.908 -0.495 . . . . 0.0 111.912 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 132' ' ' ILE . 44.0 p -117.69 -3.29 11.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.959 -1.088 . . . . 0.0 111.539 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.4 t -124.72 131.44 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.025 -1.047 . . . . 0.0 110.457 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -131.53 111.52 11.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.345 -0.847 . . . . 0.0 109.16 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.867 HG22 ' CB ' ' A' ' 14' ' ' ALA . 59.0 t -119.29 145.88 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.93 . . . . 0.0 110.525 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -107.18 120.27 6.12 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 107.813 -2.115 . . . . 0.0 107.813 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.644 HG23 ' OG ' ' A' ' 12' ' ' SER . 59.3 m -118.29 137.25 53.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.232 -1.158 . . . . 0.0 111.9 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -114.44 140.15 48.93 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.7 mt -113.66 133.1 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.103 -0.998 . . . . 0.0 110.903 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.81 133.93 22.77 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.571 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -170.5 -146.0 4.97 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.041 -1.552 . . . . 0.0 111.503 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.79 ' O ' HG23 ' A' ' 6' ' ' THR . 34.8 m -117.32 177.03 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 122.113 -0.639 . . . . 0.0 111.142 -178.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -153.26 138.58 6.39 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.635 ' O ' HG23 ' A' ' 4' ' ' THR . 69.8 t80 -134.65 153.4 52.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.571 -0.958 . . . . 0.0 109.714 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -133.82 122.03 22.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.368 -0.833 . . . . 0.0 110.986 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 65.8 t80 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.474 -0.766 . . . . 0.0 110.216 -179.662 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 66.3 p . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.004 0.43 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.6 t -124.16 137.64 54.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.427 -0.796 . . . . 0.0 109.728 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.853 HG23 ' O ' ' A' ' 146' ' ' TYR . 66.1 m -137.84 145.48 42.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.788 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.6 p -126.4 140.36 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.607 -0.683 . . . . 0.0 109.705 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.814 HG23 ' O ' ' A' ' 144' ' ' VAL . 88.9 m -156.45 130.61 8.59 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.301 -0.875 . . . . 0.0 110.481 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.486 ' HA3' HD23 ' A' ' 26' ' ' LEU . . . -149.97 158.32 27.62 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 108.831 -1.707 . . . . 0.0 108.831 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.08 -168.26 27.98 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.651 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -123.55 153.79 40.13 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.654 -0.909 . . . . 0.0 109.501 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.632 ' HB2' HG22 ' A' ' 141' ' ' ILE . . . -146.33 154.23 41.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.073 -1.017 . . . . 0.0 111.484 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -98.58 144.44 27.89 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.6 t -112.47 134.74 53.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.013 -1.055 . . . . 0.0 112.299 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -138.12 124.05 20.1 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.887 ' HB2' HG22 ' A' ' 137' ' ' VAL . . . -139.04 155.55 47.87 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 120.857 -1.152 . . . . 0.0 112.027 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -78.27 120.24 22.77 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.54 -29.24 10.72 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -113.75 97.77 6.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.607 -0.937 . . . . 0.0 109.247 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 70.6 mtm -67.43 -47.85 69.0 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.301 -0.875 . . . . 0.0 111.329 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -55.51 131.3 45.77 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.39 -0.819 . . . . 0.0 111.694 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -82.42 155.1 24.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.747 -0.595 . . . . 0.0 109.632 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.522 ' HB3' HG22 ' A' ' 46' ' ' THR . 73.4 mtm -131.3 166.18 21.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.274 -0.891 . . . . 0.0 111.224 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.805 ' O ' HG23 ' A' ' 46' ' ' THR . . . -92.97 153.23 21.38 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.54 121.85 2.92 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.114 -1.517 . . . . 0.0 111.021 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -111.5 129.6 55.99 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -137.93 126.53 23.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.937 -1.102 . . . . 0.0 111.558 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.486 HD23 ' HA3' ' A' ' 7' ' ' GLY . 81.9 mt -123.5 129.7 51.6 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HB3' ' CB ' ' A' ' 42' ' ' SER . 19.9 pttt -136.27 148.18 47.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.81 -1.181 . . . . 0.0 112.281 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -111.29 137.46 49.0 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.613 ' HA ' HG22 ' A' ' 40' ' ' ILE . 49.5 ttt180 -120.37 135.26 55.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 111.1 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -121.57 138.33 54.36 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -138.1 146.91 43.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.179 -0.951 . . . . 0.0 109.915 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -104.4 138.94 40.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 110.131 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -54.16 -27.34 33.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.621 -0.674 . . . . 0.0 111.76 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -60.82 -42.35 97.51 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.105 -0.997 . . . . 0.0 111.458 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.01 168.48 11.99 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.963 -1.085 . . . . 0.0 110.839 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -86.38 40.29 0.71 Allowed 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.714 1.376 . . . . 0.0 111.112 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 20.4 tp -111.18 76.48 0.98 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.176 -0.953 . . . . 0.0 110.15 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.76 177.19 26.65 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 120.051 -1.071 . . . . 0.0 110.445 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.0 t -131.61 140.15 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.673 -0.898 . . . . 0.0 108.982 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.613 HG22 ' HA ' ' A' ' 29' ' ' ARG . 41.3 pt -121.66 147.59 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.96 -1.087 . . . . 0.0 111.386 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.96 129.75 8.8 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.527 ' O ' HG22 ' A' ' 66' ' ' THR . 32.1 t -136.91 142.86 42.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.169 -1.195 . . . . 0.0 111.765 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -115.35 139.85 49.64 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.9 m -130.42 136.16 48.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.17 -0.956 . . . . 0.0 110.169 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -134.74 111.1 9.68 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.349 -0.844 . . . . 0.0 109.171 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.805 HG23 ' O ' ' A' ' 22' ' ' GLY . 60.3 m -112.84 138.32 49.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.432 -0.793 . . . . 0.0 109.388 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -138.11 160.52 39.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.09 -1.006 . . . . 0.0 110.532 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -85.26 143.98 28.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 110.127 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.9 t -69.92 151.39 45.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.458 -0.776 . . . . 0.0 109.597 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -61.4 133.22 55.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.358 -0.839 . . . . 0.0 110.26 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 53' ' ' SER . 38.4 m -132.09 148.8 52.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.524 -0.735 . . . . 0.0 109.872 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.58 -29.21 67.79 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.346 -0.846 . . . . 0.0 110.157 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.488 ' H ' HG22 ' A' ' 51' ' ' THR . 29.9 t -125.78 142.59 51.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.551 -0.718 . . . . 0.0 110.504 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.9 m 49.52 25.75 1.49 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.539 -0.726 . . . . 0.0 111.427 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -125.57 -66.87 0.18 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -51.41 -32.91 28.13 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.457 -1.026 . . . . 0.0 111.148 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -119.03 161.17 20.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.287 -0.883 . . . . 0.0 111.07 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 54.3 t30 57.54 34.9 25.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.632 -0.667 . . . . 0.0 110.73 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -78.0 142.25 38.39 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.305 -0.872 . . . . 0.0 110.4 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -111.35 161.26 16.25 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.412 -0.805 . . . . 0.0 110.443 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -122.62 151.84 41.06 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.347 -0.845 . . . . 0.0 109.845 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.441 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 70.5 t80 -121.8 93.15 3.91 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.331 -0.856 . . . . 0.0 111.182 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -98.24 150.86 21.07 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -158.5 132.84 3.23 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 118.195 -1.955 . . . . 0.0 111.631 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.447 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 46.8 pt -98.54 138.56 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 42' ' ' SER . 9.5 t -153.22 147.57 25.86 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.576 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.726 ' O ' HG12 ' A' ' 83' ' ' VAL . . . -149.0 151.15 34.05 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.24 165.79 36.77 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.513 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -75.76 170.49 20.07 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.798 1.42 . . . . 0.0 110.655 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.39 140.62 24.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.603 -0.685 . . . . 0.0 109.452 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -123.17 141.47 51.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.331 -0.856 . . . . 0.0 110.558 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -108.88 85.31 2.07 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.034 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 mm -72.98 -46.37 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.426 -0.796 . . . . 0.0 109.064 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -140.46 147.76 40.12 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -58.26 -34.09 70.12 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.152 -0.968 . . . . 0.0 110.196 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -60.71 -35.61 76.76 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.611 -0.681 . . . . 0.0 111.819 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -143.93 159.81 41.92 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.973 -1.079 . . . . 0.0 111.891 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.773 ' O ' HD12 ' A' ' 113' ' ' LEU . 26.6 t -138.22 155.35 48.74 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.633 -0.667 . . . . 0.0 109.618 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.7 tt -129.05 137.87 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.065 -1.022 . . . . 0.0 110.363 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -146.95 162.27 39.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.406 -0.809 . . . . 0.0 111.425 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.2 164.31 12.79 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.587 HG22 ' C ' ' A' ' 110' ' ' GLY . 34.7 m -141.75 134.82 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -1.175 . . . . 0.0 111.53 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 67' ' ' ALA . 7.2 p -138.76 148.34 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 178.65 -179.76 48.66 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.687 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.446 ' O ' ' HA2' ' A' ' 64' ' ' GLY . 57.0 t -118.64 142.02 35.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.335 0.588 . . . . 0.0 110.702 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.94 144.26 17.1 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -116.55 129.82 56.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.129 -1.219 . . . . 0.0 110.11 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -118.26 113.52 2.64 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -114.79 136.77 52.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.465 -1.021 . . . . 0.0 110.653 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -139.39 158.54 43.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.546 -0.721 . . . . 0.0 109.927 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -95.55 134.38 38.48 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.354 -0.841 . . . . 0.0 110.392 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -139.15 157.45 45.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.487 -0.758 . . . . 0.0 110.382 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.8 t -108.1 -1.26 20.55 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.472 -0.768 . . . . 0.0 110.911 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.29 -32.35 73.07 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.27 -0.893 . . . . 0.0 110.474 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.401 ' HA ' ' HD2' ' A' ' 96' ' ' PRO . 1.2 t80 -118.98 100.25 50.77 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.432 -0.793 . . . . 0.0 110.404 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 95' ' ' TYR . 41.8 Cg_endo -67.8 141.17 53.27 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.463 1.244 . . . . 0.0 110.259 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.7 p 47.1 -176.46 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.261 0.553 . . . . 0.0 111.218 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.419 ' O ' ' CD2' ' A' ' 98' ' ' TYR . 60.7 t80 46.9 66.08 1.08 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.457 -0.777 . . . . 0.0 110.888 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -65.89 -37.22 85.53 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.267 -0.895 . . . . 0.0 110.044 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.3 t30 56.78 18.35 3.73 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.503 -0.748 . . . . 0.0 111.084 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 47.34 42.88 14.6 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.24 -0.912 . . . . 0.0 111.31 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.589 ' O ' HG23 ' A' ' 102' ' ' THR . 7.2 t -68.78 111.84 5.13 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.215 -0.928 . . . . 0.0 110.657 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.2 p -142.16 160.72 39.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.402 -0.811 . . . . 0.0 110.314 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -93.2 143.22 26.47 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.472 -0.768 . . . . 0.0 109.93 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -113.08 154.78 26.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.329 -0.857 . . . . 0.0 110.11 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 85' ' ' VAL . . . -143.46 153.51 24.9 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -96.58 139.54 32.51 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -1.15 . . . . 0.0 110.735 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.9 p -124.94 159.99 29.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.532 -0.73 . . . . 0.0 110.424 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 41.1 p90 -160.25 155.67 25.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.442 -0.786 . . . . 0.0 109.854 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.587 ' C ' HG22 ' A' ' 82' ' ' VAL . . . 164.3 -169.77 39.24 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.497 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.77 165.15 20.92 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.602 -0.94 . . . . 0.0 108.905 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -152.75 -178.92 27.87 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.773 HD12 ' O ' ' A' ' 78' ' ' SER . 15.4 tp -139.54 147.37 41.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.371 -1.076 . . . . 0.0 110.22 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 93.1 mt-30 -99.11 141.72 31.52 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.087 -1.008 . . . . 0.0 109.157 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -148.2 148.64 30.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.303 -0.873 . . . . 0.0 110.868 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.593 ' OD1' HD23 ' A' ' 123' ' ' LEU . 0.8 OUTLIER 170.72 134.7 0.07 OUTLIER Pre-proline 0 N--CA 1.506 2.327 0 O-C-N 121.764 -0.585 . . . . 0.0 111.306 178.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -88.03 47.11 1.29 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.541 1.285 . . . . 0.0 109.484 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.437 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 65.3 mtt -141.71 139.45 32.91 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.424 -0.797 . . . . 0.0 109.044 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.77 -47.04 79.61 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -104.13 5.5 35.1 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.822 -1.174 . . . . 0.0 112.703 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.546 HG12 ' ND2' ' A' ' 116' ' ' ASN . 59.3 t -118.77 136.45 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.769 -1.207 . . . . 0.0 109.935 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 145' ' ' GLY . . . -142.92 139.49 30.76 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.406 -0.917 . . . . 0.0 112.308 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.835 HD13 ' O ' ' A' ' 143' ' ' GLY . 3.7 mm? -109.32 153.36 24.02 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -145.9 140.24 26.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.76 -1.212 . . . . 0.0 110.648 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 113' ' ' LEU . 49.1 p90 -132.07 142.74 49.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 0.0 109.391 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.636 ' HB3' HD11 ' A' ' 141' ' ' ILE . 28.9 t -146.51 149.42 33.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.375 -0.828 . . . . 0.0 111.231 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -118.12 126.57 52.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.698 -0.626 . . . . 0.0 109.428 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -137.35 136.42 37.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.456 -0.777 . . . . 0.0 110.593 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -112.18 130.09 56.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.42 -0.8 . . . . 0.0 109.765 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.0 m -122.1 147.59 45.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.295 -0.878 . . . . 0.0 110.436 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 42.5 ptt85 -135.78 130.53 34.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.499 -0.751 . . . . 0.0 110.23 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 132' ' ' ILE . 88.4 mt -119.17 67.22 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.567 -0.708 . . . . 0.0 109.707 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 132' ' ' ILE . 41.4 ttm180 66.45 -60.74 0.32 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.672 -0.642 . . . . 0.0 111.388 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.2 p -124.65 5.73 8.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.067 -1.021 . . . . 0.0 111.69 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 131' ' ' ARG . 51.2 t -126.52 133.35 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.934 -1.104 . . . . 0.0 110.798 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -132.22 115.87 16.23 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.887 HG22 ' HB2' ' A' ' 14' ' ' ALA . 32.0 t -110.76 145.51 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.131 -0.981 . . . . 0.0 111.121 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.84 117.85 2.58 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 107.684 -2.167 . . . . 0.0 107.684 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 10.2 t -134.14 151.96 51.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -1.184 . . . . 0.0 112.028 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' A' ' 125' ' ' PHE . 60.5 t-105 -112.04 133.93 53.9 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.636 HD11 ' HB3' ' A' ' 126' ' ' SER . 49.3 pt -115.91 147.17 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.068 -1.02 . . . . 0.0 111.319 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -147.49 136.92 22.61 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.835 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -162.96 -159.08 10.13 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 118.986 -1.578 . . . . 0.0 111.605 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.814 ' O ' HG23 ' A' ' 6' ' ' THR . 9.3 p -104.57 166.99 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 122.065 -0.667 . . . . 0.0 110.654 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.606 ' O ' ' HB3' ' A' ' 122' ' ' ALA . . . -154.32 138.97 6.46 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.853 ' O ' HG23 ' A' ' 4' ' ' THR . 68.4 t80 -132.18 153.99 50.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.543 -0.975 . . . . 0.0 109.765 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -125.29 121.17 33.23 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.307 -0.87 . . . . 0.0 111.101 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 73.6 t80 . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.495 -0.753 . . . . 0.0 110.13 179.894 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 120.965 0.412 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -126.28 147.63 49.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -0.879 . . . . 0.0 109.153 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.474 ' OG1' ' HB3' ' A' ' 29' ' ' ARG . 19.0 p -135.12 152.47 51.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.067 -1.021 . . . . 0.0 110.431 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -112.24 135.77 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 37.1 m -155.31 128.22 8.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 110.642 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.86 173.37 45.06 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.86 -137.52 3.42 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 45.5 p90 -143.26 160.02 41.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.485 -1.009 . . . . 0.0 109.888 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.58 145.34 30.07 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.626 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -113.49 144.87 42.1 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.441 ' HB3' ' CB ' ' A' ' 139' ' ' THR . 54.4 p -146.47 153.63 40.65 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.607 -1.237 . . . . 0.0 112.617 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.883 ' O ' HG13 ' A' ' 137' ' ' VAL . 88.7 m-20 -83.11 151.34 25.79 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.736 ' HB1' ' HB2' ' A' ' 17' ' ' GLN . . . -127.03 100.37 6.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.943 -1.098 . . . . 0.0 111.341 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -79.78 117.48 20.7 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.04 -13.21 58.95 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.736 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 89.2 mt-30 -107.68 178.04 4.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.118 -1.225 . . . . 0.0 110.294 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.401 ' CB ' ' HE3' ' A' ' 48' ' ' LYS . 94.3 mmm -57.75 -51.68 68.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.459 -0.776 . . . . 0.0 112.041 -178.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.531 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 19.7 t30 -169.82 -148.62 0.07 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.694 -1.254 . . . . 0.0 110.747 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mttt -81.06 154.3 26.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.076 -1.015 . . . . 0.0 110.761 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 62.5 mtt -129.94 167.59 17.98 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.416 -0.803 . . . . 0.0 110.662 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.816 ' O ' HG23 ' A' ' 46' ' ' THR . . . -98.12 158.97 20.66 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.251 -1.939 . . . . 0.0 108.251 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 9' ' ' TYR . . . -147.08 121.29 1.38 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.275 -1.44 . . . . 0.0 110.757 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -108.52 134.92 50.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.644 -0.916 . . . . 0.0 109.127 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -139.02 129.38 25.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.157 -0.964 . . . . 0.0 112.112 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.438 HD21 ' OH ' ' A' ' 28' ' ' TYR . 25.5 tp -121.85 127.59 50.69 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . 21.3 mttt -129.24 144.66 51.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.656 -1.277 . . . . 0.0 111.748 -177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.438 ' OH ' HD21 ' A' ' 26' ' ' LEU . 98.8 m-85 -112.24 140.69 46.74 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.474 ' HB3' ' OG1' ' A' ' 4' ' ' THR . 14.2 ttp180 -123.54 137.76 54.7 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.095 -1.003 . . . . 0.0 111.938 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -122.04 138.25 54.51 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -141.33 150.02 41.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.135 -0.978 . . . . 0.0 110.401 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -106.19 135.94 46.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 0.0 109.683 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -62.1 -22.85 66.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.581 -0.699 . . . . 0.0 110.646 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -61.16 -43.3 99.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.344 -0.847 . . . . 0.0 111.041 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.3 m -140.88 170.31 9.72 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.17 -0.956 . . . . 0.0 110.617 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -83.86 41.39 1.03 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.608 1.32 . . . . 0.0 111.022 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.481 ' C ' HD23 ' A' ' 37' ' ' LEU . 8.5 tt -91.3 119.56 31.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.359 -0.838 . . . . 0.0 110.043 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . -127.35 135.46 8.79 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.885 -1.15 . . . . 0.0 110.485 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -131.21 135.86 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.532 HD11 ' CD1' ' A' ' 80' ' ' TYR . 72.9 mt -125.32 141.92 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.922 -1.111 . . . . 0.0 111.455 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.81 141.07 15.15 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 106.998 -2.441 . . . . 0.0 106.998 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.415 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 42.7 t -137.53 141.18 41.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.886 -1.361 . . . . 0.0 112.649 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -122.97 134.13 54.35 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.8 m -131.03 136.93 48.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.031 . . . . 0.0 110.693 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -129.94 110.42 11.67 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 22' ' ' GLY . 96.9 m -115.03 140.01 49.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.369 -0.832 . . . . 0.0 109.588 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -141.15 163.85 31.84 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.104 -0.997 . . . . 0.0 110.446 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HE3' ' CB ' ' A' ' 18' ' ' MET . 21.4 tttm -73.6 134.98 43.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.485 -0.759 . . . . 0.0 109.932 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.5 p -79.43 145.52 33.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.416 -0.803 . . . . 0.0 109.934 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -144.74 161.79 38.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.403 -0.811 . . . . 0.0 110.049 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.424 HG22 ' HB3' ' A' ' 53' ' ' SER . 41.7 m -56.64 -38.63 72.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.348 -0.845 . . . . 0.0 109.837 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 50.81 28.25 3.55 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.437 -0.789 . . . . 0.0 111.118 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.424 ' HB3' HG22 ' A' ' 51' ' ' THR . 86.7 p -60.43 -36.56 78.47 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.291 -0.881 . . . . 0.0 109.868 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 97.7 p -80.99 -24.69 37.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.457 -0.777 . . . . 0.0 110.184 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.42 178.57 37.96 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -90.17 125.07 35.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.582 -0.952 . . . . 0.0 110.349 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -111.91 139.17 47.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.374 -0.829 . . . . 0.0 110.366 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -123.25 41.86 3.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.479 -0.763 . . . . 0.0 110.322 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -46.33 -75.58 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.634 -0.666 . . . . 0.0 111.11 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -106.67 146.13 31.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.223 -0.923 . . . . 0.0 110.477 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -143.9 165.04 28.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.408 -0.808 . . . . 0.0 110.475 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.464 ' HB2' ' HB ' ' A' ' 46' ' ' THR . 50.9 m-85 -113.81 114.12 25.86 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.703 0.763 . . . . 0.0 111.22 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.411 ' HB3' ' HB2' ' A' ' 87' ' ' TYR . 68.4 t80 -98.08 145.17 26.81 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -150.54 128.79 2.73 Favored Glycine 0 N--CA 1.485 1.904 0 C-N-CA 118.502 -1.808 . . . . 0.0 110.932 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.45 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 78.2 mt -99.1 134.77 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.749 HG23 ' O ' ' A' ' 83' ' ' VAL . 61.4 m -152.03 142.1 22.21 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.512 -1.275 . . . . 0.0 112.216 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.87 148.84 34.4 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -157.15 160.38 30.4 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.593 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 49.7 Cg_endo -75.41 165.09 31.4 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.875 1.461 . . . . 0.0 110.646 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.444 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -141.97 137.42 31.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.489 -0.757 . . . . 0.0 109.823 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -125.23 143.48 50.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.582 -0.698 . . . . 0.0 110.927 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.4 ttt-85 -109.83 119.87 40.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.644 -0.66 . . . . 0.0 109.605 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.2 mm -99.52 -88.09 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.285 -0.885 . . . . 0.0 110.865 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -153.11 173.73 15.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.071 -1.018 . . . . 0.0 110.47 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 53.05 44.27 30.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.451 -0.781 . . . . 0.0 110.887 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 95.9 m95 50.7 24.93 1.86 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.421 -0.8 . . . . 0.0 110.92 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.99 129.89 36.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.291 -0.881 . . . . 0.0 109.896 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.4 m -124.41 151.31 44.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.425 -0.797 . . . . 0.0 110.634 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.7 mt -119.46 136.85 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 109.176 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.532 ' CD1' HD11 ' A' ' 40' ' ' ILE . 38.6 m-85 -129.26 148.69 51.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.85 . . . . 0.0 111.145 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.28 159.28 19.84 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 110' ' ' GLY . 27.0 m -143.77 134.66 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.326 . . . . 0.0 112.164 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.749 ' O ' HG23 ' A' ' 66' ' ' THR . 61.9 t -134.85 144.63 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 178.78 -176.9 48.27 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 118.326 -1.892 . . . . 0.0 111.522 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.458 ' CG1' ' CZ ' ' A' ' 87' ' ' TYR . 52.8 t -121.9 144.27 31.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-O 121.652 0.739 . . . . 0.0 110.583 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.14 135.84 12.36 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.458 ' CZ ' ' CG1' ' A' ' 85' ' ' VAL . 88.5 m-85 -127.86 132.13 49.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.067 -1.255 . . . . 0.0 110.189 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.79 127.95 6.72 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 27.8 pttt -133.37 150.91 51.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.416 -1.049 . . . . 0.0 110.488 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -146.71 -179.12 6.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.634 -0.666 . . . . 0.0 110.205 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 54.99 169.88 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.52 -0.737 . . . . 0.0 110.904 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.6 t -128.02 170.03 13.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.285 -0.884 . . . . 0.0 110.395 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 94' ' ' GLU . 2.1 m 56.91 179.14 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.411 -0.805 . . . . 0.0 110.192 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.531 ' H ' HG22 ' A' ' 93' ' ' THR . 96.1 mt-10 53.15 48.87 21.23 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.298 -0.876 . . . . 0.0 110.407 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -65.75 126.62 92.04 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.48 -0.762 . . . . 0.0 110.373 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.81 164.41 35.65 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.551 1.29 . . . . 0.0 110.517 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.0 t -57.47 -172.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.41 -0.806 . . . . 0.0 110.24 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -56.04 -43.81 78.19 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.284 -0.885 . . . . 0.0 110.444 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.8 tptp -53.27 -32.95 51.12 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.323 -0.86 . . . . 0.0 110.76 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 55.64 53.52 9.48 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.395 -0.815 . . . . 0.0 110.845 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -53.24 -35.99 60.58 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.171 -0.956 . . . . 0.0 110.106 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 51.6 m -59.28 -24.6 63.38 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.539 -0.725 . . . . 0.0 110.333 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.5 p -92.35 165.05 13.27 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.434 -0.791 . . . . 0.0 110.083 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -133.21 135.31 44.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.489 -0.757 . . . . 0.0 109.458 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.727 ' O ' HG23 ' A' ' 132' ' ' ILE . 45.9 p90 -134.96 170.16 16.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.083 -1.011 . . . . 0.0 111.871 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.424 ' HA3' HG12 ' A' ' 132' ' ' ILE . . . -154.18 178.03 31.26 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.415 ' CZ ' HG13 ' A' ' 83' ' ' VAL . 68.3 t80 -99.11 142.15 30.96 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.115 -1.227 . . . . 0.0 110.862 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.1 m -121.65 150.55 41.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.446 -0.784 . . . . 0.0 110.159 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 43.2 p90 -158.34 152.98 24.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.393 -0.817 . . . . 0.0 110.037 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.558 ' O ' HG22 ' A' ' 82' ' ' VAL . . . 169.67 -176.63 43.5 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.584 -1.294 . . . . 0.0 110.65 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.99 163.46 11.37 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.681 -0.894 . . . . 0.0 109.091 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -159.71 -171.4 25.52 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.45 155.83 49.9 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.302 -1.116 . . . . 0.0 110.141 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 15.3 tt0 -120.63 142.55 49.32 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.163 -0.961 . . . . 0.0 110.228 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.67 ' O ' ' HB1' ' A' ' 122' ' ' ALA . 47.7 t80 -118.56 160.82 21.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.552 -0.718 . . . . 0.0 109.586 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -118.05 72.1 8.79 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.223 -0.923 . . . . 0.0 111.349 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.489 ' HD2' ' HA ' ' A' ' 122' ' ' ALA . 44.8 Cg_endo -72.51 -12.29 26.97 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.582 1.306 . . . . 0.0 110.064 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.599 ' HB2' HG13 ' A' ' 121' ' ' VAL . 88.0 mtp -142.89 144.15 32.34 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.29 -51.57 69.36 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -90.59 3.03 55.24 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.768 -1.207 . . . . 0.0 113.04 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.758 HG23 HG23 ' A' ' 144' ' ' VAL . 8.8 p -152.78 119.44 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 120.714 -1.241 . . . . 0.0 111.348 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.67 ' HB1' ' O ' ' A' ' 115' ' ' PHE . . . -110.75 167.45 10.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.904 . . . . 0.0 109.934 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 143' ' ' GLY . 23.4 tp -112.91 149.74 32.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.251 -0.906 . . . . 0.0 109.338 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -137.05 139.75 41.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.041 -1.037 . . . . 0.0 109.534 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -133.87 132.16 40.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 0.0 109.092 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.7 p -145.47 164.72 30.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.17 -0.956 . . . . 0.0 111.058 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -114.31 132.63 56.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.595 -0.69 . . . . 0.0 109.429 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -133.17 135.24 45.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.298 -0.877 . . . . 0.0 110.817 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -130.18 147.99 51.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 109.742 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.1 t -139.1 141.09 38.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.338 -0.851 . . . . 0.0 110.495 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.409 ' O ' ' HA3' ' A' ' 106' ' ' GLY . 63.1 mtm180 -129.11 129.19 44.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.366 -0.834 . . . . 0.0 109.868 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.727 HG23 ' O ' ' A' ' 105' ' ' TYR . 83.5 mt -125.48 54.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.534 -0.729 . . . . 0.0 109.671 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 74.2 mtp180 61.52 -55.99 0.11 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 132' ' ' ILE . 0.4 OUTLIER -105.47 -14.7 15.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.98 -1.075 . . . . 0.0 111.617 -178.429 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.499 ' CG2' ' HB ' ' A' ' 132' ' ' ILE . 32.8 m -137.17 140.21 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 118.396 -1.322 . . . . 0.0 112.111 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -133.71 119.09 18.88 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 13' ' ' ASP . 63.9 t -112.77 146.39 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.077 -1.014 . . . . 0.0 110.758 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -117.12 123.8 5.92 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 107.312 -2.315 . . . . 0.0 107.312 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.441 ' CB ' ' HB3' ' A' ' 12' ' ' SER . 14.9 t -126.19 152.55 45.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.065 -1.256 . . . . 0.0 112.469 -177.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.436 ' CD1' ' N ' ' A' ' 140' ' ' TRP . 56.4 m95 -111.69 137.45 49.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 76.7 mt -115.08 134.78 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.01 -1.056 . . . . 0.0 111.463 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.58 128.74 16.67 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.427 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -159.42 -157.98 8.87 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 118.985 -1.578 . . . . 0.0 111.789 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.758 HG23 HG23 ' A' ' 121' ' ' VAL . 7.2 p -111.45 163.13 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 122.135 -0.627 . . . . 0.0 110.555 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.42 ' N ' HG22 ' A' ' 144' ' ' VAL . . . -140.54 131.44 5.0 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -129.38 145.64 51.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.465 -1.021 . . . . 0.0 109.893 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -127.81 119.89 26.66 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.395 -0.816 . . . . 0.0 111.046 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.3 t80 . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.461 -0.774 . . . . 0.0 110.085 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.6 p . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.14 0.495 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.1 p -112.49 161.12 17.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.436 -0.79 . . . . 0.0 109.17 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.595 HG21 HH21 ' A' ' 29' ' ' ARG . 36.6 m -136.43 139.99 42.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.119 -0.988 . . . . 0.0 110.59 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.403 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 13.3 p -126.38 142.84 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.477 HG22 ' CA ' ' A' ' 145' ' ' GLY . 29.4 p -152.17 138.75 18.7 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 25' ' ' ASN . . . -134.24 155.27 21.79 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 24' ' ' PHE . . . -175.95 -163.32 28.43 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -137.35 161.44 36.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.652 -0.911 . . . . 0.0 109.356 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.06 153.69 41.01 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.644 -1.223 . . . . 0.0 112.145 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -112.5 137.77 50.23 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.4 m -121.23 145.54 47.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.991 -1.068 . . . . 0.0 112.633 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -130.2 139.39 50.84 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.898 ' CB ' HG22 ' A' ' 137' ' ' VAL . . . -145.9 148.32 32.69 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.774 -1.204 . . . . 0.0 112.11 -177.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -78.93 123.56 27.38 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.09 -24.07 25.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.694 -1.763 . . . . 0.0 108.694 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -112.75 141.03 47.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.337 -1.096 . . . . 0.0 109.492 178.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.0 mtm -98.02 -67.17 0.86 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.29 -0.881 . . . . 0.0 110.572 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 -49.03 122.92 6.36 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.521 -0.737 . . . . 0.0 112.088 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -75.83 164.44 26.23 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.533 -0.729 . . . . 0.0 109.932 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 68.3 mtm -121.02 146.8 46.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.287 -0.883 . . . . 0.0 111.58 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -142.94 124.71 2.41 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.692 ' HA3' HG22 ' A' ' 46' ' ' THR . . . -151.36 -160.06 9.24 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.124 -1.512 . . . . 0.0 110.883 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 99.1 m-85 -121.31 154.59 36.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.744 -0.856 . . . . 0.0 110.064 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.533 ' ND2' HD13 ' A' ' 141' ' ' ILE . 57.7 t30 -134.73 130.84 36.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.451 -0.781 . . . . 0.0 111.515 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.7 mt -111.87 155.13 24.13 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.733 ' HD2' HG21 ' A' ' 40' ' ' ILE . 17.4 ttpt -148.81 132.6 16.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.642 -1.286 . . . . 0.0 110.209 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -133.93 136.7 44.42 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.595 HH21 HG21 ' A' ' 4' ' ' THR . 36.8 ptt180 -142.81 150.78 40.41 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.792 -1.163 . . . . 0.0 112.581 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -116.96 138.11 51.77 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -139.45 145.88 39.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.282 -0.886 . . . . 0.0 109.862 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -98.62 131.43 44.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.933 . . . . 0.0 109.652 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -53.4 -24.25 11.92 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.543 -0.723 . . . . 0.0 111.657 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -60.35 -44.37 95.63 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.164 -0.96 . . . . 0.0 110.897 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.4 m -140.77 161.84 52.03 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.118 -0.989 . . . . 0.0 110.851 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -87.87 34.59 0.41 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.747 1.393 . . . . 0.0 111.146 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.0 mt -108.64 73.13 0.85 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.242 -0.911 . . . . 0.0 110.137 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.83 -179.01 33.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -130.23 144.39 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.623 -0.928 . . . . 0.0 108.948 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.733 HG21 ' HD2' ' A' ' 27' ' ' LYS . 62.5 mt -118.38 143.62 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.965 -1.085 . . . . 0.0 110.876 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -124.25 122.64 4.87 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 76.6 p -139.38 144.98 38.41 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.147 -1.208 . . . . 0.0 111.451 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.85 148.25 44.28 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.53 -0.731 . . . . 0.0 109.948 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.9 m -129.73 138.72 51.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.244 -0.91 . . . . 0.0 110.376 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.414 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 68.7 t80 -137.57 110.91 7.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 108.933 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.692 HG22 ' HA3' ' A' ' 23' ' ' GLY . 30.3 p -122.54 160.34 25.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.489 -0.757 . . . . 0.0 110.457 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -127.4 165.84 19.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.468 -0.77 . . . . 0.0 110.411 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -73.29 147.55 44.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.706 -0.621 . . . . 0.0 110.487 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.5 p -64.77 158.13 25.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.508 -0.745 . . . . 0.0 109.959 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 -146.68 165.5 29.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.363 -0.836 . . . . 0.0 110.767 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.3 p -105.21 171.89 7.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.49 -0.756 . . . . 0.0 110.2 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.07 -32.22 67.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.481 -0.762 . . . . 0.0 110.48 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.5 m -62.19 157.49 19.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.354 -0.841 . . . . 0.0 109.802 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.0 m -57.41 -43.33 83.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.354 -0.841 . . . . 0.0 110.354 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 48.29 -104.89 0.1 OUTLIER Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 53.97 40.86 32.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.639 -0.918 . . . . 0.0 111.014 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -63.15 -42.49 99.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.299 -0.875 . . . . 0.0 109.656 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -168.63 83.14 0.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.587 -0.696 . . . . 0.0 109.154 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -70.74 127.24 31.97 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.406 -0.809 . . . . 0.0 111.329 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -104.04 163.16 12.57 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -119.67 152.87 36.43 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.044 -1.035 . . . . 0.0 109.811 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -119.7 127.72 53.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.166 -0.959 . . . . 0.0 111.529 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.475 ' CB ' ' CZ ' ' A' ' 87' ' ' TYR . 97.8 m-85 -116.1 136.2 53.24 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.733 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.76 112.22 0.6 Allowed Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.552 -1.309 . . . . 0.0 110.183 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.496 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 77.8 mt -101.49 135.85 36.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 12.6 m -150.65 140.2 21.56 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.836 -1.146 . . . . 0.0 111.111 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.86 ' O ' HG12 ' A' ' 83' ' ' VAL . . . -152.71 151.56 30.68 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 81' ' ' GLY . . . -164.54 171.92 40.15 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.388 -1.386 . . . . 0.0 110.6 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.04 161.79 43.72 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.964 1.507 . . . . 0.0 110.995 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.717 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -140.47 137.28 33.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.672 -0.643 . . . . 0.0 109.577 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -116.38 124.01 49.0 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.915 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -109.91 130.74 55.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.631 -0.668 . . . . 0.0 109.642 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.487 HG23 ' N ' ' A' ' 74' ' ' ASN . 15.6 tt -170.26 -39.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.413 -0.804 . . . . 0.0 110.162 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.487 ' N ' HG23 ' A' ' 73' ' ' ILE . 86.2 m-20 -106.78 124.08 49.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.511 -0.743 . . . . 0.0 110.011 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.04 -31.92 69.28 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.451 -0.781 . . . . 0.0 110.13 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -54.12 -42.63 69.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.504 -0.748 . . . . 0.0 111.272 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -169.36 165.06 10.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.105 -0.997 . . . . 0.0 111.564 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 91.0 p -121.58 159.49 26.3 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.7 mt -124.87 136.29 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.922 -1.111 . . . . 0.0 110.551 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.408 ' HB2' ' CD1' ' A' ' 40' ' ' ILE . 43.5 p90 -145.65 158.92 43.79 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.912 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.46 ' C ' HG13 ' A' ' 82' ' ' VAL . . . -103.72 176.89 24.29 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.748 HG22 ' C ' ' A' ' 110' ' ' GLY . 34.9 m -147.89 131.36 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.32 -1.106 . . . . 0.0 110.545 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.86 HG12 ' O ' ' A' ' 67' ' ' ALA . 11.2 p -145.87 151.42 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.29 -0.881 . . . . 0.0 109.89 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 160.88 -153.18 23.98 Favored Glycine 0 N--CA 1.481 1.655 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.452 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.8 p -128.85 142.24 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 122.204 1.002 . . . . 0.0 112.861 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.98 126.52 6.02 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.475 ' CZ ' ' CB ' ' A' ' 63' ' ' TYR . 46.5 p90 -151.71 162.41 41.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.007 -1.29 . . . . 0.0 110.8 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.47 152.92 21.38 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -99.7 126.56 45.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.788 -0.831 . . . . 0.0 109.626 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -124.23 160.43 27.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.751 -0.593 . . . . 0.0 110.319 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 54.63 52.17 12.67 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.413 -0.805 . . . . 0.0 110.892 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.4 p -73.7 160.26 31.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.353 -0.842 . . . . 0.0 109.952 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.755 HG23 ' O ' ' A' ' 95' ' ' TYR . 9.3 t -89.51 156.88 18.35 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.397 -0.814 . . . . 0.0 110.415 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.3 -31.85 72.51 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.545 -0.722 . . . . 0.0 110.276 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.755 ' O ' HG23 ' A' ' 93' ' ' THR . 22.0 m-85 -90.4 152.71 45.8 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.82 . . . . 0.0 110.077 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.91 129.46 16.4 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.507 1.267 . . . . 0.0 110.604 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.0 p 41.88 38.61 1.05 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.755 -0.591 . . . . 0.0 111.784 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.687 ' HB3' HG21 ' A' ' 93' ' ' THR . 72.5 t80 -59.0 -42.77 90.88 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.333 -0.855 . . . . 0.0 110.269 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -138.93 178.56 7.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.408 -0.807 . . . . 0.0 110.09 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -69.19 103.29 1.88 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.381 -0.824 . . . . 0.0 109.781 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -69.41 148.6 49.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.532 -0.73 . . . . 0.0 110.362 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.6 m -119.54 135.14 54.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.535 -0.728 . . . . 0.0 110.001 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.2 m -130.21 148.25 52.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.515 -0.741 . . . . 0.0 110.227 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -88.06 129.7 35.21 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.457 -0.777 . . . . 0.0 109.73 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.457 ' CB ' ' HB3' ' A' ' 87' ' ' TYR . 43.2 p90 -127.04 169.73 13.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.279 -0.888 . . . . 0.0 110.602 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.54 ' HA2' HD13 ' A' ' 132' ' ' ILE . . . -156.12 177.19 33.3 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -96.2 137.4 35.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.327 -1.102 . . . . 0.0 110.054 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.7 m -114.89 154.55 28.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.584 -0.697 . . . . 0.0 110.985 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 37.3 p90 -158.03 154.09 27.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.687 -0.633 . . . . 0.0 109.656 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.748 ' C ' HG22 ' A' ' 82' ' ' VAL . . . 159.68 -169.45 35.71 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.525 -1.321 . . . . 0.0 110.607 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.82 165.07 28.35 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.689 -0.889 . . . . 0.0 109.338 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -152.26 -177.05 25.55 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.717 HD12 ' CZ ' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -143.59 147.33 34.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.387 -1.066 . . . . 0.0 110.346 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -114.15 148.85 36.57 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.229 -0.919 . . . . 0.0 110.697 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.717 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 91.6 m-85 -117.99 164.13 15.55 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.653 -0.654 . . . . 0.0 110.213 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -118.81 80.94 18.21 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 0.0 110.32 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.34 -14.48 42.9 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.589 1.31 . . . . 0.0 111.341 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.551 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 79.9 mtp -148.93 -177.58 5.88 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.189 -0.944 . . . . 0.0 108.485 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -69.39 -41.62 76.21 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.748 -0.595 . . . . 0.0 110.948 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -118.08 12.57 13.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.093 -1.004 . . . . 0.0 111.928 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 20.4 t -114.03 137.18 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.92 -1.112 . . . . 0.0 109.94 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 145' ' ' GLY . . . -137.7 135.59 36.59 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.45 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.84 HD12 ' O ' ' A' ' 143' ' ' GLY . 19.3 tp -110.78 147.01 35.35 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -144.68 143.7 30.86 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.483 -1.385 . . . . 0.0 111.206 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.439 ' CZ ' HD21 ' A' ' 123' ' ' LEU . 98.7 m-85 -119.02 142.06 48.15 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.3 t -134.26 139.63 45.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.0 111.263 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -118.67 111.03 18.0 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -141.89 143.76 33.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.556 -0.715 . . . . 0.0 110.596 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -137.09 151.93 49.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.442 -0.786 . . . . 0.0 109.761 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.0 t -126.52 138.65 53.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.834 . . . . 0.0 110.367 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 76.5 mtp180 -136.78 137.57 39.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.402 -0.811 . . . . 0.0 111.151 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.607 ' O ' HG23 ' A' ' 132' ' ' ILE . 6.7 tp -134.23 63.59 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.908 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 69.5 mtp85 59.91 -59.59 0.06 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 132' ' ' ILE . 56.5 p -95.49 -18.63 20.5 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.112 -0.992 . . . . 0.0 111.793 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.529 ' HB ' HG22 ' A' ' 132' ' ' ILE . 47.4 t -128.85 134.26 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 118.682 -1.207 . . . . 0.0 111.729 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -131.32 112.28 12.61 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.898 HG22 ' CB ' ' A' ' 14' ' ' ALA . 21.4 t -117.18 145.28 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.957 -1.089 . . . . 0.0 110.195 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -130.11 114.09 1.59 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.5 t -139.07 154.22 48.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.255 -1.144 . . . . 0.0 111.453 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 43.9 p90 -126.24 146.83 49.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.605 -0.685 . . . . 0.0 109.8 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.533 HD13 ' ND2' ' A' ' 25' ' ' ASN . 72.6 mt -112.4 141.42 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.329 -0.857 . . . . 0.0 110.666 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.79 145.23 31.56 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.437 -0.789 . . . . 0.0 109.895 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.84 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -177.2 -139.38 3.27 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.203 -1.475 . . . . 0.0 111.715 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 35.7 m -114.25 176.78 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 122.035 -0.685 . . . . 0.0 110.838 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.626 ' O ' ' HB3' ' A' ' 122' ' ' ALA . . . -162.42 144.56 9.78 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.33 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -129.8 157.39 42.35 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.842 -0.799 . . . . 0.0 109.263 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 32.1 mtp-105 -123.26 122.94 39.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.091 -1.006 . . . . 0.0 111.244 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 67.7 t80 . . . . . 0 N--CA 1.498 1.944 0 O-C-N 121.461 -0.774 . . . . 0.0 110.514 -179.898 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 65.3 p . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.2 m -119.8 144.21 47.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -0.866 . . . . 0.0 109.418 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.772 HG23 ' O ' ' A' ' 146' ' ' TYR . 76.6 m -136.98 142.37 42.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.579 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.414 ' C ' ' HG1' ' A' ' 6' ' ' THR . 34.4 m -123.0 141.48 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.822 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.793 HG23 ' O ' ' A' ' 144' ' ' VAL . 87.6 m -156.37 130.38 8.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.562 -0.711 . . . . 0.0 109.593 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -164.27 176.23 40.23 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.322 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.73 -125.94 1.05 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -147.06 162.0 39.69 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.478 -1.013 . . . . 0.0 109.528 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.29 142.8 30.67 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.59 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -125.07 143.9 50.68 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.628 ' OG ' HG23 ' A' ' 139' ' ' THR . 1.0 OUTLIER -147.47 149.23 32.27 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.266 -178.122 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.87 ' O ' HG13 ' A' ' 137' ' ' VAL . 52.7 t0 -74.98 148.87 39.56 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.719 ' HB1' ' HB2' ' A' ' 17' ' ' GLN . . . -125.15 100.52 6.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.804 -1.185 . . . . 0.0 111.578 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -79.58 115.06 18.98 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.51 -15.89 45.32 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.719 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 89.9 mt-30 -106.08 171.87 7.11 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.104 -1.233 . . . . 0.0 109.825 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.41 ' CG ' ' HE2' ' A' ' 48' ' ' LYS . 89.3 mtp -56.52 -49.84 73.57 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.332 -0.855 . . . . 0.0 111.659 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.541 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 47.4 p-10 -162.43 -155.7 0.37 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.698 -1.251 . . . . 0.0 110.435 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -84.25 166.92 17.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.334 -0.854 . . . . 0.0 111.005 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.6 mtt -126.03 167.9 14.69 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.442 -0.787 . . . . 0.0 110.918 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.46 128.44 2.93 Favored Glycine 0 N--CA 1.502 3.049 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.392 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.71 ' HA3' HG22 ' A' ' 46' ' ' THR . . . -145.92 -167.29 12.49 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.295 -1.431 . . . . 0.0 111.033 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -122.13 161.73 22.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.855 -0.791 . . . . 0.0 109.494 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.412 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 25.3 p-10 -148.61 135.66 20.08 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.227 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.4 mt -113.76 150.37 33.51 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 80.2 mttt -136.46 142.08 43.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.508 -1.37 . . . . 0.0 110.511 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.46 123.82 44.98 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.528 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 45.9 ttp180 -123.17 143.56 49.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.147 -0.97 . . . . 0.0 112.123 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -112.81 133.69 54.69 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -142.77 153.86 43.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.396 -0.815 . . . . 0.0 109.912 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -98.21 -173.72 2.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 0.0 110.185 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.87 -38.24 90.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.605 -0.684 . . . . 0.0 110.411 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -98.28 18.42 16.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.432 -0.792 . . . . 0.0 111.217 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.476 ' N ' ' HD3' ' A' ' 36' ' ' PRO . 1.9 m 34.46 56.02 1.91 Allowed Pre-proline 0 N--CA 1.505 2.315 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 35' ' ' SER . 43.2 Cg_endo -87.96 -70.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 122.991 0.995 . . . . 0.0 109.913 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.5 119.81 33.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.534 -0.729 . . . . 0.0 110.004 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . -121.89 134.75 10.04 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.7 t -130.48 132.86 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.336 -1.097 . . . . 0.0 108.921 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.466 HG12 ' CG ' ' A' ' 29' ' ' ARG . 72.4 mt -120.3 139.45 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.742 -1.224 . . . . 0.0 110.818 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 27' ' ' LYS . . . -112.98 117.78 4.37 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 107.703 -2.159 . . . . 0.0 107.703 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.421 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 48.3 t -123.84 141.68 51.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.144 -1.21 . . . . 0.0 112.503 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.05 142.18 49.08 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.5 m -130.91 139.14 50.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.004 -1.06 . . . . 0.0 110.902 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -136.69 110.65 8.24 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.71 HG22 ' HA3' ' A' ' 23' ' ' GLY . 44.6 p -121.69 157.83 30.04 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.464 -0.773 . . . . 0.0 109.989 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -118.31 155.38 30.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -0.853 . . . . 0.0 110.237 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.41 ' HE2' ' CG ' ' A' ' 18' ' ' MET . 18.1 tttt -93.02 135.43 34.19 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.2 t -109.72 140.67 43.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.332 -0.855 . . . . 0.0 110.655 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -125.26 140.39 52.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.629 -0.669 . . . . 0.0 109.875 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 81.1 p -66.68 -40.62 88.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.392 -0.817 . . . . 0.0 110.058 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.96 -32.86 69.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.486 -0.759 . . . . 0.0 110.216 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.8 m 52.78 21.29 1.87 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.475 -0.766 . . . . 0.0 111.099 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 82.5 p -81.28 -18.17 46.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.238 -0.914 . . . . 0.0 110.568 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -92.8 46.42 2.5 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -57.78 -40.44 79.86 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.301 -1.117 . . . . 0.0 109.944 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -70.28 -21.42 62.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.655 -0.653 . . . . 0.0 110.229 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -94.94 33.53 1.49 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.394 -0.816 . . . . 0.0 110.441 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.9 pttt -59.58 125.55 24.09 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.36 -0.837 . . . . 0.0 110.438 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -97.9 160.27 14.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.439 -0.788 . . . . 0.0 110.052 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -128.53 152.17 48.6 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.319 -0.863 . . . . 0.0 109.983 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -121.55 112.79 18.93 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.197 -0.94 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.421 ' HB3' ' HB2' ' A' ' 87' ' ' TYR . 49.0 t80 -98.42 140.3 32.89 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.07 117.7 0.95 Allowed Glycine 0 N--CA 1.486 2.01 0 C-N-CA 119.168 -1.491 . . . . 0.0 110.337 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.44 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 14.4 tt -112.03 134.97 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 83' ' ' VAL . 70.9 m -151.7 141.68 22.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.812 -1.18 . . . . 0.0 111.712 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.543 ' O ' HG22 ' A' ' 83' ' ' VAL . . . -147.58 150.05 33.72 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.86 170.59 40.7 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.751 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 48.1 Cg_endo -74.07 172.47 15.88 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 123.955 1.503 . . . . 0.0 110.741 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.61 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -148.62 141.55 24.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.482 -0.762 . . . . 0.0 109.741 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -127.19 146.17 50.5 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.611 -0.68 . . . . 0.0 110.77 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -106.0 131.65 53.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.518 -0.739 . . . . 0.0 109.927 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 79.4 mt -121.24 108.14 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.465 -0.772 . . . . 0.0 109.255 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.8 t30 53.86 42.22 31.8 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.599 -0.688 . . . . 0.0 110.072 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 77' ' ' ALA . 91.6 m-20 50.8 -175.22 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.502 -0.748 . . . . 0.0 110.788 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 99.0 m95 55.47 -84.79 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.755 -0.591 . . . . 0.0 111.389 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 75' ' ' ASP . . . -65.61 141.52 58.38 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.126 -0.984 . . . . 0.0 111.123 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.9 t -138.13 150.06 46.48 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.522 -0.736 . . . . 0.0 109.72 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.6 tt -133.55 138.04 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.999 -1.063 . . . . 0.0 109.973 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -147.89 158.15 43.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.158 -0.963 . . . . 0.0 111.635 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -107.08 161.01 13.92 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 107.919 -2.072 . . . . 0.0 107.919 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 110' ' ' GLY . 35.0 m -142.58 146.81 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.093 -1.239 . . . . 0.0 111.96 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.736 ' O ' HG23 ' A' ' 66' ' ' THR . 26.8 m -138.15 152.26 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . -179.85 177.5 48.12 Favored Glycine 0 N--CA 1.479 1.548 0 C-N-CA 118.876 -1.63 . . . . 0.0 110.734 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.442 ' CG1' ' CZ ' ' A' ' 87' ' ' TYR . 48.7 t -122.3 135.78 61.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-O 121.738 0.78 . . . . 0.0 111.002 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . -103.4 133.97 11.67 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.442 ' CZ ' ' CG1' ' A' ' 85' ' ' VAL . 91.5 m-85 -117.09 146.1 43.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.153 -1.204 . . . . 0.0 110.47 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.32 116.84 3.26 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -103.2 113.01 26.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.516 -0.991 . . . . 0.0 109.963 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -125.09 157.1 37.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.826 -0.546 . . . . 0.0 110.069 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -72.55 142.77 48.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.353 -0.842 . . . . 0.0 109.642 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.3 t -132.06 164.42 26.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.355 -0.841 . . . . 0.0 110.767 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 43.5 m -55.4 -34.17 64.15 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.547 -0.72 . . . . 0.0 110.355 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 57.34 107.04 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.677 -0.639 . . . . 0.0 110.83 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -61.31 147.18 87.75 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.386 -0.822 . . . . 0.0 109.981 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.13 -20.66 37.52 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.513 1.27 . . . . 0.0 110.974 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 49.5 m -124.41 143.71 50.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.283 -0.886 . . . . 0.0 110.854 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.414 ' O ' ' CD2' ' A' ' 98' ' ' TYR . 55.9 t80 51.49 64.59 1.78 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.512 -0.742 . . . . 0.0 111.105 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -67.31 134.28 51.26 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.333 -0.855 . . . . 0.0 110.542 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 10.0 m120 -111.35 120.43 42.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.458 -0.776 . . . . 0.0 109.88 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -89.5 111.15 21.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.4 -0.812 . . . . 0.0 110.621 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.8 t -141.16 153.71 45.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.42 -0.8 . . . . 0.0 110.505 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.2 m -130.01 147.97 51.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.434 -0.791 . . . . 0.0 110.192 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -80.13 125.2 29.51 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.299 -0.876 . . . . 0.0 109.781 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 38.6 p90 -132.04 170.34 15.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 111.436 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.709 ' HA3' HD13 ' A' ' 132' ' ' ILE . . . -160.03 -177.46 33.14 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -106.64 150.14 26.52 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.965 -1.315 . . . . 0.0 111.634 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 96.4 p -128.86 161.57 29.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.716 -0.615 . . . . 0.0 110.108 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -155.68 148.52 24.26 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.379 -0.825 . . . . 0.0 109.802 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.78 ' O ' HG22 ' A' ' 82' ' ' VAL . . . 175.0 -175.36 47.07 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.468 -1.349 . . . . 0.0 110.827 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.67 159.51 9.99 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.609 -0.936 . . . . 0.0 109.022 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.48 -174.75 30.69 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.31 162.02 36.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.22 -1.165 . . . . 0.0 111.059 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.5 ' HG2' ' HB3' ' A' ' 124' ' ' ASP . 91.3 mt-30 -107.68 144.49 34.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.523 -0.735 . . . . 0.0 109.537 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . 0.447 ' CZ ' ' CE2' ' A' ' 125' ' ' PHE . 46.2 p90 -152.23 151.85 31.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.457 -0.777 . . . . 0.0 110.302 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.433 ' CB ' ' O ' ' A' ' 115' ' ' PHE . 0.9 OUTLIER 166.75 142.34 0.05 OUTLIER Pre-proline 0 N--CA 1.509 2.493 0 O-C-N 121.776 -0.577 . . . . 0.0 111.013 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 116' ' ' ASN . 52.0 Cg_endo -88.51 47.96 1.29 Allowed 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.491 1.259 . . . . 0.0 109.155 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.438 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 95.6 mmm -142.26 135.25 28.63 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 121.401 -0.812 . . . . 0.0 108.94 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.08 -42.3 99.61 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.813 -0.554 . . . . 0.0 112.44 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -106.58 5.55 29.18 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.721 -1.237 . . . . 0.0 112.922 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 48.4 t -119.92 136.42 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.715 -1.241 . . . . 0.0 110.506 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 116' ' ' ASN . . . -145.44 129.98 17.91 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.577 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.426 HD23 ' HA ' ' A' ' 144' ' ' VAL . 80.6 mt -111.95 150.67 30.2 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.5 ' HB3' ' HG2' ' A' ' 114' ' ' GLN . 54.1 p30 -148.76 156.1 41.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.653 -1.279 . . . . 0.0 112.42 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . 0.447 ' CE2' ' CZ ' ' A' ' 115' ' ' PHE . 34.2 m-85 -123.64 141.41 52.04 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.545 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.2 m -138.98 147.75 42.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.382 -0.824 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -117.97 124.23 47.69 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -133.58 138.25 45.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.264 -0.898 . . . . 0.0 111.416 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -119.68 128.61 53.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.639 -0.663 . . . . 0.0 109.537 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.9 m -122.31 146.34 47.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.287 -0.883 . . . . 0.0 110.626 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -129.39 125.18 36.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.432 -0.793 . . . . 0.0 110.117 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.709 HD13 ' HA3' ' A' ' 106' ' ' GLY . 14.7 mm -113.87 63.44 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.456 ' HB3' ' O ' ' A' ' 132' ' ' ILE . 22.9 ttt180 66.23 -60.04 0.32 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.406 -0.809 . . . . 0.0 111.349 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 132' ' ' ILE . 0.6 OUTLIER -125.68 9.23 7.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.057 -1.027 . . . . 0.0 111.16 -179.6 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.562 HG11 ' NE2' ' A' ' 17' ' ' GLN . 43.9 t -124.77 132.88 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.182 -0.949 . . . . 0.0 110.678 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -131.54 111.78 12.06 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 13' ' ' ASP . 88.1 t -115.24 145.13 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 110.799 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -107.47 103.9 2.02 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 107.116 -2.394 . . . . 0.0 107.116 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.628 HG23 ' OG ' ' A' ' 12' ' ' SER . 53.2 m -104.9 136.85 43.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -1.069 . . . . 0.0 112.105 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -114.22 134.34 54.99 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 75.1 mt -116.05 132.55 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 110.52 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.0 143.06 31.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.479 -0.763 . . . . 0.0 109.425 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -174.77 -146.71 5.83 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 118.709 -1.71 . . . . 0.0 112.151 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.793 ' O ' HG23 ' A' ' 6' ' ' THR . 34.1 m -118.47 175.69 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.289 0.566 . . . . 0.0 111.075 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -157.36 139.84 6.7 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.772 ' O ' HG23 ' A' ' 4' ' ' THR . 97.7 m-85 -132.98 157.37 45.36 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.598 -0.942 . . . . 0.0 109.837 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -131.9 121.33 23.85 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.271 -0.893 . . . . 0.0 111.065 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.403 -0.81 . . . . 0.0 110.29 -179.874 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.4 p . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.9 p -112.44 145.82 39.49 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.36 -0.838 . . . . 0.0 109.68 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.71 HG21 ' CZ ' ' A' ' 29' ' ' ARG . 91.8 m -136.98 139.18 41.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.857 . . . . 0.0 110.634 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.05 142.25 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.571 -0.705 . . . . 0.0 109.846 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.785 HG23 ' O ' ' A' ' 144' ' ' VAL . 62.8 m -156.42 130.52 8.56 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.44 -0.788 . . . . 0.0 110.123 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.411 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -165.66 171.6 40.91 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.61 -136.36 2.3 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -132.76 158.54 42.16 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.549 -0.971 . . . . 0.0 109.108 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.469 ' HB1' ' O ' ' A' ' 140' ' ' TRP . . . -145.39 142.3 29.22 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.286 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -111.54 145.8 38.45 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.614 ' HB2' HG23 ' A' ' 139' ' ' THR . 19.8 t -146.35 151.22 37.14 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.411 -1.316 . . . . 0.0 112.914 -177.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.712 ' O ' HG13 ' A' ' 137' ' ' VAL . 86.5 m-20 -100.92 150.64 22.65 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.743 ' HB3' ' HB2' ' A' ' 17' ' ' GLN . . . -134.12 116.3 15.26 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.787 -1.196 . . . . 0.0 111.823 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -67.03 117.14 8.68 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.59 -14.18 38.82 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.743 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 87.6 mt-30 -114.59 156.62 24.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.348 -1.09 . . . . 0.0 109.356 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 70.1 mtm -100.51 -75.52 0.58 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.206 -0.933 . . . . 0.0 111.613 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -57.46 132.04 51.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.366 -0.834 . . . . 0.0 111.553 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -63.6 169.07 4.17 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.663 . . . . 0.0 110.237 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 90.1 mtp -128.15 166.7 18.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.279 -0.888 . . . . 0.0 111.44 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.814 ' O ' HG23 ' A' ' 46' ' ' THR . . . -124.86 178.94 16.34 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 107.904 -2.079 . . . . 0.0 107.904 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.94 148.27 9.19 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 118.57 -1.776 . . . . 0.0 111.89 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -109.24 133.68 52.72 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.411 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 76.1 m-20 -120.85 128.4 52.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.201 -0.937 . . . . 0.0 111.852 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.579 HD21 ' OH ' ' A' ' 28' ' ' TYR . 25.0 tp -121.58 133.53 55.0 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.43 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 22.7 mttt -136.08 146.71 47.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.313 -1.492 . . . . 0.0 111.44 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.579 ' OH ' HD21 ' A' ' 26' ' ' LEU . 97.4 m-85 -115.96 129.46 56.4 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.71 ' CZ ' HG21 ' A' ' 4' ' ' THR . 56.2 ttp180 -128.57 134.32 48.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.15 -0.969 . . . . 0.0 112.106 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . 0.468 ' O ' HG22 ' A' ' 39' ' ' VAL . 99.4 m-85 -125.06 139.95 53.33 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.592 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -142.04 150.26 41.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.144 -0.973 . . . . 0.0 110.278 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -99.85 132.68 45.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.368 -0.833 . . . . 0.0 109.662 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -56.71 -24.15 47.32 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.481 -0.762 . . . . 0.0 111.226 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -60.61 -40.56 92.3 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.273 -0.892 . . . . 0.0 110.946 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.611 ' CB ' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -140.43 166.92 19.92 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.226 -0.921 . . . . 0.0 110.559 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -84.61 42.1 1.1 Allowed 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.722 1.38 . . . . 0.0 111.061 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.611 HD23 ' CB ' ' A' ' 35' ' ' SER . 0.6 OUTLIER -89.05 76.27 7.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.318 -0.864 . . . . 0.0 110.203 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 69' ' ' PRO . . . -79.67 132.85 11.74 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 30' ' ' TYR . 35.6 m -132.67 129.26 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.359 -1.083 . . . . 0.0 108.925 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 17.0 tt -132.11 144.75 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.893 . . . . 0.0 111.431 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.58 148.21 16.38 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.43 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 42.3 t -138.72 141.53 38.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.272 . . . . 0.0 111.891 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -125.49 138.31 53.98 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 t -134.62 145.78 48.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.974 -1.079 . . . . 0.0 111.216 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -127.99 111.38 13.48 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.814 HG23 ' O ' ' A' ' 22' ' ' GLY . 87.1 m -119.24 141.9 48.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.692 -0.63 . . . . 0.0 110.68 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -148.75 179.63 7.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.843 . . . . 0.0 110.075 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -72.93 154.74 40.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.437 -0.789 . . . . 0.0 109.99 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 m -57.74 156.93 7.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.455 -0.778 . . . . 0.0 110.448 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -55.62 148.82 15.15 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.456 -0.778 . . . . 0.0 110.69 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.4 p -114.88 168.71 9.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.499 -0.75 . . . . 0.0 110.098 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.67 -30.08 67.09 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.454 -0.779 . . . . 0.0 110.318 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -58.36 -35.73 72.4 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.433 -0.792 . . . . 0.0 110.243 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.5 p 47.33 40.84 11.36 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.583 -0.698 . . . . 0.0 111.156 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.51 178.29 51.52 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.412 ' OD1' ' CD2' ' A' ' 57' ' ' TYR . 53.3 p30 -90.67 11.15 23.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.456 -1.026 . . . . 0.0 111.104 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.412 ' CD2' ' OD1' ' A' ' 56' ' ' ASP . 34.5 m-85 -113.0 144.51 42.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.151 -0.968 . . . . 0.0 110.09 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -114.66 15.79 17.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.482 -0.762 . . . . 0.0 110.453 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.5 tttp 53.33 -88.72 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.439 -0.788 . . . . 0.0 110.989 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -105.07 143.1 33.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.918 -1.114 . . . . 0.0 110.468 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -121.4 154.77 36.07 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.479 -0.763 . . . . 0.0 109.538 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -110.33 118.41 36.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.217 -0.927 . . . . 0.0 110.748 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.465 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 46.6 t80 -98.44 139.66 33.85 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.73 122.27 1.4 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 118.969 -1.586 . . . . 0.0 110.987 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.581 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 43.7 pt -112.85 138.0 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 1.3 p -153.57 144.29 22.62 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.584 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.617 ' O ' HG22 ' A' ' 83' ' ' VAL . . . -151.26 153.59 35.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.473 -0.767 . . . . 0.0 109.27 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.85 174.15 43.43 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.536 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 45.9 Cg_endo -71.8 167.69 25.88 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.891 1.469 . . . . 0.0 110.846 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -148.51 141.7 25.04 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.412 -0.805 . . . . 0.0 110.404 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -120.5 131.56 54.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.503 -0.748 . . . . 0.0 110.503 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -111.32 143.69 41.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.657 -0.652 . . . . 0.0 110.391 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.632 HG22 ' O ' ' A' ' 73' ' ' ILE . 80.4 mt 54.07 22.88 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.397 -0.814 . . . . 0.0 110.639 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -89.67 116.32 27.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.154 -0.966 . . . . 0.0 110.086 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 51.62 -92.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.575 -0.703 . . . . 0.0 110.638 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -130.31 139.73 50.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.804 -1.185 . . . . 0.0 110.407 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.78 ' HB1' ' O ' ' A' ' 114' ' ' GLN . . . 48.76 -166.91 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.384 -0.822 . . . . 0.0 111.139 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 24.6 m -115.5 146.14 41.97 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.357 -0.839 . . . . 0.0 109.364 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.0 mt -131.31 138.44 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.149 -0.969 . . . . 0.0 111.234 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -142.25 157.22 45.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.492 -0.755 . . . . 0.0 110.461 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.51 164.2 13.5 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.519 HG13 ' HB ' ' A' ' 66' ' ' THR . 48.9 t -139.24 132.79 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -1.158 . . . . 0.0 111.086 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 67' ' ' ALA . 26.7 m -141.89 151.95 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.581 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 164.24 -161.42 34.42 Favored Glycine 0 N--CA 1.48 1.572 0 C-N-CA 119.157 -1.497 . . . . 0.0 110.755 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.554 HG22 ' CG1' ' A' ' 65' ' ' ILE . 33.8 m -130.16 162.87 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 122.226 1.013 . . . . 0.0 112.651 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.07 137.84 7.9 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.465 ' CE2' ' HB3' ' A' ' 63' ' ' TYR . 13.9 p90 -150.82 163.94 37.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.081 -1.246 . . . . 0.0 110.701 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -119.36 141.28 15.61 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -134.01 140.9 47.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.826 -0.808 . . . . 0.0 109.942 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -99.64 131.98 45.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -0.876 . . . . 0.0 110.13 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -93.22 19.36 8.17 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.45 -0.781 . . . . 0.0 110.83 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.6 p -71.33 158.59 36.07 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.282 -0.886 . . . . 0.0 110.058 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 45.6 m -57.78 -40.03 78.87 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.441 -0.787 . . . . 0.0 110.451 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.407 ' HG2' ' N ' ' A' ' 95' ' ' TYR . 86.3 tt0 56.14 164.72 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.553 -0.717 . . . . 0.0 110.675 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.407 ' N ' ' HG2' ' A' ' 94' ' ' GLU . 1.1 m-85 -58.03 166.49 2.0 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.279 -0.888 . . . . 0.0 110.221 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.67 -15.73 51.61 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.635 1.334 . . . . 0.0 110.583 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.1 t -128.62 155.54 44.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.362 -0.836 . . . . 0.0 109.721 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 98' ' ' TYR . 31.7 p90 -137.33 149.03 46.75 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.304 -0.872 . . . . 0.0 110.918 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -89.69 4.61 49.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.581 -0.699 . . . . 0.0 110.571 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 30.6 t30 59.13 36.24 23.98 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.26 -0.9 . . . . 0.0 110.276 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -131.67 3.56 4.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.489 -0.757 . . . . 0.0 110.843 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 74.9 p -78.03 -28.11 48.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.169 -0.957 . . . . 0.0 110.589 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.7 m -83.63 151.01 25.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.417 -0.802 . . . . 0.0 110.475 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -134.84 136.92 42.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.528 -0.733 . . . . 0.0 109.73 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.896 ' O ' HG23 ' A' ' 132' ' ' ILE . 43.2 p90 -133.04 169.44 16.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.256 -0.902 . . . . 0.0 110.912 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -163.03 -175.75 34.38 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.432 ' CD1' HG12 ' A' ' 85' ' ' VAL . 98.8 m-85 -112.03 155.28 24.07 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.186 -1.185 . . . . 0.0 110.655 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 97.6 p -129.86 160.92 32.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.491 -0.755 . . . . 0.0 110.646 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.561 ' CD1' HG12 ' A' ' 83' ' ' VAL . 65.7 t80 -155.26 148.03 24.35 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.439 -0.788 . . . . 0.0 109.673 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 175.82 -176.77 47.59 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.602 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.88 160.0 9.94 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.713 -0.875 . . . . 0.0 108.707 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.433 ' C ' HD12 ' A' ' 113' ' ' LEU . . . -152.47 -179.1 27.77 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.589 ' N ' HD12 ' A' ' 113' ' ' LEU . 5.3 mp -126.68 160.1 31.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.453 -1.027 . . . . 0.0 110.002 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.78 ' O ' ' HB1' ' A' ' 77' ' ' ALA . 36.5 tt0 -106.65 140.65 39.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.81 -1.181 . . . . 0.0 108.057 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -124.65 165.19 18.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.372 -0.83 . . . . 0.0 111.518 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.84 88.94 0.1 OUTLIER Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.865 -0.522 . . . . 0.0 109.927 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.96 125.49 12.63 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.734 1.386 . . . . 0.0 110.398 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.43 ' CB ' ' HB ' ' A' ' 121' ' ' VAL . 95.5 mmm -145.21 163.25 35.0 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.13 -49.08 77.31 Favored 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.688 -0.632 . . . . 0.0 110.401 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -134.17 25.26 3.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.274 -0.891 . . . . 0.0 111.349 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.43 ' HB ' ' CB ' ' A' ' 118' ' ' MET . 48.2 t -127.11 139.66 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.95 -1.094 . . . . 0.0 109.964 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.715 ' HB1' ' CD ' ' A' ' 114' ' ' GLN . . . -154.81 137.7 15.41 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.785 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' A' ' 144' ' ' VAL . 77.7 mt -121.65 143.62 49.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -149.45 153.25 37.0 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 118.246 -1.381 . . . . 0.0 112.395 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.31 140.14 53.08 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.6 t -143.62 149.23 37.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -0.977 . . . . 0.0 111.181 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -104.9 123.41 47.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.637 -0.665 . . . . 0.0 109.368 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -137.36 142.84 41.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.634 -0.666 . . . . 0.0 110.481 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -138.5 156.88 47.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.52 -0.738 . . . . 0.0 109.765 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.2 t -133.33 143.53 49.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.385 -0.822 . . . . 0.0 110.53 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -124.59 127.73 47.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.563 -0.71 . . . . 0.0 109.761 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.896 HG23 ' O ' ' A' ' 105' ' ' TYR . 85.1 mt -121.17 39.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 68.5 mtt180 63.64 -55.13 0.21 Allowed 'General case' 0 N--CA 1.503 2.207 0 O-C-N 122.03 -0.419 . . . . 0.0 111.578 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 132' ' ' ILE . 66.5 p -99.93 -24.14 14.73 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.121 -0.987 . . . . 0.0 110.398 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 56.1 t -126.51 132.39 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.246 -0.909 . . . . 0.0 110.732 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -132.55 113.19 12.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 109.02 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.712 HG22 ' CB ' ' A' ' 14' ' ' ALA . 61.3 t -117.54 146.4 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.937 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -115.78 114.62 3.17 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.614 HG23 ' HB2' ' A' ' 12' ' ' SER . 27.8 m -109.03 140.56 42.39 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.209 -1.171 . . . . 0.0 112.322 -178.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.469 ' O ' ' HB1' ' A' ' 10' ' ' ALA . 41.6 m95 -109.01 136.75 48.03 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 46.4 pt -124.14 147.06 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.98 -1.075 . . . . 0.0 111.654 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -154.43 139.6 17.48 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -168.59 -153.21 8.12 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 118.695 -1.717 . . . . 0.0 112.072 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.785 ' O ' HG23 ' A' ' 6' ' ' THR . 34.5 m -116.97 177.64 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 122.236 -0.567 . . . . 0.0 110.738 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -156.4 140.21 7.06 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.485 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -130.34 152.31 49.88 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.578 -0.954 . . . . 0.0 109.654 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -128.04 120.68 27.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.206 -0.934 . . . . 0.0 110.81 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.5 t80 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.48 -0.763 . . . . 0.0 110.205 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.6 p . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.5 m -116.44 145.21 43.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.9 . . . . 0.0 109.453 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 29' ' ' ARG . 57.9 m -136.21 142.0 44.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.895 . . . . 0.0 110.673 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.435 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 14.7 p -128.61 141.39 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.655 -0.653 . . . . 0.0 109.571 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 144' ' ' VAL . 71.8 m -156.68 133.07 9.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.51 -0.744 . . . . 0.0 109.815 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -166.23 173.47 41.73 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.156 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.85 -128.23 1.19 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -118.35 152.77 35.17 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.406 -1.055 . . . . 0.0 109.866 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.02 116.52 22.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 110.688 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -110.62 142.71 42.11 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.3 t -148.49 145.35 27.9 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.42 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -73.3 150.86 41.6 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.899 ' HB1' ' HB2' ' A' ' 17' ' ' GLN . . . -127.94 90.52 3.11 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.959 -1.096 . . . . 0.0 112.046 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -80.91 116.09 20.71 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.87 -14.41 60.22 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.899 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 93.2 mt-30 -100.83 172.75 6.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.018 -1.283 . . . . 0.0 110.463 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 88.0 mtp -57.55 -49.39 76.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.432 -0.792 . . . . 0.0 112.11 -178.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -164.55 -158.26 0.41 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.771 -1.206 . . . . 0.0 110.655 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -77.68 159.98 28.78 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.437 -0.79 . . . . 0.0 110.304 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.733 ' HB3' HG22 ' A' ' 46' ' ' THR . 85.9 mtp -126.75 163.98 22.35 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.26 -0.9 . . . . 0.0 111.083 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.736 ' C ' HG23 ' A' ' 46' ' ' THR . . . -145.96 126.02 2.42 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.573 ' N ' HG23 ' A' ' 46' ' ' THR . . . -142.75 -171.78 13.53 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.567 -1.302 . . . . 0.0 110.771 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.48 146.62 40.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.636 -0.92 . . . . 0.0 109.988 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.418 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 51.2 t-20 -130.85 127.85 39.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.831 . . . . 0.0 110.997 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.794 HD13 ' N ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -115.83 141.62 47.85 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.592 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.794 ' N ' HD13 ' A' ' 26' ' ' LEU . 31.9 mttm -130.8 144.86 51.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.419 -1.425 . . . . 0.0 110.501 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -122.75 124.46 43.41 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.47 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 59.0 ttt180 -122.74 142.72 50.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.147 -0.971 . . . . 0.0 111.953 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -114.07 137.23 51.99 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -138.44 152.01 47.95 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.4 -0.813 . . . . 0.0 109.61 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -96.21 178.22 5.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.045 -1.034 . . . . 0.0 109.93 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.11 -37.0 78.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.385 -0.822 . . . . 0.0 110.425 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -90.97 12.16 20.53 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.431 -0.793 . . . . 0.0 111.338 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.576 ' N ' ' HD3' ' A' ' 36' ' ' PRO . 13.4 p 38.79 51.81 3.3 Favored Pre-proline 0 N--CA 1.503 2.178 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.576 ' HD3' ' N ' ' A' ' 35' ' ' SER . 44.4 Cg_endo -94.66 -66.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 122.882 0.938 . . . . 0.0 110.547 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.1 tp -94.48 120.35 34.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.843 -0.536 . . . . 0.0 110.909 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.49 134.19 9.57 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.4 t -130.8 135.13 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.341 -1.094 . . . . 0.0 109.044 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.525 HD12 ' HB2' ' A' ' 80' ' ' TYR . 73.5 mt -119.87 140.59 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.855 -1.153 . . . . 0.0 110.936 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.43 125.63 6.68 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 107.758 -2.137 . . . . 0.0 107.758 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.45 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 92.7 p -134.02 144.98 49.03 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.012 -1.287 . . . . 0.0 112.577 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -125.54 140.27 52.89 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 m -132.34 142.42 49.32 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.912 -1.117 . . . . 0.0 111.402 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.417 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 78.3 t80 -131.79 109.67 10.3 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.736 HG23 ' C ' ' A' ' 22' ' ' GLY . 9.1 m -122.1 145.62 47.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.467 -0.771 . . . . 0.0 110.733 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -147.32 167.6 23.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.288 -0.882 . . . . 0.0 110.275 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -94.21 140.54 29.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.439 -0.788 . . . . 0.0 109.976 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.3 t -124.77 134.72 52.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.418 -0.801 . . . . 0.0 110.506 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 50.5 mtm-85 -144.1 159.39 42.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.496 -0.752 . . . . 0.0 110.055 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.1 m -114.54 133.33 55.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.415 -0.803 . . . . 0.0 110.077 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.96 157.59 36.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.44 -0.788 . . . . 0.0 110.195 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.3 p -62.07 -24.06 66.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.421 -0.8 . . . . 0.0 110.256 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.9 t -102.32 150.88 22.88 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.405 -0.81 . . . . 0.0 110.3 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.423 ' HA2' ' CE2' ' A' ' 57' ' ' TYR . . . -91.75 20.68 40.52 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -81.98 112.05 18.71 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.144 -1.209 . . . . 0.0 110.146 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.423 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 91.5 m-85 -126.53 150.89 48.52 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.471 -0.768 . . . . 0.0 110.64 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -59.03 -29.84 67.57 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.536 -0.727 . . . . 0.0 109.884 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 63.32 39.65 9.29 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.65 -0.657 . . . . 0.0 110.527 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -84.35 153.58 23.38 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.314 -0.866 . . . . 0.0 109.438 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -136.4 157.72 46.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.169 -0.957 . . . . 0.0 110.261 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -125.02 117.6 24.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.384 -0.822 . . . . 0.0 110.851 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' A' ' 87' ' ' TYR . 95.5 m-85 -109.78 139.11 45.21 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.58 125.93 2.1 Favored Glycine 0 N--CA 1.485 1.957 0 C-N-CA 119.094 -1.527 . . . . 0.0 110.292 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.578 ' CG2' HG12 ' A' ' 85' ' ' VAL . 16.7 tt -108.43 137.59 39.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -151.41 140.19 20.84 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.018 -1.073 . . . . 0.0 111.126 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.793 ' O ' HG22 ' A' ' 83' ' ' VAL . . . -156.34 152.07 27.15 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.36 178.32 43.13 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.601 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.26 169.23 21.21 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 O-C-N 123.949 1.5 . . . . 0.0 110.638 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.93 145.89 21.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.586 -0.696 . . . . 0.0 110.028 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -120.99 141.18 50.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.655 -0.653 . . . . 0.0 109.948 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.46 ' O ' HD13 ' A' ' 73' ' ' ILE . 44.8 ttt180 -108.05 126.84 53.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.499 -0.75 . . . . 0.0 110.263 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.46 HD13 ' O ' ' A' ' 72' ' ' ARG . 46.8 mm -124.43 115.16 43.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.3 t30 59.34 177.63 0.08 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.377 -0.827 . . . . 0.0 109.86 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -57.36 -36.69 71.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.412 -0.805 . . . . 0.0 111.198 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TRP . . . . . 0.628 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 11.3 m0 -119.18 175.43 5.8 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.246 -0.909 . . . . 0.0 110.885 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 76' ' ' TRP . . . 72.3 95.4 0.07 Allowed 'General case' 0 N--CA 1.506 2.367 0 CA-C-O 121.447 0.641 . . . . 0.0 111.045 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.806 ' O ' HD12 ' A' ' 113' ' ' LEU . 50.6 m -125.83 148.74 49.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.542 -0.724 . . . . 0.0 109.8 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.58 HG12 HD13 ' A' ' 113' ' ' LEU . 81.1 mt -123.41 137.17 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.151 -0.968 . . . . 0.0 110.474 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.525 ' HB2' HD12 ' A' ' 40' ' ' ILE . 39.7 p90 -146.9 166.19 27.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.367 -0.833 . . . . 0.0 110.878 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.41 162.15 19.73 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.409 ' HB ' ' HB ' ' A' ' 66' ' ' THR . 34.6 m -135.26 141.07 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -1.108 . . . . 0.0 111.232 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 67' ' ' ALA . 36.0 m -142.63 151.44 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 160.36 -149.34 18.62 Favored Glycine 0 N--CA 1.483 1.772 0 C-N-CA 119.265 -1.445 . . . . 0.0 110.953 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.578 HG12 ' CG2' ' A' ' 65' ' ' ILE . 11.1 p -133.04 144.29 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 122.459 1.123 . . . . 0.0 113.567 -177.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.2 137.68 14.46 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.525 ' CE2' HG13 ' A' ' 85' ' ' VAL . 90.0 m-85 -120.65 143.56 48.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.141 -1.211 . . . . 0.0 110.796 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -125.02 114.59 2.22 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -101.74 121.08 41.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.491 -1.005 . . . . 0.0 110.253 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -119.89 146.69 45.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.536 -0.728 . . . . 0.0 110.254 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -59.0 -36.65 75.27 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.404 -0.81 . . . . 0.0 110.53 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.65 HG22 ' HG3' ' A' ' 94' ' ' GLU . 2.2 m 59.66 154.96 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.504 -0.747 . . . . 0.0 110.432 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 77.7 p -109.74 12.33 24.14 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.32 -0.862 . . . . 0.0 110.936 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.65 ' HG3' HG22 ' A' ' 92' ' ' THR . 97.0 mt-10 -60.09 143.03 53.13 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.123 -0.986 . . . . 0.0 110.285 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -60.31 151.16 69.5 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.398 -0.814 . . . . 0.0 110.292 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.4 -21.53 40.68 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.624 1.328 . . . . 0.0 111.05 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.6 HG22 ' CE2' ' A' ' 98' ' ' TYR . 31.0 m -59.38 -43.77 92.86 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.119 -0.988 . . . . 0.0 110.389 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . 0.6 ' CE2' HG22 ' A' ' 97' ' ' THR . 86.9 m-85 -130.34 142.43 50.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.473 -0.767 . . . . 0.0 110.446 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt 55.21 66.51 1.21 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.394 -0.817 . . . . 0.0 110.697 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -53.33 -39.73 64.3 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.27 -0.893 . . . . 0.0 110.538 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -170.13 137.52 1.56 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.375 -0.828 . . . . 0.0 110.18 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.0 t -138.41 154.31 48.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.364 -0.835 . . . . 0.0 110.623 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 88.9 p -130.8 154.99 47.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.435 -0.791 . . . . 0.0 110.121 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.527 ' HB3' HD12 ' A' ' 132' ' ' ILE . 52.4 t0 -110.27 148.56 31.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.391 -0.818 . . . . 0.0 110.194 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.453 ' HB3' ' CD1' ' A' ' 87' ' ' TYR . 43.4 p90 -127.6 168.83 14.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.275 -0.89 . . . . 0.0 110.305 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.682 ' HA3' HG22 ' A' ' 132' ' ' ILE . . . -159.83 -175.86 31.27 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -103.38 144.71 31.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.134 -1.215 . . . . 0.0 111.333 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.0 m -118.08 150.33 39.51 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 110.059 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -154.63 146.57 23.52 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.452 -0.78 . . . . 0.0 109.978 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.91 -176.27 42.55 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.016 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 80' ' ' TYR . . . -160.81 162.89 32.43 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.46 -178.07 24.12 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.289 -1.434 . . . . 0.0 110.221 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.806 HD12 ' O ' ' A' ' 78' ' ' SER . 20.2 tp -139.51 149.39 43.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.609 -0.936 . . . . 0.0 109.923 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -127.06 151.81 48.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.185 -0.947 . . . . 0.0 109.824 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -156.88 161.19 39.68 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.359 -0.838 . . . . 0.0 110.883 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . 0.489 ' HB2' ' HA ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER 172.77 140.36 0.13 Allowed Pre-proline 0 N--CA 1.504 2.266 0 O-C-N 121.643 -0.661 . . . . 0.0 111.323 179.251 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 116' ' ' ASN . 52.2 Cg_endo -88.37 50.6 1.7 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.581 1.306 . . . . 0.0 109.011 177.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.457 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 86.6 mtp -146.25 140.58 26.63 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.527 -0.733 . . . . 0.0 109.068 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.48 -39.46 91.95 Favored 'General case' 0 C--N 1.292 -1.914 0 O-C-N 121.781 -0.574 . . . . 0.0 112.423 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -115.46 13.6 16.5 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.665 -1.272 . . . . 0.0 112.631 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 47.1 t -123.94 136.28 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.781 -1.199 . . . . 0.0 109.787 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.489 ' HA ' ' HB2' ' A' ' 116' ' ' ASN . . . -153.3 138.15 17.11 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.643 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.1 mt -103.13 153.1 20.67 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 142' ' ' ALA . 52.5 t0 -143.97 136.52 26.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.569 -1.332 . . . . 0.0 110.361 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -128.71 142.28 51.06 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.6 t -145.91 155.74 43.07 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.132 -0.98 . . . . 0.0 111.375 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -107.14 119.27 38.91 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.532 ' HB3' HG23 ' A' ' 139' ' ' THR . 84.5 tt0 -131.96 144.32 50.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 110.9 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -141.26 155.0 46.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.577 -0.702 . . . . 0.0 109.609 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 29.3 t -142.46 141.3 32.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.397 -0.814 . . . . 0.0 110.294 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 -129.42 133.35 47.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.472 -0.768 . . . . 0.0 109.87 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.682 HG22 ' HA3' ' A' ' 106' ' ' GLY . 24.6 pt -125.15 48.76 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 76.7 mtt85 60.59 -56.62 0.08 Allowed 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 132' ' ' ILE . 53.4 m -92.18 -21.67 20.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 111.006 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.468 ' HB ' HG12 ' A' ' 132' ' ' ILE . 37.6 t -135.12 137.55 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.646 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -132.74 113.69 13.27 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.847 HG12 ' HA ' ' A' ' 14' ' ' ALA . 34.0 m -121.33 149.19 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.234 -0.916 . . . . 0.0 110.835 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -114.28 129.35 8.68 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.532 HG23 ' HB3' ' A' ' 128' ' ' GLU . 14.7 t -126.31 143.9 51.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -1.134 . . . . 0.0 112.263 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -123.06 140.89 52.55 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.542 HD12 ' HE3' ' A' ' 27' ' ' LYS . 49.6 pt -120.5 149.94 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.122 -0.986 . . . . 0.0 111.187 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 124' ' ' ASP . . . -150.07 140.08 21.99 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -173.53 -146.3 5.47 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 118.783 -1.675 . . . . 0.0 111.906 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.784 ' O ' HG23 ' A' ' 6' ' ' THR . 35.4 m -118.77 179.87 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 122.229 -0.571 . . . . 0.0 110.908 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 5' ' ' VAL . . . -160.84 143.61 9.11 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.899 -1.143 . . . . 0.0 110.729 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -132.73 156.12 47.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.655 -0.909 . . . . 0.0 109.726 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 46.3 ptt85 -133.96 123.85 25.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.346 -0.846 . . . . 0.0 111.268 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.8 p90 . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.346 -0.846 . . . . 0.0 110.397 179.939 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 48.5 m . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.0 p -117.34 144.31 45.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 109.751 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 146' ' ' TYR . 56.7 m -135.83 140.21 44.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.418 -0.801 . . . . 0.0 110.505 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -115.18 138.31 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 144' ' ' VAL . 27.6 m -156.34 132.54 9.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.237 -0.914 . . . . 0.0 110.023 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.99 171.95 38.89 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.82 -148.43 7.91 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 46.2 p90 -139.36 159.86 41.17 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.442 -1.034 . . . . 0.0 109.85 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.829 ' HB2' HG22 ' A' ' 141' ' ' ILE . . . -145.67 147.07 31.58 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.838 -1.145 . . . . 0.0 111.628 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.89 ' O ' HG23 ' A' ' 139' ' ' THR . 94.5 mt-30 -99.19 138.16 36.68 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.404 ' HB3' HG11 ' A' ' 137' ' ' VAL . 43.5 m -119.73 145.13 46.82 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.193 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -136.69 141.09 43.09 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.894 ' CB ' HG22 ' A' ' 137' ' ' VAL . . . -153.96 149.52 27.34 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 120.411 -1.431 . . . . 0.0 112.482 -177.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -79.32 128.03 32.82 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.6 -28.29 14.77 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . 0.536 ' NE2' HG11 ' A' ' 135' ' ' VAL . 96.5 mt-30 -114.02 157.26 22.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.457 -1.025 . . . . 0.0 110.212 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . 0.406 ' O ' ' HB2' ' A' ' 19' ' ' ASN . 64.8 mtt -121.46 171.33 8.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.442 -0.786 . . . . 0.0 110.29 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 18' ' ' MET . 18.2 m120 61.7 115.97 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.631 -0.668 . . . . 0.0 110.511 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -65.95 164.09 15.8 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.578 -0.701 . . . . 0.0 110.305 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 87.2 mtp -126.19 165.75 18.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.46 -0.775 . . . . 0.0 110.713 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.1 123.37 1.83 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.709 ' HA3' HG22 ' A' ' 46' ' ' THR . . . -135.73 -172.67 12.74 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.153 -1.498 . . . . 0.0 110.754 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -119.0 148.6 42.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.804 -0.821 . . . . 0.0 108.999 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.405 ' ND2' ' HE2' ' A' ' 27' ' ' LYS . 44.9 t-20 -125.59 134.65 51.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 111.265 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.2 mt -113.27 147.72 37.02 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 26.5 mttt -147.89 137.34 22.37 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.63 -1.294 . . . . 0.0 110.979 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -119.84 130.9 55.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.459 -0.776 . . . . 0.0 108.928 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.414 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 14.2 ttp180 -132.27 140.27 48.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.14 -0.975 . . . . 0.0 111.878 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -119.0 133.3 55.91 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -141.97 142.75 32.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.199 -0.938 . . . . 0.0 110.459 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -104.5 129.74 52.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.419 -0.8 . . . . 0.0 109.879 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -54.35 -22.49 12.3 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.565 -0.709 . . . . 0.0 111.657 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -60.64 -36.09 77.81 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.238 -0.914 . . . . 0.0 110.686 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.3 m -145.51 160.39 45.01 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.151 -0.968 . . . . 0.0 110.539 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -88.11 33.99 0.4 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.695 1.366 . . . . 0.0 111.183 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 28.1 tp -116.59 84.72 2.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.26 -0.9 . . . . 0.0 110.595 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.74 -175.83 24.8 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.02 147.04 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.488 -1.007 . . . . 0.0 109.342 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.77 HG22 ' O ' ' A' ' 68' ' ' GLY . 16.5 tt -135.75 146.64 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.239 -0.913 . . . . 0.0 111.451 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 27' ' ' LYS . . . -115.73 151.16 18.49 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.5 t -140.35 142.27 35.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.075 -1.25 . . . . 0.0 111.788 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -129.95 138.67 50.99 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.4 t -134.04 148.55 51.09 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.95 -1.094 . . . . 0.0 111.677 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -141.59 114.37 8.48 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.709 HG22 ' HA3' ' A' ' 23' ' ' GLY . 32.3 p -122.11 159.73 26.53 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.418 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -142.35 170.9 14.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.747 . . . . 0.0 110.418 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -128.99 155.48 45.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.398 -0.814 . . . . 0.0 110.305 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.1 m -96.71 156.42 16.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.49 -0.756 . . . . 0.0 110.185 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.3 ptt-85 -141.35 161.1 38.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.431 -0.793 . . . . 0.0 110.542 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.2 m -120.92 142.55 49.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.432 -0.793 . . . . 0.0 110.11 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 53' ' ' SER . . . -60.1 142.68 53.77 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.456 -0.778 . . . . 0.0 110.144 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 52' ' ' ALA . 0.6 OUTLIER 60.09 132.44 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.557 -0.715 . . . . 0.0 110.435 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 m 52.41 64.47 1.84 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.176 -0.953 . . . . 0.0 110.324 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.17 -171.06 36.76 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -65.47 130.17 42.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.332 -1.099 . . . . 0.0 110.155 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 39.9 p90 -85.0 -15.83 42.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.479 -0.763 . . . . 0.0 111.042 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.424 ' HB3' ' CE2' ' A' ' 57' ' ' TYR . 48.0 p-10 -126.68 -164.28 1.32 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.262 -0.899 . . . . 0.0 110.784 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -143.97 117.01 8.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.519 -0.738 . . . . 0.0 109.482 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 84.2 m-20 -98.41 148.45 23.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.354 -0.842 . . . . 0.0 111.169 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -109.77 145.52 36.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.613 -0.679 . . . . 0.0 109.752 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.415 ' HB3' ' OG1' ' A' ' 46' ' ' THR . 69.4 t80 -110.48 117.53 33.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.779 . . . . 0.0 110.98 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' A' ' 87' ' ' TYR . 86.4 m-85 -113.62 135.08 54.31 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.098 0.475 . . . . 0.0 109.776 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.01 126.8 2.52 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.547 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.551 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 14.0 tt -122.03 134.63 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 1.1 p -149.71 143.79 25.68 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.668 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 40' ' ' ILE . . . -141.23 150.09 42.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.685 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.77 ' O ' HG22 ' A' ' 40' ' ' ILE . . . -167.84 168.24 40.58 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.65 176.97 8.1 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.788 1.415 . . . . 0.0 110.681 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.404 ' CB ' ' HD2' ' A' ' 29' ' ' ARG . . . -157.49 147.99 21.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.476 -0.765 . . . . 0.0 110.847 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -118.49 134.81 54.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.429 -0.795 . . . . 0.0 109.646 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.5 ttt-85 -68.97 150.93 47.16 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.456 -0.777 . . . . 0.0 110.765 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.614 HG23 ' O ' ' A' ' 73' ' ' ILE . 15.0 tt -63.83 82.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 121.486 0.66 . . . . 0.0 110.116 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -55.6 -33.92 64.39 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.521 -0.737 . . . . 0.0 110.52 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -164.08 -39.37 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.413 -0.804 . . . . 0.0 110.717 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 18.2 m0 -93.85 -69.77 0.73 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.29 -0.881 . . . . 0.0 110.854 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.453 ' HA ' HD12 ' A' ' 73' ' ' ILE . . . -160.56 172.06 17.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.333 -0.854 . . . . 0.0 110.521 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 33.7 t -95.77 142.44 28.05 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.492 -0.755 . . . . 0.0 109.8 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.0 tt -132.62 144.43 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.361 -0.837 . . . . 0.0 110.451 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -142.96 153.98 43.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -0.812 . . . . 0.0 110.882 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.48 161.79 21.42 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 110' ' ' GLY . 47.3 t -134.45 132.77 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.119 -1.224 . . . . 0.0 111.467 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 66' ' ' THR . 60.5 t -137.29 145.59 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 170.7 -166.39 39.59 Favored Glycine 0 N--CA 1.477 1.412 0 C-N-CA 118.537 -1.792 . . . . 0.0 111.337 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.595 HG11 ' CE2' ' A' ' 105' ' ' TYR . 33.2 m -133.84 177.07 7.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 121.838 0.827 . . . . 0.0 111.529 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.39 145.05 15.67 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' A' ' 63' ' ' TYR . 99.2 m-85 -126.06 132.49 51.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.201 -1.176 . . . . 0.0 109.732 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.06 129.02 9.15 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 26.3 tttt -127.15 132.91 50.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.594 -0.945 . . . . 0.0 109.676 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -131.79 165.85 22.87 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.441 -0.787 . . . . 0.0 110.467 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -104.85 147.01 28.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.526 -0.733 . . . . 0.0 110.358 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.5 m -84.58 152.39 23.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.529 -0.732 . . . . 0.0 110.079 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.762 HG22 ' HG3' ' A' ' 94' ' ' GLU . 40.8 m -57.27 144.34 36.0 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.44 -0.787 . . . . 0.0 110.156 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.762 ' HG3' HG22 ' A' ' 93' ' ' THR . 96.1 mt-10 56.27 171.47 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.503 -0.748 . . . . 0.0 110.209 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.14 115.17 13.0 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.375 -0.828 . . . . 0.0 110.444 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.87 -19.86 35.04 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 123.482 1.254 . . . . 0.0 110.803 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 68.5 p 45.42 28.18 0.45 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.572 -0.705 . . . . 0.0 111.257 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -135.84 134.65 39.09 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.371 -0.831 . . . . 0.0 109.662 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 101' ' ' ASP . 99.1 mttt -55.12 -40.94 71.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.387 -0.821 . . . . 0.0 110.976 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.582 ' O ' HG23 ' A' ' 102' ' ' THR . 26.9 t-20 49.5 -90.29 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.538 -0.726 . . . . 0.0 111.191 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 99' ' ' LYS . 84.7 m-20 53.57 46.76 25.42 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.852 -1.155 . . . . 0.0 110.848 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 100' ' ' ASN . 63.2 p -125.24 143.07 51.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.338 -0.851 . . . . 0.0 110.218 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.4 m -136.03 152.63 51.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.44 -0.788 . . . . 0.0 110.352 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -83.27 131.12 35.1 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.395 -0.816 . . . . 0.0 109.571 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.595 ' CE2' HG11 ' A' ' 85' ' ' VAL . 39.4 t80 -81.69 131.0 35.25 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.108 -0.995 . . . . 0.0 111.443 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.714 ' HA3' HD13 ' A' ' 132' ' ' ILE . . . -117.96 -164.13 13.02 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 66.0 t80 -140.8 148.86 41.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.443 -1.033 . . . . 0.0 109.917 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.7 m -136.6 143.57 43.65 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.198 -0.939 . . . . 0.0 110.858 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 128' ' ' GLU . 69.2 t80 -151.7 141.38 21.8 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.449 -0.782 . . . . 0.0 110.014 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 82' ' ' VAL . . . 174.87 -176.07 47.04 Favored Glycine 0 N--CA 1.497 2.727 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.451 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -169.2 161.23 10.13 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.458 -1.025 . . . . 0.0 109.0 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -156.06 -174.89 26.42 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.303 -1.427 . . . . 0.0 109.946 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 78' ' ' SER . 0.5 OUTLIER -124.01 162.42 23.49 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.43 -1.041 . . . . 0.0 110.069 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . 0.537 ' HG2' ' HB3' ' A' ' 124' ' ' ASP . 75.2 mt-30 -119.21 131.85 55.87 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.862 -1.148 . . . . 0.0 109.04 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -129.28 129.2 44.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.293 -0.879 . . . . 0.0 110.629 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -177.34 150.69 0.86 Allowed Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.331 -0.855 . . . . 0.0 110.471 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -77.01 -77.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.577 1.304 . . . . 0.0 110.131 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' MET . . . . . 0.415 ' HB2' HG22 ' A' ' 121' ' ' VAL . 89.0 mtp -47.22 119.17 2.47 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.435 1.112 . . . . 0.0 110.596 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.5 -10.43 7.82 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.437 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -92.06 -4.06 54.93 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.531 -1.356 . . . . 0.0 110.743 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 118' ' ' MET . 34.1 m -128.28 161.1 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -0.875 . . . . 0.0 110.51 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 144' ' ' VAL . . . -156.11 138.64 14.98 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.685 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . 0.837 HD12 ' O ' ' A' ' 143' ' ' GLY . 18.3 tp -119.68 132.31 55.64 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.537 ' HB3' ' HG2' ' A' ' 114' ' ' GLN . 49.5 p30 -143.85 156.72 44.56 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.088 -1.445 . . . . 0.0 113.797 -177.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -124.51 134.86 52.88 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.615 ' HB3' HD11 ' A' ' 141' ' ' ILE . 31.2 t -138.45 142.82 39.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 111.016 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.44 ' CD1' ' CZ2' ' A' ' 140' ' ' TRP . 81.0 t80 -109.23 127.54 54.33 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 109' ' ' TYR . 21.9 pt-20 -142.14 147.39 36.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.526 -0.734 . . . . 0.0 110.41 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -112.22 135.14 53.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.547 -0.72 . . . . 0.0 110.106 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 50.7 m -128.4 143.61 51.02 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.608 -0.682 . . . . 0.0 109.315 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 39.5 ptt180 -147.06 144.7 29.29 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.81 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.714 HD13 ' HA3' ' A' ' 106' ' ' GLY . 44.8 mm -122.67 90.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.57 -0.706 . . . . 0.0 110.031 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 51.7 mtt180 61.75 -66.45 0.07 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.667 -0.645 . . . . 0.0 112.385 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 132' ' ' ILE . 32.2 p -125.86 20.84 7.68 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.033 -1.042 . . . . 0.0 110.96 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.536 HG11 ' NE2' ' A' ' 17' ' ' GLN . 61.5 t -124.57 133.94 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 119.261 -0.975 . . . . 0.0 111.024 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -129.3 111.89 13.32 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.894 HG22 ' CB ' ' A' ' 14' ' ' ALA . 18.6 t -113.15 144.2 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.807 -1.183 . . . . 0.0 111.276 -177.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -117.12 107.12 1.52 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.125 -2.39 . . . . 0.0 107.125 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . 0.89 HG23 ' O ' ' A' ' 11' ' ' GLN . 90.5 m -121.81 142.33 50.33 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -1.13 . . . . 0.0 112.051 -177.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TRP . . . . . 0.44 ' CZ2' ' CD1' ' A' ' 127' ' ' TYR . 89.3 m95 -105.63 135.51 46.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.829 HG22 ' HB2' ' A' ' 10' ' ' ALA . 49.3 pt -119.53 150.5 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.147 -0.97 . . . . 0.0 111.312 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -151.66 139.03 19.42 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.837 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -164.23 -157.71 9.65 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 118.92 -1.61 . . . . 0.0 111.745 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.745 ' O ' HG23 ' A' ' 6' ' ' THR . 34.8 m -117.38 173.71 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 122.135 -0.626 . . . . 0.0 110.385 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 121' ' ' VAL . . . -152.41 138.75 6.59 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.699 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.71 ' O ' HG23 ' A' ' 4' ' ' THR . 84.7 m-85 -127.04 147.35 50.15 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.582 -0.952 . . . . 0.0 109.357 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -129.22 122.89 30.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.133 -0.979 . . . . 0.0 111.046 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 69.0 t80 . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.466 -0.771 . . . . 0.0 110.2 179.862 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 3' ' ' SER . 93.8 m . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 120.546 0.212 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.416 ' N ' HG22 ' A' ' 2' ' ' THR . 82.8 p -149.4 154.39 38.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.867 -1.145 . . . . 0.0 109.779 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.646 HG23 ' O ' ' A' ' 146' ' ' TYR . 27.2 m -136.11 137.69 41.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.418 -0.801 . . . . 0.0 110.06 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.421 HG23 ' HE2' ' A' ' 148' ' ' PHE . 58.0 t -106.79 138.05 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 144' ' ' VAL . 47.6 m -156.58 133.59 10.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.217 -0.927 . . . . 0.0 110.367 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.35 176.12 44.72 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.09 -120.85 0.78 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.404 ' CE2' ' HA3' ' A' ' 22' ' ' GLY . 27.1 t80 -139.46 158.92 43.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.482 -1.01 . . . . 0.0 109.228 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.2 117.4 14.5 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.143 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -106.76 144.63 33.13 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.426 ' HB3' HG23 ' A' ' 139' ' ' THR . 54.3 p -150.12 154.08 37.46 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.342 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -77.22 154.32 33.17 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.917 ' HB1' ' HB2' ' A' ' 17' ' ' GLN . . . -125.76 98.57 5.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.099 -1.001 . . . . 0.0 111.821 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -80.13 115.68 19.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.396 -0.815 . . . . 0.0 108.802 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.51 -14.09 59.43 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.917 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 96.6 mt-30 -115.05 160.03 20.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.439 -1.036 . . . . 0.0 109.402 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.1 ttm -98.99 137.96 36.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 111.052 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.6 t30 64.63 138.59 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.541 -0.724 . . . . 0.0 111.099 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -69.17 177.79 2.59 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.613 -0.679 . . . . 0.0 110.128 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.753 ' HB3' HG22 ' A' ' 46' ' ' THR . 68.9 mtm -129.16 169.91 14.2 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.343 -0.848 . . . . 0.0 110.724 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.79 ' C ' HG23 ' A' ' 46' ' ' THR . . . -152.68 128.94 2.61 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 45' ' ' TYR . . . -136.09 177.28 19.67 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.78 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -108.54 139.99 42.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.709 -0.877 . . . . 0.0 109.785 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -121.4 125.68 47.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.43 -0.794 . . . . 0.0 111.394 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.1 tp -119.94 135.08 55.04 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.699 ' HD2' HD12 ' A' ' 40' ' ' ILE . 24.8 ttpt -138.91 144.98 39.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.489 -1.382 . . . . 0.0 111.754 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -110.34 145.18 37.93 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.529 ' HG3' HG22 ' A' ' 40' ' ' ILE . 20.6 ttm-85 -128.74 146.72 50.81 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.186 -0.946 . . . . 0.0 111.78 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -136.21 133.86 37.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.736 -0.603 . . . . 0.0 109.412 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -141.06 153.91 45.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.154 -0.966 . . . . 0.0 110.131 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 0.0 110.0 179.734 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo . . . . . 0 N--CA 1.483 0.862 0 N-CA-C 111.045 -0.406 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.0 tp -92.02 125.27 36.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.262 -0.899 . . . . 0.0 110.043 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.55 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . -133.71 134.4 7.44 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.57 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.41 131.8 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.699 HD12 ' HD2' ' A' ' 27' ' ' LYS . 33.0 pt -127.0 145.63 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.895 -1.128 . . . . 0.0 112.041 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.6 120.18 4.32 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.0 t -125.18 144.47 50.43 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.191 -1.182 . . . . 0.0 111.657 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -114.57 144.41 43.43 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.3 m -131.61 138.61 48.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.925 -1.11 . . . . 0.0 110.883 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.403 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 60.7 t80 -133.19 109.6 9.55 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.79 HG23 ' C ' ' A' ' 22' ' ' GLY . 27.9 m -123.07 143.82 49.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.395 -0.816 . . . . 0.0 111.147 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.4 ' OE2' ' CE2' ' A' ' 45' ' ' TYR . 93.9 mt-10 -137.82 165.34 26.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.406 -0.809 . . . . 0.0 110.316 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 tttt . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.539 -0.726 . . . . 0.0 109.719 179.459 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 . . . . . 0 N--CA 1.495 1.814 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -120.38 100.82 7.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.249 -0.907 . . . . 0.0 111.011 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -102.81 142.56 33.74 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.77 158.06 27.66 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 118.63 -1.748 . . . . 0.0 111.173 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.476 ' C ' HG23 ' A' ' 66' ' ' THR . 44.3 pt -121.79 137.17 56.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.476 HG23 ' C ' ' A' ' 65' ' ' ILE . 65.3 p -150.21 139.59 21.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 110.919 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.767 ' O ' HG12 ' A' ' 83' ' ' VAL . . . -160.29 155.09 24.21 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.0 175.25 42.86 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.414 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 44.9 Cg_endo -71.21 165.73 31.51 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.93 1.489 . . . . 0.0 110.538 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.55 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -146.65 140.68 26.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.487 -0.758 . . . . 0.0 110.079 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -123.66 143.75 50.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.543 -0.723 . . . . 0.0 109.978 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 . . . . . 0 N--CA 1.493 1.687 0 O-C-N 121.542 -0.724 . . . . 0.0 110.962 -179.311 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 121.344 0.593 . . . . 0.0 111.332 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.2 m -134.93 147.33 49.76 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.591 -0.693 . . . . 0.0 109.573 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.5 pt -129.8 138.72 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.01 -1.056 . . . . 0.0 110.607 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.43 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 40.6 p90 -147.47 167.91 23.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.448 -0.782 . . . . 0.0 111.202 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.83 164.95 21.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 110' ' ' GLY . 34.7 m -135.87 135.48 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -1.112 . . . . 0.0 110.7 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 67' ' ' ALA . 10.5 p -141.05 147.83 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 159.18 -149.94 20.16 Favored Glycine 0 N--CA 1.477 1.426 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.442 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.46 HG22 ' CG1' ' A' ' 65' ' ' ILE . 34.1 m -135.5 -172.72 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.527 1.156 . . . . 0.0 113.272 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.09 152.18 23.04 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -123.82 133.8 53.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -1.166 . . . . 0.0 109.916 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -116.2 113.23 2.78 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.2 mttt . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.622 -0.928 . . . . 0.0 109.492 179.541 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.9 t0 . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.844 ' O ' HG23 ' A' ' 132' ' ' ILE . 48.5 p90 -136.17 170.78 15.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.075 -1.016 . . . . 0.0 111.778 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -157.56 -178.0 31.2 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.419 ' CD1' HG12 ' A' ' 85' ' ' VAL . 99.4 m-85 -108.25 152.41 24.65 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.033 -1.275 . . . . 0.0 110.876 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -125.51 153.9 42.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.414 -0.804 . . . . 0.0 110.515 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 64.1 t80 -154.83 146.75 23.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.465 -0.772 . . . . 0.0 109.868 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.508 ' O ' HG22 ' A' ' 82' ' ' VAL . . . 169.03 -178.23 42.39 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.841 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 80' ' ' TYR . . . -165.16 165.88 19.45 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.695 -0.885 . . . . 0.0 108.915 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -155.94 -173.74 24.91 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -136.8 155.44 49.82 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.352 -1.087 . . . . 0.0 110.072 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.679 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 30.4 tt0 -115.73 141.87 47.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.178 -0.951 . . . . 0.0 109.564 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -146.12 150.02 35.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.41 -0.806 . . . . 0.0 110.438 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.448 ' HB2' ' HA ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER 175.66 138.43 0.19 Allowed Pre-proline 0 N--CA 1.503 2.178 0 O-C-N 121.65 -0.656 . . . . 0.0 111.553 179.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 116' ' ' ASN . 52.5 Cg_endo -88.69 48.09 1.26 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.576 1.303 . . . . 0.0 109.168 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.475 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 86.5 mtp -147.15 137.01 23.13 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.459 -0.776 . . . . 0.0 108.945 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.43 -38.19 89.14 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.778 -0.576 . . . . 0.0 112.43 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -109.26 7.81 25.44 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.67 -1.269 . . . . 0.0 112.66 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 60.8 t -122.45 138.69 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.739 -1.226 . . . . 0.0 110.063 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.679 ' HB1' ' CD ' ' A' ' 114' ' ' GLN . . . -146.45 139.18 25.34 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.386 -0.926 . . . . 0.0 112.338 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 143' ' ' GLY . 13.8 tp -122.13 135.58 54.81 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' HB3' ' CB ' ' A' ' 114' ' ' GLN . 53.0 p30 -139.06 153.8 48.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.458 -1.401 . . . . 0.0 112.167 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -124.44 138.94 54.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.804 -0.56 . . . . 0.0 109.616 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.1 p -146.2 157.22 43.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.843 . . . . 0.0 110.191 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -133.82 143.1 48.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.519 -0.738 . . . . 0.0 110.342 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -150.98 143.86 24.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.509 -0.744 . . . . 0.0 110.164 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -113.78 146.61 39.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.403 -0.811 . . . . 0.0 109.97 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.5 t -129.18 139.61 51.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.44 -0.787 . . . . 0.0 110.246 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.3 ttp85 -127.98 127.89 44.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.475 -0.766 . . . . 0.0 109.837 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.844 HG23 ' O ' ' A' ' 105' ' ' TYR . 89.5 mt -119.15 56.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.668 -0.645 . . . . 0.0 109.56 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.455 ' HB3' ' O ' ' A' ' 132' ' ' ILE . 17.6 ttm180 66.05 -57.26 0.35 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.884 -0.51 . . . . 0.0 111.647 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.07 -7.32 11.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.085 -1.009 . . . . 0.0 111.401 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.498 HG11 ' NE2' ' A' ' 17' ' ' GLN . 48.9 t -119.64 130.82 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.967 -1.083 . . . . 0.0 110.653 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -133.44 114.01 13.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.561 -0.712 . . . . 0.0 109.242 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.897 HG12 ' HA ' ' A' ' 14' ' ' ALA . 31.5 m -124.65 149.3 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 110.506 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.89 103.65 2.34 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.126 -1.989 . . . . 0.0 108.126 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.426 HG23 ' HB3' ' A' ' 12' ' ' SER . 24.3 m -111.03 145.49 38.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.42 -1.047 . . . . 0.0 111.765 -178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.601 ' HZ3' ' HB3' ' A' ' 142' ' ' ALA . 60.2 p-90 -132.1 145.37 51.36 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 75.4 mt -117.35 131.11 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.252 -0.905 . . . . 0.0 110.175 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.601 ' HB3' ' HZ3' ' A' ' 140' ' ' TRP . . . -149.27 145.54 27.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.44 -0.787 . . . . 0.0 110.185 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.818 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -177.09 -128.71 1.17 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.381 -1.39 . . . . 0.0 111.163 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.7 ' O ' HG23 ' A' ' 6' ' ' THR . 35.2 m -117.87 171.51 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.861 -0.788 . . . . 0.0 111.383 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 122' ' ' ALA . . . -148.81 135.56 5.48 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.646 ' O ' HG23 ' A' ' 4' ' ' THR . 64.8 t80 -130.46 149.56 52.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.576 -0.956 . . . . 0.0 109.394 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -131.89 122.38 25.57 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.261 -0.899 . . . . 0.0 111.478 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.421 ' HE2' HG23 ' A' ' 5' ' ' VAL . 95.9 m-85 . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.494 -0.754 . . . . 0.0 110.181 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.936 0.398 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.7 t -128.08 144.85 51.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.903 . . . . 0.0 109.793 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 146' ' ' TYR . 26.9 m -136.01 136.31 40.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.873 . . . . 0.0 109.996 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -107.69 139.37 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.579 -0.701 . . . . 0.0 109.26 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 144' ' ' VAL . 51.5 m -154.8 129.66 9.39 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.08 -1.012 . . . . 0.0 110.323 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -164.12 169.05 38.85 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.56 -130.4 1.34 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -127.3 158.24 37.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.45 -1.029 . . . . 0.0 109.763 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.79 116.5 16.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 111.066 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -113.75 142.36 46.15 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.428 ' HB2' HG12 ' A' ' 137' ' ' VAL . 59.1 p -153.63 154.6 34.5 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.695 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.746 ' O ' HG13 ' A' ' 137' ' ' VAL . 88.5 m-20 -93.85 153.15 18.42 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.759 ' CB ' HG22 ' A' ' 137' ' ' VAL . . . -135.59 119.16 17.0 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.775 -1.203 . . . . 0.0 111.878 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -71.17 119.88 15.94 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.03 -15.25 44.09 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.663 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 91.6 mt-30 -115.79 156.44 26.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.603 -0.939 . . . . 0.0 109.138 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 65.6 mtt -96.24 -77.69 0.48 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.09 -1.006 . . . . 0.0 110.985 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -66.06 134.45 52.89 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.372 -0.83 . . . . 0.0 110.962 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -68.8 178.5 2.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.525 -0.734 . . . . 0.0 110.103 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.628 ' HB3' HG22 ' A' ' 46' ' ' THR . 64.3 mtm -124.05 163.29 21.73 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.273 -0.892 . . . . 0.0 110.69 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.66 ' C ' HG23 ' A' ' 46' ' ' THR . . . -149.94 125.68 2.02 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.55 ' N ' HG23 ' A' ' 46' ' ' THR . . . -143.0 -159.34 7.9 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.523 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' A' ' 45' ' ' TYR . 51.3 p90 -129.19 161.16 30.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.537 -0.978 . . . . 0.0 110.047 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.433 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 45.5 t-20 -141.34 132.26 26.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.46 -0.775 . . . . 0.0 111.359 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.0 tp -118.62 141.15 48.87 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 47.3 mttt -134.86 146.72 49.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.403 -1.436 . . . . 0.0 111.26 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -115.91 138.97 50.68 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.516 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 53.2 ttt-85 -129.5 143.04 50.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.202 -0.936 . . . . 0.0 111.817 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -134.15 133.0 40.5 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -142.99 149.99 39.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.169 -0.957 . . . . 0.0 110.48 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.337 -0.852 . . . . 0.0 109.462 179.663 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo . . . . . 0 N--CA 1.483 0.88 0 N-CA-C 111.142 -0.369 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 37' ' ' LEU . 2.7 mm? -87.77 98.97 11.75 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.941 . . . . 0.0 110.11 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 69' ' ' PRO . . . -107.98 131.66 10.71 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.78 129.36 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.558 -0.966 . . . . 0.0 108.721 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.452 ' CD1' ' CD1' ' A' ' 80' ' ' TYR . 77.8 mt -123.55 142.57 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.101 -0.999 . . . . 0.0 111.339 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 27' ' ' LYS . . . -109.46 145.45 16.76 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 107.086 -2.406 . . . . 0.0 107.086 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.406 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 34.7 t -139.71 142.46 36.86 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 118.969 1.384 . . . . 0.0 112.174 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -123.42 137.83 54.72 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.6 m -132.03 140.07 48.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.823 -1.173 . . . . 0.0 111.074 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.438 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 75.6 t80 -134.33 110.28 9.37 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.66 HG23 ' C ' ' A' ' 22' ' ' GLY . 4.2 m -119.48 146.5 45.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.525 -0.734 . . . . 0.0 110.276 -178.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -124.6 158.96 31.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.114 -0.991 . . . . 0.0 110.416 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 47.8 pttt . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.549 -0.72 . . . . 0.0 110.485 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 . . . . . 0 N--CA 1.497 1.886 0 CA-C-O 120.981 0.419 . . . . 0.0 110.427 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -114.08 126.91 55.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.346 -0.846 . . . . 0.0 110.88 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.499 ' CD2' ' CE1' ' A' ' 87' ' ' TYR . 97.8 m-85 -110.38 137.06 48.6 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.802 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.28 115.02 0.74 Allowed Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.411 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.481 ' O ' HG23 ' A' ' 66' ' ' THR . 76.5 mt -104.53 136.14 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 3.3 p -151.23 139.33 20.12 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.291 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.94 151.6 33.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.08 165.14 37.54 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.34 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 48.2 Cg_endo -74.07 172.7 15.43 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.858 1.451 . . . . 0.0 110.741 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.34 138.91 28.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.587 -0.696 . . . . 0.0 109.675 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -120.79 135.86 55.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.439 -0.788 . . . . 0.0 110.779 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.1 ttp85 . . . . . 0 N--CA 1.491 1.581 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.024 179.394 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.9 0 CA-C-O 121.606 0.717 . . . . 0.0 111.82 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.804 ' O ' HD12 ' A' ' 113' ' ' LEU . 49.7 m -126.75 161.48 28.06 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.697 -0.627 . . . . 0.0 109.526 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.3 mt -118.01 136.67 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.002 -1.061 . . . . 0.0 110.222 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.452 ' CD1' ' CD1' ' A' ' 40' ' ' ILE . 85.7 m-85 -132.58 154.16 50.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.685 -0.634 . . . . 0.0 110.284 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.13 163.06 21.11 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.528 HG22 ' C ' ' A' ' 110' ' ' GLY . 34.1 m -136.32 132.06 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.094 -1.239 . . . . 0.0 111.281 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 66' ' ' THR . 59.5 t -140.74 145.31 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 160.87 -149.02 17.77 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 119.346 -1.407 . . . . 0.0 110.848 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 33.3 m -127.21 158.19 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.315 1.055 . . . . 0.0 112.977 -177.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.628 ' O ' HD12 ' A' ' 132' ' ' ILE . . . -140.57 130.69 4.67 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.499 ' CE1' ' CD2' ' A' ' 63' ' ' TYR . 43.6 p90 -151.89 164.2 37.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.002 -1.293 . . . . 0.0 111.242 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.32 154.58 20.4 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.8 tttp . . . . . 0 N--CA 1.491 1.592 0 O-C-N 121.825 -0.809 . . . . 0.0 110.332 -179.843 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.486 ' CG ' HG22 ' A' ' 132' ' ' ILE . 56.2 t0 . . . . . 0 N--CA 1.497 1.893 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.471 ' CD2' ' CB ' ' A' ' 87' ' ' TYR . 85.9 m-85 -114.85 162.52 16.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.172 -0.955 . . . . 0.0 111.042 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.677 ' HA3' HD13 ' A' ' 132' ' ' ILE . . . -160.94 -176.86 33.51 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 99.0 m-85 -116.02 156.78 25.71 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.017 -1.284 . . . . 0.0 111.398 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.9 m -124.58 154.9 39.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.53 -0.731 . . . . 0.0 110.417 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -153.06 145.19 23.83 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.421 -0.799 . . . . 0.0 109.907 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.528 ' C ' HG22 ' A' ' 82' ' ' VAL . . . 171.47 -177.59 44.25 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.908 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.28 163.47 13.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.653 -0.91 . . . . 0.0 108.949 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -157.33 -172.05 24.07 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.58 -1.295 . . . . 0.0 109.93 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 78' ' ' SER . 19.6 tp -130.74 152.44 50.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.467 -1.019 . . . . 0.0 109.673 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.4 ' CB ' ' HB3' ' A' ' 124' ' ' ASP . 51.3 tt0 -118.52 149.39 41.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.998 -1.064 . . . . 0.0 109.771 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.66 ' O ' ' HB1' ' A' ' 122' ' ' ALA . 99.5 m-85 -115.36 154.96 28.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.51 -0.744 . . . . 0.0 109.705 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -113.94 64.09 1.2 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.844 . . . . 0.0 111.279 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.69 -14.26 36.05 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.436 1.23 . . . . 0.0 109.904 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.603 ' HB2' HG23 ' A' ' 121' ' ' VAL . 64.9 mtt -145.4 139.87 27.24 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -60.92 -38.69 86.65 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.69 -0.631 . . . . 0.0 112.209 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.485 ' OD1' HG22 ' A' ' 121' ' ' VAL . 46.2 p-10 -94.94 -3.73 48.08 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.777 -1.202 . . . . 0.0 112.745 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.603 HG23 ' HB2' ' A' ' 118' ' ' MET . 30.1 m -150.42 121.46 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 120.809 -1.182 . . . . 0.0 111.604 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.66 ' HB1' ' O ' ' A' ' 115' ' ' PHE . . . -117.78 154.66 31.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.502 -0.749 . . . . 0.0 109.249 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.0 mt -113.3 144.45 42.71 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.114 -0.991 . . . . 0.0 109.776 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 114' ' ' GLN . 48.7 p30 -138.79 151.04 46.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.139 -0.975 . . . . 0.0 111.267 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -133.01 141.64 48.39 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.2 p -145.91 164.44 31.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.238 -0.914 . . . . 0.0 111.159 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -112.42 127.87 56.15 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -127.47 132.13 50.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.239 -0.913 . . . . 0.0 111.262 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -123.28 127.04 47.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.607 -0.683 . . . . 0.0 109.282 178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.6 t -130.35 143.73 50.95 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.198 -0.939 . . . . 0.0 110.742 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.4 ' O ' ' HA3' ' A' ' 106' ' ' GLY . 65.2 mtm180 -124.04 129.68 51.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.591 -0.693 . . . . 0.0 109.718 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.677 HD13 ' HA3' ' A' ' 106' ' ' GLY . 17.3 mm -114.74 63.1 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.429 ' HB3' ' O ' ' A' ' 132' ' ' ILE . 50.8 ttp180 66.42 -59.96 0.33 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.562 -0.711 . . . . 0.0 111.224 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 132' ' ' ILE . 51.6 p -124.38 6.66 8.36 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.062 -1.024 . . . . 0.0 111.394 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.422 ' HB ' ' HB ' ' A' ' 132' ' ' ILE . 47.1 t -125.87 133.34 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.124 -0.985 . . . . 0.0 110.646 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -131.44 112.27 12.53 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.759 HG22 ' CB ' ' A' ' 14' ' ' ALA . 55.5 t -119.18 146.28 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.151 -0.968 . . . . 0.0 110.742 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -109.5 107.34 2.35 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.413 HG23 ' HB3' ' A' ' 12' ' ' SER . 26.0 m -109.78 139.58 44.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.328 -1.101 . . . . 0.0 112.02 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -111.49 142.16 44.12 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.7 mm -112.65 129.6 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.115 -0.991 . . . . 0.0 110.659 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -137.96 128.61 26.7 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.52 -0.738 . . . . 0.0 109.027 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -164.73 -158.04 10.05 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 118.715 -1.707 . . . . 0.0 112.13 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 6' ' ' THR . 8.9 p -110.82 170.02 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 122.211 -0.582 . . . . 0.0 110.221 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.486 ' N ' HG22 ' A' ' 144' ' ' VAL . . . -142.15 134.95 6.38 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.932 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.606 ' O ' HG23 ' A' ' 4' ' ' THR . 83.3 m-85 -122.86 138.5 54.63 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.3 ttt-85 -126.74 121.21 31.36 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.936 -1.103 . . . . 0.0 111.108 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 55.8 t80 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.51 -0.744 . . . . 0.0 110.224 -179.883 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 70.0 p . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.9 p -109.19 152.31 25.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 0.0 109.531 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 146' ' ' TYR . 36.8 m -135.34 138.66 43.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 110.52 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.7 t -115.76 136.52 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.548 -0.72 . . . . 0.0 109.333 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 144' ' ' VAL . 85.2 m -154.01 129.59 9.96 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.272 -0.892 . . . . 0.0 110.247 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -165.48 172.5 41.03 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.65 -132.14 1.64 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 40.7 p90 -143.55 161.94 37.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.485 -1.009 . . . . 0.0 109.688 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.03 136.03 28.0 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.679 -1.208 . . . . 0.0 112.131 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -107.32 125.53 51.29 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.644 ' OG ' HG23 ' A' ' 139' ' ' THR . 10.5 m -126.94 148.55 50.05 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.808 -177.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.756 ' O ' HG13 ' A' ' 137' ' ' VAL . 52.5 t0 -95.55 152.22 18.62 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.867 ' CB ' HG22 ' A' ' 137' ' ' VAL . . . -135.83 122.95 21.56 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.697 -1.201 . . . . 0.0 111.837 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -73.31 116.4 13.81 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.3 -30.87 8.94 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.423 ' HB3' ' CB ' ' A' ' 14' ' ' ALA . 63.6 tt0 -115.07 99.02 7.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.644 -0.915 . . . . 0.0 109.052 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 65.1 mtt -62.33 -40.22 95.67 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.411 -0.806 . . . . 0.0 111.146 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -57.77 119.83 7.35 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.264 -0.898 . . . . 0.0 111.228 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -71.41 162.43 29.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.617 -0.677 . . . . 0.0 109.704 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.862 ' HB3' HG22 ' A' ' 46' ' ' THR . 66.7 mtm -127.19 157.66 39.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.205 -0.935 . . . . 0.0 111.463 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.824 ' C ' HG23 ' A' ' 46' ' ' THR . . . -142.39 124.08 2.33 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.625 ' N ' HG23 ' A' ' 46' ' ' THR . . . -137.84 -174.41 13.36 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.501 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.466 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . 99.2 m-85 -122.97 160.51 26.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.7 -0.882 . . . . 0.0 110.157 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.403 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 34.4 t-20 -140.8 131.71 26.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.543 -0.723 . . . . 0.0 111.101 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.704 HD13 ' N ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -123.39 132.85 54.09 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.704 ' N ' HD13 ' A' ' 26' ' ' LEU . 74.6 mttt -131.3 145.4 51.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.639 -1.288 . . . . 0.0 111.595 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.514 ' CE2' HD12 ' A' ' 26' ' ' LEU . 97.9 m-85 -116.24 132.19 56.73 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.461 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 44.8 ttt180 -125.16 138.85 54.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.104 -0.997 . . . . 0.0 112.149 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -119.5 138.82 52.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -149.2 163.71 36.86 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.973 . . . . 0.0 110.858 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 . . . . . 0 N--CA 1.487 1.386 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.166 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo . . . . . 0 N--CA 1.48 0.728 0 N-CA-C 111.085 -0.39 . . . . 0.0 111.085 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.0 mt -88.87 139.45 30.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.251 -0.906 . . . . 0.0 109.817 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . -148.56 140.3 8.19 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.538 -1.315 . . . . 0.0 111.039 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.68 129.71 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.462 HD11 ' CB ' ' A' ' 27' ' ' LYS . 17.1 tt -129.13 143.58 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.977 -1.077 . . . . 0.0 111.322 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.8 135.67 12.95 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.466 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 61.1 p -130.26 142.71 50.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.125 -1.221 . . . . 0.0 111.759 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -126.22 135.34 51.47 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 14.9 t -135.77 148.31 48.73 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.645 -1.222 . . . . 0.0 111.498 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.466 ' CE1' ' HB2' ' A' ' 24' ' ' PHE . 42.7 p90 -141.88 111.43 6.56 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.862 HG22 ' HB3' ' A' ' 21' ' ' MET . 73.4 m -121.97 137.02 54.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 110.672 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 85.5 tt0 -155.63 164.33 38.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.585 -0.697 . . . . 0.0 109.566 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.41 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 29.2 tttp . . . . . 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.865 . . . . 0.0 109.795 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 . . . . . 0 N--CA 1.494 1.736 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.406 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 71.9 t80 -112.89 90.17 3.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.431 -0.793 . . . . 0.0 110.589 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 44' ' ' THR . 69.2 t80 -116.92 141.35 48.35 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.48 168.58 38.19 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.027 -2.035 . . . . 0.0 112.298 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.659 HG12 HG12 ' A' ' 85' ' ' VAL . 49.8 pt -105.68 140.55 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 114.48 -0.86 . . . . 0.0 109.246 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -150.87 141.55 22.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 110.619 -179.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.58 ' O ' HG22 ' A' ' 83' ' ' VAL . . . -156.94 154.55 29.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 108.946 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.46 163.61 37.05 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.493 -1.336 . . . . 0.0 110.276 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.38 173.06 14.41 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.91 1.479 . . . . 0.0 110.679 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.501 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -141.11 136.5 31.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.811 -0.556 . . . . 0.0 109.617 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . 0.552 ' HB2' HD11 ' A' ' 79' ' ' ILE . 93.8 m-85 -126.28 145.78 50.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.698 -0.626 . . . . 0.0 110.67 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.492 -0.755 . . . . 0.0 109.554 179.058 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.057 0.456 . . . . 0.0 110.194 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m -139.34 155.07 47.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.335 -0.853 . . . . 0.0 110.565 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.843 HG22 ' CD2' ' A' ' 113' ' ' LEU . 50.6 pt -121.14 144.35 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.331 -0.856 . . . . 0.0 109.716 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -132.41 154.44 49.83 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.328 -0.857 . . . . 0.0 111.169 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.87 162.66 17.81 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.137 -1.985 . . . . 0.0 108.137 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.839 HG21 ' OE2' ' A' ' 128' ' ' GLU . 35.2 m -142.66 132.63 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.96 -1.318 . . . . 0.0 111.683 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 67' ' ' ALA . 33.0 m -142.99 150.66 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 158.12 -151.06 22.16 Favored Glycine 0 N--CA 1.479 1.553 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.049 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.659 HG12 HG12 ' A' ' 65' ' ' ILE . 12.4 p -129.59 144.62 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.488 1.137 . . . . 0.0 113.502 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.41 149.62 19.19 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.41 ' CE2' ' HB2' ' A' ' 89' ' ' LYS . 66.4 t80 -126.67 129.47 48.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.002 -1.293 . . . . 0.0 111.577 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -109.56 113.51 3.67 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 107.934 -2.066 . . . . 0.0 107.934 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.41 ' HB2' ' CE2' ' A' ' 87' ' ' TYR . 36.3 tttp . . . . . 0 N--CA 1.494 1.767 0 O-C-N 121.493 -1.004 . . . . 0.0 111.609 -178.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.67 ' OD2' HG22 ' A' ' 132' ' ' ILE . 47.6 t0 . . . . . 0 N--CA 1.494 1.774 0 CA-C-O 121.044 0.45 . . . . 0.0 110.44 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -112.03 156.69 21.78 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.376 -0.827 . . . . 0.0 110.601 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -144.25 161.54 27.91 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -97.63 145.8 25.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.927 -1.337 . . . . 0.0 110.937 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.0 t -122.46 148.65 44.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.482 -0.761 . . . . 0.0 110.3 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.558 ' CD1' HG12 ' A' ' 83' ' ' VAL . 66.6 t80 -154.01 145.67 23.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.494 -0.754 . . . . 0.0 109.661 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.465 ' O ' HG22 ' A' ' 82' ' ' VAL . . . 171.84 -178.9 43.85 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.906 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -167.2 163.7 15.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.818 -0.813 . . . . 0.0 108.812 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -156.06 -173.32 24.5 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.843 ' CD2' HG22 ' A' ' 79' ' ' ILE . 76.3 mt -128.44 152.85 47.75 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.373 -1.075 . . . . 0.0 109.278 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -119.53 140.97 49.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.818 -1.176 . . . . 0.0 109.971 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -117.35 161.1 20.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.508 -0.745 . . . . 0.0 110.061 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -120.96 86.59 42.1 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.464 -0.773 . . . . 0.0 110.459 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.623 ' HG3' HD23 ' A' ' 123' ' ' LEU . 43.8 Cg_endo -69.4 -7.39 20.81 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.664 1.35 . . . . 0.0 111.535 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.556 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 80.0 mtp -149.95 175.66 11.47 Favored 'General case' 0 C--N 1.311 -1.077 0 O-C-N 121.056 -1.027 . . . . 0.0 108.452 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.88 -39.7 95.27 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.807 -0.558 . . . . 0.0 110.993 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.469 ' OD1' HG23 ' A' ' 121' ' ' VAL . 48.0 p-10 -121.99 18.16 10.9 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.201 -0.937 . . . . 0.0 112.2 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 21.3 t -118.46 139.38 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.933 -1.105 . . . . 0.0 109.729 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.651 ' C ' HD22 ' A' ' 123' ' ' LEU . . . -141.34 137.48 32.4 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.736 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.651 HD22 ' C ' ' A' ' 122' ' ' ALA . 4.4 mm? -112.29 152.24 28.73 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -145.49 139.42 26.81 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.719 -1.238 . . . . 0.0 110.736 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -124.7 126.24 45.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 109.179 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -130.64 151.46 51.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.32 -0.863 . . . . 0.0 111.178 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -113.97 126.87 55.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.597 -0.689 . . . . 0.0 109.187 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.839 ' OE2' HG21 ' A' ' 82' ' ' VAL . 94.8 mt-10 -137.74 152.31 49.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.339 -0.85 . . . . 0.0 111.172 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -138.63 147.89 43.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 0.0 109.405 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 51.1 m -134.62 145.96 49.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.197 -0.939 . . . . 0.0 110.822 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -132.54 128.55 37.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.489 -0.757 . . . . 0.0 109.828 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.67 HG22 ' OD2' ' A' ' 104' ' ' ASP . 91.4 mt -119.8 59.26 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.47 -0.769 . . . . 0.0 109.709 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 93.2 mtt-85 64.65 -57.46 0.26 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.908 -0.495 . . . . 0.0 111.912 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 132' ' ' ILE . 44.0 p -117.69 -3.29 11.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.959 -1.088 . . . . 0.0 111.539 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.4 t -124.72 131.44 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.025 -1.047 . . . . 0.0 110.457 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -131.53 111.52 11.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.345 -0.847 . . . . 0.0 109.16 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.867 HG22 ' CB ' ' A' ' 14' ' ' ALA . 59.0 t -119.29 145.88 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.93 . . . . 0.0 110.525 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -107.18 120.27 6.12 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 107.813 -2.115 . . . . 0.0 107.813 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.644 HG23 ' OG ' ' A' ' 12' ' ' SER . 59.3 m -118.29 137.25 53.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.232 -1.158 . . . . 0.0 111.9 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -114.44 140.15 48.93 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.7 mt -113.66 133.1 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.103 -0.998 . . . . 0.0 110.903 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.81 133.93 22.77 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.571 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -170.5 -146.0 4.97 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.041 -1.552 . . . . 0.0 111.503 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.79 ' O ' HG23 ' A' ' 6' ' ' THR . 34.8 m -117.32 177.03 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 122.113 -0.639 . . . . 0.0 111.142 -178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -153.26 138.58 6.39 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.635 ' O ' HG23 ' A' ' 4' ' ' THR . 69.8 t80 -134.65 153.4 52.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.571 -0.958 . . . . 0.0 109.714 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -133.82 122.03 22.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.368 -0.833 . . . . 0.0 110.986 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 65.8 t80 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.474 -0.766 . . . . 0.0 110.216 -179.662 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 66.3 p . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.004 0.43 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.6 t -124.16 137.64 54.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.427 -0.796 . . . . 0.0 109.728 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.853 HG23 ' O ' ' A' ' 146' ' ' TYR . 66.1 m -137.84 145.48 42.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.788 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.6 p -126.4 140.36 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.607 -0.683 . . . . 0.0 109.705 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.814 HG23 ' O ' ' A' ' 144' ' ' VAL . 88.9 m -156.45 130.61 8.59 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.301 -0.875 . . . . 0.0 110.481 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.486 ' HA3' HD23 ' A' ' 26' ' ' LEU . . . -149.97 158.32 27.62 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 108.831 -1.707 . . . . 0.0 108.831 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.08 -168.26 27.98 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.651 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -123.55 153.79 40.13 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.654 -0.909 . . . . 0.0 109.501 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.632 ' HB2' HG22 ' A' ' 141' ' ' ILE . . . -146.33 154.23 41.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.073 -1.017 . . . . 0.0 111.484 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -98.58 144.44 27.89 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.6 t -112.47 134.74 53.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.013 -1.055 . . . . 0.0 112.299 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -138.12 124.05 20.1 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.887 ' HB2' HG22 ' A' ' 137' ' ' VAL . . . -139.04 155.55 47.87 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 120.857 -1.152 . . . . 0.0 112.027 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -78.27 120.24 22.77 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.54 -29.24 10.72 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -113.75 97.77 6.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.607 -0.937 . . . . 0.0 109.247 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 70.6 mtm -67.43 -47.85 69.0 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.301 -0.875 . . . . 0.0 111.329 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -55.51 131.3 45.77 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.39 -0.819 . . . . 0.0 111.694 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -82.42 155.1 24.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.747 -0.595 . . . . 0.0 109.632 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.522 ' HB3' HG22 ' A' ' 46' ' ' THR . 73.4 mtm -131.3 166.18 21.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.274 -0.891 . . . . 0.0 111.224 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.805 ' O ' HG23 ' A' ' 46' ' ' THR . . . -92.97 153.23 21.38 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.54 121.85 2.92 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.114 -1.517 . . . . 0.0 111.021 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -111.5 129.6 55.99 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -137.93 126.53 23.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.937 -1.102 . . . . 0.0 111.558 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.486 HD23 ' HA3' ' A' ' 7' ' ' GLY . 81.9 mt -123.5 129.7 51.6 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HB3' ' CB ' ' A' ' 42' ' ' SER . 19.9 pttt -136.27 148.18 47.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.81 -1.181 . . . . 0.0 112.281 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -111.29 137.46 49.0 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.613 ' HA ' HG22 ' A' ' 40' ' ' ILE . 49.5 ttt180 -120.37 135.26 55.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 111.1 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -121.57 138.33 54.36 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -138.1 146.91 43.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.179 -0.951 . . . . 0.0 109.915 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 110.131 179.941 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo . . . . . 0 N--CA 1.483 0.867 0 N-CA-C 111.112 -0.38 . . . . 0.0 111.112 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 20.4 tp -111.18 76.48 0.98 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.176 -0.953 . . . . 0.0 110.15 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.76 177.19 26.65 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 120.051 -1.071 . . . . 0.0 110.445 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.0 t -131.61 140.15 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.673 -0.898 . . . . 0.0 108.982 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.613 HG22 ' HA ' ' A' ' 29' ' ' ARG . 41.3 pt -121.66 147.59 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.96 -1.087 . . . . 0.0 111.386 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.96 129.75 8.8 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.527 ' O ' HG22 ' A' ' 66' ' ' THR . 32.1 t -136.91 142.86 42.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.169 -1.195 . . . . 0.0 111.765 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -115.35 139.85 49.64 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.9 m -130.42 136.16 48.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.17 -0.956 . . . . 0.0 110.169 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -134.74 111.1 9.68 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.349 -0.844 . . . . 0.0 109.171 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.805 HG23 ' O ' ' A' ' 22' ' ' GLY . 60.3 m -112.84 138.32 49.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.432 -0.793 . . . . 0.0 109.388 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -138.11 160.52 39.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.09 -1.006 . . . . 0.0 110.532 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.4 mttt . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 110.127 179.933 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 . . . . . 0 N--CA 1.494 1.726 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.441 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 70.5 t80 -121.8 93.15 3.91 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.331 -0.856 . . . . 0.0 111.182 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -98.24 150.86 21.07 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -158.5 132.84 3.23 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 118.195 -1.955 . . . . 0.0 111.631 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.447 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 46.8 pt -98.54 138.56 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 42' ' ' SER . 9.5 t -153.22 147.57 25.86 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.576 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.726 ' O ' HG12 ' A' ' 83' ' ' VAL . . . -149.0 151.15 34.05 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.24 165.79 36.77 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.513 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -75.76 170.49 20.07 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.798 1.42 . . . . 0.0 110.655 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.39 140.62 24.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.603 -0.685 . . . . 0.0 109.452 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -123.17 141.47 51.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.331 -0.856 . . . . 0.0 110.558 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 . . . . . 0 N--CA 1.489 1.499 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.034 179.244 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.944 0 CA-C-O 121.656 0.741 . . . . 0.0 111.891 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.773 ' O ' HD12 ' A' ' 113' ' ' LEU . 26.6 t -138.22 155.35 48.74 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.633 -0.667 . . . . 0.0 109.618 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.7 tt -129.05 137.87 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.065 -1.022 . . . . 0.0 110.363 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -146.95 162.27 39.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.406 -0.809 . . . . 0.0 111.425 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.2 164.31 12.79 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.587 HG22 ' C ' ' A' ' 110' ' ' GLY . 34.7 m -141.75 134.82 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -1.175 . . . . 0.0 111.53 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 67' ' ' ALA . 7.2 p -138.76 148.34 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 178.65 -179.76 48.66 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.687 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.446 ' O ' ' HA2' ' A' ' 64' ' ' GLY . 57.0 t -118.64 142.02 35.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.335 0.588 . . . . 0.0 110.702 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.94 144.26 17.1 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -116.55 129.82 56.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.129 -1.219 . . . . 0.0 110.11 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -118.26 113.52 2.64 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.8 mttt . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.465 -1.021 . . . . 0.0 110.653 -179.724 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 . . . . . 0 N--CA 1.496 1.836 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -113.08 154.78 26.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.329 -0.857 . . . . 0.0 110.11 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 85' ' ' VAL . . . -143.46 153.51 24.9 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -96.58 139.54 32.51 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -1.15 . . . . 0.0 110.735 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.9 p -124.94 159.99 29.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.532 -0.73 . . . . 0.0 110.424 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 41.1 p90 -160.25 155.67 25.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.442 -0.786 . . . . 0.0 109.854 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.587 ' C ' HG22 ' A' ' 82' ' ' VAL . . . 164.3 -169.77 39.24 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.497 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.77 165.15 20.92 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.602 -0.94 . . . . 0.0 108.905 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -152.75 -178.92 27.87 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.773 HD12 ' O ' ' A' ' 78' ' ' SER . 15.4 tp -139.54 147.37 41.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.371 -1.076 . . . . 0.0 110.22 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 93.1 mt-30 -99.11 141.72 31.52 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.087 -1.008 . . . . 0.0 109.157 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -148.2 148.64 30.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.303 -0.873 . . . . 0.0 110.868 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.593 ' OD1' HD23 ' A' ' 123' ' ' LEU . 0.8 OUTLIER 170.72 134.7 0.07 OUTLIER Pre-proline 0 N--CA 1.506 2.327 0 O-C-N 121.764 -0.585 . . . . 0.0 111.306 178.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -88.03 47.11 1.29 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.541 1.285 . . . . 0.0 109.484 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.437 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 65.3 mtt -141.71 139.45 32.91 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.424 -0.797 . . . . 0.0 109.044 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.77 -47.04 79.61 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -104.13 5.5 35.1 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.822 -1.174 . . . . 0.0 112.703 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.546 HG12 ' ND2' ' A' ' 116' ' ' ASN . 59.3 t -118.77 136.45 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.769 -1.207 . . . . 0.0 109.935 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 145' ' ' GLY . . . -142.92 139.49 30.76 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.406 -0.917 . . . . 0.0 112.308 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.835 HD13 ' O ' ' A' ' 143' ' ' GLY . 3.7 mm? -109.32 153.36 24.02 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -145.9 140.24 26.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.76 -1.212 . . . . 0.0 110.648 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 113' ' ' LEU . 49.1 p90 -132.07 142.74 49.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 0.0 109.391 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.636 ' HB3' HD11 ' A' ' 141' ' ' ILE . 28.9 t -146.51 149.42 33.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.375 -0.828 . . . . 0.0 111.231 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -118.12 126.57 52.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.698 -0.626 . . . . 0.0 109.428 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -137.35 136.42 37.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.456 -0.777 . . . . 0.0 110.593 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -112.18 130.09 56.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.42 -0.8 . . . . 0.0 109.765 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.0 m -122.1 147.59 45.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.295 -0.878 . . . . 0.0 110.436 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 42.5 ptt85 -135.78 130.53 34.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.499 -0.751 . . . . 0.0 110.23 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.47 ' O ' HG22 ' A' ' 132' ' ' ILE . 88.4 mt -119.17 67.22 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.567 -0.708 . . . . 0.0 109.707 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 132' ' ' ILE . 41.4 ttm180 66.45 -60.74 0.32 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.672 -0.642 . . . . 0.0 111.388 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.2 p -124.65 5.73 8.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.067 -1.021 . . . . 0.0 111.69 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 131' ' ' ARG . 51.2 t -126.52 133.35 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.934 -1.104 . . . . 0.0 110.798 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -132.22 115.87 16.23 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.887 HG22 ' HB2' ' A' ' 14' ' ' ALA . 32.0 t -110.76 145.51 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.131 -0.981 . . . . 0.0 111.121 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.84 117.85 2.58 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 107.684 -2.167 . . . . 0.0 107.684 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 10.2 t -134.14 151.96 51.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -1.184 . . . . 0.0 112.028 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' A' ' 125' ' ' PHE . 60.5 t-105 -112.04 133.93 53.9 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.636 HD11 ' HB3' ' A' ' 126' ' ' SER . 49.3 pt -115.91 147.17 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.068 -1.02 . . . . 0.0 111.319 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -147.49 136.92 22.61 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.835 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -162.96 -159.08 10.13 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 118.986 -1.578 . . . . 0.0 111.605 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.814 ' O ' HG23 ' A' ' 6' ' ' THR . 9.3 p -104.57 166.99 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 122.065 -0.667 . . . . 0.0 110.654 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.606 ' O ' ' HB3' ' A' ' 122' ' ' ALA . . . -154.32 138.97 6.46 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.853 ' O ' HG23 ' A' ' 4' ' ' THR . 68.4 t80 -132.18 153.99 50.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.543 -0.975 . . . . 0.0 109.765 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -125.29 121.17 33.23 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.307 -0.87 . . . . 0.0 111.101 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 73.6 t80 . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.495 -0.753 . . . . 0.0 110.13 179.894 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 120.965 0.412 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -126.28 147.63 49.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -0.879 . . . . 0.0 109.153 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.474 ' OG1' ' HB3' ' A' ' 29' ' ' ARG . 19.0 p -135.12 152.47 51.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.067 -1.021 . . . . 0.0 110.431 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -112.24 135.77 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 37.1 m -155.31 128.22 8.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 110.642 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.86 173.37 45.06 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.86 -137.52 3.42 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 45.5 p90 -143.26 160.02 41.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.485 -1.009 . . . . 0.0 109.888 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.58 145.34 30.07 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.626 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -113.49 144.87 42.1 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.441 ' HB3' ' CB ' ' A' ' 139' ' ' THR . 54.4 p -146.47 153.63 40.65 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.607 -1.237 . . . . 0.0 112.617 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.883 ' O ' HG13 ' A' ' 137' ' ' VAL . 88.7 m-20 -83.11 151.34 25.79 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.736 ' HB1' ' HB2' ' A' ' 17' ' ' GLN . . . -127.03 100.37 6.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.943 -1.098 . . . . 0.0 111.341 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -79.78 117.48 20.7 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.04 -13.21 58.95 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.736 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 89.2 mt-30 -107.68 178.04 4.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.118 -1.225 . . . . 0.0 110.294 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.401 ' CB ' ' HE3' ' A' ' 48' ' ' LYS . 94.3 mmm -57.75 -51.68 68.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.459 -0.776 . . . . 0.0 112.041 -178.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.531 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 19.7 t30 -169.82 -148.62 0.07 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.694 -1.254 . . . . 0.0 110.747 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mttt -81.06 154.3 26.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.076 -1.015 . . . . 0.0 110.761 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 62.5 mtt -129.94 167.59 17.98 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.416 -0.803 . . . . 0.0 110.662 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.816 ' O ' HG23 ' A' ' 46' ' ' THR . . . -98.12 158.97 20.66 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.251 -1.939 . . . . 0.0 108.251 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 9' ' ' TYR . . . -147.08 121.29 1.38 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.275 -1.44 . . . . 0.0 110.757 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -108.52 134.92 50.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.644 -0.916 . . . . 0.0 109.127 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -139.02 129.38 25.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.157 -0.964 . . . . 0.0 112.112 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.438 HD21 ' OH ' ' A' ' 28' ' ' TYR . 25.5 tp -121.85 127.59 50.69 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . 21.3 mttt -129.24 144.66 51.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.656 -1.277 . . . . 0.0 111.748 -177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.438 ' OH ' HD21 ' A' ' 26' ' ' LEU . 98.8 m-85 -112.24 140.69 46.74 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.474 ' HB3' ' OG1' ' A' ' 4' ' ' THR . 14.2 ttp180 -123.54 137.76 54.7 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.095 -1.003 . . . . 0.0 111.938 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -122.04 138.25 54.51 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -141.33 150.02 41.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.135 -0.978 . . . . 0.0 110.401 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 . . . . . 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 0.0 109.683 179.626 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo . . . . . 0 N--CA 1.482 0.838 0 N-CA-C 111.022 -0.414 . . . . 0.0 111.022 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.481 HD23 ' C ' ' A' ' 37' ' ' LEU . 8.5 tt -91.3 119.56 31.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.359 -0.838 . . . . 0.0 110.043 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . -127.35 135.46 8.79 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.885 -1.15 . . . . 0.0 110.485 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -131.21 135.86 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.532 HD11 ' CD1' ' A' ' 80' ' ' TYR . 72.9 mt -125.32 141.92 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.922 -1.111 . . . . 0.0 111.455 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.81 141.07 15.15 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 106.998 -2.441 . . . . 0.0 106.998 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.415 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 42.7 t -137.53 141.18 41.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.886 -1.361 . . . . 0.0 112.649 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -122.97 134.13 54.35 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.8 m -131.03 136.93 48.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.031 . . . . 0.0 110.693 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -129.94 110.42 11.67 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 22' ' ' GLY . 96.9 m -115.03 140.01 49.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.369 -0.832 . . . . 0.0 109.588 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -141.15 163.85 31.84 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.104 -0.997 . . . . 0.0 110.446 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HE3' ' CB ' ' A' ' 18' ' ' MET . 21.4 tttm . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.485 -0.759 . . . . 0.0 109.932 179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 . . . . . 0 N--CA 1.493 1.723 0 CA-C-O 121.099 0.476 . . . . 0.0 110.475 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.464 ' HB2' ' HB ' ' A' ' 46' ' ' THR . 50.9 m-85 -113.81 114.12 25.86 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.703 0.763 . . . . 0.0 111.22 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.411 ' HB3' ' HB2' ' A' ' 87' ' ' TYR . 68.4 t80 -98.08 145.17 26.81 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -150.54 128.79 2.73 Favored Glycine 0 N--CA 1.485 1.904 0 C-N-CA 118.502 -1.808 . . . . 0.0 110.932 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.45 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 78.2 mt -99.1 134.77 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.749 HG23 ' O ' ' A' ' 83' ' ' VAL . 61.4 m -152.03 142.1 22.21 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.512 -1.275 . . . . 0.0 112.216 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.87 148.84 34.4 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -157.15 160.38 30.4 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.593 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 49.7 Cg_endo -75.41 165.09 31.4 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.875 1.461 . . . . 0.0 110.646 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.444 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -141.97 137.42 31.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.489 -0.757 . . . . 0.0 109.823 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -125.23 143.48 50.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.582 -0.698 . . . . 0.0 110.927 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.4 ttt-85 . . . . . 0 N--CA 1.494 1.77 0 O-C-N 121.644 -0.66 . . . . 0.0 109.605 178.915 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.701 0 CA-C-O 121.032 0.444 . . . . 0.0 109.896 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.4 m -124.41 151.31 44.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.425 -0.797 . . . . 0.0 110.634 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.7 mt -119.46 136.85 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 109.176 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.532 ' CD1' HD11 ' A' ' 40' ' ' ILE . 38.6 m-85 -129.26 148.69 51.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.85 . . . . 0.0 111.145 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.28 159.28 19.84 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 110' ' ' GLY . 27.0 m -143.77 134.66 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.326 . . . . 0.0 112.164 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.749 ' O ' HG23 ' A' ' 66' ' ' THR . 61.9 t -134.85 144.63 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 178.78 -176.9 48.27 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 118.326 -1.892 . . . . 0.0 111.522 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.458 ' CG1' ' CZ ' ' A' ' 87' ' ' TYR . 52.8 t -121.9 144.27 31.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-O 121.652 0.739 . . . . 0.0 110.583 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.14 135.84 12.36 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.458 ' CZ ' ' CG1' ' A' ' 85' ' ' VAL . 88.5 m-85 -127.86 132.13 49.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.067 -1.255 . . . . 0.0 110.189 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.79 127.95 6.72 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 27.8 pttt . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.416 -1.049 . . . . 0.0 110.488 -179.96 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 54.7 t0 . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.727 ' O ' HG23 ' A' ' 132' ' ' ILE . 45.9 p90 -134.96 170.16 16.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.083 -1.011 . . . . 0.0 111.871 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.424 ' HA3' HG12 ' A' ' 132' ' ' ILE . . . -154.18 178.03 31.26 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.415 ' CZ ' HG13 ' A' ' 83' ' ' VAL . 68.3 t80 -99.11 142.15 30.96 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.115 -1.227 . . . . 0.0 110.862 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.1 m -121.65 150.55 41.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.446 -0.784 . . . . 0.0 110.159 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 43.2 p90 -158.34 152.98 24.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.393 -0.817 . . . . 0.0 110.037 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.558 ' O ' HG22 ' A' ' 82' ' ' VAL . . . 169.67 -176.63 43.5 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.584 -1.294 . . . . 0.0 110.65 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.99 163.46 11.37 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.681 -0.894 . . . . 0.0 109.091 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -159.71 -171.4 25.52 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.45 155.83 49.9 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.302 -1.116 . . . . 0.0 110.141 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -120.63 142.55 49.32 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.163 -0.961 . . . . 0.0 110.228 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.67 ' O ' ' HB1' ' A' ' 122' ' ' ALA . 47.7 t80 -118.56 160.82 21.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.552 -0.718 . . . . 0.0 109.586 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -118.05 72.1 8.79 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.223 -0.923 . . . . 0.0 111.349 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.489 ' HD2' ' HA ' ' A' ' 122' ' ' ALA . 44.8 Cg_endo -72.51 -12.29 26.97 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.582 1.306 . . . . 0.0 110.064 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.599 ' HB2' HG13 ' A' ' 121' ' ' VAL . 88.0 mtp -142.89 144.15 32.34 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.29 -51.57 69.36 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -90.59 3.03 55.24 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.768 -1.207 . . . . 0.0 113.04 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.758 HG23 HG23 ' A' ' 144' ' ' VAL . 8.8 p -152.78 119.44 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 120.714 -1.241 . . . . 0.0 111.348 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.67 ' HB1' ' O ' ' A' ' 115' ' ' PHE . . . -110.75 167.45 10.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.904 . . . . 0.0 109.934 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 143' ' ' GLY . 23.4 tp -112.91 149.74 32.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.251 -0.906 . . . . 0.0 109.338 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -137.05 139.75 41.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.041 -1.037 . . . . 0.0 109.534 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -133.87 132.16 40.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 0.0 109.092 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.7 p -145.47 164.72 30.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.17 -0.956 . . . . 0.0 111.058 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -114.31 132.63 56.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.595 -0.69 . . . . 0.0 109.429 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -133.17 135.24 45.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.298 -0.877 . . . . 0.0 110.817 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -130.18 147.99 51.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 109.742 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.1 t -139.1 141.09 38.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.338 -0.851 . . . . 0.0 110.495 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.409 ' O ' ' HA3' ' A' ' 106' ' ' GLY . 63.1 mtm180 -129.11 129.19 44.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.366 -0.834 . . . . 0.0 109.868 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.727 HG23 ' O ' ' A' ' 105' ' ' TYR . 83.5 mt -125.48 54.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.534 -0.729 . . . . 0.0 109.671 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 74.2 mtp180 61.52 -55.99 0.11 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 132' ' ' ILE . 0.4 OUTLIER -105.47 -14.7 15.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.98 -1.075 . . . . 0.0 111.617 -178.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.499 ' CG2' ' HB ' ' A' ' 132' ' ' ILE . 32.8 m -137.17 140.21 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 118.396 -1.322 . . . . 0.0 112.111 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -133.71 119.09 18.88 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 13' ' ' ASP . 63.9 t -112.77 146.39 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.077 -1.014 . . . . 0.0 110.758 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -117.12 123.8 5.92 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 107.312 -2.315 . . . . 0.0 107.312 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.441 ' CB ' ' HB3' ' A' ' 12' ' ' SER . 14.9 t -126.19 152.55 45.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.065 -1.256 . . . . 0.0 112.469 -177.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.436 ' N ' ' CD1' ' A' ' 140' ' ' TRP . 56.4 m95 -111.69 137.45 49.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 76.7 mt -115.08 134.78 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.01 -1.056 . . . . 0.0 111.463 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.58 128.74 16.67 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.427 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -159.42 -157.98 8.87 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 118.985 -1.578 . . . . 0.0 111.789 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.758 HG23 HG23 ' A' ' 121' ' ' VAL . 7.2 p -111.45 163.13 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 122.135 -0.627 . . . . 0.0 110.555 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.42 ' N ' HG22 ' A' ' 144' ' ' VAL . . . -140.54 131.44 5.0 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -129.38 145.64 51.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.465 -1.021 . . . . 0.0 109.893 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -127.81 119.89 26.66 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.395 -0.816 . . . . 0.0 111.046 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.3 t80 . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.461 -0.774 . . . . 0.0 110.085 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.6 p . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.14 0.495 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.1 p -112.49 161.12 17.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.436 -0.79 . . . . 0.0 109.17 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.595 HG21 HH21 ' A' ' 29' ' ' ARG . 36.6 m -136.43 139.99 42.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.119 -0.988 . . . . 0.0 110.59 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.403 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 13.3 p -126.38 142.84 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.477 HG22 ' CA ' ' A' ' 145' ' ' GLY . 29.4 p -152.17 138.75 18.7 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 25' ' ' ASN . . . -134.24 155.27 21.79 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 24' ' ' PHE . . . -175.95 -163.32 28.43 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -137.35 161.44 36.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.652 -0.911 . . . . 0.0 109.356 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.06 153.69 41.01 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.644 -1.223 . . . . 0.0 112.145 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -112.5 137.77 50.23 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.4 m -121.23 145.54 47.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.991 -1.068 . . . . 0.0 112.633 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -130.2 139.39 50.84 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.898 ' CB ' HG22 ' A' ' 137' ' ' VAL . . . -145.9 148.32 32.69 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.774 -1.204 . . . . 0.0 112.11 -177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -78.93 123.56 27.38 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.09 -24.07 25.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.694 -1.763 . . . . 0.0 108.694 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.405 ' NE2' ' CG1' ' A' ' 135' ' ' VAL . 48.4 mt-30 -112.75 141.03 47.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.337 -1.096 . . . . 0.0 109.492 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.0 mtm -98.02 -67.17 0.86 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.29 -0.881 . . . . 0.0 110.572 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 -49.03 122.92 6.36 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.521 -0.737 . . . . 0.0 112.088 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -75.83 164.44 26.23 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.533 -0.729 . . . . 0.0 109.932 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 68.3 mtm -121.02 146.8 46.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.287 -0.883 . . . . 0.0 111.58 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -142.94 124.71 2.41 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.692 ' HA3' HG22 ' A' ' 46' ' ' THR . . . -151.36 -160.06 9.24 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.124 -1.512 . . . . 0.0 110.883 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 99.1 m-85 -121.31 154.59 36.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.744 -0.856 . . . . 0.0 110.064 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.533 ' ND2' HD13 ' A' ' 141' ' ' ILE . 57.7 t30 -134.73 130.84 36.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.451 -0.781 . . . . 0.0 111.515 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.7 mt -111.87 155.13 24.13 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.733 ' HD2' HG21 ' A' ' 40' ' ' ILE . 17.4 ttpt -148.81 132.6 16.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.642 -1.286 . . . . 0.0 110.209 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -133.93 136.7 44.42 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.595 HH21 HG21 ' A' ' 4' ' ' THR . 36.8 ptt180 -142.81 150.78 40.41 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.792 -1.163 . . . . 0.0 112.581 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -116.96 138.11 51.77 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -139.45 145.88 39.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.282 -0.886 . . . . 0.0 109.862 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 . . . . . 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.933 . . . . 0.0 109.652 179.946 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo . . . . . 0 N--CA 1.481 0.765 0 N-CA-C 111.146 -0.367 . . . . 0.0 111.146 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.0 mt -108.64 73.13 0.85 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.242 -0.911 . . . . 0.0 110.137 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.83 -179.01 33.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -130.23 144.39 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.623 -0.928 . . . . 0.0 108.948 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.733 HG21 ' HD2' ' A' ' 27' ' ' LYS . 62.5 mt -118.38 143.62 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.965 -1.085 . . . . 0.0 110.876 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -124.25 122.64 4.87 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 76.6 p -139.38 144.98 38.41 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.147 -1.208 . . . . 0.0 111.451 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.85 148.25 44.28 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.53 -0.731 . . . . 0.0 109.948 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.9 m -129.73 138.72 51.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.244 -0.91 . . . . 0.0 110.376 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.414 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 68.7 t80 -137.57 110.91 7.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 108.933 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.692 HG22 ' HA3' ' A' ' 23' ' ' GLY . 30.3 p -122.54 160.34 25.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.489 -0.757 . . . . 0.0 110.457 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -127.4 165.84 19.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.468 -0.77 . . . . 0.0 110.411 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.8 tttt . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.706 -0.621 . . . . 0.0 110.487 179.784 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 . . . . . 0 N--CA 1.496 1.863 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -119.7 127.72 53.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.166 -0.959 . . . . 0.0 111.529 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.475 ' CB ' ' CZ ' ' A' ' 87' ' ' TYR . 97.8 m-85 -116.1 136.2 53.24 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.733 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.76 112.22 0.6 Allowed Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.552 -1.309 . . . . 0.0 110.183 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.496 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 77.8 mt -101.49 135.85 36.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 12.6 m -150.65 140.2 21.56 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.836 -1.146 . . . . 0.0 111.111 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.86 ' O ' HG12 ' A' ' 83' ' ' VAL . . . -152.71 151.56 30.68 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 81' ' ' GLY . . . -164.54 171.92 40.15 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.388 -1.386 . . . . 0.0 110.6 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.04 161.79 43.72 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.964 1.507 . . . . 0.0 110.995 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.717 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -140.47 137.28 33.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.672 -0.643 . . . . 0.0 109.577 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -116.38 124.01 49.0 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.915 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.631 -0.668 . . . . 0.0 109.642 179.145 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.82 0 CA-C-O 121.535 0.684 . . . . 0.0 111.564 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 91.0 p -121.58 159.49 26.3 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.7 mt -124.87 136.29 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.922 -1.111 . . . . 0.0 110.551 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.408 ' HB2' ' CD1' ' A' ' 40' ' ' ILE . 43.5 p90 -145.65 158.92 43.79 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.912 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.46 ' C ' HG13 ' A' ' 82' ' ' VAL . . . -103.72 176.89 24.29 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.748 HG22 ' C ' ' A' ' 110' ' ' GLY . 34.9 m -147.89 131.36 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.32 -1.106 . . . . 0.0 110.545 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.86 HG12 ' O ' ' A' ' 67' ' ' ALA . 11.2 p -145.87 151.42 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.29 -0.881 . . . . 0.0 109.89 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 160.88 -153.18 23.98 Favored Glycine 0 N--CA 1.481 1.655 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.452 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.8 p -128.85 142.24 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 122.204 1.002 . . . . 0.0 112.861 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.98 126.52 6.02 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.475 ' CZ ' ' CB ' ' A' ' 63' ' ' TYR . 46.5 p90 -151.71 162.41 41.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.007 -1.29 . . . . 0.0 110.8 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.47 152.92 21.38 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.788 -0.831 . . . . 0.0 109.626 179.545 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 . . . . . 0 N--CA 1.496 1.861 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.457 ' CB ' ' HB3' ' A' ' 87' ' ' TYR . 43.2 p90 -127.04 169.73 13.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.279 -0.888 . . . . 0.0 110.602 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.54 ' HA2' HD13 ' A' ' 132' ' ' ILE . . . -156.12 177.19 33.3 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -96.2 137.4 35.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.327 -1.102 . . . . 0.0 110.054 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.7 m -114.89 154.55 28.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.584 -0.697 . . . . 0.0 110.985 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 37.3 p90 -158.03 154.09 27.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.687 -0.633 . . . . 0.0 109.656 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.748 ' C ' HG22 ' A' ' 82' ' ' VAL . . . 159.68 -169.45 35.71 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.525 -1.321 . . . . 0.0 110.607 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.82 165.07 28.35 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.689 -0.889 . . . . 0.0 109.338 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -152.26 -177.05 25.55 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.717 HD12 ' CZ ' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -143.59 147.33 34.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.387 -1.066 . . . . 0.0 110.346 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -114.15 148.85 36.57 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.229 -0.919 . . . . 0.0 110.697 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.717 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 91.6 m-85 -117.99 164.13 15.55 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.653 -0.654 . . . . 0.0 110.213 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -118.81 80.94 18.21 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 0.0 110.32 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.34 -14.48 42.9 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.589 1.31 . . . . 0.0 111.341 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.551 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 79.9 mtp -148.93 -177.58 5.88 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.189 -0.944 . . . . 0.0 108.485 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -69.39 -41.62 76.21 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.748 -0.595 . . . . 0.0 110.948 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -118.08 12.57 13.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.093 -1.004 . . . . 0.0 111.928 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 20.4 t -114.03 137.18 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.92 -1.112 . . . . 0.0 109.94 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 145' ' ' GLY . . . -137.7 135.59 36.59 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.45 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.84 HD12 ' O ' ' A' ' 143' ' ' GLY . 19.3 tp -110.78 147.01 35.35 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -144.68 143.7 30.86 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.483 -1.385 . . . . 0.0 111.206 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.439 ' CZ ' HD21 ' A' ' 123' ' ' LEU . 98.7 m-85 -119.02 142.06 48.15 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.3 t -134.26 139.63 45.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.0 111.263 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -118.67 111.03 18.0 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -141.89 143.76 33.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.556 -0.715 . . . . 0.0 110.596 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -137.09 151.93 49.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.442 -0.786 . . . . 0.0 109.761 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.0 t -126.52 138.65 53.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.834 . . . . 0.0 110.367 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 76.5 mtp180 -136.78 137.57 39.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.402 -0.811 . . . . 0.0 111.151 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.607 HG23 ' O ' ' A' ' 132' ' ' ILE . 6.7 tp -134.23 63.59 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.908 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 69.5 mtp85 59.91 -59.59 0.06 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 132' ' ' ILE . 56.5 p -95.49 -18.63 20.5 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.112 -0.992 . . . . 0.0 111.793 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.529 ' HB ' HG22 ' A' ' 132' ' ' ILE . 47.4 t -128.85 134.26 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 118.682 -1.207 . . . . 0.0 111.729 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -131.32 112.28 12.61 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.898 HG22 ' CB ' ' A' ' 14' ' ' ALA . 21.4 t -117.18 145.28 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.957 -1.089 . . . . 0.0 110.195 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -130.11 114.09 1.59 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.5 t -139.07 154.22 48.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.255 -1.144 . . . . 0.0 111.453 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 43.9 p90 -126.24 146.83 49.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.605 -0.685 . . . . 0.0 109.8 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.533 HD13 ' ND2' ' A' ' 25' ' ' ASN . 72.6 mt -112.4 141.42 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.329 -0.857 . . . . 0.0 110.666 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.79 145.23 31.56 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.437 -0.789 . . . . 0.0 109.895 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.84 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -177.2 -139.38 3.27 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.203 -1.475 . . . . 0.0 111.715 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 35.7 m -114.25 176.78 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 122.035 -0.685 . . . . 0.0 110.838 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.626 ' O ' ' HB3' ' A' ' 122' ' ' ALA . . . -162.42 144.56 9.78 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.33 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -129.8 157.39 42.35 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.842 -0.799 . . . . 0.0 109.263 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 32.1 mtp-105 -123.26 122.94 39.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.091 -1.006 . . . . 0.0 111.244 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 67.7 t80 . . . . . 0 N--CA 1.498 1.944 0 O-C-N 121.461 -0.774 . . . . 0.0 110.514 -179.898 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 65.3 p . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.2 m -119.8 144.21 47.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -0.866 . . . . 0.0 109.418 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.772 HG23 ' O ' ' A' ' 146' ' ' TYR . 76.6 m -136.98 142.37 42.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.579 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.414 ' C ' ' HG1' ' A' ' 6' ' ' THR . 34.4 m -123.0 141.48 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.822 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.793 HG23 ' O ' ' A' ' 144' ' ' VAL . 87.6 m -156.37 130.38 8.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.562 -0.711 . . . . 0.0 109.593 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -164.27 176.23 40.23 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.322 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.73 -125.94 1.05 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -147.06 162.0 39.69 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.478 -1.013 . . . . 0.0 109.528 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.29 142.8 30.67 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.59 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -125.07 143.9 50.68 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.628 ' OG ' HG23 ' A' ' 139' ' ' THR . 1.0 OUTLIER -147.47 149.23 32.27 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.266 -178.122 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.87 ' O ' HG13 ' A' ' 137' ' ' VAL . 52.7 t0 -74.98 148.87 39.56 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.719 ' HB1' ' HB2' ' A' ' 17' ' ' GLN . . . -125.15 100.52 6.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.804 -1.185 . . . . 0.0 111.578 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -79.58 115.06 18.98 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.51 -15.89 45.32 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.719 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 89.9 mt-30 -106.08 171.87 7.11 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.104 -1.233 . . . . 0.0 109.825 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.41 ' CG ' ' HE2' ' A' ' 48' ' ' LYS . 89.3 mtp -56.52 -49.84 73.57 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.332 -0.855 . . . . 0.0 111.659 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.541 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 47.4 p-10 -162.43 -155.7 0.37 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.698 -1.251 . . . . 0.0 110.435 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -84.25 166.92 17.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.334 -0.854 . . . . 0.0 111.005 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.6 mtt -126.03 167.9 14.69 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.442 -0.787 . . . . 0.0 110.918 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.46 128.44 2.93 Favored Glycine 0 N--CA 1.502 3.049 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.392 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.71 ' HA3' HG22 ' A' ' 46' ' ' THR . . . -145.92 -167.29 12.49 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.295 -1.431 . . . . 0.0 111.033 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -122.13 161.73 22.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.855 -0.791 . . . . 0.0 109.494 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.412 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 25.3 p-10 -148.61 135.66 20.08 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.227 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.4 mt -113.76 150.37 33.51 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 80.2 mttt -136.46 142.08 43.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.508 -1.37 . . . . 0.0 110.511 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.46 123.82 44.98 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.528 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 45.9 ttp180 -123.17 143.56 49.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.147 -0.97 . . . . 0.0 112.123 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -112.81 133.69 54.69 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -142.77 153.86 43.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.396 -0.815 . . . . 0.0 109.912 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 0.0 110.185 179.718 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo . . . . . 0 CA--C 1.537 0.627 0 N-CA-C 109.913 -0.841 . . . . 0.0 109.913 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.5 119.81 33.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.534 -0.729 . . . . 0.0 110.004 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . -121.89 134.75 10.04 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.7 t -130.48 132.86 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.336 -1.097 . . . . 0.0 108.921 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.466 HG12 ' CG ' ' A' ' 29' ' ' ARG . 72.4 mt -120.3 139.45 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.742 -1.224 . . . . 0.0 110.818 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 27' ' ' LYS . . . -112.98 117.78 4.37 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 107.703 -2.159 . . . . 0.0 107.703 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.421 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 48.3 t -123.84 141.68 51.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.144 -1.21 . . . . 0.0 112.503 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.05 142.18 49.08 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.5 m -130.91 139.14 50.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.004 -1.06 . . . . 0.0 110.902 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -136.69 110.65 8.24 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.71 HG22 ' HA3' ' A' ' 23' ' ' GLY . 44.6 p -121.69 157.83 30.04 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.464 -0.773 . . . . 0.0 109.989 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -118.31 155.38 30.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -0.853 . . . . 0.0 110.237 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.41 ' HE2' ' CG ' ' A' ' 18' ' ' MET . 18.1 tttt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 . . . . . 0 N--CA 1.497 1.889 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -121.55 112.79 18.93 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.197 -0.94 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.421 ' HB3' ' HB2' ' A' ' 87' ' ' TYR . 49.0 t80 -98.42 140.3 32.89 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.07 117.7 0.95 Allowed Glycine 0 N--CA 1.486 2.01 0 C-N-CA 119.168 -1.491 . . . . 0.0 110.337 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.44 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 14.4 tt -112.03 134.97 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 83' ' ' VAL . 70.9 m -151.7 141.68 22.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.812 -1.18 . . . . 0.0 111.712 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.543 ' O ' HG22 ' A' ' 83' ' ' VAL . . . -147.58 150.05 33.72 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.86 170.59 40.7 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.751 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 48.1 Cg_endo -74.07 172.47 15.88 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 123.955 1.503 . . . . 0.0 110.741 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.61 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -148.62 141.55 24.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.482 -0.762 . . . . 0.0 109.741 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -127.19 146.17 50.5 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.611 -0.68 . . . . 0.0 110.77 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.518 -0.739 . . . . 0.0 109.927 179.271 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.897 0 CA-C-O 121.357 0.599 . . . . 0.0 111.123 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.9 t -138.13 150.06 46.48 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.522 -0.736 . . . . 0.0 109.72 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.6 tt -133.55 138.04 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.999 -1.063 . . . . 0.0 109.973 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -147.89 158.15 43.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.158 -0.963 . . . . 0.0 111.635 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -107.08 161.01 13.92 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 107.919 -2.072 . . . . 0.0 107.919 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 110' ' ' GLY . 35.0 m -142.58 146.81 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.093 -1.239 . . . . 0.0 111.96 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.736 ' O ' HG23 ' A' ' 66' ' ' THR . 26.8 m -138.15 152.26 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . -179.85 177.5 48.12 Favored Glycine 0 N--CA 1.479 1.548 0 C-N-CA 118.876 -1.63 . . . . 0.0 110.734 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.442 ' CG1' ' CZ ' ' A' ' 87' ' ' TYR . 48.7 t -122.3 135.78 61.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-O 121.738 0.78 . . . . 0.0 111.002 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . -103.4 133.97 11.67 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.442 ' CZ ' ' CG1' ' A' ' 85' ' ' VAL . 91.5 m-85 -117.09 146.1 43.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.153 -1.204 . . . . 0.0 110.47 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.32 116.84 3.26 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.7 mttp . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.516 -0.991 . . . . 0.0 109.963 179.775 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 52.6 t0 . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 38.6 p90 -132.04 170.34 15.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 111.436 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.709 ' HA3' HD13 ' A' ' 132' ' ' ILE . . . -160.03 -177.46 33.14 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -106.64 150.14 26.52 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.965 -1.315 . . . . 0.0 111.634 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 96.4 p -128.86 161.57 29.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.716 -0.615 . . . . 0.0 110.108 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -155.68 148.52 24.26 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.379 -0.825 . . . . 0.0 109.802 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.78 ' O ' HG22 ' A' ' 82' ' ' VAL . . . 175.0 -175.36 47.07 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.468 -1.349 . . . . 0.0 110.827 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.67 159.51 9.99 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.609 -0.936 . . . . 0.0 109.022 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.48 -174.75 30.69 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.31 162.02 36.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.22 -1.165 . . . . 0.0 111.059 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.5 ' HG2' ' HB3' ' A' ' 124' ' ' ASP . 91.3 mt-30 -107.68 144.49 34.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.523 -0.735 . . . . 0.0 109.537 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . 0.447 ' CZ ' ' CE2' ' A' ' 125' ' ' PHE . 46.2 p90 -152.23 151.85 31.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.457 -0.777 . . . . 0.0 110.302 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.483 HD21 HD12 ' A' ' 123' ' ' LEU . 0.2 OUTLIER 166.75 142.34 0.05 OUTLIER Pre-proline 0 N--CA 1.509 2.493 0 O-C-N 121.776 -0.577 . . . . 0.0 111.013 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 116' ' ' ASN . 52.0 Cg_endo -88.51 47.96 1.29 Allowed 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.491 1.259 . . . . 0.0 109.155 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.438 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 95.6 mmm -142.26 135.25 28.63 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 121.401 -0.812 . . . . 0.0 108.94 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.08 -42.3 99.61 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.813 -0.554 . . . . 0.0 112.44 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -106.58 5.55 29.18 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.721 -1.237 . . . . 0.0 112.922 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 48.4 t -119.92 136.42 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.715 -1.241 . . . . 0.0 110.506 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 116' ' ' ASN . . . -145.44 129.98 17.91 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.577 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.483 HD12 HD21 ' A' ' 116' ' ' ASN . 80.6 mt -111.95 150.67 30.2 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.5 ' HB3' ' HG2' ' A' ' 114' ' ' GLN . 54.1 p30 -148.76 156.1 41.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.653 -1.279 . . . . 0.0 112.42 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . 0.447 ' CE2' ' CZ ' ' A' ' 115' ' ' PHE . 34.2 m-85 -123.64 141.41 52.04 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.545 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.2 m -138.98 147.75 42.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.382 -0.824 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -117.97 124.23 47.69 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -133.58 138.25 45.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.264 -0.898 . . . . 0.0 111.416 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -119.68 128.61 53.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.639 -0.663 . . . . 0.0 109.537 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.9 m -122.31 146.34 47.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.287 -0.883 . . . . 0.0 110.626 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -129.39 125.18 36.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.432 -0.793 . . . . 0.0 110.117 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.709 HD13 ' HA3' ' A' ' 106' ' ' GLY . 14.7 mm -113.87 63.44 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.456 ' HB3' ' O ' ' A' ' 132' ' ' ILE . 22.9 ttt180 66.23 -60.04 0.32 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.406 -0.809 . . . . 0.0 111.349 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 132' ' ' ILE . 0.6 OUTLIER -125.68 9.23 7.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.057 -1.027 . . . . 0.0 111.16 -179.6 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.562 HG11 ' NE2' ' A' ' 17' ' ' GLN . 43.9 t -124.77 132.88 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.182 -0.949 . . . . 0.0 110.678 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -131.54 111.78 12.06 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 13' ' ' ASP . 88.1 t -115.24 145.13 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 110.799 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -107.47 103.9 2.02 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 107.116 -2.394 . . . . 0.0 107.116 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.628 HG23 ' OG ' ' A' ' 12' ' ' SER . 53.2 m -104.9 136.85 43.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -1.069 . . . . 0.0 112.105 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -114.22 134.34 54.99 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 75.1 mt -116.05 132.55 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 110.52 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.0 143.06 31.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.479 -0.763 . . . . 0.0 109.425 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -174.77 -146.71 5.83 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 118.709 -1.71 . . . . 0.0 112.151 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.793 ' O ' HG23 ' A' ' 6' ' ' THR . 34.1 m -118.47 175.69 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.289 0.566 . . . . 0.0 111.075 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -157.36 139.84 6.7 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.772 ' O ' HG23 ' A' ' 4' ' ' THR . 97.7 m-85 -132.98 157.37 45.36 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.598 -0.942 . . . . 0.0 109.837 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -131.9 121.33 23.85 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.271 -0.893 . . . . 0.0 111.065 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.403 -0.81 . . . . 0.0 110.29 -179.874 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.4 p . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.9 p -112.44 145.82 39.49 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.36 -0.838 . . . . 0.0 109.68 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.71 HG21 ' CZ ' ' A' ' 29' ' ' ARG . 91.8 m -136.98 139.18 41.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.857 . . . . 0.0 110.634 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.05 142.25 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.571 -0.705 . . . . 0.0 109.846 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.785 HG23 ' O ' ' A' ' 144' ' ' VAL . 62.8 m -156.42 130.52 8.56 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.44 -0.788 . . . . 0.0 110.123 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.411 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -165.66 171.6 40.91 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.61 -136.36 2.3 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -132.76 158.54 42.16 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.549 -0.971 . . . . 0.0 109.108 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.469 ' HB1' ' O ' ' A' ' 140' ' ' TRP . . . -145.39 142.3 29.22 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.286 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -111.54 145.8 38.45 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.614 ' HB2' HG23 ' A' ' 139' ' ' THR . 19.8 t -146.35 151.22 37.14 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.411 -1.316 . . . . 0.0 112.914 -177.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.712 ' O ' HG13 ' A' ' 137' ' ' VAL . 86.5 m-20 -100.92 150.64 22.65 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.743 ' HB3' ' HB2' ' A' ' 17' ' ' GLN . . . -134.12 116.3 15.26 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.787 -1.196 . . . . 0.0 111.823 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -67.03 117.14 8.68 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.59 -14.18 38.82 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.743 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 87.6 mt-30 -114.59 156.62 24.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.348 -1.09 . . . . 0.0 109.356 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 70.1 mtm -100.51 -75.52 0.58 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.206 -0.933 . . . . 0.0 111.613 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -57.46 132.04 51.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.366 -0.834 . . . . 0.0 111.553 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -63.6 169.07 4.17 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.663 . . . . 0.0 110.237 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 90.1 mtp -128.15 166.7 18.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.279 -0.888 . . . . 0.0 111.44 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.814 ' O ' HG23 ' A' ' 46' ' ' THR . . . -124.86 178.94 16.34 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 107.904 -2.079 . . . . 0.0 107.904 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.94 148.27 9.19 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 118.57 -1.776 . . . . 0.0 111.89 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -109.24 133.68 52.72 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.411 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 76.1 m-20 -120.85 128.4 52.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.201 -0.937 . . . . 0.0 111.852 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.579 HD21 ' OH ' ' A' ' 28' ' ' TYR . 25.0 tp -121.58 133.53 55.0 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.43 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 22.7 mttt -136.08 146.71 47.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.313 -1.492 . . . . 0.0 111.44 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . 0.579 ' OH ' HD21 ' A' ' 26' ' ' LEU . 97.4 m-85 -115.96 129.46 56.4 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.71 ' CZ ' HG21 ' A' ' 4' ' ' THR . 56.2 ttp180 -128.57 134.32 48.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.15 -0.969 . . . . 0.0 112.106 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . 0.468 ' O ' HG22 ' A' ' 39' ' ' VAL . 99.4 m-85 -125.06 139.95 53.33 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.592 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -142.04 150.26 41.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.144 -0.973 . . . . 0.0 110.278 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 . . . . . 0 N--CA 1.489 1.518 0 O-C-N 121.368 -0.833 . . . . 0.0 109.662 -179.931 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo . . . . . 0 N--CA 1.481 0.784 0 N-CA-C 111.061 -0.4 . . . . 0.0 111.061 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -89.05 76.27 7.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.318 -0.864 . . . . 0.0 110.203 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 69' ' ' PRO . . . -79.67 132.85 11.74 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 30' ' ' TYR . 35.6 m -132.67 129.26 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.359 -1.083 . . . . 0.0 108.925 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 17.0 tt -132.11 144.75 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.893 . . . . 0.0 111.431 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.58 148.21 16.38 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.43 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 42.3 t -138.72 141.53 38.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.272 . . . . 0.0 111.891 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -125.49 138.31 53.98 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 t -134.62 145.78 48.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.974 -1.079 . . . . 0.0 111.216 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -127.99 111.38 13.48 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.814 HG23 ' O ' ' A' ' 22' ' ' GLY . 87.1 m -119.24 141.9 48.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.692 -0.63 . . . . 0.0 110.68 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -148.75 179.63 7.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.843 . . . . 0.0 110.075 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 mttp . . . . . 0 N--CA 1.494 1.735 0 O-C-N 121.437 -0.789 . . . . 0.0 109.99 179.898 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 . . . . . 0 N--CA 1.494 1.756 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -110.33 118.41 36.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.217 -0.927 . . . . 0.0 110.748 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.465 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 46.6 t80 -98.44 139.66 33.85 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.73 122.27 1.4 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 118.969 -1.586 . . . . 0.0 110.987 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.581 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 43.7 pt -112.85 138.0 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 1.3 p -153.57 144.29 22.62 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.584 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.617 ' O ' HG22 ' A' ' 83' ' ' VAL . . . -151.26 153.59 35.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.473 -0.767 . . . . 0.0 109.27 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.85 174.15 43.43 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.536 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 45.9 Cg_endo -71.8 167.69 25.88 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.891 1.469 . . . . 0.0 110.846 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -148.51 141.7 25.04 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.412 -0.805 . . . . 0.0 110.404 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -120.5 131.56 54.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.503 -0.748 . . . . 0.0 110.503 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.657 -0.652 . . . . 0.0 110.391 179.361 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.78 ' HB1' ' O ' ' A' ' 114' ' ' GLN . . . . . . . . 0 N--CA 1.499 1.98 0 CA-C-O 121.123 0.487 . . . . 0.0 111.139 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 24.6 m -115.5 146.14 41.97 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.357 -0.839 . . . . 0.0 109.364 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.0 mt -131.31 138.44 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.149 -0.969 . . . . 0.0 111.234 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -142.25 157.22 45.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.492 -0.755 . . . . 0.0 110.461 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.51 164.2 13.5 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.519 HG13 ' HB ' ' A' ' 66' ' ' THR . 48.9 t -139.24 132.79 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -1.158 . . . . 0.0 111.086 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 67' ' ' ALA . 26.7 m -141.89 151.95 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.581 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 164.24 -161.42 34.42 Favored Glycine 0 N--CA 1.48 1.572 0 C-N-CA 119.157 -1.497 . . . . 0.0 110.755 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.554 HG22 ' CG1' ' A' ' 65' ' ' ILE . 33.8 m -130.16 162.87 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 122.226 1.013 . . . . 0.0 112.651 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.07 137.84 7.9 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.465 ' CE2' ' HB3' ' A' ' 63' ' ' TYR . 13.9 p90 -150.82 163.94 37.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.081 -1.246 . . . . 0.0 110.701 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -119.36 141.28 15.61 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.4 tttt . . . . . 0 N--CA 1.493 1.707 0 O-C-N 121.826 -0.808 . . . . 0.0 109.942 179.914 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 . . . . . 0 N--CA 1.494 1.762 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.896 ' O ' HG23 ' A' ' 132' ' ' ILE . 43.2 p90 -133.04 169.44 16.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.256 -0.902 . . . . 0.0 110.912 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -163.03 -175.75 34.38 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.432 ' CD1' HG12 ' A' ' 85' ' ' VAL . 98.8 m-85 -112.03 155.28 24.07 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.186 -1.185 . . . . 0.0 110.655 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 97.6 p -129.86 160.92 32.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.491 -0.755 . . . . 0.0 110.646 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.561 ' CD1' HG12 ' A' ' 83' ' ' VAL . 65.7 t80 -155.26 148.03 24.35 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.439 -0.788 . . . . 0.0 109.673 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 175.82 -176.77 47.59 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.602 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.88 160.0 9.94 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.713 -0.875 . . . . 0.0 108.707 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.433 ' C ' HD12 ' A' ' 113' ' ' LEU . . . -152.47 -179.1 27.77 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.3 mp -126.68 160.1 31.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.453 -1.027 . . . . 0.0 110.002 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.78 ' O ' ' HB1' ' A' ' 77' ' ' ALA . 36.5 tt0 -106.65 140.65 39.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.81 -1.181 . . . . 0.0 108.057 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -124.65 165.19 18.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.372 -0.83 . . . . 0.0 111.518 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.84 88.94 0.1 OUTLIER Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.865 -0.522 . . . . 0.0 109.927 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.96 125.49 12.63 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.734 1.386 . . . . 0.0 110.398 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.43 ' CB ' ' HB ' ' A' ' 121' ' ' VAL . 95.5 mmm -145.21 163.25 35.0 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.13 -49.08 77.31 Favored 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.688 -0.632 . . . . 0.0 110.401 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -134.17 25.26 3.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.274 -0.891 . . . . 0.0 111.349 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.43 ' HB ' ' CB ' ' A' ' 118' ' ' MET . 48.2 t -127.11 139.66 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.95 -1.094 . . . . 0.0 109.964 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.715 ' HB1' ' CD ' ' A' ' 114' ' ' GLN . . . -154.81 137.7 15.41 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.785 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' A' ' 144' ' ' VAL . 77.7 mt -121.65 143.62 49.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -149.45 153.25 37.0 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 118.246 -1.381 . . . . 0.0 112.395 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.31 140.14 53.08 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.6 t -143.62 149.23 37.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -0.977 . . . . 0.0 111.181 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -104.9 123.41 47.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.637 -0.665 . . . . 0.0 109.368 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -137.36 142.84 41.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.634 -0.666 . . . . 0.0 110.481 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -138.5 156.88 47.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.52 -0.738 . . . . 0.0 109.765 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.2 t -133.33 143.53 49.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.385 -0.822 . . . . 0.0 110.53 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -124.59 127.73 47.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.563 -0.71 . . . . 0.0 109.761 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.896 HG23 ' O ' ' A' ' 105' ' ' TYR . 85.1 mt -121.17 39.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 68.5 mtt180 63.64 -55.13 0.21 Allowed 'General case' 0 N--CA 1.503 2.207 0 O-C-N 122.03 -0.419 . . . . 0.0 111.578 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 132' ' ' ILE . 66.5 p -99.93 -24.14 14.73 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.121 -0.987 . . . . 0.0 110.398 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 56.1 t -126.51 132.39 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.246 -0.909 . . . . 0.0 110.732 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -132.55 113.19 12.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 109.02 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.712 HG22 ' CB ' ' A' ' 14' ' ' ALA . 61.3 t -117.54 146.4 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.937 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -115.78 114.62 3.17 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.614 HG23 ' HB2' ' A' ' 12' ' ' SER . 27.8 m -109.03 140.56 42.39 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.209 -1.171 . . . . 0.0 112.322 -178.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.469 ' O ' ' HB1' ' A' ' 10' ' ' ALA . 41.6 m95 -109.01 136.75 48.03 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 46.4 pt -124.14 147.06 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.98 -1.075 . . . . 0.0 111.654 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -154.43 139.6 17.48 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -168.59 -153.21 8.12 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 118.695 -1.717 . . . . 0.0 112.072 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.785 ' O ' HG23 ' A' ' 6' ' ' THR . 34.5 m -116.97 177.64 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 122.236 -0.567 . . . . 0.0 110.738 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -156.4 140.21 7.06 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.485 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -130.34 152.31 49.88 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.578 -0.954 . . . . 0.0 109.654 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -128.04 120.68 27.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.206 -0.934 . . . . 0.0 110.81 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.5 t80 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.48 -0.763 . . . . 0.0 110.205 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.6 p . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.5 m -116.44 145.21 43.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.9 . . . . 0.0 109.453 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 29' ' ' ARG . 57.9 m -136.21 142.0 44.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.895 . . . . 0.0 110.673 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.435 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 14.7 p -128.61 141.39 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.655 -0.653 . . . . 0.0 109.571 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 144' ' ' VAL . 71.8 m -156.68 133.07 9.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.51 -0.744 . . . . 0.0 109.815 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -166.23 173.47 41.73 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.156 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.85 -128.23 1.19 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -118.35 152.77 35.17 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.406 -1.055 . . . . 0.0 109.866 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.02 116.52 22.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 110.688 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -110.62 142.71 42.11 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.3 t -148.49 145.35 27.9 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.42 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -73.3 150.86 41.6 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.899 ' HB1' ' HB2' ' A' ' 17' ' ' GLN . . . -127.94 90.52 3.11 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.959 -1.096 . . . . 0.0 112.046 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -80.91 116.09 20.71 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.87 -14.41 60.22 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.899 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 93.2 mt-30 -100.83 172.75 6.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.018 -1.283 . . . . 0.0 110.463 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 88.0 mtp -57.55 -49.39 76.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.432 -0.792 . . . . 0.0 112.11 -178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -164.55 -158.26 0.41 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.771 -1.206 . . . . 0.0 110.655 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -77.68 159.98 28.78 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.437 -0.79 . . . . 0.0 110.304 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.733 ' HB3' HG22 ' A' ' 46' ' ' THR . 85.9 mtp -126.75 163.98 22.35 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.26 -0.9 . . . . 0.0 111.083 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.736 ' C ' HG23 ' A' ' 46' ' ' THR . . . -145.96 126.02 2.42 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.573 ' N ' HG23 ' A' ' 46' ' ' THR . . . -142.75 -171.78 13.53 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.567 -1.302 . . . . 0.0 110.771 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.48 146.62 40.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.636 -0.92 . . . . 0.0 109.988 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.418 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 51.2 t-20 -130.85 127.85 39.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.831 . . . . 0.0 110.997 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.794 HD13 ' N ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -115.83 141.62 47.85 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.794 ' N ' HD13 ' A' ' 26' ' ' LEU . 31.9 mttm -130.8 144.86 51.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.419 -1.425 . . . . 0.0 110.501 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -122.75 124.46 43.41 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.47 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 59.0 ttt180 -122.74 142.72 50.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.147 -0.971 . . . . 0.0 111.953 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -114.07 137.23 51.99 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -138.44 152.01 47.95 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.4 -0.813 . . . . 0.0 109.61 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 . . . . . 0 N--CA 1.491 1.598 0 O-C-N 121.045 -1.034 . . . . 0.0 109.93 179.773 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo . . . . . 0 CA--C 1.541 0.844 0 N-CA-C 110.547 -0.597 . . . . 0.0 110.547 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.1 tp -94.48 120.35 34.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.843 -0.536 . . . . 0.0 110.909 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.49 134.19 9.57 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.4 t -130.8 135.13 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.341 -1.094 . . . . 0.0 109.044 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.525 HD12 ' HB2' ' A' ' 80' ' ' TYR . 73.5 mt -119.87 140.59 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.855 -1.153 . . . . 0.0 110.936 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.43 125.63 6.68 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 107.758 -2.137 . . . . 0.0 107.758 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.45 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 92.7 p -134.02 144.98 49.03 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.012 -1.287 . . . . 0.0 112.577 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -125.54 140.27 52.89 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 m -132.34 142.42 49.32 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.912 -1.117 . . . . 0.0 111.402 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.417 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 78.3 t80 -131.79 109.67 10.3 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.736 HG23 ' C ' ' A' ' 22' ' ' GLY . 9.1 m -122.1 145.62 47.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.467 -0.771 . . . . 0.0 110.733 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -147.32 167.6 23.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.288 -0.882 . . . . 0.0 110.275 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.4 mttp . . . . . 0 N--CA 1.493 1.693 0 O-C-N 121.439 -0.788 . . . . 0.0 109.976 179.742 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 . . . . . 0 N--CA 1.495 1.798 0 CA-C-O 120.883 0.373 . . . . 0.0 110.261 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -125.02 117.6 24.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.384 -0.822 . . . . 0.0 110.851 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' A' ' 87' ' ' TYR . 95.5 m-85 -109.78 139.11 45.21 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.58 125.93 2.1 Favored Glycine 0 N--CA 1.485 1.957 0 C-N-CA 119.094 -1.527 . . . . 0.0 110.292 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.578 ' CG2' HG12 ' A' ' 85' ' ' VAL . 16.7 tt -108.43 137.59 39.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -151.41 140.19 20.84 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.018 -1.073 . . . . 0.0 111.126 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.793 ' O ' HG22 ' A' ' 83' ' ' VAL . . . -156.34 152.07 27.15 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.36 178.32 43.13 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.601 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.26 169.23 21.21 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 O-C-N 123.949 1.5 . . . . 0.0 110.638 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.93 145.89 21.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.586 -0.696 . . . . 0.0 110.028 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -120.99 141.18 50.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.655 -0.653 . . . . 0.0 109.948 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 44.8 ttt180 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.499 -0.75 . . . . 0.0 110.263 179.909 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.367 0 CA-C-O 121.447 0.641 . . . . 0.0 111.045 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.806 ' O ' HD12 ' A' ' 113' ' ' LEU . 50.6 m -125.83 148.74 49.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.542 -0.724 . . . . 0.0 109.8 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.58 HG12 HD13 ' A' ' 113' ' ' LEU . 81.1 mt -123.41 137.17 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.151 -0.968 . . . . 0.0 110.474 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.525 ' HB2' HD12 ' A' ' 40' ' ' ILE . 39.7 p90 -146.9 166.19 27.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.367 -0.833 . . . . 0.0 110.878 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.41 162.15 19.73 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.409 ' HB ' ' HB ' ' A' ' 66' ' ' THR . 34.6 m -135.26 141.07 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -1.108 . . . . 0.0 111.232 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 67' ' ' ALA . 36.0 m -142.63 151.44 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 160.36 -149.34 18.62 Favored Glycine 0 N--CA 1.483 1.772 0 C-N-CA 119.265 -1.445 . . . . 0.0 110.953 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.578 HG12 ' CG2' ' A' ' 65' ' ' ILE . 11.1 p -133.04 144.29 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 122.459 1.123 . . . . 0.0 113.567 -177.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.2 137.68 14.46 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.525 ' CE2' HG13 ' A' ' 85' ' ' VAL . 90.0 m-85 -120.65 143.56 48.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.141 -1.211 . . . . 0.0 110.796 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -125.02 114.59 2.22 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.0 tptm . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.491 -1.005 . . . . 0.0 110.253 -179.725 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.527 ' HB3' HD12 ' A' ' 132' ' ' ILE . 52.4 t0 . . . . . 0 N--CA 1.495 1.782 0 CA-C-O 121.024 0.44 . . . . 0.0 110.194 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.453 ' HB3' ' CD1' ' A' ' 87' ' ' TYR . 43.4 p90 -127.6 168.83 14.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.275 -0.89 . . . . 0.0 110.305 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.682 ' HA3' HG22 ' A' ' 132' ' ' ILE . . . -159.83 -175.86 31.27 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -103.38 144.71 31.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.134 -1.215 . . . . 0.0 111.333 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.0 m -118.08 150.33 39.51 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 110.059 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -154.63 146.57 23.52 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.452 -0.78 . . . . 0.0 109.978 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.91 -176.27 42.55 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.016 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 80' ' ' TYR . . . -160.81 162.89 32.43 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.46 -178.07 24.12 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.289 -1.434 . . . . 0.0 110.221 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.806 HD12 ' O ' ' A' ' 78' ' ' SER . 20.2 tp -139.51 149.39 43.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.609 -0.936 . . . . 0.0 109.923 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -127.06 151.81 48.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.185 -0.947 . . . . 0.0 109.824 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -156.88 161.19 39.68 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.359 -0.838 . . . . 0.0 110.883 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . 0.489 ' HB2' ' HA ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER 172.77 140.36 0.13 Allowed Pre-proline 0 N--CA 1.504 2.266 0 O-C-N 121.643 -0.661 . . . . 0.0 111.323 179.251 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 116' ' ' ASN . 52.2 Cg_endo -88.37 50.6 1.7 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.581 1.306 . . . . 0.0 109.011 177.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.457 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 86.6 mtp -146.25 140.58 26.63 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.527 -0.733 . . . . 0.0 109.068 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.48 -39.46 91.95 Favored 'General case' 0 C--N 1.292 -1.914 0 O-C-N 121.781 -0.574 . . . . 0.0 112.423 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -115.46 13.6 16.5 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.665 -1.272 . . . . 0.0 112.631 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 47.1 t -123.94 136.28 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.781 -1.199 . . . . 0.0 109.787 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.489 ' HA ' ' HB2' ' A' ' 116' ' ' ASN . . . -153.3 138.15 17.11 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.643 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.1 mt -103.13 153.1 20.67 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 142' ' ' ALA . 52.5 t0 -143.97 136.52 26.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.569 -1.332 . . . . 0.0 110.361 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -128.71 142.28 51.06 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.6 t -145.91 155.74 43.07 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.132 -0.98 . . . . 0.0 111.375 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -107.14 119.27 38.91 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.532 ' HB3' HG23 ' A' ' 139' ' ' THR . 84.5 tt0 -131.96 144.32 50.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 110.9 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -141.26 155.0 46.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.577 -0.702 . . . . 0.0 109.609 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 29.3 t -142.46 141.3 32.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.397 -0.814 . . . . 0.0 110.294 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 -129.42 133.35 47.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.472 -0.768 . . . . 0.0 109.87 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.682 HG22 ' HA3' ' A' ' 106' ' ' GLY . 24.6 pt -125.15 48.76 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 76.7 mtt85 60.59 -56.62 0.08 Allowed 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 132' ' ' ILE . 53.4 m -92.18 -21.67 20.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 111.006 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.468 ' HB ' HG12 ' A' ' 132' ' ' ILE . 37.6 t -135.12 137.55 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.646 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -132.74 113.69 13.27 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.847 HG12 ' HA ' ' A' ' 14' ' ' ALA . 34.0 m -121.33 149.19 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.234 -0.916 . . . . 0.0 110.835 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -114.28 129.35 8.68 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.532 HG23 ' HB3' ' A' ' 128' ' ' GLU . 14.7 t -126.31 143.9 51.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -1.134 . . . . 0.0 112.263 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -123.06 140.89 52.55 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.542 HD12 ' HE3' ' A' ' 27' ' ' LYS . 49.6 pt -120.5 149.94 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.122 -0.986 . . . . 0.0 111.187 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 124' ' ' ASP . . . -150.07 140.08 21.99 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -173.53 -146.3 5.47 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 118.783 -1.675 . . . . 0.0 111.906 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.784 ' O ' HG23 ' A' ' 6' ' ' THR . 35.4 m -118.77 179.87 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 122.229 -0.571 . . . . 0.0 110.908 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 5' ' ' VAL . . . -160.84 143.61 9.11 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.899 -1.143 . . . . 0.0 110.729 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -132.73 156.12 47.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.655 -0.909 . . . . 0.0 109.726 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 46.3 ptt85 -133.96 123.85 25.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.346 -0.846 . . . . 0.0 111.268 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.8 p90 . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.346 -0.846 . . . . 0.0 110.397 179.939 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 48.5 m . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.0 p -117.34 144.31 45.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 109.751 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 146' ' ' TYR . 56.7 m -135.83 140.21 44.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.418 -0.801 . . . . 0.0 110.505 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -115.18 138.31 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 144' ' ' VAL . 27.6 m -156.34 132.54 9.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.237 -0.914 . . . . 0.0 110.023 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.99 171.95 38.89 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.82 -148.43 7.91 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 46.2 p90 -139.36 159.86 41.17 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.442 -1.034 . . . . 0.0 109.85 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.829 ' HB2' HG22 ' A' ' 141' ' ' ILE . . . -145.67 147.07 31.58 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.838 -1.145 . . . . 0.0 111.628 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.89 ' O ' HG23 ' A' ' 139' ' ' THR . 94.5 mt-30 -99.19 138.16 36.68 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.404 ' HB3' HG11 ' A' ' 137' ' ' VAL . 43.5 m -119.73 145.13 46.82 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.193 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -136.69 141.09 43.09 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.894 ' CB ' HG22 ' A' ' 137' ' ' VAL . . . -153.96 149.52 27.34 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 120.411 -1.431 . . . . 0.0 112.482 -177.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -79.32 128.03 32.82 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.6 -28.29 14.77 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . 0.536 ' NE2' HG11 ' A' ' 135' ' ' VAL . 96.5 mt-30 -114.02 157.26 22.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.457 -1.025 . . . . 0.0 110.212 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . 0.406 ' O ' ' HB2' ' A' ' 19' ' ' ASN . 64.8 mtt -121.46 171.33 8.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.442 -0.786 . . . . 0.0 110.29 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 18' ' ' MET . 18.2 m120 61.7 115.97 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.631 -0.668 . . . . 0.0 110.511 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -65.95 164.09 15.8 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.578 -0.701 . . . . 0.0 110.305 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 87.2 mtp -126.19 165.75 18.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.46 -0.775 . . . . 0.0 110.713 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.1 123.37 1.83 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.709 ' HA3' HG22 ' A' ' 46' ' ' THR . . . -135.73 -172.67 12.74 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.153 -1.498 . . . . 0.0 110.754 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -119.0 148.6 42.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.804 -0.821 . . . . 0.0 108.999 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.405 ' ND2' ' HE2' ' A' ' 27' ' ' LYS . 44.9 t-20 -125.59 134.65 51.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 111.265 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.2 mt -113.27 147.72 37.02 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 26.5 mttt -147.89 137.34 22.37 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.63 -1.294 . . . . 0.0 110.979 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -119.84 130.9 55.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.459 -0.776 . . . . 0.0 108.928 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.414 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 14.2 ttp180 -132.27 140.27 48.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.14 -0.975 . . . . 0.0 111.878 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -119.0 133.3 55.91 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -141.97 142.75 32.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.199 -0.938 . . . . 0.0 110.459 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.419 -0.8 . . . . 0.0 109.879 179.557 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo . . . . . 0 N--CA 1.481 0.759 0 N-CA-C 111.183 -0.353 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 28.1 tp -116.59 84.72 2.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.26 -0.9 . . . . 0.0 110.595 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.74 -175.83 24.8 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.02 147.04 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.488 -1.007 . . . . 0.0 109.342 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.77 HG22 ' O ' ' A' ' 68' ' ' GLY . 16.5 tt -135.75 146.64 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.239 -0.913 . . . . 0.0 111.451 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 27' ' ' LYS . . . -115.73 151.16 18.49 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.5 t -140.35 142.27 35.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.075 -1.25 . . . . 0.0 111.788 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -129.95 138.67 50.99 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.4 t -134.04 148.55 51.09 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.95 -1.094 . . . . 0.0 111.677 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -141.59 114.37 8.48 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.709 HG22 ' HA3' ' A' ' 23' ' ' GLY . 32.3 p -122.11 159.73 26.53 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.418 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -142.35 170.9 14.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.747 . . . . 0.0 110.418 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.0 pttt . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.398 -0.814 . . . . 0.0 110.305 179.847 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 . . . . . 0 N--CA 1.493 1.683 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.415 ' HB3' ' OG1' ' A' ' 46' ' ' THR . 69.4 t80 -110.48 117.53 33.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.779 . . . . 0.0 110.98 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' A' ' 87' ' ' TYR . 86.4 m-85 -113.62 135.08 54.31 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.098 0.475 . . . . 0.0 109.776 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.01 126.8 2.52 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.547 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.551 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 14.0 tt -122.03 134.63 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 1.1 p -149.71 143.79 25.68 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.668 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 40' ' ' ILE . . . -141.23 150.09 42.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.685 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.77 ' O ' HG22 ' A' ' 40' ' ' ILE . . . -167.84 168.24 40.58 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.65 176.97 8.1 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.788 1.415 . . . . 0.0 110.681 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.404 ' CB ' ' HD2' ' A' ' 29' ' ' ARG . . . -157.49 147.99 21.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.476 -0.765 . . . . 0.0 110.847 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -118.49 134.81 54.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.429 -0.795 . . . . 0.0 109.646 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.5 ttt-85 . . . . . 0 N--CA 1.496 1.86 0 O-C-N 121.456 -0.777 . . . . 0.0 110.765 -179.485 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 121.103 0.477 . . . . 0.0 110.521 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 33.7 t -95.77 142.44 28.05 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.492 -0.755 . . . . 0.0 109.8 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.0 tt -132.62 144.43 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.361 -0.837 . . . . 0.0 110.451 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -142.96 153.98 43.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -0.812 . . . . 0.0 110.882 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.48 161.79 21.42 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 110' ' ' GLY . 47.3 t -134.45 132.77 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.119 -1.224 . . . . 0.0 111.467 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 66' ' ' THR . 60.5 t -137.29 145.59 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 170.7 -166.39 39.59 Favored Glycine 0 N--CA 1.477 1.412 0 C-N-CA 118.537 -1.792 . . . . 0.0 111.337 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.595 HG11 ' CE2' ' A' ' 105' ' ' TYR . 33.2 m -133.84 177.07 7.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 121.838 0.827 . . . . 0.0 111.529 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.39 145.05 15.67 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' A' ' 63' ' ' TYR . 99.2 m-85 -126.06 132.49 51.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.201 -1.176 . . . . 0.0 109.732 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.06 129.02 9.15 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 26.3 tttt . . . . . 0 N--CA 1.492 1.655 0 O-C-N 121.594 -0.945 . . . . 0.0 109.676 179.695 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 . . . . . 0 N--CA 1.495 1.822 0 N-CA-C 109.571 -0.529 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.595 ' CE2' HG11 ' A' ' 85' ' ' VAL . 39.4 t80 -81.69 131.0 35.25 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.108 -0.995 . . . . 0.0 111.443 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . 0.714 ' HA3' HD13 ' A' ' 132' ' ' ILE . . . -117.96 -164.13 13.02 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 66.0 t80 -140.8 148.86 41.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.443 -1.033 . . . . 0.0 109.917 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.7 m -136.6 143.57 43.65 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.198 -0.939 . . . . 0.0 110.858 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 128' ' ' GLU . 69.2 t80 -151.7 141.38 21.8 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.449 -0.782 . . . . 0.0 110.014 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 82' ' ' VAL . . . 174.87 -176.07 47.04 Favored Glycine 0 N--CA 1.497 2.727 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.451 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -169.2 161.23 10.13 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.458 -1.025 . . . . 0.0 109.0 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -156.06 -174.89 26.42 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.303 -1.427 . . . . 0.0 109.946 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 78' ' ' SER . 0.5 OUTLIER -124.01 162.42 23.49 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.43 -1.041 . . . . 0.0 110.069 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . 0.537 ' HG2' ' HB3' ' A' ' 124' ' ' ASP . 75.2 mt-30 -119.21 131.85 55.87 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.862 -1.148 . . . . 0.0 109.04 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -129.28 129.2 44.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.293 -0.879 . . . . 0.0 110.629 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -177.34 150.69 0.86 Allowed Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.331 -0.855 . . . . 0.0 110.471 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -77.01 -77.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.577 1.304 . . . . 0.0 110.131 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . 0.415 ' HB2' HG22 ' A' ' 121' ' ' VAL . 89.0 mtp -47.22 119.17 2.47 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.435 1.112 . . . . 0.0 110.596 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.5 -10.43 7.82 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.437 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -92.06 -4.06 54.93 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.531 -1.356 . . . . 0.0 110.743 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 118' ' ' MET . 34.1 m -128.28 161.1 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -0.875 . . . . 0.0 110.51 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 144' ' ' VAL . . . -156.11 138.64 14.98 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.685 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . 0.837 HD12 ' O ' ' A' ' 143' ' ' GLY . 18.3 tp -119.68 132.31 55.64 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.537 ' HB3' ' HG2' ' A' ' 114' ' ' GLN . 49.5 p30 -143.85 156.72 44.56 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.088 -1.445 . . . . 0.0 113.797 -177.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -124.51 134.86 52.88 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . 0.615 ' HB3' HD11 ' A' ' 141' ' ' ILE . 31.2 t -138.45 142.82 39.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 111.016 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.44 ' CD1' ' CZ2' ' A' ' 140' ' ' TRP . 81.0 t80 -109.23 127.54 54.33 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 109' ' ' TYR . 21.9 pt-20 -142.14 147.39 36.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.526 -0.734 . . . . 0.0 110.41 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -112.22 135.14 53.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.547 -0.72 . . . . 0.0 110.106 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 50.7 m -128.4 143.61 51.02 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.608 -0.682 . . . . 0.0 109.315 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 39.5 ptt180 -147.06 144.7 29.29 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.81 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.714 HD13 ' HA3' ' A' ' 106' ' ' GLY . 44.8 mm -122.67 90.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.57 -0.706 . . . . 0.0 110.031 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 51.7 mtt180 61.75 -66.45 0.07 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.667 -0.645 . . . . 0.0 112.385 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 132' ' ' ILE . 32.2 p -125.86 20.84 7.68 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.033 -1.042 . . . . 0.0 110.96 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.536 HG11 ' NE2' ' A' ' 17' ' ' GLN . 61.5 t -124.57 133.94 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 119.261 -0.975 . . . . 0.0 111.024 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -129.3 111.89 13.32 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.894 HG22 ' CB ' ' A' ' 14' ' ' ALA . 18.6 t -113.15 144.2 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.807 -1.183 . . . . 0.0 111.276 -177.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -117.12 107.12 1.52 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.125 -2.39 . . . . 0.0 107.125 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . 0.89 HG23 ' O ' ' A' ' 11' ' ' GLN . 90.5 m -121.81 142.33 50.33 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -1.13 . . . . 0.0 112.051 -177.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.44 ' CZ2' ' CD1' ' A' ' 127' ' ' TYR . 89.3 m95 -105.63 135.51 46.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.829 HG22 ' HB2' ' A' ' 10' ' ' ALA . 49.3 pt -119.53 150.5 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.147 -0.97 . . . . 0.0 111.312 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -151.66 139.03 19.42 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.837 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -164.23 -157.71 9.65 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 118.92 -1.61 . . . . 0.0 111.745 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.745 ' O ' HG23 ' A' ' 6' ' ' THR . 34.8 m -117.38 173.71 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 122.135 -0.626 . . . . 0.0 110.385 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 121' ' ' VAL . . . -152.41 138.75 6.59 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.699 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.71 ' O ' HG23 ' A' ' 4' ' ' THR . 84.7 m-85 -127.04 147.35 50.15 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.582 -0.952 . . . . 0.0 109.357 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -129.22 122.89 30.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.133 -0.979 . . . . 0.0 111.046 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 69.0 t80 . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.466 -0.771 . . . . 0.0 110.2 179.862 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 3' ' ' SER . 93.8 m . . . . . 0 N--CA 1.499 2.003 0 CA-C-O 120.546 0.212 . . . . 0.0 110.818 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.416 ' N ' HG22 ' A' ' 2' ' ' THR . 82.8 p -149.4 154.39 38.82 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.867 -1.145 . . . . 0.0 109.779 179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.646 HG23 ' O ' ' A' ' 146' ' ' TYR . 27.2 m -136.11 137.69 41.29 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.418 -0.801 . . . . 0.0 110.06 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.421 HG23 ' HE2' ' A' ' 148' ' ' PHE . 58.0 t -106.79 138.05 34.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.7 HG23 ' O ' ' A' ' 144' ' ' VAL . 47.6 m -156.58 133.59 10.43 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.217 -0.927 . . . . 0.0 110.367 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.35 176.12 44.72 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.09 -120.85 0.78 Allowed Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.404 ' CE2' ' HA3' ' A' ' 22' ' ' GLY . 27.1 t80 -139.46 158.92 43.31 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.482 -1.01 . . . . 0.0 109.228 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -136.2 117.4 14.5 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.199 -1.0 . . . . 0.0 111.143 -179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -106.76 144.63 33.13 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 178.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.426 ' HB3' HG23 ' A' ' 139' ' ' THR . 54.3 p -150.12 154.08 37.46 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.95 -1.1 . . . . 0.0 112.342 -178.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -77.22 154.32 33.17 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 177.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.917 ' HB1' ' HB2' ' A' ' 17' ' ' GLN . . . -125.76 98.57 5.6 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.099 -1.001 . . . . 0.0 111.821 -178.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -80.13 115.68 19.82 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.396 -0.815 . . . . 0.0 108.802 178.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 100.51 -14.09 59.43 Favored Glycine 0 N--CA 1.493 2.496 0 N-CA-C 109.113 -1.595 . . . . 0.0 109.113 -178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.917 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 96.6 mt-30 -115.05 160.03 20.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.439 -1.036 . . . . 0.0 109.402 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 52.1 ttm -98.99 137.96 36.79 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.246 -0.909 . . . . 0.0 111.052 -179.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 38.6 t30 64.63 138.59 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.541 -0.724 . . . . 0.0 111.099 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 46.4 mttp -69.17 177.79 2.59 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.613 -0.679 . . . . 0.0 110.128 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.753 ' HB3' HG22 ' A' ' 46' ' ' THR . 68.9 mtm -129.16 169.91 14.2 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.343 -0.848 . . . . 0.0 110.724 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.79 ' C ' HG23 ' A' ' 46' ' ' THR . . . -152.68 128.94 2.61 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 45' ' ' TYR . . . -136.09 177.28 19.67 Favored Glycine 0 N--CA 1.493 2.436 0 C-N-CA 119.696 -1.24 . . . . 0.0 110.78 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -108.54 139.99 42.52 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.709 -0.877 . . . . 0.0 109.785 179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -121.4 125.68 47.54 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.43 -0.794 . . . . 0.0 111.394 -179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 26.1 tp -119.94 135.08 55.04 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 107.375 -1.343 . . . . 0.0 107.375 177.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.699 ' HD2' HD12 ' A' ' 40' ' ' ILE . 24.8 ttpt -138.91 144.98 39.33 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.489 -1.382 . . . . 0.0 111.754 -178.232 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 92.9 m-85 -110.34 145.18 37.93 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 178.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.529 ' HG3' HG22 ' A' ' 40' ' ' ILE . 20.6 ttm-85 -128.74 146.72 50.81 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.186 -0.946 . . . . 0.0 111.78 -178.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 68.6 t80 -136.21 133.86 37.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.736 -0.603 . . . . 0.0 109.412 178.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -141.06 153.91 45.71 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.154 -0.966 . . . . 0.0 110.131 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -111.16 135.65 51.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 0.0 110.0 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -58.55 -24.97 61.95 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.582 -0.699 . . . . 0.0 110.772 -179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -60.39 -42.07 95.12 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.293 -0.88 . . . . 0.0 110.994 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.3 m -143.75 169.68 9.92 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.198 -0.939 . . . . 0.0 110.567 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -83.26 45.36 1.84 Allowed 'Trans proline' 0 C--N 1.314 -1.24 0 O-C-N 123.604 1.318 . . . . 0.0 111.045 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.0 tp -92.02 125.27 36.65 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.262 -0.899 . . . . 0.0 110.043 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.55 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . -133.71 134.4 7.44 Favored Glycine 0 N--CA 1.491 2.327 0 C-N-CA 119.792 -1.194 . . . . 0.0 110.57 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.5 t -128.41 131.8 68.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.699 HD12 ' HD2' ' A' ' 27' ' ' LYS . 33.0 pt -127.0 145.63 34.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 120.895 -1.128 . . . . 0.0 112.041 -178.17 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -121.6 120.18 4.32 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 108.227 -1.949 . . . . 0.0 108.227 178.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 15.0 t -125.18 144.47 50.43 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.191 -1.182 . . . . 0.0 111.657 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -114.57 144.41 43.43 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 178.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 51.3 m -131.61 138.61 48.88 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.925 -1.11 . . . . 0.0 110.883 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.403 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 60.7 t80 -133.19 109.6 9.55 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 178.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.79 HG23 ' C ' ' A' ' 22' ' ' GLY . 27.9 m -123.07 143.82 49.71 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.395 -0.816 . . . . 0.0 111.147 -178.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.4 ' OE2' ' CE2' ' A' ' 45' ' ' TYR . 93.9 mt-10 -137.82 165.34 26.69 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.406 -0.809 . . . . 0.0 110.316 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -70.68 145.41 50.6 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.539 -0.726 . . . . 0.0 109.719 179.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 36.5 m -58.57 148.9 27.11 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.336 -0.853 . . . . 0.0 110.449 -179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 49.8 mtm180 -129.59 157.28 42.52 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.536 -0.727 . . . . 0.0 110.225 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 72.1 p -106.24 161.56 14.42 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.428 -0.795 . . . . 0.0 109.954 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -61.23 -35.49 77.38 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.427 -0.796 . . . . 0.0 110.192 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 85.9 p -63.47 -26.08 68.56 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.432 -0.792 . . . . 0.0 110.17 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.5 m -62.65 155.8 25.21 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.43 -0.794 . . . . 0.0 110.403 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -77.72 -162.19 17.54 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 90.3 m-20 -95.54 10.17 37.55 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.539 -0.977 . . . . 0.0 110.642 179.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.9 t80 -85.38 145.52 27.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.209 -0.932 . . . . 0.0 110.308 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 35.3 t30 -113.64 119.74 38.48 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.394 -0.817 . . . . 0.0 109.852 179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.5 mttt -53.3 -91.84 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.32 -0.862 . . . . 0.0 110.689 -179.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 26.9 p30 -113.36 162.03 16.57 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.812 -1.18 . . . . 0.0 110.854 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -122.76 154.15 38.55 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.513 -0.742 . . . . 0.0 110.0 179.767 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -120.38 100.82 7.38 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.249 -0.907 . . . . 0.0 111.011 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 59.3 t80 -102.81 142.56 33.74 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 108.405 -0.961 . . . . 0.0 108.405 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.77 158.06 27.66 Favored Glycine 0 N--CA 1.485 1.96 0 C-N-CA 118.63 -1.748 . . . . 0.0 111.173 -179.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.476 ' C ' HG23 ' A' ' 66' ' ' THR . 44.3 pt -121.79 137.17 56.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.476 HG23 ' C ' ' A' ' 65' ' ' ILE . 65.3 p -150.21 139.59 21.4 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.245 -0.909 . . . . 0.0 110.919 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.767 ' O ' HG12 ' A' ' 83' ' ' VAL . . . -160.29 155.09 24.21 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.0 175.25 42.86 Favored Glycine 0 N--CA 1.492 2.41 0 C-N-CA 119.368 -1.396 . . . . 0.0 110.414 -179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.409 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 44.9 Cg_endo -71.21 165.73 31.51 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 O-C-N 123.93 1.489 . . . . 0.0 110.538 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.55 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -146.65 140.68 26.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.487 -0.758 . . . . 0.0 110.079 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 67.3 t80 -123.66 143.75 50.06 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.543 -0.723 . . . . 0.0 109.978 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 76.6 ttt-85 -96.6 125.7 41.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.542 -0.724 . . . . 0.0 110.962 -179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 78.5 mt -127.6 115.95 41.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 178.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 53.6 -178.72 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.506 -0.746 . . . . 0.0 109.951 -179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.44 ' OD1' ' CE3' ' A' ' 76' ' ' TRP . 53.1 p30 -91.43 10.37 27.93 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.289 -0.882 . . . . 0.0 111.284 -179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.44 ' CE3' ' OD1' ' A' ' 75' ' ' ASP . 1.0 OUTLIER -140.85 22.86 2.28 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.092 -1.005 . . . . 0.0 111.102 179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -150.04 122.25 8.35 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.089 -1.007 . . . . 0.0 111.332 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.2 m -134.93 147.33 49.76 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.591 -0.693 . . . . 0.0 109.573 179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.5 pt -129.8 138.72 53.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.01 -1.056 . . . . 0.0 110.607 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.43 ' O ' ' HB1' ' A' ' 111' ' ' ALA . 40.6 p90 -147.47 167.91 23.23 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.448 -0.782 . . . . 0.0 111.202 -179.665 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.83 164.95 21.04 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.256 -1.538 . . . . 0.0 109.256 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 110' ' ' GLY . 34.7 m -135.87 135.48 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.31 -1.112 . . . . 0.0 110.7 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.767 HG12 ' O ' ' A' ' 67' ' ' ALA . 10.5 p -141.05 147.83 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 159.18 -149.94 20.16 Favored Glycine 0 N--CA 1.477 1.426 0 C-N-CA 119.473 -1.346 . . . . 0.0 110.442 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.46 HG22 ' CG1' ' A' ' 65' ' ' ILE . 34.1 m -135.5 -172.72 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 CA-C-O 122.527 1.156 . . . . 0.0 113.272 -177.728 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -141.09 152.18 23.04 Favored Glycine 0 N--CA 1.495 2.589 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 98.8 m-85 -123.82 133.8 53.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.218 -1.166 . . . . 0.0 109.916 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -116.2 113.23 2.78 Favored Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.446 -1.461 . . . . 0.0 109.446 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 43.2 mttt -101.39 116.76 33.52 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.622 -0.928 . . . . 0.0 109.492 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -123.48 148.74 45.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.663 -0.648 . . . . 0.0 110.353 -179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 51.27 45.04 28.48 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.39 -0.819 . . . . 0.0 110.784 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 48.1 m -80.7 130.3 35.02 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.298 -0.876 . . . . 0.0 110.195 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 95' ' ' TYR . 15.0 t -140.2 152.86 46.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.443 -0.786 . . . . 0.0 110.507 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -66.68 -31.43 72.09 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.455 -0.778 . . . . 0.0 110.181 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.581 ' O ' HG23 ' A' ' 93' ' ' THR . 7.0 m-85 -81.53 164.03 51.42 Favored Pre-proline 0 N--CA 1.494 1.742 0 O-C-N 121.464 -0.773 . . . . 0.0 110.265 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -69.26 145.76 61.09 Favored 'Trans proline' 0 C--N 1.313 -1.327 0 O-C-N 123.6 1.316 . . . . 0.0 110.449 179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.8 p -101.91 16.57 25.55 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.457 -0.777 . . . . 0.0 110.667 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 59.1 17.71 5.79 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.351 -0.843 . . . . 0.0 111.017 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 44.1 mttm -119.71 144.82 47.01 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.18 -0.95 . . . . 0.0 109.891 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -56.9 -44.33 82.25 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.256 -0.902 . . . . 0.0 110.224 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 44.8 p30 -176.47 150.87 0.91 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.441 -0.787 . . . . 0.0 110.488 179.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 45.7 m -139.04 122.53 17.27 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.283 -0.886 . . . . 0.0 109.996 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 30.5 t -154.75 135.42 13.54 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.296 -0.877 . . . . 0.0 110.685 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -120.85 116.11 24.55 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.408 -0.808 . . . . 0.0 109.177 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.844 ' O ' HG23 ' A' ' 132' ' ' ILE . 48.5 p90 -136.17 170.78 15.47 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.075 -1.016 . . . . 0.0 111.778 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -157.56 -178.0 31.2 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 108.483 -1.847 . . . . 0.0 108.483 179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.419 ' CD1' HG12 ' A' ' 85' ' ' VAL . 99.4 m-85 -108.25 152.41 24.65 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.033 -1.275 . . . . 0.0 110.876 -179.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.0 m -125.51 153.9 42.91 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.414 -0.804 . . . . 0.0 110.515 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.401 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 64.1 t80 -154.83 146.75 23.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.465 -0.772 . . . . 0.0 109.868 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.508 ' O ' HG22 ' A' ' 82' ' ' VAL . . . 169.03 -178.23 42.39 Favored Glycine 0 N--CA 1.496 2.669 0 C-N-CA 119.585 -1.293 . . . . 0.0 110.841 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.43 ' HB1' ' O ' ' A' ' 80' ' ' TYR . . . -165.16 165.88 19.45 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.695 -0.885 . . . . 0.0 108.915 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -155.94 -173.74 24.91 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 109.566 -1.414 . . . . 0.0 109.566 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.461 HD23 ' N ' ' A' ' 113' ' ' LEU . 0.6 OUTLIER -136.8 155.44 49.82 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.352 -1.087 . . . . 0.0 110.072 -179.921 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.679 ' CD ' ' HB1' ' A' ' 122' ' ' ALA . 30.4 tt0 -115.73 141.87 47.5 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.178 -0.951 . . . . 0.0 109.564 179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -146.12 150.02 35.11 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.41 -0.806 . . . . 0.0 110.438 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.448 ' HB2' ' HA ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER 175.66 138.43 0.19 Allowed Pre-proline 0 N--CA 1.503 2.178 0 O-C-N 121.65 -0.656 . . . . 0.0 111.553 179.413 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 116' ' ' ASN . 52.5 Cg_endo -88.69 48.09 1.26 Allowed 'Trans proline' 0 C--N 1.316 -1.133 0 O-C-N 123.576 1.303 . . . . 0.0 109.168 177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.475 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 86.5 mtp -147.15 137.01 23.13 Favored 'General case' 0 C--N 1.309 -1.186 0 O-C-N 121.459 -0.776 . . . . 0.0 108.945 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -65.43 -38.19 89.14 Favored 'General case' 0 C--N 1.294 -1.844 0 O-C-N 121.778 -0.576 . . . . 0.0 112.43 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -109.26 7.81 25.44 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 120.67 -1.269 . . . . 0.0 112.66 -178.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.475 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 60.8 t -122.45 138.69 51.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.913 0 O-C-N 120.739 -1.226 . . . . 0.0 110.063 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.679 ' HB1' ' CD ' ' A' ' 114' ' ' GLN . . . -146.45 139.18 25.34 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 119.386 -0.926 . . . . 0.0 112.338 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 143' ' ' GLY . 13.8 tp -122.13 135.58 54.81 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' HB3' ' CB ' ' A' ' 114' ' ' GLN . 53.0 p30 -139.06 153.8 48.11 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.458 -1.401 . . . . 0.0 112.167 -179.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -124.44 138.94 54.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.804 -0.56 . . . . 0.0 109.616 179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 85.1 p -146.2 157.22 43.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.352 -0.843 . . . . 0.0 110.191 179.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 47.5 p90 -133.82 143.1 48.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.519 -0.738 . . . . 0.0 110.342 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -150.98 143.86 24.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.509 -0.744 . . . . 0.0 110.164 179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -113.78 146.61 39.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.403 -0.811 . . . . 0.0 109.97 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.5 t -129.18 139.61 51.83 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.44 -0.787 . . . . 0.0 110.246 179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.3 ttp85 -127.98 127.89 44.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.475 -0.766 . . . . 0.0 109.837 179.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.844 HG23 ' O ' ' A' ' 105' ' ' TYR . 89.5 mt -119.15 56.79 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.668 -0.645 . . . . 0.0 109.56 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.455 ' HB3' ' O ' ' A' ' 132' ' ' ILE . 17.6 ttm180 66.05 -57.26 0.35 Allowed 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.884 -0.51 . . . . 0.0 111.647 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.07 -7.32 11.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.085 -1.009 . . . . 0.0 111.401 -179.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.498 HG11 ' NE2' ' A' ' 17' ' ' GLN . 48.9 t -119.64 130.82 73.62 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 120.967 -1.083 . . . . 0.0 110.653 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -133.44 114.01 13.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.561 -0.712 . . . . 0.0 109.242 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.897 HG12 ' HA ' ' A' ' 14' ' ' ALA . 31.5 m -124.65 149.3 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.286 -0.884 . . . . 0.0 110.506 -179.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -103.89 103.65 2.34 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 108.126 -1.989 . . . . 0.0 108.126 178.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.426 HG23 ' HB3' ' A' ' 12' ' ' SER . 24.3 m -111.03 145.49 38.4 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.42 -1.047 . . . . 0.0 111.765 -178.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.601 ' HZ3' ' HB3' ' A' ' 142' ' ' ALA . 60.2 p-90 -132.1 145.37 51.36 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 75.4 mt -117.35 131.11 71.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.252 -0.905 . . . . 0.0 110.175 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.601 ' HB3' ' HZ3' ' A' ' 140' ' ' TRP . . . -149.27 145.54 27.12 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.44 -0.787 . . . . 0.0 110.185 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.818 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -177.09 -128.71 1.17 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.381 -1.39 . . . . 0.0 111.163 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.7 ' O ' HG23 ' A' ' 6' ' ' THR . 35.2 m -117.87 171.51 6.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.861 -0.788 . . . . 0.0 111.383 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.437 ' O ' ' HB3' ' A' ' 122' ' ' ALA . . . -148.81 135.56 5.48 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.885 -1.286 . . . . 0.0 109.885 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.646 ' O ' HG23 ' A' ' 4' ' ' THR . 64.8 t80 -130.46 149.56 52.08 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.576 -0.956 . . . . 0.0 109.394 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -131.89 122.38 25.57 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.261 -0.899 . . . . 0.0 111.478 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.421 ' HE2' HG23 ' A' ' 5' ' ' VAL . 95.9 m-85 . . . . . 0 N--CA 1.494 1.732 0 O-C-N 121.494 -0.754 . . . . 0.0 110.181 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.1 t . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 120.936 0.398 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.7 t -128.08 144.85 51.13 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.254 -0.903 . . . . 0.0 109.793 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.606 HG23 ' O ' ' A' ' 146' ' ' TYR . 26.9 m -136.01 136.31 40.19 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.304 -0.873 . . . . 0.0 109.996 179.243 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.9 t -107.69 139.37 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.579 -0.701 . . . . 0.0 109.26 179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.53 HG23 ' O ' ' A' ' 144' ' ' VAL . 51.5 m -154.8 129.66 9.39 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.08 -1.012 . . . . 0.0 110.323 179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.433 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -164.12 169.05 38.85 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.749 -1.34 . . . . 0.0 109.749 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -176.56 -130.4 1.34 Allowed Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.811 -1.316 . . . . 0.0 109.811 179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -127.3 158.24 37.73 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.45 -1.029 . . . . 0.0 109.763 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.79 116.5 16.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.162 -0.961 . . . . 0.0 111.066 -179.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -113.75 142.36 46.15 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 178.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.428 ' HB2' HG12 ' A' ' 137' ' ' VAL . 59.1 p -153.63 154.6 34.5 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 118.662 -1.215 . . . . 0.0 112.695 -178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.746 ' O ' HG13 ' A' ' 137' ' ' VAL . 88.5 m-20 -93.85 153.15 18.42 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 176.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.759 ' CB ' HG22 ' A' ' 137' ' ' VAL . . . -135.59 119.16 17.0 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 120.775 -1.203 . . . . 0.0 111.878 -178.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -71.17 119.88 15.94 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 178.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.03 -15.25 44.09 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 108.592 -1.803 . . . . 0.0 108.592 -177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.663 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 91.6 mt-30 -115.79 156.44 26.04 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.603 -0.939 . . . . 0.0 109.138 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 65.6 mtt -96.24 -77.69 0.48 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.09 -1.006 . . . . 0.0 110.985 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 86.5 m-20 -66.06 134.45 52.89 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.372 -0.83 . . . . 0.0 110.962 -179.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 15.7 pttp -68.8 178.5 2.12 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.525 -0.734 . . . . 0.0 110.103 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.628 ' HB3' HG22 ' A' ' 46' ' ' THR . 64.3 mtm -124.05 163.29 21.73 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.273 -0.892 . . . . 0.0 110.69 -179.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.66 ' C ' HG23 ' A' ' 46' ' ' THR . . . -149.94 125.68 2.02 Favored Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.8 -1.32 . . . . 0.0 109.8 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.55 ' N ' HG23 ' A' ' 46' ' ' THR . . . -143.0 -159.34 7.9 Favored Glycine 0 N--CA 1.493 2.435 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.523 -178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.438 ' CE1' ' HB3' ' A' ' 45' ' ' TYR . 51.3 p90 -129.19 161.16 30.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.537 -0.978 . . . . 0.0 110.047 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.433 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 45.5 t-20 -141.34 132.26 26.01 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.46 -0.775 . . . . 0.0 111.359 -179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 27.0 tp -118.62 141.15 48.87 Favored 'General case' 0 N--CA 1.495 1.796 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 47.3 mttt -134.86 146.72 49.51 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.403 -1.436 . . . . 0.0 111.26 -178.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -115.91 138.97 50.68 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.516 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 53.2 ttt-85 -129.5 143.04 50.67 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.202 -0.936 . . . . 0.0 111.817 -178.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 67.8 t80 -134.15 133.0 40.5 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -142.99 149.99 39.05 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.169 -0.957 . . . . 0.0 110.48 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 75.9 tt0 -104.18 132.57 50.29 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.337 -0.852 . . . . 0.0 109.462 179.663 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -57.23 -24.48 54.93 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.391 -0.818 . . . . 0.0 111.013 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -60.02 -40.0 87.77 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.324 -0.86 . . . . 0.0 110.964 -179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.442 ' HB3' HD23 ' A' ' 37' ' ' LEU . 1.6 m -141.38 169.52 11.19 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.209 -0.932 . . . . 0.0 110.702 -179.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -84.52 41.97 1.08 Allowed 'Trans proline' 0 C--N 1.316 -1.139 0 O-C-N 123.637 1.335 . . . . 0.0 111.142 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 37' ' ' LEU . 2.7 mm? -87.77 98.97 11.75 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.195 -0.941 . . . . 0.0 110.11 179.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' ' HA ' ' A' ' 69' ' ' PRO . . . -107.98 131.66 10.71 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.0 t -130.78 129.36 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.558 -0.966 . . . . 0.0 108.721 178.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.452 ' CD1' ' CD1' ' A' ' 80' ' ' TYR . 77.8 mt -123.55 142.57 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.101 -0.999 . . . . 0.0 111.339 -178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.447 ' O ' ' HA ' ' A' ' 27' ' ' LYS . . . -109.46 145.45 16.76 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 107.086 -2.406 . . . . 0.0 107.086 177.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.406 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 34.7 t -139.71 142.46 36.86 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 118.969 1.384 . . . . 0.0 112.174 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -123.42 137.83 54.72 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 108.148 -1.056 . . . . 0.0 108.148 178.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.6 m -132.03 140.07 48.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.823 -1.173 . . . . 0.0 111.074 -179.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.438 ' HB3' ' CE1' ' A' ' 24' ' ' PHE . 75.6 t80 -134.33 110.28 9.37 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.66 HG23 ' C ' ' A' ' 22' ' ' GLY . 4.2 m -119.48 146.5 45.36 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.525 -0.734 . . . . 0.0 110.276 -178.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -124.6 158.96 31.81 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.114 -0.991 . . . . 0.0 110.416 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.448 ' HB3' ' HG2' ' A' ' 21' ' ' MET . 47.8 pttt -127.43 150.3 49.7 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.549 -0.72 . . . . 0.0 110.485 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 29.1 t -123.04 139.66 53.84 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.436 -0.79 . . . . 0.0 110.154 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 47.0 mtm105 -128.36 152.21 48.44 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.432 -0.793 . . . . 0.0 110.335 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 11.5 m 51.52 46.11 27.01 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 121.449 -0.782 . . . . 0.0 110.767 179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 51.23 -156.22 0.13 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.476 -0.765 . . . . 0.0 110.831 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 1.6 t 55.1 173.43 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.38 -0.825 . . . . 0.0 110.574 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 84.8 p -142.22 161.01 39.11 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.393 -0.817 . . . . 0.0 110.201 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.46 49.59 19.02 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.604 -1.399 . . . . 0.0 109.604 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -60.06 147.85 37.8 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.354 -1.086 . . . . 0.0 110.296 -179.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -62.0 -26.69 68.37 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.518 -0.739 . . . . 0.0 110.336 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 -59.16 -39.03 81.2 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.304 -0.873 . . . . 0.0 109.998 179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 44.5 mttt 54.32 53.28 11.12 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.522 -0.736 . . . . 0.0 110.733 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -84.49 133.96 34.45 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.472 -0.768 . . . . 0.0 109.637 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -122.89 155.84 35.87 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.386 -0.821 . . . . 0.0 110.427 -179.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 69.8 t80 -114.08 126.91 55.63 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.346 -0.846 . . . . 0.0 110.88 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.499 ' CD2' ' CE1' ' A' ' 87' ' ' TYR . 97.8 m-85 -110.38 137.06 48.6 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 120.336 -0.546 . . . . 0.0 109.802 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.28 115.02 0.74 Allowed Glycine 0 N--CA 1.488 2.108 0 C-N-CA 119.586 -1.293 . . . . 0.0 110.411 -179.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.481 ' O ' HG23 ' A' ' 66' ' ' THR . 76.5 mt -104.53 136.14 39.29 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 N-CA-C 107.683 -1.229 . . . . 0.0 107.683 178.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 3.3 p -151.23 139.33 20.12 Favored 'General case' 0 N--CA 1.487 1.413 0 C-N-CA 119.033 -1.067 . . . . 0.0 111.291 -179.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.94 151.6 33.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 178.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.08 165.14 37.54 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.576 -1.297 . . . . 0.0 110.34 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.434 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 48.2 Cg_endo -74.07 172.7 15.43 Favored 'Trans proline' 0 C--N 1.313 -1.325 0 O-C-N 123.858 1.451 . . . . 0.0 110.741 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -144.34 138.91 28.18 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.587 -0.696 . . . . 0.0 109.675 179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -120.79 135.86 55.05 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.439 -0.788 . . . . 0.0 110.779 -179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.1 ttp85 -108.89 87.85 2.59 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 120.038 -0.665 . . . . 0.0 110.024 179.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.408 HG13 ' N ' ' A' ' 74' ' ' ASN . 42.7 pt -95.19 -31.04 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 121.426 -0.796 . . . . 0.0 109.526 179.411 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.408 ' N ' HG13 ' A' ' 73' ' ' ILE . 85.4 m-20 -132.89 128.83 37.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.654 -0.654 . . . . 0.0 109.504 179.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -58.01 -34.23 69.81 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.213 -0.929 . . . . 0.0 110.154 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 99.0 m95 -59.28 -36.02 74.79 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.648 -0.658 . . . . 0.0 111.434 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.19 155.14 42.49 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 120.996 -1.065 . . . . 0.0 111.82 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.804 ' O ' HD12 ' A' ' 113' ' ' LEU . 49.7 m -126.75 161.48 28.06 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 121.697 -0.627 . . . . 0.0 109.526 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.3 mt -118.01 136.67 54.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.002 -1.061 . . . . 0.0 110.222 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.452 ' CD1' ' CD1' ' A' ' 40' ' ' ILE . 85.7 m-85 -132.58 154.16 50.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.685 -0.634 . . . . 0.0 110.284 -179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -127.13 163.06 21.11 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 108.442 -1.863 . . . . 0.0 108.442 179.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.528 HG22 ' C ' ' A' ' 110' ' ' GLY . 34.1 m -136.32 132.06 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.094 -1.239 . . . . 0.0 111.281 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' A' ' 66' ' ' THR . 59.5 t -140.74 145.31 25.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.436 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 160.87 -149.02 17.77 Favored Glycine 0 N--CA 1.482 1.74 0 C-N-CA 119.346 -1.407 . . . . 0.0 110.848 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.41 ' HA ' ' HA ' ' A' ' 107' ' ' PHE . 33.3 m -127.21 158.19 38.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 CA-C-O 122.315 1.055 . . . . 0.0 112.977 -177.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.628 ' O ' HD12 ' A' ' 132' ' ' ILE . . . -140.57 130.69 4.67 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.499 ' CE1' ' CD2' ' A' ' 63' ' ' TYR . 43.6 p90 -151.89 164.2 37.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.002 -1.293 . . . . 0.0 111.242 -179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -129.32 154.58 20.4 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.8 tttp -129.03 139.63 51.97 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.825 -0.809 . . . . 0.0 110.332 -179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -115.08 154.14 29.44 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.787 -0.571 . . . . 0.0 110.132 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -117.54 103.47 10.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.378 -0.826 . . . . 0.0 110.116 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.522 ' HG1' ' HH ' ' A' ' 95' ' ' TYR . 70.7 p -131.57 157.82 42.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.445 -0.784 . . . . 0.0 110.265 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.408 ' O ' ' O ' ' A' ' 94' ' ' GLU . 70.6 p -128.3 159.85 34.0 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.447 -0.783 . . . . 0.0 110.317 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.408 ' O ' ' O ' ' A' ' 93' ' ' THR . 77.9 mm-40 55.5 114.09 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.088 0 CA-C-O 121.435 0.636 . . . . 0.0 111.177 179.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.522 ' HH ' ' HG1' ' A' ' 92' ' ' THR . 43.7 m-85 -119.12 98.89 50.89 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.198 -0.939 . . . . 0.0 110.217 179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -77.22 -64.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.314 -1.252 0 O-C-N 123.43 1.226 . . . . 0.0 110.322 179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.2 t -145.69 143.43 29.78 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.284 -0.885 . . . . 0.0 110.023 179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 46.05 -168.89 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.544 -0.722 . . . . 0.0 111.18 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 67.0 mttm 56.27 51.46 11.61 Favored 'General case' 0 N--CA 1.5 2.042 0 O-C-N 121.466 -0.771 . . . . 0.0 110.477 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -54.97 -30.68 59.62 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.415 -0.803 . . . . 0.0 110.603 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 83.1 m-20 55.16 46.53 23.71 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 121.402 -0.811 . . . . 0.0 110.305 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.532 HG22 ' H ' ' A' ' 103' ' ' SER . 0.9 OUTLIER -94.89 -176.35 3.83 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.597 -0.69 . . . . 0.0 110.179 -179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . 0.532 ' H ' HG22 ' A' ' 102' ' ' THR . 59.0 m -103.17 157.12 17.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.536 -0.727 . . . . 0.0 109.832 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.486 ' CG ' HG22 ' A' ' 132' ' ' ILE . 56.2 t0 -134.96 141.25 46.21 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.317 -0.864 . . . . 0.0 110.018 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.471 ' CD2' ' CB ' ' A' ' 87' ' ' TYR . 85.9 m-85 -114.85 162.52 16.79 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.172 -0.955 . . . . 0.0 111.042 -179.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.677 ' HA3' HD13 ' A' ' 132' ' ' ILE . . . -160.94 -176.86 33.51 Favored Glycine 0 N--CA 1.494 2.509 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.41 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 99.0 m-85 -116.02 156.78 25.71 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.017 -1.284 . . . . 0.0 111.398 -178.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 50.9 m -124.58 154.9 39.95 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.53 -0.731 . . . . 0.0 110.417 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -153.06 145.19 23.83 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.421 -0.799 . . . . 0.0 109.907 179.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.528 ' C ' HG22 ' A' ' 82' ' ' VAL . . . 171.47 -177.59 44.25 Favored Glycine 0 N--CA 1.496 2.641 0 C-N-CA 119.571 -1.3 . . . . 0.0 110.908 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.28 163.47 13.0 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.653 -0.91 . . . . 0.0 108.949 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -157.33 -172.05 24.07 Favored Glycine 0 N--CA 1.494 2.551 0 C-N-CA 119.58 -1.295 . . . . 0.0 109.93 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.804 HD12 ' O ' ' A' ' 78' ' ' SER . 19.6 tp -130.74 152.44 50.08 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.467 -1.019 . . . . 0.0 109.673 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.4 ' CB ' ' HB3' ' A' ' 124' ' ' ASP . 51.3 tt0 -118.52 149.39 41.38 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.998 -1.064 . . . . 0.0 109.771 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.66 ' O ' ' HB1' ' A' ' 122' ' ' ALA . 99.5 m-85 -115.36 154.96 28.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.51 -0.744 . . . . 0.0 109.705 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -113.94 64.09 1.2 Allowed Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.844 . . . . 0.0 111.279 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.69 -14.26 36.05 Favored 'Trans proline' 0 C--N 1.314 -1.276 0 O-C-N 123.436 1.23 . . . . 0.0 109.904 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.603 ' HB2' HG23 ' A' ' 121' ' ' VAL . 64.9 mtt -145.4 139.87 27.24 Favored 'General case' 0 C--N 1.31 -1.123 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -60.92 -38.69 86.65 Favored 'General case' 0 C--N 1.292 -1.91 0 O-C-N 121.69 -0.631 . . . . 0.0 112.209 -178.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.485 ' OD1' HG22 ' A' ' 121' ' ' VAL . 46.2 p-10 -94.94 -3.73 48.08 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 120.777 -1.202 . . . . 0.0 112.745 -178.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.603 HG23 ' HB2' ' A' ' 118' ' ' MET . 30.1 m -150.42 121.46 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.092 0 O-C-N 120.809 -1.182 . . . . 0.0 111.604 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.66 ' HB1' ' O ' ' A' ' 115' ' ' PHE . . . -117.78 154.66 31.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.502 -0.749 . . . . 0.0 109.249 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 79.0 mt -113.3 144.45 42.71 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.114 -0.991 . . . . 0.0 109.776 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.4 ' HB3' ' CB ' ' A' ' 114' ' ' GLN . 48.7 p30 -138.79 151.04 46.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.139 -0.975 . . . . 0.0 111.267 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -133.01 141.64 48.39 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.2 p -145.91 164.44 31.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.238 -0.914 . . . . 0.0 111.159 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -112.42 127.87 56.15 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -127.47 132.13 50.06 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.239 -0.913 . . . . 0.0 111.262 -179.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -123.28 127.04 47.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.607 -0.683 . . . . 0.0 109.282 178.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.6 t -130.35 143.73 50.95 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.198 -0.939 . . . . 0.0 110.742 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.4 ' O ' ' HA3' ' A' ' 106' ' ' GLY . 65.2 mtm180 -124.04 129.68 51.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.591 -0.693 . . . . 0.0 109.718 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.677 HD13 ' HA3' ' A' ' 106' ' ' GLY . 17.3 mm -114.74 63.1 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.429 ' HB3' ' O ' ' A' ' 132' ' ' ILE . 50.8 ttp180 66.42 -59.96 0.33 Allowed 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.562 -0.711 . . . . 0.0 111.224 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.411 ' N ' ' O ' ' A' ' 132' ' ' ILE . 51.6 p -124.38 6.66 8.36 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.062 -1.024 . . . . 0.0 111.394 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.422 ' HB ' ' HB ' ' A' ' 132' ' ' ILE . 47.1 t -125.87 133.34 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.124 -0.985 . . . . 0.0 110.646 -179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 52.3 t0 -131.44 112.27 12.53 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.759 HG22 ' CB ' ' A' ' 14' ' ' ALA . 55.5 t -119.18 146.28 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.151 -0.968 . . . . 0.0 110.742 -178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -109.5 107.34 2.35 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 107.831 -2.108 . . . . 0.0 107.831 178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.413 HG23 ' HB3' ' A' ' 12' ' ' SER . 26.0 m -109.78 139.58 44.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.328 -1.101 . . . . 0.0 112.02 -178.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.7 m-90 -111.49 142.16 44.12 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 45.7 mm -112.65 129.6 67.95 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.115 -0.991 . . . . 0.0 110.659 -179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -137.96 128.61 26.7 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.52 -0.738 . . . . 0.0 109.027 179.229 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -164.73 -158.04 10.05 Favored Glycine 0 N--CA 1.492 2.389 0 C-N-CA 118.715 -1.707 . . . . 0.0 112.13 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.53 ' O ' HG23 ' A' ' 6' ' ' THR . 8.9 p -110.82 170.02 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 122.211 -0.582 . . . . 0.0 110.221 -179.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.486 ' N ' HG22 ' A' ' 144' ' ' VAL . . . -142.15 134.95 6.38 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.82 -1.181 . . . . 0.0 110.932 -179.617 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.606 ' O ' HG23 ' A' ' 4' ' ' THR . 83.3 m-85 -122.86 138.5 54.63 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 43.3 ttt-85 -126.74 121.21 31.36 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.936 -1.103 . . . . 0.0 111.108 -179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 55.8 t80 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.51 -0.744 . . . . 0.0 110.224 -179.883 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 70.0 p . . . . . 0 N--CA 1.493 1.691 0 N-CA-C 109.827 -0.434 . . . . 0.0 109.827 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 89.9 p -109.19 152.31 25.32 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.319 -0.863 . . . . 0.0 109.531 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 146' ' ' TYR . 36.8 m -135.34 138.66 43.61 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.877 . . . . 0.0 110.52 179.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 58.7 t -115.76 136.52 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.548 -0.72 . . . . 0.0 109.333 179.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.79 HG23 ' O ' ' A' ' 144' ' ' VAL . 85.2 m -154.01 129.59 9.96 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.272 -0.892 . . . . 0.0 110.247 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.403 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -165.48 172.5 41.03 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.939 -1.264 . . . . 0.0 109.939 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -177.65 -132.14 1.64 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 110.067 -1.213 . . . . 0.0 110.067 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 40.7 p90 -143.55 161.94 37.16 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.485 -1.009 . . . . 0.0 109.688 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -143.03 136.03 28.0 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 118.679 -1.208 . . . . 0.0 112.131 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -107.32 125.53 51.29 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 107.619 -1.252 . . . . 0.0 107.619 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.644 ' OG ' HG23 ' A' ' 139' ' ' THR . 10.5 m -126.94 148.55 50.05 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.044 -1.062 . . . . 0.0 112.808 -177.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.756 ' O ' HG13 ' A' ' 137' ' ' VAL . 52.5 t0 -95.55 152.22 18.62 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.409 -1.7 . . . . 0.0 106.409 176.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.867 ' CB ' HG22 ' A' ' 137' ' ' VAL . . . -135.83 122.95 21.56 Favored 'General case' 0 C--N 1.304 -1.406 0 C-N-CA 118.697 -1.201 . . . . 0.0 111.837 -178.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -73.31 116.4 13.81 Favored 'General case' 0 C--N 1.299 -1.606 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 178.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 106.3 -30.87 8.94 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 107.851 -2.1 . . . . 0.0 107.851 -177.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.423 ' HB3' ' CB ' ' A' ' 14' ' ' ALA . 63.6 tt0 -115.07 99.02 7.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.644 -0.915 . . . . 0.0 109.052 177.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 65.1 mtt -62.33 -40.22 95.67 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.411 -0.806 . . . . 0.0 111.146 -179.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -57.77 119.83 7.35 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.264 -0.898 . . . . 0.0 111.228 -178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.7 pttt -71.41 162.43 29.44 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.617 -0.677 . . . . 0.0 109.704 179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.862 ' HB3' HG22 ' A' ' 46' ' ' THR . 66.7 mtm -127.19 157.66 39.17 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.205 -0.935 . . . . 0.0 111.463 -179.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.824 ' C ' HG23 ' A' ' 46' ' ' THR . . . -142.39 124.08 2.33 Favored Glycine 0 N--CA 1.496 2.65 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.625 ' N ' HG23 ' A' ' 46' ' ' THR . . . -137.84 -174.41 13.36 Favored Glycine 0 N--CA 1.493 2.454 0 C-N-CA 119.545 -1.312 . . . . 0.0 110.501 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.466 ' HB2' ' CE1' ' A' ' 45' ' ' TYR . 99.2 m-85 -122.97 160.51 26.07 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.7 -0.882 . . . . 0.0 110.157 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.403 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 34.4 t-20 -140.8 131.71 26.01 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.543 -0.723 . . . . 0.0 111.101 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.704 HD13 ' N ' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -123.39 132.85 54.09 Favored 'General case' 0 N--CA 1.496 1.828 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.704 ' N ' HD13 ' A' ' 26' ' ' LEU . 74.6 mttt -131.3 145.4 51.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.639 -1.288 . . . . 0.0 111.595 -178.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.514 ' CE2' HD12 ' A' ' 26' ' ' LEU . 97.9 m-85 -116.24 132.19 56.73 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 177.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.461 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 44.8 ttt180 -125.16 138.85 54.14 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.104 -0.997 . . . . 0.0 112.149 -178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -119.5 138.82 52.91 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -149.2 163.71 36.86 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.144 -0.973 . . . . 0.0 110.858 -179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.5 tt0 -113.07 130.16 56.26 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -58.12 -25.75 61.77 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.4 -0.813 . . . . 0.0 110.767 -179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 -61.31 -38.0 85.26 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.406 -0.809 . . . . 0.0 111.091 -179.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.8 p -134.38 166.69 27.35 Favored Pre-proline 0 N--CA 1.495 1.777 0 O-C-N 121.22 -0.925 . . . . 0.0 110.774 -179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -87.17 33.25 0.43 Allowed 'Trans proline' 0 C--N 1.316 -1.157 0 O-C-N 123.719 1.379 . . . . 0.0 111.085 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.0 mt -88.87 139.45 30.45 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.251 -0.906 . . . . 0.0 109.817 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.501 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . -148.56 140.3 8.19 Favored Glycine 0 N--CA 1.492 2.377 0 C-N-CA 119.538 -1.315 . . . . 0.0 111.039 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.8 t -129.68 129.71 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.462 HD11 ' CB ' ' A' ' 27' ' ' LYS . 17.1 tt -129.13 143.58 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.977 -1.077 . . . . 0.0 111.322 -178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -107.8 135.67 12.95 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 107.647 -2.181 . . . . 0.0 107.647 178.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.466 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 61.1 p -130.26 142.71 50.53 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.125 -1.221 . . . . 0.0 111.759 -178.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -126.22 135.34 51.47 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 107.844 -1.169 . . . . 0.0 107.844 178.141 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.425 ' O ' ' HA ' ' A' ' 63' ' ' TYR . 14.9 t -135.77 148.31 48.73 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 118.645 -1.222 . . . . 0.0 111.498 -179.332 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.466 ' CE1' ' HB2' ' A' ' 24' ' ' PHE . 42.7 p90 -141.88 111.43 6.56 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.117 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.862 HG22 ' HB3' ' A' ' 21' ' ' MET . 73.4 m -121.97 137.02 54.95 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -0.927 . . . . 0.0 110.672 -178.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.41 ' HG2' ' N ' ' A' ' 48' ' ' LYS . 85.5 tt0 -155.63 164.33 38.77 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.585 -0.697 . . . . 0.0 109.566 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.41 ' N ' ' HG2' ' A' ' 47' ' ' GLU . 29.2 tttp -68.69 143.16 54.83 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.317 -0.865 . . . . 0.0 109.795 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.2 t -82.97 141.92 31.76 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.36 -0.838 . . . . 0.0 110.519 -179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -125.04 159.07 32.22 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.534 -0.728 . . . . 0.0 110.252 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 67.5 p -75.47 164.45 26.35 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.392 -0.817 . . . . 0.0 109.813 179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.13 96.73 0.84 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.417 -0.802 . . . . 0.0 110.202 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 45.4 m -126.31 152.08 46.67 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.632 -0.668 . . . . 0.0 110.16 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 31.7 m -56.79 -33.45 66.67 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.325 -0.859 . . . . 0.0 110.132 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -101.13 102.53 2.43 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.125 -1.59 . . . . 0.0 109.125 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -58.27 -40.74 82.66 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.448 -1.031 . . . . 0.0 110.623 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 68.0 t80 48.07 92.64 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.516 -0.74 . . . . 0.0 110.922 179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 32.1 p-10 -107.82 111.93 24.32 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.256 -0.902 . . . . 0.0 110.73 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -72.52 -100.37 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.332 -0.855 . . . . 0.0 109.951 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -103.23 143.03 33.17 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.669 -1.269 . . . . 0.0 110.571 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 -119.04 149.18 42.1 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.478 -0.764 . . . . 0.0 109.682 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.406 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 71.9 t80 -112.89 90.17 3.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.431 -0.793 . . . . 0.0 110.589 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.425 ' HA ' ' O ' ' A' ' 44' ' ' THR . 69.2 t80 -116.92 141.35 48.35 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -163.48 168.58 38.19 Favored Glycine 0 N--CA 1.487 2.079 0 C-N-CA 118.027 -2.035 . . . . 0.0 112.298 -179.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.659 HG12 HG12 ' A' ' 85' ' ' VAL . 49.8 pt -105.68 140.55 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 CA-C-N 114.48 -0.86 . . . . 0.0 109.246 179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.472 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -150.87 141.55 22.69 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.289 -0.882 . . . . 0.0 110.619 -179.809 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.58 ' O ' HG22 ' A' ' 83' ' ' VAL . . . -156.94 154.55 29.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.396 -0.815 . . . . 0.0 108.946 179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -166.46 163.61 37.05 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.493 -1.336 . . . . 0.0 110.276 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -73.38 173.06 14.41 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.91 1.479 . . . . 0.0 110.679 179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.501 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -141.11 136.5 31.98 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.811 -0.556 . . . . 0.0 109.617 179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.552 ' HB2' HD11 ' A' ' 79' ' ' ILE . 93.8 m-85 -126.28 145.78 50.27 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.698 -0.626 . . . . 0.0 110.67 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.3 ttp85 -98.13 87.89 4.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.492 -0.755 . . . . 0.0 109.554 179.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.3 tt -66.65 -33.83 66.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.459 -0.776 . . . . 0.0 110.847 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 38.3 t-20 -155.61 172.95 17.42 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.465 -0.772 . . . . 0.0 110.145 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.455 ' HB3' ' CE3' ' A' ' 76' ' ' TRP . 85.9 m-20 -65.69 146.89 54.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.511 -0.743 . . . . 0.0 109.975 179.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.455 ' CE3' ' HB3' ' A' ' 75' ' ' ASP . 7.8 m-90 53.35 23.4 3.27 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.384 -0.823 . . . . 0.0 110.883 -179.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -144.5 129.51 18.5 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.297 -0.877 . . . . 0.0 110.194 179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 51.1 m -139.34 155.07 47.94 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.335 -0.853 . . . . 0.0 110.565 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.843 HG22 ' CD2' ' A' ' 113' ' ' LEU . 50.6 pt -121.14 144.35 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.331 -0.856 . . . . 0.0 109.716 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 93.6 m-85 -132.41 154.44 49.83 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.328 -0.857 . . . . 0.0 111.169 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -123.87 162.66 17.81 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 108.137 -1.985 . . . . 0.0 108.137 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.839 HG21 ' OE2' ' A' ' 128' ' ' GLU . 35.2 m -142.66 132.63 22.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.96 -1.318 . . . . 0.0 111.683 -179.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.58 HG22 ' O ' ' A' ' 67' ' ' ALA . 33.0 m -142.99 150.66 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 178.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 158.12 -151.06 22.16 Favored Glycine 0 N--CA 1.479 1.553 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.049 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.659 HG12 HG12 ' A' ' 65' ' ' ILE . 12.4 p -129.59 144.62 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 CA-C-O 122.488 1.137 . . . . 0.0 113.502 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.41 149.62 19.19 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 108.075 -2.01 . . . . 0.0 108.075 178.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.41 ' CE2' ' HB2' ' A' ' 89' ' ' LYS . 66.4 t80 -126.67 129.47 48.53 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.002 -1.293 . . . . 0.0 111.577 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -109.56 113.51 3.67 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 107.934 -2.066 . . . . 0.0 107.934 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.41 ' HB2' ' CE2' ' A' ' 87' ' ' TYR . 36.3 tttp -111.68 126.26 54.85 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.493 -1.004 . . . . 0.0 111.609 -178.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 80.4 t80 -115.23 135.41 54.19 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.2 tt0 59.0 105.66 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.273 -0.892 . . . . 0.0 110.226 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.477 HG23 ' N ' ' A' ' 93' ' ' THR . 9.6 t -56.36 -39.44 72.9 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.454 -0.779 . . . . 0.0 110.896 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.477 ' N ' HG23 ' A' ' 92' ' ' THR . 42.1 m -72.44 130.86 41.68 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.376 -0.828 . . . . 0.0 110.279 -179.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -125.71 155.32 41.11 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.516 -0.74 . . . . 0.0 110.073 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -83.58 146.0 49.07 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.417 -0.802 . . . . 0.0 109.918 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.442 ' O ' ' CD2' ' A' ' 98' ' ' TYR . 44.1 Cg_endo -70.55 128.65 15.59 Favored 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.539 1.284 . . . . 0.0 110.531 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 81.4 p 43.29 25.34 0.06 Allowed 'General case' 0 N--CA 1.503 2.209 0 O-C-N 121.708 -0.62 . . . . 0.0 112.298 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.442 ' CD2' ' O ' ' A' ' 96' ' ' PRO . 21.3 m-85 -135.63 144.99 46.37 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.112 -0.993 . . . . 0.0 110.46 179.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 41.3 mttt 56.19 46.8 20.68 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.562 -0.711 . . . . 0.0 110.58 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.9 t30 -57.3 -21.43 34.76 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.464 -0.772 . . . . 0.0 110.708 179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 86.8 m-20 -83.62 17.98 2.06 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.293 -0.879 . . . . 0.0 111.896 -179.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 82.6 m -60.99 -33.74 73.71 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 120.962 -1.086 . . . . 0.0 109.804 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.7 p -116.3 160.29 20.68 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.633 -0.667 . . . . 0.0 109.59 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.67 ' OD2' HG22 ' A' ' 132' ' ' ILE . 47.6 t0 -134.84 154.23 51.72 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.309 -0.869 . . . . 0.0 110.44 -179.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -112.03 156.69 21.78 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.376 -0.827 . . . . 0.0 110.601 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.541 ' O ' HG23 ' A' ' 85' ' ' VAL . . . -144.25 161.54 27.91 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 108.2 -1.96 . . . . 0.0 108.2 178.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -97.63 145.8 25.94 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.927 -1.337 . . . . 0.0 110.937 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 27.0 t -122.46 148.65 44.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.482 -0.761 . . . . 0.0 110.3 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.558 ' CD1' HG12 ' A' ' 83' ' ' VAL . 66.6 t80 -154.01 145.67 23.3 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.494 -0.754 . . . . 0.0 109.661 179.205 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.465 ' O ' HG22 ' A' ' 82' ' ' VAL . . . 171.84 -178.9 43.85 Favored Glycine 0 N--CA 1.493 2.486 0 C-N-CA 119.342 -1.409 . . . . 0.0 110.906 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -167.2 163.7 15.51 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.818 -0.813 . . . . 0.0 108.812 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -156.06 -173.32 24.5 Favored Glycine 0 N--CA 1.494 2.501 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.843 ' CD2' HG22 ' A' ' 79' ' ' ILE . 76.3 mt -128.44 152.85 47.75 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.373 -1.075 . . . . 0.0 109.278 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 51.3 tt0 -119.53 140.97 49.66 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.818 -1.176 . . . . 0.0 109.971 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -117.35 161.1 20.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.508 -0.745 . . . . 0.0 110.061 -179.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.403 ' HB2' ' HB3' ' A' ' 76' ' ' TRP . 0.7 OUTLIER -120.96 86.59 42.1 Favored Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.464 -0.773 . . . . 0.0 110.459 -179.691 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.623 ' HG3' HD23 ' A' ' 123' ' ' LEU . 43.8 Cg_endo -69.4 -7.39 20.81 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 O-C-N 123.664 1.35 . . . . 0.0 111.535 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.556 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 80.0 mtp -149.95 175.66 11.47 Favored 'General case' 0 C--N 1.311 -1.077 0 O-C-N 121.056 -1.027 . . . . 0.0 108.452 178.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -62.88 -39.7 95.27 Favored 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.807 -0.558 . . . . 0.0 110.993 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.469 ' OD1' HG23 ' A' ' 121' ' ' VAL . 48.0 p-10 -121.99 18.16 10.9 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.201 -0.937 . . . . 0.0 112.2 -178.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.556 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 21.3 t -118.46 139.38 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.933 -1.105 . . . . 0.0 109.729 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.651 ' C ' HD22 ' A' ' 123' ' ' LEU . . . -141.34 137.48 32.4 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 119.588 -0.845 . . . . 0.0 111.736 -179.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.651 HD22 ' C ' ' A' ' 122' ' ' ALA . 4.4 mm? -112.29 152.24 28.73 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 108.069 -1.085 . . . . 0.0 108.069 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -145.49 139.42 26.81 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.719 -1.238 . . . . 0.0 110.736 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -124.7 126.24 45.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.0 109.179 178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 50.5 m -130.64 151.46 51.07 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.32 -0.863 . . . . 0.0 111.178 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -113.97 126.87 55.63 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.597 -0.689 . . . . 0.0 109.187 179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.839 ' OE2' HG21 ' A' ' 82' ' ' VAL . 94.8 mt-10 -137.74 152.31 49.08 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.339 -0.85 . . . . 0.0 111.172 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -138.63 147.89 43.43 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.633 -0.667 . . . . 0.0 109.405 178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 51.1 m -134.62 145.96 49.12 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.197 -0.939 . . . . 0.0 110.822 -179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 95.2 mtt180 -132.54 128.55 37.51 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.489 -0.757 . . . . 0.0 109.828 179.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.67 HG22 ' OD2' ' A' ' 104' ' ' ASP . 91.4 mt -119.8 59.26 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 O-C-N 121.47 -0.769 . . . . 0.0 109.709 -179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 93.2 mtt-85 64.65 -57.46 0.26 Allowed 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.908 -0.495 . . . . 0.0 111.912 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 132' ' ' ILE . 44.0 p -117.69 -3.29 11.29 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.959 -1.088 . . . . 0.0 111.539 -179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 59.4 t -124.72 131.44 72.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.025 -1.047 . . . . 0.0 110.457 -179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -131.53 111.52 11.83 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.345 -0.847 . . . . 0.0 109.16 179.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.867 HG22 ' CB ' ' A' ' 14' ' ' ALA . 59.0 t -119.29 145.88 24.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.93 . . . . 0.0 110.525 -178.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -107.18 120.27 6.12 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 107.813 -2.115 . . . . 0.0 107.813 178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.644 HG23 ' OG ' ' A' ' 12' ' ' SER . 59.3 m -118.29 137.25 53.19 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.232 -1.158 . . . . 0.0 111.9 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.3 m-90 -114.44 140.15 48.93 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 73.7 mt -113.66 133.1 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.103 -0.998 . . . . 0.0 110.903 -179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.81 133.93 22.77 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.571 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -170.5 -146.0 4.97 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.041 -1.552 . . . . 0.0 111.503 -179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.79 ' O ' HG23 ' A' ' 6' ' ' THR . 34.8 m -117.32 177.03 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 122.113 -0.639 . . . . 0.0 111.142 -178.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -153.26 138.58 6.39 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.862 -1.295 . . . . 0.0 109.862 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.635 ' O ' HG23 ' A' ' 4' ' ' THR . 69.8 t80 -134.65 153.4 52.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.571 -0.958 . . . . 0.0 109.714 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -133.82 122.03 22.67 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.368 -0.833 . . . . 0.0 110.986 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 65.8 t80 . . . . . 0 N--CA 1.493 1.689 0 O-C-N 121.474 -0.766 . . . . 0.0 110.216 -179.662 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 66.3 p . . . . . 0 N--CA 1.494 1.735 0 CA-C-O 121.004 0.43 . . . . 0.0 110.042 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 31.6 t -124.16 137.64 54.52 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.427 -0.796 . . . . 0.0 109.728 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.853 HG23 ' O ' ' A' ' 146' ' ' TYR . 66.1 m -137.84 145.48 42.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.264 -0.898 . . . . 0.0 110.788 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 9.6 p -126.4 140.36 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.607 -0.683 . . . . 0.0 109.705 179.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.814 HG23 ' O ' ' A' ' 144' ' ' VAL . 88.9 m -156.45 130.61 8.59 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.301 -0.875 . . . . 0.0 110.481 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.486 ' HA3' HD23 ' A' ' 26' ' ' LEU . . . -149.97 158.32 27.62 Favored Glycine 0 N--CA 1.495 2.572 0 N-CA-C 108.831 -1.707 . . . . 0.0 108.831 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -166.08 -168.26 27.98 Favored Glycine 0 N--CA 1.495 2.612 0 C-N-CA 119.518 -1.325 . . . . 0.0 110.651 -179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -123.55 153.79 40.13 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.654 -0.909 . . . . 0.0 109.501 -179.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.632 ' HB2' HG22 ' A' ' 141' ' ' ILE . . . -146.33 154.23 41.44 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.073 -1.017 . . . . 0.0 111.484 -179.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -98.58 144.44 27.89 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.6 t -112.47 134.74 53.84 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.013 -1.055 . . . . 0.0 112.299 -178.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -138.12 124.05 20.1 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 178.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.887 ' HB2' HG22 ' A' ' 137' ' ' VAL . . . -139.04 155.55 47.87 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 120.857 -1.152 . . . . 0.0 112.027 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 49.3 tt0 -78.27 120.24 22.77 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 178.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.54 -29.24 10.72 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.355 -1.898 . . . . 0.0 108.355 -177.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 62.9 tp60 -113.75 97.77 6.62 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.607 -0.937 . . . . 0.0 109.247 178.562 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 70.6 mtm -67.43 -47.85 69.0 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.301 -0.875 . . . . 0.0 111.329 -179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 84.5 m-20 -55.51 131.3 45.77 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 121.39 -0.819 . . . . 0.0 111.694 -178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -82.42 155.1 24.84 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.747 -0.595 . . . . 0.0 109.632 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.522 ' HB3' HG22 ' A' ' 46' ' ' THR . 73.4 mtm -131.3 166.18 21.77 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.274 -0.891 . . . . 0.0 111.224 -179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.805 ' O ' HG23 ' A' ' 46' ' ' THR . . . -92.97 153.23 21.38 Favored Glycine 0 N--CA 1.496 2.634 0 N-CA-C 108.068 -2.013 . . . . 0.0 108.068 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -133.54 121.85 2.92 Favored Glycine 0 N--CA 1.494 2.506 0 C-N-CA 119.114 -1.517 . . . . 0.0 111.021 -179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -111.5 129.6 55.99 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -137.93 126.53 23.59 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.937 -1.102 . . . . 0.0 111.558 -179.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.486 HD23 ' HA3' ' A' ' 7' ' ' GLY . 81.9 mt -123.5 129.7 51.6 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HB3' ' CB ' ' A' ' 42' ' ' SER . 19.9 pttt -136.27 148.18 47.88 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.81 -1.181 . . . . 0.0 112.281 -178.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -111.29 137.46 49.0 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.613 ' HA ' HG22 ' A' ' 40' ' ' ILE . 49.5 ttt180 -120.37 135.26 55.09 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.314 -0.866 . . . . 0.0 111.1 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 94.1 m-85 -121.57 138.33 54.36 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.879 -0.785 . . . . 0.0 108.879 178.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -138.1 146.91 43.46 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.179 -0.951 . . . . 0.0 109.915 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -104.4 138.94 40.07 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.199 -0.938 . . . . 0.0 110.131 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -54.16 -27.34 33.16 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.621 -0.674 . . . . 0.0 111.76 -178.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 31.9 p-10 -60.82 -42.35 97.51 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.105 -0.997 . . . . 0.0 111.458 -178.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -155.01 168.48 11.99 Favored Pre-proline 0 N--CA 1.495 1.824 0 O-C-N 120.963 -1.085 . . . . 0.0 110.839 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -86.38 40.29 0.71 Allowed 'Trans proline' 0 C--N 1.315 -1.187 0 O-C-N 123.714 1.376 . . . . 0.0 111.112 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 20.4 tp -111.18 76.48 0.98 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.176 -0.953 . . . . 0.0 110.15 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -101.76 177.19 26.65 Favored Glycine 0 N--CA 1.493 2.459 0 C-N-CA 120.051 -1.071 . . . . 0.0 110.445 -179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 62.0 t -131.61 140.15 48.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.673 -0.898 . . . . 0.0 108.982 179.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.613 HG22 ' HA ' ' A' ' 29' ' ' ARG . 41.3 pt -121.66 147.59 25.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 120.96 -1.087 . . . . 0.0 111.386 -179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.96 129.75 8.8 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 178.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.527 ' O ' HG22 ' A' ' 66' ' ' THR . 32.1 t -136.91 142.86 42.71 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.169 -1.195 . . . . 0.0 111.765 -178.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -115.35 139.85 49.64 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.887 -0.782 . . . . 0.0 108.887 178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.9 m -130.42 136.16 48.75 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.17 -0.956 . . . . 0.0 110.169 -179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 74.8 t80 -134.74 111.1 9.68 Favored 'General case' 0 N--CA 1.485 1.312 0 O-C-N 121.349 -0.844 . . . . 0.0 109.171 179.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.805 HG23 ' O ' ' A' ' 22' ' ' GLY . 60.3 m -112.84 138.32 49.86 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.432 -0.793 . . . . 0.0 109.388 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -138.11 160.52 39.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.09 -1.006 . . . . 0.0 110.532 -179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -85.26 143.98 28.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.606 -0.684 . . . . 0.0 110.127 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 30.9 t -69.92 151.39 45.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.458 -0.776 . . . . 0.0 109.597 179.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 43.2 mtm-85 -61.4 133.22 55.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.358 -0.839 . . . . 0.0 110.26 -179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.488 HG22 ' H ' ' A' ' 53' ' ' SER . 38.4 m -132.09 148.8 52.51 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.524 -0.735 . . . . 0.0 109.872 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -59.58 -29.21 67.79 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.346 -0.846 . . . . 0.0 110.157 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.488 ' H ' HG22 ' A' ' 51' ' ' THR . 29.9 t -125.78 142.59 51.44 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.551 -0.718 . . . . 0.0 110.504 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 42.9 m 49.52 25.75 1.49 Allowed 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.539 -0.726 . . . . 0.0 111.427 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -125.57 -66.87 0.18 Allowed Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.744 -1.342 . . . . 0.0 109.744 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 95.9 m-20 -51.41 -32.91 28.13 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.457 -1.026 . . . . 0.0 111.148 -179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -119.03 161.17 20.69 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.287 -0.883 . . . . 0.0 111.07 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 54.3 t30 57.54 34.9 25.18 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.632 -0.667 . . . . 0.0 110.73 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.0 pttm -78.0 142.25 38.39 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.305 -0.872 . . . . 0.0 110.4 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -111.35 161.26 16.25 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.412 -0.805 . . . . 0.0 110.443 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -122.62 151.84 41.06 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.347 -0.845 . . . . 0.0 109.845 179.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.441 ' HB3' ' HB ' ' A' ' 46' ' ' THR . 70.5 t80 -121.8 93.15 3.91 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.331 -0.856 . . . . 0.0 111.182 -179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 61.5 t80 -98.24 150.86 21.07 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.446 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -158.5 132.84 3.23 Favored Glycine 0 N--CA 1.485 1.919 0 C-N-CA 118.195 -1.955 . . . . 0.0 111.631 -179.517 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.447 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 46.8 pt -98.54 138.56 22.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 42' ' ' SER . 9.5 t -153.22 147.57 25.86 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 118.723 -1.191 . . . . 0.0 111.576 -179.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.726 ' O ' HG12 ' A' ' 83' ' ' VAL . . . -149.0 151.15 34.05 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 178.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.24 165.79 36.77 Favored Glycine 0 N--CA 1.493 2.5 0 C-N-CA 119.418 -1.372 . . . . 0.0 110.513 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_endo -75.76 170.49 20.07 Favored 'Trans proline' 0 C--N 1.313 -1.308 0 O-C-N 123.798 1.42 . . . . 0.0 110.655 179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -148.39 140.62 24.15 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.603 -0.685 . . . . 0.0 109.452 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -123.17 141.47 51.94 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.331 -0.856 . . . . 0.0 110.558 -179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 74.6 ttt180 -108.88 85.31 2.07 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 119.925 -0.71 . . . . 0.0 110.034 179.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 45.8 mm -72.98 -46.37 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.426 -0.796 . . . . 0.0 109.064 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -140.46 147.76 40.12 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -58.26 -34.09 70.12 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.152 -0.968 . . . . 0.0 110.196 179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -60.71 -35.61 76.76 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.611 -0.681 . . . . 0.0 111.819 -179.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -143.93 159.81 41.92 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.973 -1.079 . . . . 0.0 111.891 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.773 ' O ' HD12 ' A' ' 113' ' ' LEU . 26.6 t -138.22 155.35 48.74 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.633 -0.667 . . . . 0.0 109.618 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.7 tt -129.05 137.87 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 O-C-N 121.065 -1.022 . . . . 0.0 110.363 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 51.2 p90 -146.95 162.27 39.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.406 -0.809 . . . . 0.0 111.425 -179.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -108.2 164.31 12.79 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.587 HG22 ' C ' ' A' ' 110' ' ' GLY . 34.7 m -141.75 134.82 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.203 -1.175 . . . . 0.0 111.53 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.726 HG12 ' O ' ' A' ' 67' ' ' ALA . 7.2 p -138.76 148.34 24.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 N-CA-C 107.761 -1.199 . . . . 0.0 107.761 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.447 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 178.65 -179.76 48.66 Favored Glycine 0 N--CA 1.478 1.472 0 C-N-CA 119.1 -1.524 . . . . 0.0 110.687 -179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.446 ' O ' ' HA2' ' A' ' 64' ' ' GLY . 57.0 t -118.64 142.02 35.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.688 0 CA-C-O 121.335 0.588 . . . . 0.0 110.702 -179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -98.94 144.26 17.1 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -116.55 129.82 56.4 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.129 -1.219 . . . . 0.0 110.11 -179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -118.26 113.52 2.64 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -114.79 136.77 52.71 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.465 -1.021 . . . . 0.0 110.653 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -139.39 158.54 43.98 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.546 -0.721 . . . . 0.0 109.927 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -95.55 134.38 38.48 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.354 -0.841 . . . . 0.0 110.392 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.0 t -139.15 157.45 45.92 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.487 -0.758 . . . . 0.0 110.382 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.8 t -108.1 -1.26 20.55 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.472 -0.768 . . . . 0.0 110.911 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -62.29 -32.35 73.07 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.27 -0.893 . . . . 0.0 110.474 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.401 ' HA ' ' HD2' ' A' ' 96' ' ' PRO . 1.2 t80 -118.98 100.25 50.77 Favored Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.432 -0.793 . . . . 0.0 110.404 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 95' ' ' TYR . 41.8 Cg_endo -67.8 141.17 53.27 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 O-C-N 123.463 1.244 . . . . 0.0 110.259 179.783 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 43.7 p 47.1 -176.46 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.178 0 CA-C-O 121.261 0.553 . . . . 0.0 111.218 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.419 ' CD2' ' O ' ' A' ' 98' ' ' TYR . 60.7 t80 46.9 66.08 1.08 Allowed 'General case' 0 N--CA 1.501 2.085 0 O-C-N 121.457 -0.777 . . . . 0.0 110.888 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.2 mttt -65.89 -37.22 85.53 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.267 -0.895 . . . . 0.0 110.044 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.3 t30 56.78 18.35 3.73 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 121.503 -0.748 . . . . 0.0 111.084 -179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 47.34 42.88 14.6 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.24 -0.912 . . . . 0.0 111.31 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.589 HG23 ' O ' ' A' ' 102' ' ' THR . 7.2 t -68.78 111.84 5.13 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.215 -0.928 . . . . 0.0 110.657 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 86.2 p -142.16 160.72 39.68 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.402 -0.811 . . . . 0.0 110.314 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -93.2 143.22 26.47 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.472 -0.768 . . . . 0.0 109.93 179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -113.08 154.78 26.03 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.329 -0.857 . . . . 0.0 110.11 -179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 85' ' ' VAL . . . -143.46 153.51 24.9 Favored Glycine 0 N--CA 1.493 2.474 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 69.0 t80 -96.58 139.54 32.51 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.244 -1.15 . . . . 0.0 110.735 -179.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.9 p -124.94 159.99 29.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.532 -0.73 . . . . 0.0 110.424 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.415 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 41.1 p90 -160.25 155.67 25.23 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.442 -0.786 . . . . 0.0 109.854 179.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.587 ' C ' HG22 ' A' ' 82' ' ' VAL . . . 164.3 -169.77 39.24 Favored Glycine 0 N--CA 1.494 2.507 0 C-N-CA 119.597 -1.287 . . . . 0.0 110.497 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -164.77 165.15 20.92 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.602 -0.94 . . . . 0.0 108.905 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -152.75 -178.92 27.87 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.773 HD12 ' O ' ' A' ' 78' ' ' SER . 15.4 tp -139.54 147.37 41.12 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.371 -1.076 . . . . 0.0 110.22 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.418 ' HA ' ' O ' ' A' ' 123' ' ' LEU . 93.1 mt-30 -99.11 141.72 31.52 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.087 -1.008 . . . . 0.0 109.157 179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -148.2 148.64 30.75 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.303 -0.873 . . . . 0.0 110.868 -179.553 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.593 ' OD1' HD23 ' A' ' 123' ' ' LEU . 0.8 OUTLIER 170.72 134.7 0.07 OUTLIER Pre-proline 0 N--CA 1.506 2.327 0 O-C-N 121.764 -0.585 . . . . 0.0 111.306 178.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -88.03 47.11 1.29 Allowed 'Trans proline' 0 C--N 1.316 -1.161 0 O-C-N 123.541 1.285 . . . . 0.0 109.484 177.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.437 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 65.3 mtt -141.71 139.45 32.91 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.424 -0.797 . . . . 0.0 109.044 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -64.77 -47.04 79.61 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 112.485 0.55 . . . . 0.0 112.485 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -104.13 5.5 35.1 Favored 'General case' 0 N--CA 1.5 2.04 0 O-C-N 120.822 -1.174 . . . . 0.0 112.703 -177.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.546 HG12 ' ND2' ' A' ' 116' ' ' ASN . 59.3 t -118.77 136.45 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.769 -1.207 . . . . 0.0 109.935 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 145' ' ' GLY . . . -142.92 139.49 30.76 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.406 -0.917 . . . . 0.0 112.308 -179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.835 HD13 ' O ' ' A' ' 143' ' ' GLY . 3.7 mm? -109.32 153.36 24.02 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 178.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 52.8 t0 -145.9 140.24 26.84 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.76 -1.212 . . . . 0.0 110.648 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 113' ' ' LEU . 49.1 p90 -132.07 142.74 49.63 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.434 -0.791 . . . . 0.0 109.391 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.636 ' HB3' HD11 ' A' ' 141' ' ' ILE . 28.9 t -146.51 149.42 33.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.375 -0.828 . . . . 0.0 111.231 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 77.6 t80 -118.12 126.57 52.51 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.698 -0.626 . . . . 0.0 109.428 179.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -137.35 136.42 37.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.456 -0.777 . . . . 0.0 110.593 -179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -112.18 130.09 56.03 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.42 -0.8 . . . . 0.0 109.765 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 46.0 m -122.1 147.59 45.94 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.295 -0.878 . . . . 0.0 110.436 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 42.5 ptt85 -135.78 130.53 34.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.499 -0.751 . . . . 0.0 110.23 179.615 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.47 ' O ' HG22 ' A' ' 132' ' ' ILE . 88.4 mt -119.17 67.22 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.567 -0.708 . . . . 0.0 109.707 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 132' ' ' ILE . 41.4 ttm180 66.45 -60.74 0.32 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.672 -0.642 . . . . 0.0 111.388 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 48.2 p -124.65 5.73 8.19 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.067 -1.021 . . . . 0.0 111.69 -179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.426 ' O ' ' HA ' ' A' ' 131' ' ' ARG . 51.2 t -126.52 133.35 68.87 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 120.934 -1.104 . . . . 0.0 110.798 -179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -132.22 115.87 16.23 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 179.153 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.887 HG22 ' HB2' ' A' ' 14' ' ' ALA . 32.0 t -110.76 145.51 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.131 -0.981 . . . . 0.0 111.121 -178.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.84 117.85 2.58 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 107.684 -2.167 . . . . 0.0 107.684 178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 10.2 t -134.14 151.96 51.61 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.188 -1.184 . . . . 0.0 112.028 -178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.423 ' CZ2' ' HB2' ' A' ' 125' ' ' PHE . 60.5 t-105 -112.04 133.93 53.9 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.009 -1.108 . . . . 0.0 108.009 178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.636 HD11 ' HB3' ' A' ' 126' ' ' SER . 49.3 pt -115.91 147.17 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.068 -1.02 . . . . 0.0 111.319 -178.799 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -147.49 136.92 22.61 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.835 ' O ' HD13 ' A' ' 123' ' ' LEU . . . -162.96 -159.08 10.13 Favored Glycine 0 N--CA 1.489 2.214 0 C-N-CA 118.986 -1.578 . . . . 0.0 111.605 -178.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.814 ' O ' HG23 ' A' ' 6' ' ' THR . 9.3 p -104.57 166.99 2.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 O-C-N 122.065 -0.667 . . . . 0.0 110.654 -179.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.606 ' O ' ' HB3' ' A' ' 122' ' ' ALA . . . -154.32 138.97 6.46 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 110.297 -1.121 . . . . 0.0 110.297 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.853 ' O ' HG23 ' A' ' 4' ' ' THR . 68.4 t80 -132.18 153.99 50.0 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.543 -0.975 . . . . 0.0 109.765 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 48.6 mtm180 -125.29 121.17 33.23 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.307 -0.87 . . . . 0.0 111.101 -179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 73.6 t80 . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.495 -0.753 . . . . 0.0 110.13 179.894 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 120.965 0.412 . . . . 0.0 110.018 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.0 m -126.28 147.63 49.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.294 -0.879 . . . . 0.0 109.153 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.474 ' OG1' ' HB3' ' A' ' 29' ' ' ARG . 19.0 p -135.12 152.47 51.67 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.067 -1.021 . . . . 0.0 110.431 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 57.7 t -112.24 135.77 50.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.439 ' HA ' ' O ' ' A' ' 144' ' ' VAL . 37.1 m -155.31 128.22 8.1 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.234 -0.916 . . . . 0.0 110.642 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -171.86 173.37 45.06 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.058 -1.617 . . . . 0.0 109.058 179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.86 -137.52 3.42 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.417 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 45.5 p90 -143.26 160.02 41.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.485 -1.009 . . . . 0.0 109.888 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.58 145.34 30.07 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 119.308 -0.957 . . . . 0.0 111.626 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -113.49 144.87 42.1 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.441 ' HB3' ' CB ' ' A' ' 139' ' ' THR . 54.4 p -146.47 153.63 40.65 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 118.607 -1.237 . . . . 0.0 112.617 -178.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.883 ' O ' HG13 ' A' ' 137' ' ' VAL . 88.7 m-20 -83.11 151.34 25.79 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 177.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.736 ' HB1' ' HB2' ' A' ' 17' ' ' GLN . . . -127.03 100.37 6.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.943 -1.098 . . . . 0.0 111.341 -179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -79.78 117.48 20.7 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 101.04 -13.21 58.95 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 110.059 -1.217 . . . . 0.0 110.059 -179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.736 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 89.2 mt-30 -107.68 178.04 4.65 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.118 -1.225 . . . . 0.0 110.294 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.401 ' CB ' ' HE3' ' A' ' 48' ' ' LYS . 94.3 mmm -57.75 -51.68 68.58 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.459 -0.776 . . . . 0.0 112.041 -178.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.531 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 19.7 t30 -169.82 -148.62 0.07 Allowed 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.694 -1.254 . . . . 0.0 110.747 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 51.1 mttt -81.06 154.3 26.91 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.076 -1.015 . . . . 0.0 110.761 -179.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 62.5 mtt -129.94 167.59 17.98 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.416 -0.803 . . . . 0.0 110.662 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.816 ' O ' HG23 ' A' ' 46' ' ' THR . . . -98.12 158.97 20.66 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.251 -1.939 . . . . 0.0 108.251 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 9' ' ' TYR . . . -147.08 121.29 1.38 Allowed Glycine 0 N--CA 1.492 2.411 0 C-N-CA 119.275 -1.44 . . . . 0.0 110.757 -179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -108.52 134.92 50.62 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.644 -0.916 . . . . 0.0 109.127 178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -139.02 129.38 25.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.157 -0.964 . . . . 0.0 112.112 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.438 HD21 ' OH ' ' A' ' 28' ' ' TYR . 25.5 tp -121.85 127.59 50.69 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 178.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB3' ' CG2' ' A' ' 40' ' ' ILE . 21.3 mttt -129.24 144.66 51.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.656 -1.277 . . . . 0.0 111.748 -177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.438 ' OH ' HD21 ' A' ' 26' ' ' LEU . 98.8 m-85 -112.24 140.69 46.74 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.474 ' HB3' ' OG1' ' A' ' 4' ' ' THR . 14.2 ttp180 -123.54 137.76 54.7 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.095 -1.003 . . . . 0.0 111.938 -178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -122.04 138.25 54.51 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -141.33 150.02 41.94 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.135 -0.978 . . . . 0.0 110.401 -179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -106.19 135.94 46.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.368 -0.833 . . . . 0.0 109.683 179.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -62.1 -22.85 66.14 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.581 -0.699 . . . . 0.0 110.646 -179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -61.16 -43.3 99.09 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.344 -0.847 . . . . 0.0 111.041 -179.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.3 m -140.88 170.31 9.72 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.17 -0.956 . . . . 0.0 110.617 -179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_endo -83.86 41.39 1.03 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 O-C-N 123.608 1.32 . . . . 0.0 111.022 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.481 HD23 ' C ' ' A' ' 37' ' ' LEU . 8.5 tt -91.3 119.56 31.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.359 -0.838 . . . . 0.0 110.043 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . -127.35 135.46 8.79 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.885 -1.15 . . . . 0.0 110.485 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.1 p -131.21 135.86 58.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 178.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.532 HD11 ' CD1' ' A' ' 80' ' ' TYR . 72.9 mt -125.32 141.92 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.922 -1.111 . . . . 0.0 111.455 -178.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.81 141.07 15.15 Favored Glycine 0 N--CA 1.493 2.444 0 N-CA-C 106.998 -2.441 . . . . 0.0 106.998 177.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.415 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 42.7 t -137.53 141.18 41.43 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.886 -1.361 . . . . 0.0 112.649 -178.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -122.97 134.13 54.35 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 177.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 49.8 m -131.03 136.93 48.92 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.05 -1.031 . . . . 0.0 110.693 -179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -129.94 110.42 11.67 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.816 HG23 ' O ' ' A' ' 22' ' ' GLY . 96.9 m -115.03 140.01 49.4 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.369 -0.832 . . . . 0.0 109.588 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -141.15 163.85 31.84 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.104 -0.997 . . . . 0.0 110.446 -179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.401 ' HE3' ' CB ' ' A' ' 18' ' ' MET . 21.4 tttm -73.6 134.98 43.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.485 -0.759 . . . . 0.0 109.932 179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 53.5 p -79.43 145.52 33.27 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.416 -0.803 . . . . 0.0 109.934 179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -144.74 161.79 38.36 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.403 -0.811 . . . . 0.0 110.049 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.424 HG22 ' HB3' ' A' ' 53' ' ' SER . 41.7 m -56.64 -38.63 72.4 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.348 -0.845 . . . . 0.0 109.837 179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 50.81 28.25 3.55 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.437 -0.789 . . . . 0.0 111.118 179.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.424 ' HB3' HG22 ' A' ' 51' ' ' THR . 86.7 p -60.43 -36.56 78.47 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.291 -0.881 . . . . 0.0 109.868 179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 97.7 p -80.99 -24.69 37.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.457 -0.777 . . . . 0.0 110.184 179.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 164.42 178.57 37.96 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 50.6 t0 -90.17 125.07 35.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.582 -0.952 . . . . 0.0 110.349 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -111.91 139.17 47.62 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.374 -0.829 . . . . 0.0 110.366 179.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 48.1 p-10 -123.25 41.86 3.36 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.479 -0.763 . . . . 0.0 110.322 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -46.33 -75.58 0.03 OUTLIER 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.634 -0.666 . . . . 0.0 111.11 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.8 p-10 -106.67 146.13 31.13 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.223 -0.923 . . . . 0.0 110.477 179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -143.9 165.04 28.83 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.408 -0.808 . . . . 0.0 110.475 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.464 ' HB2' ' HB ' ' A' ' 46' ' ' THR . 50.9 m-85 -113.81 114.12 25.86 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.703 0.763 . . . . 0.0 111.22 -179.783 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.411 ' HB3' ' HB2' ' A' ' 87' ' ' TYR . 68.4 t80 -98.08 145.17 26.81 Favored 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 85' ' ' VAL . . . -150.54 128.79 2.73 Favored Glycine 0 N--CA 1.485 1.904 0 C-N-CA 118.502 -1.808 . . . . 0.0 110.932 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.45 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 78.2 mt -99.1 134.77 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.749 HG23 ' O ' ' A' ' 83' ' ' VAL . 61.4 m -152.03 142.1 22.21 Favored 'General case' 0 N--CA 1.491 1.583 0 C-N-CA 118.512 -1.275 . . . . 0.0 112.216 -179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.87 148.84 34.4 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 178.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -157.15 160.38 30.4 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 119.412 -1.375 . . . . 0.0 110.593 -179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.407 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 49.7 Cg_endo -75.41 165.09 31.4 Favored 'Trans proline' 0 C--N 1.315 -1.2 0 O-C-N 123.875 1.461 . . . . 0.0 110.646 179.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.444 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -141.97 137.42 31.2 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.489 -0.757 . . . . 0.0 109.823 179.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -125.23 143.48 50.93 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.582 -0.698 . . . . 0.0 110.927 -179.224 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 65.4 ttt-85 -109.83 119.87 40.7 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.644 -0.66 . . . . 0.0 109.605 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 47.2 mm -99.52 -88.09 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.285 -0.885 . . . . 0.0 110.865 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -153.11 173.73 15.11 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.071 -1.018 . . . . 0.0 110.47 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 85.1 m-20 53.05 44.27 30.61 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.451 -0.781 . . . . 0.0 110.887 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 95.9 m95 50.7 24.93 1.86 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.421 -0.8 . . . . 0.0 110.92 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -90.99 129.89 36.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.291 -0.881 . . . . 0.0 109.896 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.4 m -124.41 151.31 44.62 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.425 -0.797 . . . . 0.0 110.634 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 76.7 mt -119.46 136.85 55.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.324 -0.86 . . . . 0.0 109.176 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.532 ' CD1' HD11 ' A' ' 40' ' ' ILE . 38.6 m-85 -129.26 148.69 51.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.339 -0.85 . . . . 0.0 111.145 -179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.28 159.28 19.84 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 107.573 -2.211 . . . . 0.0 107.573 178.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.558 HG22 ' O ' ' A' ' 110' ' ' GLY . 27.0 m -143.77 134.66 21.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 120.945 -1.326 . . . . 0.0 112.164 -179.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.749 ' O ' HG23 ' A' ' 66' ' ' THR . 61.9 t -134.85 144.63 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 106.786 -1.561 . . . . 0.0 106.786 177.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 178.78 -176.9 48.27 Favored Glycine 0 N--CA 1.477 1.389 0 C-N-CA 118.326 -1.892 . . . . 0.0 111.522 -179.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.458 ' CG1' ' CZ ' ' A' ' 87' ' ' TYR . 52.8 t -121.9 144.27 31.67 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.764 0 CA-C-O 121.652 0.739 . . . . 0.0 110.583 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -99.14 135.84 12.36 Favored Glycine 0 N--CA 1.496 2.651 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 179.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.458 ' CZ ' ' CG1' ' A' ' 85' ' ' VAL . 88.5 m-85 -127.86 132.13 49.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.067 -1.255 . . . . 0.0 110.189 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -123.79 127.95 6.72 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.235 -1.546 . . . . 0.0 109.235 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 27.8 pttt -133.37 150.91 51.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.416 -1.049 . . . . 0.0 110.488 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -146.71 -179.12 6.56 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.634 -0.666 . . . . 0.0 110.205 -179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 54.99 169.88 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 O-C-N 121.52 -0.737 . . . . 0.0 110.904 179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 14.6 t -128.02 170.03 13.36 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.285 -0.884 . . . . 0.0 110.395 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 94' ' ' GLU . 2.1 m 56.91 179.14 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.411 -0.805 . . . . 0.0 110.192 -179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.531 ' H ' HG22 ' A' ' 93' ' ' THR . 96.1 mt-10 53.15 48.87 21.23 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.298 -0.876 . . . . 0.0 110.407 -179.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 34.1 t80 -65.75 126.62 92.04 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.48 -0.762 . . . . 0.0 110.373 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.81 164.41 35.65 Favored 'Trans proline' 0 C--N 1.315 -1.231 0 O-C-N 123.551 1.29 . . . . 0.0 110.517 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.0 t -57.47 -172.03 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.41 -0.806 . . . . 0.0 110.24 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 71.4 t80 -56.04 -43.81 78.19 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.284 -0.885 . . . . 0.0 110.444 -179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.8 tptp -53.27 -32.95 51.12 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.323 -0.86 . . . . 0.0 110.76 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 55.64 53.52 9.48 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.395 -0.815 . . . . 0.0 110.845 179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 94.9 m-20 -53.24 -35.99 60.58 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.171 -0.956 . . . . 0.0 110.106 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 51.6 m -59.28 -24.6 63.38 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.539 -0.725 . . . . 0.0 110.333 179.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 44.5 p -92.35 165.05 13.27 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.434 -0.791 . . . . 0.0 110.083 179.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 54.7 t0 -133.21 135.31 44.97 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.489 -0.757 . . . . 0.0 109.458 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.727 ' O ' HG23 ' A' ' 132' ' ' ILE . 45.9 p90 -134.96 170.16 16.31 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.083 -1.011 . . . . 0.0 111.871 -178.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.424 ' HA3' HG12 ' A' ' 132' ' ' ILE . . . -154.18 178.03 31.26 Favored Glycine 0 N--CA 1.493 2.483 0 N-CA-C 108.67 -1.772 . . . . 0.0 108.67 179.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.415 ' CZ ' HG13 ' A' ' 83' ' ' VAL . 68.3 t80 -99.11 142.15 30.96 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.115 -1.227 . . . . 0.0 110.862 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 51.1 m -121.65 150.55 41.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.446 -0.784 . . . . 0.0 110.159 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.487 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 43.2 p90 -158.34 152.98 24.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.393 -0.817 . . . . 0.0 110.037 179.187 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.558 ' O ' HG22 ' A' ' 82' ' ' VAL . . . 169.67 -176.63 43.5 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.584 -1.294 . . . . 0.0 110.65 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.99 163.46 11.37 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.681 -0.894 . . . . 0.0 109.091 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -159.71 -171.4 25.52 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -135.45 155.83 49.9 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.302 -1.116 . . . . 0.0 110.141 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -120.63 142.55 49.32 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.163 -0.961 . . . . 0.0 110.228 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.67 ' O ' ' HB1' ' A' ' 122' ' ' ALA . 47.7 t80 -118.56 160.82 21.08 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.552 -0.718 . . . . 0.0 109.586 179.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -118.05 72.1 8.79 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.223 -0.923 . . . . 0.0 111.349 -178.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.489 ' HD2' ' HA ' ' A' ' 122' ' ' ALA . 44.8 Cg_endo -72.51 -12.29 26.97 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.582 1.306 . . . . 0.0 110.064 178.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.599 ' HB2' HG13 ' A' ' 121' ' ' VAL . 88.0 mtp -142.89 144.15 32.34 Favored 'General case' 0 C--N 1.311 -1.089 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 179.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.29 -51.57 69.36 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -90.59 3.03 55.24 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 120.768 -1.207 . . . . 0.0 113.04 -177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.758 HG23 HG23 ' A' ' 144' ' ' VAL . 8.8 p -152.78 119.44 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 O-C-N 120.714 -1.241 . . . . 0.0 111.348 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.67 ' HB1' ' O ' ' A' ' 115' ' ' PHE . . . -110.75 167.45 10.22 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.253 -0.904 . . . . 0.0 109.934 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 143' ' ' GLY . 23.4 tp -112.91 149.74 32.78 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.251 -0.906 . . . . 0.0 109.338 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -137.05 139.75 41.56 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.041 -1.037 . . . . 0.0 109.534 179.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -133.87 132.16 40.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.323 -0.861 . . . . 0.0 109.092 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 82.7 p -145.47 164.72 30.71 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.17 -0.956 . . . . 0.0 111.058 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 74.8 m-85 -114.31 132.63 56.1 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.595 -0.69 . . . . 0.0 109.429 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -133.17 135.24 45.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.298 -0.877 . . . . 0.0 110.817 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -130.18 147.99 51.97 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.464 -0.773 . . . . 0.0 109.742 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.1 t -139.1 141.09 38.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.338 -0.851 . . . . 0.0 110.495 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.409 ' O ' ' HA3' ' A' ' 106' ' ' GLY . 63.1 mtm180 -129.11 129.19 44.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.366 -0.834 . . . . 0.0 109.868 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.727 HG23 ' O ' ' A' ' 105' ' ' TYR . 83.5 mt -125.48 54.19 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 O-C-N 121.534 -0.729 . . . . 0.0 109.671 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.422 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 74.2 mtp180 61.52 -55.99 0.11 Allowed 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 132' ' ' ILE . 0.4 OUTLIER -105.47 -14.7 15.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.98 -1.075 . . . . 0.0 111.617 -178.429 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.499 ' CG2' ' HB ' ' A' ' 132' ' ' ILE . 32.8 m -137.17 140.21 42.76 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.928 0 C-N-CA 118.396 -1.322 . . . . 0.0 112.111 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 -133.71 119.09 18.88 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 13' ' ' ASP . 63.9 t -112.77 146.39 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.077 -1.014 . . . . 0.0 110.758 -178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -117.12 123.8 5.92 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 107.312 -2.315 . . . . 0.0 107.312 178.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.441 ' CB ' ' HB3' ' A' ' 12' ' ' SER . 14.9 t -126.19 152.55 45.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.065 -1.256 . . . . 0.0 112.469 -177.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.436 ' N ' ' CD1' ' A' ' 140' ' ' TRP . 56.4 m95 -111.69 137.45 49.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 76.7 mt -115.08 134.78 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.825 0 O-C-N 121.01 -1.056 . . . . 0.0 111.463 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.58 128.74 16.67 Favored 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.427 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -159.42 -157.98 8.87 Favored Glycine 0 N--CA 1.491 2.355 0 C-N-CA 118.985 -1.578 . . . . 0.0 111.789 -178.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.758 HG23 HG23 ' A' ' 121' ' ' VAL . 7.2 p -111.45 163.13 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 122.135 -0.627 . . . . 0.0 110.555 -178.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.42 ' N ' HG22 ' A' ' 144' ' ' VAL . . . -140.54 131.44 5.0 Favored Glycine 0 N--CA 1.493 2.466 0 N-CA-C 109.979 -1.248 . . . . 0.0 109.979 -179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -129.38 145.64 51.37 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.465 -1.021 . . . . 0.0 109.893 179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 75.5 ttt-85 -127.81 119.89 26.66 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.395 -0.816 . . . . 0.0 111.046 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.3 t80 . . . . . 0 N--CA 1.495 1.78 0 O-C-N 121.461 -0.774 . . . . 0.0 110.085 -179.95 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.6 p . . . . . 0 N--CA 1.493 1.689 0 CA-C-O 121.14 0.495 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.1 p -112.49 161.12 17.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.436 -0.79 . . . . 0.0 109.17 179.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.595 HG21 HH21 ' A' ' 29' ' ' ARG . 36.6 m -136.43 139.99 42.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.119 -0.988 . . . . 0.0 110.59 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.403 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 13.3 p -126.38 142.84 41.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.477 HG22 ' CA ' ' A' ' 145' ' ' GLY . 29.4 p -152.17 138.75 18.7 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 179.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.423 ' HA2' ' O ' ' A' ' 25' ' ' ASN . . . -134.24 155.27 21.79 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 109.099 -1.6 . . . . 0.0 109.099 179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.402 ' O ' ' HA ' ' A' ' 24' ' ' PHE . . . -175.95 -163.32 28.43 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.974 -1.251 . . . . 0.0 109.974 -179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 46.9 p90 -137.35 161.44 36.27 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.652 -0.911 . . . . 0.0 109.356 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -146.06 153.69 41.01 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.644 -1.223 . . . . 0.0 112.145 -179.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -112.5 137.77 50.23 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 39.4 m -121.23 145.54 47.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.991 -1.068 . . . . 0.0 112.633 -177.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -130.2 139.39 50.84 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 107.17 -1.419 . . . . 0.0 107.17 177.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.898 ' CB ' HG22 ' A' ' 137' ' ' VAL . . . -145.9 148.32 32.69 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 120.774 -1.204 . . . . 0.0 112.11 -177.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -78.93 123.56 27.38 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.09 -24.07 25.81 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.694 -1.763 . . . . 0.0 108.694 -177.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.405 ' NE2' ' CG1' ' A' ' 135' ' ' VAL . 48.4 mt-30 -112.75 141.03 47.03 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.337 -1.096 . . . . 0.0 109.492 178.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 71.0 mtm -98.02 -67.17 0.86 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.29 -0.881 . . . . 0.0 110.572 -179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.7 p-10 -49.03 122.92 6.36 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.521 -0.737 . . . . 0.0 112.088 -178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -75.83 164.44 26.23 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.533 -0.729 . . . . 0.0 109.932 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 68.3 mtm -121.02 146.8 46.32 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.287 -0.883 . . . . 0.0 111.58 -179.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -142.94 124.71 2.41 Favored Glycine 0 N--CA 1.498 2.814 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.692 ' HA3' HG22 ' A' ' 46' ' ' THR . . . -151.36 -160.06 9.24 Favored Glycine 0 N--CA 1.494 2.527 0 C-N-CA 119.124 -1.512 . . . . 0.0 110.883 -178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . 0.402 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 99.1 m-85 -121.31 154.59 36.2 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.744 -0.856 . . . . 0.0 110.064 -179.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.533 ' ND2' HD13 ' A' ' 141' ' ' ILE . 57.7 t30 -134.73 130.84 36.84 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.451 -0.781 . . . . 0.0 111.515 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 83.7 mt -111.87 155.13 24.13 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 178.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.733 ' HD2' HG21 ' A' ' 40' ' ' ILE . 17.4 ttpt -148.81 132.6 16.98 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.642 -1.286 . . . . 0.0 110.209 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -133.93 136.7 44.42 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.595 HH21 HG21 ' A' ' 4' ' ' THR . 36.8 ptt180 -142.81 150.78 40.41 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.792 -1.163 . . . . 0.0 112.581 -178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.2 t80 -116.96 138.11 51.77 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 178.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -139.45 145.88 39.37 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.282 -0.886 . . . . 0.0 109.862 -179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.0 tt0 -98.62 131.43 44.82 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.208 -0.933 . . . . 0.0 109.652 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -53.4 -24.25 11.92 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.543 -0.723 . . . . 0.0 111.657 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -60.35 -44.37 95.63 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.164 -0.96 . . . . 0.0 110.897 -179.017 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.4 m -140.77 161.84 52.03 Favored Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.118 -0.989 . . . . 0.0 110.851 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -87.87 34.59 0.41 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 O-C-N 123.747 1.393 . . . . 0.0 111.146 179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 86.0 mt -108.64 73.13 0.85 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.242 -0.911 . . . . 0.0 110.137 179.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -97.83 -179.01 33.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.9 p -130.23 144.39 38.13 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.623 -0.928 . . . . 0.0 108.948 179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.733 HG21 ' HD2' ' A' ' 27' ' ' LYS . 62.5 mt -118.38 143.62 28.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 120.965 -1.085 . . . . 0.0 110.876 -178.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -124.25 122.64 4.87 Favored Glycine 0 N--CA 1.496 2.666 0 N-CA-C 109.139 -1.585 . . . . 0.0 109.139 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 76.6 p -139.38 144.98 38.41 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.147 -1.208 . . . . 0.0 111.451 -179.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -120.85 148.25 44.28 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.53 -0.731 . . . . 0.0 109.948 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.9 m -129.73 138.72 51.27 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.244 -0.91 . . . . 0.0 110.376 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.414 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 68.7 t80 -137.57 110.91 7.92 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.225 -0.922 . . . . 0.0 108.933 178.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.692 HG22 ' HA3' ' A' ' 23' ' ' GLY . 30.3 p -122.54 160.34 25.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.489 -0.757 . . . . 0.0 110.457 -179.211 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 -127.4 165.84 19.01 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.468 -0.77 . . . . 0.0 110.411 -179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -73.29 147.55 44.41 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.706 -0.621 . . . . 0.0 110.487 179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 55.5 p -64.77 158.13 25.71 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.508 -0.745 . . . . 0.0 109.959 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 24.8 ptt-85 -146.68 165.5 29.39 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.363 -0.836 . . . . 0.0 110.767 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 58.3 p -105.21 171.89 7.08 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.49 -0.756 . . . . 0.0 110.2 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.07 -32.22 67.83 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.481 -0.762 . . . . 0.0 110.48 -179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 46.5 m -62.19 157.49 19.2 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.354 -0.841 . . . . 0.0 109.802 179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.0 m -57.41 -43.33 83.68 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.354 -0.841 . . . . 0.0 110.354 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 48.29 -104.89 0.1 OUTLIER Glycine 0 N--CA 1.499 2.882 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 179.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 85.9 m-20 53.97 40.86 32.05 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.639 -0.918 . . . . 0.0 111.014 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 73.6 t80 -63.15 -42.49 99.47 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.299 -0.875 . . . . 0.0 109.656 179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -168.63 83.14 0.16 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.587 -0.696 . . . . 0.0 109.154 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 52.6 tttp -70.74 127.24 31.97 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.406 -0.809 . . . . 0.0 111.329 -178.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -104.04 163.16 12.57 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.261 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -119.67 152.87 36.43 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.044 -1.035 . . . . 0.0 109.811 179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -119.7 127.72 53.13 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.166 -0.959 . . . . 0.0 111.529 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.475 ' CB ' ' CZ ' ' A' ' 87' ' ' TYR . 97.8 m-85 -116.1 136.2 53.24 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.733 179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -146.76 112.22 0.6 Allowed Glycine 0 N--CA 1.485 1.959 0 C-N-CA 119.552 -1.309 . . . . 0.0 110.183 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.496 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 77.8 mt -101.49 135.85 36.09 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.325 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 178.321 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 12.6 m -150.65 140.2 21.56 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 118.836 -1.146 . . . . 0.0 111.111 -179.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.86 ' O ' HG12 ' A' ' 83' ' ' VAL . . . -152.71 151.56 30.68 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 81' ' ' GLY . . . -164.54 171.92 40.15 Favored Glycine 0 N--CA 1.492 2.386 0 C-N-CA 119.388 -1.386 . . . . 0.0 110.6 -179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.04 161.79 43.72 Favored 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.964 1.507 . . . . 0.0 110.995 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.717 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -140.47 137.28 33.75 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.672 -0.643 . . . . 0.0 109.577 179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -116.38 124.01 49.0 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 119.481 -0.888 . . . . 0.0 110.915 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 60.0 ttt-85 -109.91 130.74 55.49 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.631 -0.668 . . . . 0.0 109.642 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.487 HG23 ' N ' ' A' ' 74' ' ' ASN . 15.6 tt -170.26 -39.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.413 -0.804 . . . . 0.0 110.162 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.487 ' N ' HG23 ' A' ' 73' ' ' ILE . 86.2 m-20 -106.78 124.08 49.09 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.511 -0.743 . . . . 0.0 110.011 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -59.04 -31.92 69.28 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.451 -0.781 . . . . 0.0 110.13 179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 72.2 t-105 -54.12 -42.63 69.67 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.504 -0.748 . . . . 0.0 111.272 -179.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -169.36 165.06 10.77 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.105 -0.997 . . . . 0.0 111.564 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 91.0 p -121.58 159.49 26.3 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 74.7 mt -124.87 136.29 61.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 120.922 -1.111 . . . . 0.0 110.551 -179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.408 ' HB2' ' CD1' ' A' ' 40' ' ' ILE . 43.5 p90 -145.65 158.92 43.79 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.814 -0.754 . . . . 0.0 110.912 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.46 ' C ' HG13 ' A' ' 82' ' ' VAL . . . -103.72 176.89 24.29 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.732 -1.747 . . . . 0.0 108.732 179.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.748 HG22 ' C ' ' A' ' 110' ' ' GLY . 34.9 m -147.89 131.36 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.32 -1.106 . . . . 0.0 110.545 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.86 HG12 ' O ' ' A' ' 67' ' ' ALA . 11.2 p -145.87 151.42 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 121.29 -0.881 . . . . 0.0 109.89 179.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.496 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 160.88 -153.18 23.98 Favored Glycine 0 N--CA 1.481 1.655 0 C-N-CA 119.706 -1.235 . . . . 0.0 110.452 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 13.8 p -128.85 142.24 44.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 CA-C-O 122.204 1.002 . . . . 0.0 112.861 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.98 126.52 6.02 Favored Glycine 0 N--CA 1.495 2.597 0 N-CA-C 108.853 -1.699 . . . . 0.0 108.853 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.475 ' CZ ' ' CB ' ' A' ' 63' ' ' TYR . 46.5 p90 -151.71 162.41 41.06 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.007 -1.29 . . . . 0.0 110.8 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -136.47 152.92 21.38 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 11.2 ttpt -99.7 126.56 45.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.788 -0.831 . . . . 0.0 109.626 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -124.23 160.43 27.95 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.751 -0.593 . . . . 0.0 110.319 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 54.63 52.17 12.67 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.413 -0.805 . . . . 0.0 110.892 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 69.4 p -73.7 160.26 31.81 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.353 -0.842 . . . . 0.0 109.952 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.755 HG23 ' O ' ' A' ' 95' ' ' TYR . 9.3 t -89.51 156.88 18.35 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.397 -0.814 . . . . 0.0 110.415 -179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -62.3 -31.85 72.51 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.545 -0.722 . . . . 0.0 110.276 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.755 ' O ' HG23 ' A' ' 93' ' ' THR . 22.0 m-85 -90.4 152.71 45.8 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.389 -0.82 . . . . 0.0 110.077 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -70.91 129.46 16.4 Favored 'Trans proline' 0 C--N 1.313 -1.301 0 O-C-N 123.507 1.267 . . . . 0.0 110.604 -179.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 74.0 p 41.88 38.61 1.05 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.755 -0.591 . . . . 0.0 111.784 179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.687 ' HB3' HG21 ' A' ' 93' ' ' THR . 72.5 t80 -59.0 -42.77 90.88 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.333 -0.855 . . . . 0.0 110.269 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.5 pttp -138.93 178.56 7.07 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.408 -0.807 . . . . 0.0 110.09 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -69.19 103.29 1.88 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.381 -0.824 . . . . 0.0 109.781 179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -69.41 148.6 49.38 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.532 -0.73 . . . . 0.0 110.362 -179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 49.6 m -119.54 135.14 54.91 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.535 -0.728 . . . . 0.0 110.001 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 38.2 m -130.21 148.25 52.02 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.515 -0.741 . . . . 0.0 110.227 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -88.06 129.7 35.21 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.457 -0.777 . . . . 0.0 109.73 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.457 ' CB ' ' HB3' ' A' ' 87' ' ' TYR . 43.2 p90 -127.04 169.73 13.07 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.279 -0.888 . . . . 0.0 110.602 -179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.54 ' HA2' HD13 ' A' ' 132' ' ' ILE . . . -156.12 177.19 33.3 Favored Glycine 0 N--CA 1.494 2.518 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -96.2 137.4 35.33 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.327 -1.102 . . . . 0.0 110.054 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 42.7 m -114.89 154.55 28.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.584 -0.697 . . . . 0.0 110.985 -179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.465 ' HA ' ' O ' ' A' ' 82' ' ' VAL . 37.3 p90 -158.03 154.09 27.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.687 -0.633 . . . . 0.0 109.656 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.748 ' C ' HG22 ' A' ' 82' ' ' VAL . . . 159.68 -169.45 35.71 Favored Glycine 0 N--CA 1.496 2.69 0 C-N-CA 119.525 -1.321 . . . . 0.0 110.607 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -161.82 165.07 28.35 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.689 -0.889 . . . . 0.0 109.338 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -152.26 -177.05 25.55 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.662 -1.375 . . . . 0.0 109.662 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.717 HD12 ' CZ ' ' A' ' 115' ' ' PHE . 0.7 OUTLIER -143.59 147.33 34.23 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.387 -1.066 . . . . 0.0 110.346 -179.814 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 48.7 tt0 -114.15 148.85 36.57 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.229 -0.919 . . . . 0.0 110.697 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.717 ' CZ ' HD12 ' A' ' 113' ' ' LEU . 91.6 m-85 -117.99 164.13 15.55 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.653 -0.654 . . . . 0.0 110.213 179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.7 m-20 -118.81 80.94 18.21 Favored Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 0.0 110.32 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -67.34 -14.48 42.9 Favored 'Trans proline' 0 C--N 1.313 -1.302 0 O-C-N 123.589 1.31 . . . . 0.0 111.341 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.551 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 79.9 mtp -148.93 -177.58 5.88 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 121.189 -0.944 . . . . 0.0 108.485 179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -69.39 -41.62 76.21 Favored 'General case' 0 C--N 1.291 -1.963 0 O-C-N 121.748 -0.595 . . . . 0.0 110.948 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -118.08 12.57 13.65 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.093 -1.004 . . . . 0.0 111.928 -179.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.551 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 20.4 t -114.03 137.18 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.981 0 O-C-N 120.92 -1.112 . . . . 0.0 109.94 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.626 ' HB3' ' O ' ' A' ' 145' ' ' GLY . . . -137.7 135.59 36.59 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.45 -179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.84 HD12 ' O ' ' A' ' 143' ' ' GLY . 19.3 tp -110.78 147.01 35.35 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 65.2 t0 -144.68 143.7 30.86 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.483 -1.385 . . . . 0.0 111.206 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.439 ' CZ ' HD21 ' A' ' 123' ' ' LEU . 98.7 m-85 -119.02 142.06 48.15 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 23.3 t -134.26 139.63 45.88 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.0 111.263 -179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -118.67 111.03 18.0 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -141.89 143.76 33.48 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.556 -0.715 . . . . 0.0 110.596 -179.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -137.09 151.93 49.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.442 -0.786 . . . . 0.0 109.761 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.0 t -126.52 138.65 53.51 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.365 -0.834 . . . . 0.0 110.367 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.422 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 76.5 mtp180 -136.78 137.57 39.96 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.402 -0.811 . . . . 0.0 111.151 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.607 HG23 ' O ' ' A' ' 132' ' ' ILE . 6.7 tp -134.23 63.59 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 C-N-CA 119.931 -0.708 . . . . 0.0 109.908 179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 69.5 mtp85 59.91 -59.59 0.06 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 179.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.492 ' N ' ' O ' ' A' ' 132' ' ' ILE . 56.5 p -95.49 -18.63 20.5 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.112 -0.992 . . . . 0.0 111.793 -178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.529 ' HB ' HG22 ' A' ' 132' ' ' ILE . 47.4 t -128.85 134.26 64.67 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.07 0 C-N-CA 118.682 -1.207 . . . . 0.0 111.729 -178.744 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -131.32 112.28 12.61 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.898 HG22 ' CB ' ' A' ' 14' ' ' ALA . 21.4 t -117.18 145.28 23.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.833 0 O-C-N 120.957 -1.089 . . . . 0.0 110.195 -179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -130.11 114.09 1.59 Allowed Glycine 0 N--CA 1.494 2.524 0 N-CA-C 108.958 -1.657 . . . . 0.0 108.958 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.5 t -139.07 154.22 48.16 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.255 -1.144 . . . . 0.0 111.453 -179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 43.9 p90 -126.24 146.83 49.84 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.605 -0.685 . . . . 0.0 109.8 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.533 HD13 ' ND2' ' A' ' 25' ' ' ASN . 72.6 mt -112.4 141.42 27.99 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.329 -0.857 . . . . 0.0 110.666 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.79 145.23 31.56 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.437 -0.789 . . . . 0.0 109.895 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.84 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -177.2 -139.38 3.27 Favored Glycine 0 N--CA 1.493 2.462 0 C-N-CA 119.203 -1.475 . . . . 0.0 111.715 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.422 ' HA ' ' O ' ' A' ' 122' ' ' ALA . 35.7 m -114.25 176.78 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 O-C-N 122.035 -0.685 . . . . 0.0 110.838 -178.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.626 ' O ' ' HB3' ' A' ' 122' ' ' ALA . . . -162.42 144.56 9.78 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.645 -1.264 . . . . 0.0 111.33 -179.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -129.8 157.39 42.35 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.842 -0.799 . . . . 0.0 109.263 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 32.1 mtp-105 -123.26 122.94 39.63 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.091 -1.006 . . . . 0.0 111.244 -179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 67.7 t80 . . . . . 0 N--CA 1.498 1.944 0 O-C-N 121.461 -0.774 . . . . 0.0 110.514 -179.898 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 65.3 p . . . . . 0 N--CA 1.494 1.748 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 49.2 m -119.8 144.21 47.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.315 -0.866 . . . . 0.0 109.418 179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.772 HG23 ' O ' ' A' ' 146' ' ' TYR . 76.6 m -136.98 142.37 42.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.273 -0.892 . . . . 0.0 110.579 179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.414 ' C ' ' HG1' ' A' ' 6' ' ' THR . 34.4 m -123.0 141.48 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 C-N-CA 120.153 -0.619 . . . . 0.0 109.822 179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.793 HG23 ' O ' ' A' ' 144' ' ' VAL . 87.6 m -156.37 130.38 8.53 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.562 -0.711 . . . . 0.0 109.593 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.412 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -164.27 176.23 40.23 Favored Glycine 0 N--CA 1.491 2.346 0 C-N-CA 119.502 -1.332 . . . . 0.0 110.322 -179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.73 -125.94 1.05 Allowed Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -147.06 162.0 39.69 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.478 -1.013 . . . . 0.0 109.528 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -144.29 142.8 30.67 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 118.737 -1.185 . . . . 0.0 111.59 -179.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.3 pt20 -125.07 143.9 50.68 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.628 ' OG ' HG23 ' A' ' 139' ' ' THR . 1.0 OUTLIER -147.47 149.23 32.27 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.638 -1.225 . . . . 0.0 112.266 -178.122 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.87 ' O ' HG13 ' A' ' 137' ' ' VAL . 52.7 t0 -74.98 148.87 39.56 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.177 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.719 ' HB1' ' HB2' ' A' ' 17' ' ' GLN . . . -125.15 100.52 6.59 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.804 -1.185 . . . . 0.0 111.578 -178.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -79.58 115.06 18.98 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 178.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.51 -15.89 45.32 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.719 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 89.9 mt-30 -106.08 171.87 7.11 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.104 -1.233 . . . . 0.0 109.825 179.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.41 ' CG ' ' HE2' ' A' ' 48' ' ' LYS . 89.3 mtp -56.52 -49.84 73.57 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.332 -0.855 . . . . 0.0 111.659 -178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.541 ' O ' ' HB3' ' A' ' 14' ' ' ALA . 47.4 p-10 -162.43 -155.7 0.37 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.698 -1.251 . . . . 0.0 110.435 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 55.3 pttt -84.25 166.92 17.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.334 -0.854 . . . . 0.0 111.005 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 64.6 mtt -126.03 167.9 14.69 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.442 -0.787 . . . . 0.0 110.918 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.46 128.44 2.93 Favored Glycine 0 N--CA 1.502 3.049 0 C-N-CA 120.013 -1.089 . . . . 0.0 110.392 -179.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.71 ' HA3' HG22 ' A' ' 46' ' ' THR . . . -145.92 -167.29 12.49 Favored Glycine 0 N--CA 1.494 2.53 0 C-N-CA 119.295 -1.431 . . . . 0.0 111.033 -178.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.3 m-85 -122.13 161.73 22.57 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.855 -0.791 . . . . 0.0 109.494 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.412 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 25.3 p-10 -148.61 135.66 20.08 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.285 -0.966 . . . . 0.0 112.227 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 79.4 mt -113.76 150.37 33.51 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 178.349 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 80.2 mttt -136.46 142.08 43.57 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.508 -1.37 . . . . 0.0 110.511 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -119.46 123.82 44.98 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 178.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.528 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 45.9 ttp180 -123.17 143.56 49.93 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.147 -0.97 . . . . 0.0 112.123 -178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -112.81 133.69 54.69 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -142.77 153.86 43.69 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.396 -0.815 . . . . 0.0 109.912 -179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -98.21 -173.72 2.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.282 -0.886 . . . . 0.0 110.185 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -62.87 -38.24 90.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.605 -0.684 . . . . 0.0 110.411 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -98.28 18.42 16.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.432 -0.792 . . . . 0.0 111.217 -179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.476 ' N ' ' HD3' ' A' ' 36' ' ' PRO . 1.9 m 34.46 56.02 1.91 Allowed Pre-proline 0 N--CA 1.505 2.315 0 N-CA-C 113.596 0.961 . . . . 0.0 113.596 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 35' ' ' SER . 43.2 Cg_endo -87.96 -70.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 122.991 0.995 . . . . 0.0 109.913 178.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 83.2 mt -93.5 119.81 33.02 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.534 -0.729 . . . . 0.0 110.004 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.61 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . -121.89 134.75 10.04 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.273 -1.131 . . . . 0.0 110.273 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 61.7 t -130.48 132.86 64.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.336 -1.097 . . . . 0.0 108.921 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.466 HG12 ' CG ' ' A' ' 29' ' ' ARG . 72.4 mt -120.3 139.45 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 120.742 -1.224 . . . . 0.0 110.818 -179.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 27' ' ' LYS . . . -112.98 117.78 4.37 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 107.703 -2.159 . . . . 0.0 107.703 178.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.421 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 48.3 t -123.84 141.68 51.81 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.144 -1.21 . . . . 0.0 112.503 -177.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -120.05 142.18 49.08 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 178.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 47.5 m -130.91 139.14 50.05 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.004 -1.06 . . . . 0.0 110.902 -179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -136.69 110.65 8.24 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.71 HG22 ' HA3' ' A' ' 23' ' ' GLY . 44.6 p -121.69 157.83 30.04 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.464 -0.773 . . . . 0.0 109.989 -179.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -118.31 155.38 30.72 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.336 -0.853 . . . . 0.0 110.237 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.41 ' HE2' ' CG ' ' A' ' 18' ' ' MET . 18.1 tttt -93.02 135.43 34.19 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 33.2 t -109.72 140.67 43.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.332 -0.855 . . . . 0.0 110.655 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 88.5 mtt180 -125.26 140.39 52.88 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.629 -0.669 . . . . 0.0 109.875 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 81.1 p -66.68 -40.62 88.65 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.392 -0.817 . . . . 0.0 110.058 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.96 -32.86 69.85 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.486 -0.759 . . . . 0.0 110.216 179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 66.8 m 52.78 21.29 1.87 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.475 -0.766 . . . . 0.0 111.099 -179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 82.5 p -81.28 -18.17 46.84 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.238 -0.914 . . . . 0.0 110.568 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -92.8 46.42 2.5 Favored Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -57.78 -40.44 79.86 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.301 -1.117 . . . . 0.0 109.944 179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -70.28 -21.42 62.96 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.655 -0.653 . . . . 0.0 110.229 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -94.94 33.53 1.49 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.394 -0.816 . . . . 0.0 110.441 -179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 8.9 pttt -59.58 125.55 24.09 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.36 -0.837 . . . . 0.0 110.438 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 -97.9 160.27 14.41 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.439 -0.788 . . . . 0.0 110.052 -179.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -128.53 152.17 48.6 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.319 -0.863 . . . . 0.0 109.983 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 74.6 t80 -121.55 112.79 18.93 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.197 -0.94 . . . . 0.0 110.87 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.421 ' HB3' ' HB2' ' A' ' 87' ' ' TYR . 49.0 t80 -98.42 140.3 32.89 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.07 117.7 0.95 Allowed Glycine 0 N--CA 1.486 2.01 0 C-N-CA 119.168 -1.491 . . . . 0.0 110.337 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.44 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 14.4 tt -112.03 134.97 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 N-CA-C 107.349 -1.352 . . . . 0.0 107.349 178.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.736 HG23 ' O ' ' A' ' 83' ' ' VAL . 70.9 m -151.7 141.68 22.09 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.812 -1.18 . . . . 0.0 111.712 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.543 ' O ' HG22 ' A' ' 83' ' ' VAL . . . -147.58 150.05 33.72 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 178.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.86 170.59 40.7 Favored Glycine 0 N--CA 1.495 2.631 0 C-N-CA 119.345 -1.407 . . . . 0.0 110.751 -179.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.429 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 48.1 Cg_endo -74.07 172.47 15.88 Favored 'Trans proline' 0 C--N 1.316 -1.162 0 O-C-N 123.955 1.503 . . . . 0.0 110.741 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.61 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -148.62 141.55 24.77 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.482 -0.762 . . . . 0.0 109.741 179.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -127.19 146.17 50.5 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.611 -0.68 . . . . 0.0 110.77 -179.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.6 ttp85 -106.0 131.65 53.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.518 -0.739 . . . . 0.0 109.927 179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 79.4 mt -121.24 108.14 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.465 -0.772 . . . . 0.0 109.255 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 46.8 t30 53.86 42.22 31.8 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.599 -0.688 . . . . 0.0 110.072 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 77' ' ' ALA . 91.6 m-20 50.8 -175.22 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.502 -0.748 . . . . 0.0 110.788 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 99.0 m95 55.47 -84.79 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.755 -0.591 . . . . 0.0 111.389 179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' N ' ' O ' ' A' ' 75' ' ' ASP . . . -65.61 141.52 58.38 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.126 -0.984 . . . . 0.0 111.123 -179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 29.9 t -138.13 150.06 46.48 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.522 -0.736 . . . . 0.0 109.72 179.396 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 15.6 tt -133.55 138.04 51.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 120.999 -1.063 . . . . 0.0 109.973 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.0 p90 -147.89 158.15 43.89 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.158 -0.963 . . . . 0.0 111.635 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -107.08 161.01 13.92 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 107.919 -2.072 . . . . 0.0 107.919 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.78 HG22 ' O ' ' A' ' 110' ' ' GLY . 35.0 m -142.58 146.81 21.69 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.093 -1.239 . . . . 0.0 111.96 -179.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.736 ' O ' HG23 ' A' ' 66' ' ' THR . 26.8 m -138.15 152.26 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 177.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . -179.85 177.5 48.12 Favored Glycine 0 N--CA 1.479 1.548 0 C-N-CA 118.876 -1.63 . . . . 0.0 110.734 -179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.442 ' CG1' ' CZ ' ' A' ' 87' ' ' TYR . 48.7 t -122.3 135.78 61.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-O 121.738 0.78 . . . . 0.0 111.002 -179.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.469 ' O ' ' HA ' ' A' ' 105' ' ' TYR . . . -103.4 133.97 11.67 Favored Glycine 0 N--CA 1.494 2.563 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.442 ' CZ ' ' CG1' ' A' ' 85' ' ' VAL . 91.5 m-85 -117.09 146.1 43.34 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.153 -1.204 . . . . 0.0 110.47 -179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -121.32 116.84 3.26 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.395 -1.482 . . . . 0.0 109.395 179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.7 mttp -103.2 113.01 26.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.516 -0.991 . . . . 0.0 109.963 179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -125.09 157.1 37.14 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.826 -0.546 . . . . 0.0 110.069 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 47.6 tt0 -72.55 142.77 48.46 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.353 -0.842 . . . . 0.0 109.642 179.374 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 15.3 t -132.06 164.42 26.28 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.355 -0.841 . . . . 0.0 110.767 -179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 43.5 m -55.4 -34.17 64.15 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.547 -0.72 . . . . 0.0 110.355 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 57.34 107.04 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.677 -0.639 . . . . 0.0 110.83 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -61.31 147.18 87.75 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.386 -0.822 . . . . 0.0 109.981 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.13 -20.66 37.52 Favored 'Trans proline' 0 C--N 1.313 -1.329 0 O-C-N 123.513 1.27 . . . . 0.0 110.974 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 49.5 m -124.41 143.71 50.47 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.283 -0.886 . . . . 0.0 110.854 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.414 ' CD2' ' O ' ' A' ' 98' ' ' TYR . 55.9 t80 51.49 64.59 1.78 Allowed 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.512 -0.742 . . . . 0.0 111.105 179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 40.2 tttm -67.31 134.28 51.26 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.333 -0.855 . . . . 0.0 110.542 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.404 ' OD1' ' CE2' ' A' ' 98' ' ' TYR . 84.5 m-20 -111.35 120.43 42.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.458 -0.776 . . . . 0.0 109.88 179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 51.8 t0 -89.5 111.15 21.97 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.4 -0.812 . . . . 0.0 110.621 -179.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 14.8 t -141.16 153.71 45.5 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.42 -0.8 . . . . 0.0 110.505 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.2 m -130.01 147.97 51.81 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.434 -0.791 . . . . 0.0 110.192 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 52.6 t0 -80.13 125.2 29.51 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.299 -0.876 . . . . 0.0 109.781 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 86' ' ' GLY . 38.6 p90 -132.04 170.34 15.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.262 -0.899 . . . . 0.0 111.436 -179.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.709 ' HA3' HD13 ' A' ' 132' ' ' ILE . . . -160.03 -177.46 33.14 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 108.619 -1.792 . . . . 0.0 108.619 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 65.0 t80 -106.64 150.14 26.52 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.965 -1.315 . . . . 0.0 111.634 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 96.4 p -128.86 161.57 29.53 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.716 -0.615 . . . . 0.0 110.108 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 75.4 t80 -155.68 148.52 24.26 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.379 -0.825 . . . . 0.0 109.802 179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.78 ' O ' HG22 ' A' ' 82' ' ' VAL . . . 175.0 -175.36 47.07 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.468 -1.349 . . . . 0.0 110.827 179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.67 159.51 9.99 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.609 -0.936 . . . . 0.0 109.022 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -160.48 -174.75 30.69 Favored Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.802 -1.719 . . . . 0.0 108.802 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -143.31 162.02 36.8 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.22 -1.165 . . . . 0.0 111.059 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.5 ' HG2' ' HB3' ' A' ' 124' ' ' ASP . 91.3 mt-30 -107.68 144.49 34.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.523 -0.735 . . . . 0.0 109.537 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . 0.447 ' CZ ' ' CE2' ' A' ' 125' ' ' PHE . 46.2 p90 -152.23 151.85 31.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.457 -0.777 . . . . 0.0 110.302 179.663 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.483 HD21 HD12 ' A' ' 123' ' ' LEU . 0.2 OUTLIER 166.75 142.34 0.05 OUTLIER Pre-proline 0 N--CA 1.509 2.493 0 O-C-N 121.776 -0.577 . . . . 0.0 111.013 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 116' ' ' ASN . 52.0 Cg_endo -88.51 47.96 1.29 Allowed 'Trans proline' 0 C--N 1.315 -1.192 0 O-C-N 123.491 1.259 . . . . 0.0 109.155 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.438 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 95.6 mmm -142.26 135.25 28.63 Favored 'General case' 0 N--CA 1.483 1.182 0 O-C-N 121.401 -0.812 . . . . 0.0 108.94 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -63.08 -42.3 99.61 Favored 'General case' 0 C--N 1.293 -1.865 0 O-C-N 121.813 -0.554 . . . . 0.0 112.44 -178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -106.58 5.55 29.18 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.721 -1.237 . . . . 0.0 112.922 -178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.438 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 48.4 t -119.92 136.42 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 120.715 -1.241 . . . . 0.0 110.506 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 116' ' ' ASN . . . -145.44 129.98 17.91 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.781 -0.768 . . . . 0.0 111.577 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.483 HD12 HD21 ' A' ' 116' ' ' ASN . 80.6 mt -111.95 150.67 30.2 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.5 ' HB3' ' HG2' ' A' ' 114' ' ' GLN . 54.1 p30 -148.76 156.1 41.88 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.653 -1.279 . . . . 0.0 112.42 -179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . 0.447 ' CE2' ' CZ ' ' A' ' 115' ' ' PHE . 34.2 m-85 -123.64 141.41 52.04 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.545 179.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.2 m -138.98 147.75 42.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.382 -0.824 . . . . 0.0 110.916 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -117.97 124.23 47.69 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -133.58 138.25 45.91 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.264 -0.898 . . . . 0.0 111.416 -179.255 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -119.68 128.61 53.98 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.639 -0.663 . . . . 0.0 109.537 179.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.9 m -122.31 146.34 47.39 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.287 -0.883 . . . . 0.0 110.626 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.8 mtm180 -129.39 125.18 36.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.432 -0.793 . . . . 0.0 110.117 179.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.709 HD13 ' HA3' ' A' ' 106' ' ' GLY . 14.7 mm -113.87 63.44 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.456 ' HB3' ' O ' ' A' ' 132' ' ' ILE . 22.9 ttt180 66.23 -60.04 0.32 Allowed 'General case' 0 N--CA 1.503 2.201 0 O-C-N 121.406 -0.809 . . . . 0.0 111.349 -179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.429 ' N ' ' O ' ' A' ' 132' ' ' ILE . 0.6 OUTLIER -125.68 9.23 7.66 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.057 -1.027 . . . . 0.0 111.16 -179.6 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.562 HG11 ' NE2' ' A' ' 17' ' ' GLN . 43.9 t -124.77 132.88 70.73 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.182 -0.949 . . . . 0.0 110.678 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -131.54 111.78 12.06 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.87 HG13 ' O ' ' A' ' 13' ' ' ASP . 88.1 t -115.24 145.13 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.331 -0.856 . . . . 0.0 110.799 -178.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -107.47 103.9 2.02 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 107.116 -2.394 . . . . 0.0 107.116 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.628 HG23 ' OG ' ' A' ' 12' ' ' SER . 53.2 m -104.9 136.85 43.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.383 -1.069 . . . . 0.0 112.105 -177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -114.22 134.34 54.99 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 178.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 75.1 mt -116.05 132.55 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.216 -0.928 . . . . 0.0 110.52 -179.362 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.0 143.06 31.03 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.479 -0.763 . . . . 0.0 109.425 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -174.77 -146.71 5.83 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 118.709 -1.71 . . . . 0.0 112.151 -179.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.793 ' O ' HG23 ' A' ' 6' ' ' THR . 34.1 m -118.47 175.69 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 CA-C-O 121.289 0.566 . . . . 0.0 111.075 -178.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -157.36 139.84 6.7 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 110.396 -1.082 . . . . 0.0 110.396 -179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.772 ' O ' HG23 ' A' ' 4' ' ' THR . 97.7 m-85 -132.98 157.37 45.36 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.598 -0.942 . . . . 0.0 109.837 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -131.9 121.33 23.85 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.271 -0.893 . . . . 0.0 111.065 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 . . . . . 0 N--CA 1.491 1.575 0 O-C-N 121.403 -0.81 . . . . 0.0 110.29 -179.874 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 73.4 p . . . . . 0 N--CA 1.494 1.741 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 96.9 p -112.44 145.82 39.49 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.36 -0.838 . . . . 0.0 109.68 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.71 HG21 ' CZ ' ' A' ' 29' ' ' ARG . 91.8 m -136.98 139.18 41.27 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.328 -0.857 . . . . 0.0 110.634 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 34.0 m -128.05 142.25 44.28 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.571 -0.705 . . . . 0.0 109.846 179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.785 HG23 ' O ' ' A' ' 144' ' ' VAL . 62.8 m -156.42 130.52 8.56 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.44 -0.788 . . . . 0.0 110.123 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.411 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -165.66 171.6 40.91 Favored Glycine 0 N--CA 1.493 2.442 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.61 -136.36 2.3 Favored Glycine 0 N--CA 1.494 2.537 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -132.76 158.54 42.16 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.549 -0.971 . . . . 0.0 109.108 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.469 ' HB1' ' O ' ' A' ' 140' ' ' TRP . . . -145.39 142.3 29.22 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.541 -1.264 . . . . 0.0 112.286 -179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 95.8 mt-30 -111.54 145.8 38.45 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 107.257 -1.386 . . . . 0.0 107.257 177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.614 ' HB2' HG23 ' A' ' 139' ' ' THR . 19.8 t -146.35 151.22 37.14 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.411 -1.316 . . . . 0.0 112.914 -177.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.712 ' O ' HG13 ' A' ' 137' ' ' VAL . 86.5 m-20 -100.92 150.64 22.65 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 107.073 -1.454 . . . . 0.0 107.073 177.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.743 ' HB3' ' HB2' ' A' ' 17' ' ' GLN . . . -134.12 116.3 15.26 Favored 'General case' 0 C--N 1.305 -1.368 0 O-C-N 120.787 -1.196 . . . . 0.0 111.823 -178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.5 tt0 -67.03 117.14 8.68 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 107.59 -14.18 38.82 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -177.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.743 ' HB2' ' HB3' ' A' ' 14' ' ' ALA . 87.6 mt-30 -114.59 156.62 24.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.348 -1.09 . . . . 0.0 109.356 178.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 70.1 mtm -100.51 -75.52 0.58 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.206 -0.933 . . . . 0.0 111.613 -179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 40.7 t-20 -57.46 132.04 51.93 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.366 -0.834 . . . . 0.0 111.553 -178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.6 pttm -63.6 169.07 4.17 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.64 -0.663 . . . . 0.0 110.237 179.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 90.1 mtp -128.15 166.7 18.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.279 -0.888 . . . . 0.0 111.44 -178.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.814 ' O ' HG23 ' A' ' 46' ' ' THR . . . -124.86 178.94 16.34 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 107.904 -2.079 . . . . 0.0 107.904 179.177 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.94 148.27 9.19 Favored Glycine 0 N--CA 1.494 2.513 0 C-N-CA 118.57 -1.776 . . . . 0.0 111.89 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 74.2 t80 -109.24 133.68 52.72 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.411 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 76.1 m-20 -120.85 128.4 52.79 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.201 -0.937 . . . . 0.0 111.852 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.579 HD21 ' OH ' ' A' ' 28' ' ' TYR . 25.0 tp -121.58 133.53 55.0 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 107.253 -1.388 . . . . 0.0 107.253 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.43 ' HG2' ' CB ' ' A' ' 42' ' ' SER . 22.7 mttt -136.08 146.71 47.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.313 -1.492 . . . . 0.0 111.44 -178.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.579 ' OH ' HD21 ' A' ' 26' ' ' LEU . 97.4 m-85 -115.96 129.46 56.4 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.71 ' CZ ' HG21 ' A' ' 4' ' ' THR . 56.2 ttp180 -128.57 134.32 48.59 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.15 -0.969 . . . . 0.0 112.106 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . 0.468 ' O ' HG22 ' A' ' 39' ' ' VAL . 99.4 m-85 -125.06 139.95 53.33 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.592 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -142.04 150.26 41.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.144 -0.973 . . . . 0.0 110.278 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 74.8 tt0 -99.85 132.68 45.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.368 -0.833 . . . . 0.0 109.662 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -56.71 -24.15 47.32 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.481 -0.762 . . . . 0.0 111.226 -179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -60.61 -40.56 92.3 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.273 -0.892 . . . . 0.0 110.946 -178.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.611 ' CB ' HD23 ' A' ' 37' ' ' LEU . 0.4 OUTLIER -140.43 166.92 19.92 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.226 -0.921 . . . . 0.0 110.559 -179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -84.61 42.1 1.1 Allowed 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 123.722 1.38 . . . . 0.0 111.061 179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.611 HD23 ' CB ' ' A' ' 35' ' ' SER . 0.6 OUTLIER -89.05 76.27 7.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.318 -0.864 . . . . 0.0 110.203 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 69' ' ' PRO . . . -79.67 132.85 11.74 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 30' ' ' TYR . 35.6 m -132.67 129.26 58.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.359 -1.083 . . . . 0.0 108.925 178.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 28' ' ' TYR . 17.0 tt -132.11 144.75 36.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.272 -0.893 . . . . 0.0 111.431 -178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -106.58 148.21 16.38 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 107.137 -2.385 . . . . 0.0 107.137 177.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.43 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 42.3 t -138.72 141.53 38.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.037 -1.272 . . . . 0.0 111.891 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -125.49 138.31 53.98 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 9.4 t -134.62 145.78 48.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.974 -1.079 . . . . 0.0 111.216 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -127.99 111.38 13.48 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.086 -1.079 . . . . 0.0 108.086 178.28 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.814 HG23 ' O ' ' A' ' 22' ' ' GLY . 87.1 m -119.24 141.9 48.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.692 -0.63 . . . . 0.0 110.68 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.1 pt-20 -148.75 179.63 7.69 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.352 -0.843 . . . . 0.0 110.075 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.3 mttp -72.93 154.74 40.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.437 -0.789 . . . . 0.0 109.99 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 35.2 m -57.74 156.93 7.93 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.455 -0.778 . . . . 0.0 110.448 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -55.62 148.82 15.15 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.456 -0.778 . . . . 0.0 110.69 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 60.4 p -114.88 168.71 9.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.499 -0.75 . . . . 0.0 110.098 -179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -58.67 -30.08 67.09 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.454 -0.779 . . . . 0.0 110.318 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 22.9 t -58.36 -35.73 72.4 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.433 -0.792 . . . . 0.0 110.243 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.5 p 47.33 40.84 11.36 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.583 -0.698 . . . . 0.0 111.156 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -84.51 178.29 51.52 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.412 ' OD1' ' CD2' ' A' ' 57' ' ' TYR . 53.3 p30 -90.67 11.15 23.04 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.456 -1.026 . . . . 0.0 111.104 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.412 ' CD2' ' OD1' ' A' ' 56' ' ' ASP . 34.5 m-85 -113.0 144.51 42.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.151 -0.968 . . . . 0.0 110.09 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 87.4 m-20 -114.66 15.79 17.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.482 -0.762 . . . . 0.0 110.453 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 36.5 tttp 53.33 -88.72 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.439 -0.788 . . . . 0.0 110.989 -179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -105.07 143.1 33.73 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.918 -1.114 . . . . 0.0 110.468 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -121.4 154.77 36.07 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.479 -0.763 . . . . 0.0 109.538 179.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -110.33 118.41 36.23 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.217 -0.927 . . . . 0.0 110.748 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.465 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 46.6 t80 -98.44 139.66 33.85 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.73 122.27 1.4 Allowed Glycine 0 N--CA 1.49 2.26 0 C-N-CA 118.969 -1.586 . . . . 0.0 110.987 -179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.581 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 43.7 pt -112.85 138.0 43.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 178.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.56 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 1.3 p -153.57 144.29 22.62 Favored 'General case' 0 N--CA 1.49 1.543 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.584 -179.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.617 ' O ' HG22 ' A' ' 83' ' ' VAL . . . -151.26 153.59 35.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.473 -0.767 . . . . 0.0 109.27 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -168.85 174.15 43.43 Favored Glycine 0 N--CA 1.495 2.611 0 C-N-CA 119.563 -1.303 . . . . 0.0 110.536 -179.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.453 ' HA ' ' O ' ' A' ' 38' ' ' GLY . 45.9 Cg_endo -71.8 167.69 25.88 Favored 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.891 1.469 . . . . 0.0 110.846 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -148.51 141.7 25.04 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.412 -0.805 . . . . 0.0 110.404 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -120.5 131.56 54.78 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.503 -0.748 . . . . 0.0 110.503 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 72.8 mtm180 -111.32 143.69 41.71 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.657 -0.652 . . . . 0.0 110.391 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.632 HG22 ' O ' ' A' ' 73' ' ' ILE . 80.4 mt 54.07 22.88 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 O-C-N 121.397 -0.814 . . . . 0.0 110.639 179.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -89.67 116.32 27.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.154 -0.966 . . . . 0.0 110.086 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 51.62 -92.87 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.575 -0.703 . . . . 0.0 110.638 -179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 99.8 m95 -130.31 139.73 50.69 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.804 -1.185 . . . . 0.0 110.407 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.78 ' HB1' ' O ' ' A' ' 114' ' ' GLN . . . 48.76 -166.91 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.384 -0.822 . . . . 0.0 111.139 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.495 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 24.6 m -115.5 146.14 41.97 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 121.357 -0.839 . . . . 0.0 109.364 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 77.0 mt -131.31 138.44 53.2 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 121.149 -0.969 . . . . 0.0 111.234 -179.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 45.0 p90 -142.25 157.22 45.08 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.492 -0.755 . . . . 0.0 110.461 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -106.51 164.2 13.5 Favored Glycine 0 N--CA 1.494 2.558 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.519 HG13 ' HB ' ' A' ' 66' ' ' THR . 48.9 t -139.24 132.79 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.231 -1.158 . . . . 0.0 111.086 -179.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.617 HG22 ' O ' ' A' ' 67' ' ' ALA . 26.7 m -141.89 151.95 18.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 178.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.581 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 164.24 -161.42 34.42 Favored Glycine 0 N--CA 1.48 1.572 0 C-N-CA 119.157 -1.497 . . . . 0.0 110.755 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.554 HG22 ' CG1' ' A' ' 65' ' ' ILE . 33.8 m -130.16 162.87 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-O 122.226 1.013 . . . . 0.0 112.651 -178.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -143.07 137.84 7.9 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 109.804 -1.318 . . . . 0.0 109.804 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.465 ' CE2' ' HB3' ' A' ' 63' ' ' TYR . 13.9 p90 -150.82 163.94 37.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.081 -1.246 . . . . 0.0 110.701 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -119.36 141.28 15.61 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -134.01 140.9 47.0 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.826 -0.808 . . . . 0.0 109.942 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -99.64 131.98 45.28 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.298 -0.876 . . . . 0.0 110.13 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 21.6 pt20 -93.22 19.36 8.17 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.45 -0.781 . . . . 0.0 110.83 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 61.6 p -71.33 158.59 36.07 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.282 -0.886 . . . . 0.0 110.058 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 45.6 m -57.78 -40.03 78.87 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.441 -0.787 . . . . 0.0 110.451 -179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.407 ' HG2' ' N ' ' A' ' 95' ' ' TYR . 86.3 tt0 56.14 164.72 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.553 -0.717 . . . . 0.0 110.675 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.407 ' N ' ' HG2' ' A' ' 94' ' ' GLU . 1.1 m-85 -58.03 166.49 2.0 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 121.279 -0.888 . . . . 0.0 110.221 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 38.6 Cg_endo -64.67 -15.73 51.61 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 O-C-N 123.635 1.334 . . . . 0.0 110.583 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.1 t -128.62 155.54 44.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.362 -0.836 . . . . 0.0 109.721 179.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 98' ' ' TYR . 31.7 p90 -137.33 149.03 46.75 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.304 -0.872 . . . . 0.0 110.918 -179.715 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -89.69 4.61 49.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.581 -0.699 . . . . 0.0 110.571 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 30.6 t30 59.13 36.24 23.98 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.26 -0.9 . . . . 0.0 110.276 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -131.67 3.56 4.17 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.489 -0.757 . . . . 0.0 110.843 179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 74.9 p -78.03 -28.11 48.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.169 -0.957 . . . . 0.0 110.589 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 59.7 m -83.63 151.01 25.54 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.417 -0.802 . . . . 0.0 110.475 -179.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 83.8 m-20 -134.84 136.92 42.83 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.528 -0.733 . . . . 0.0 109.73 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.896 ' O ' HG23 ' A' ' 132' ' ' ILE . 43.2 p90 -133.04 169.44 16.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.256 -0.902 . . . . 0.0 110.912 -179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -163.03 -175.75 34.38 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.074 -1.61 . . . . 0.0 109.074 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.432 ' CD1' HG12 ' A' ' 85' ' ' VAL . 98.8 m-85 -112.03 155.28 24.07 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.186 -1.185 . . . . 0.0 110.655 -179.387 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 97.6 p -129.86 160.92 32.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.491 -0.755 . . . . 0.0 110.646 -179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.561 ' CD1' HG12 ' A' ' 83' ' ' VAL . 65.7 t80 -155.26 148.03 24.35 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.439 -0.788 . . . . 0.0 109.673 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 175.82 -176.77 47.59 Favored Glycine 0 N--CA 1.495 2.584 0 C-N-CA 119.519 -1.324 . . . . 0.0 110.602 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -168.88 160.0 9.94 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.713 -0.875 . . . . 0.0 108.707 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.433 ' C ' HD12 ' A' ' 113' ' ' LEU . . . -152.47 -179.1 27.77 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 -179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.589 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.3 mp -126.68 160.1 31.74 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.453 -1.027 . . . . 0.0 110.002 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.78 ' O ' ' HB1' ' A' ' 77' ' ' ALA . 36.5 tt0 -106.65 140.65 39.17 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.81 -1.181 . . . . 0.0 108.057 178.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -124.65 165.19 18.34 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.372 -0.83 . . . . 0.0 111.518 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.84 88.94 0.1 OUTLIER Pre-proline 0 N--CA 1.5 2.035 0 O-C-N 121.865 -0.522 . . . . 0.0 109.927 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.96 125.49 12.63 Favored 'Trans proline' 0 C--N 1.313 -1.294 0 O-C-N 123.734 1.386 . . . . 0.0 110.398 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.43 ' CB ' ' HB ' ' A' ' 121' ' ' VAL . 95.5 mmm -145.21 163.25 35.0 Favored 'General case' 0 C--N 1.304 -1.379 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -62.13 -49.08 77.31 Favored 'General case' 0 C--N 1.289 -2.032 0 O-C-N 121.688 -0.632 . . . . 0.0 110.401 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 89.7 m-20 -134.17 25.26 3.87 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.274 -0.891 . . . . 0.0 111.349 -179.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.43 ' HB ' ' CB ' ' A' ' 118' ' ' MET . 48.2 t -127.11 139.66 51.27 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.95 -1.094 . . . . 0.0 109.964 179.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.715 ' HB1' ' CD ' ' A' ' 114' ' ' GLN . . . -154.81 137.7 15.41 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.568 -0.853 . . . . 0.0 111.785 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.562 HD23 ' HA ' ' A' ' 144' ' ' VAL . 77.7 mt -121.65 143.62 49.22 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 49.8 p30 -149.45 153.25 37.0 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 118.246 -1.381 . . . . 0.0 112.395 -179.278 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -125.31 140.14 53.08 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.716 -0.846 . . . . 0.0 108.716 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.6 t -143.62 149.23 37.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -0.977 . . . . 0.0 111.181 -179.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -104.9 123.41 47.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.637 -0.665 . . . . 0.0 109.368 179.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -137.36 142.84 41.76 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.634 -0.666 . . . . 0.0 110.481 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -138.5 156.88 47.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.52 -0.738 . . . . 0.0 109.765 179.439 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 30.2 t -133.33 143.53 49.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.385 -0.822 . . . . 0.0 110.53 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -124.59 127.73 47.82 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.563 -0.71 . . . . 0.0 109.761 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.896 HG23 ' O ' ' A' ' 105' ' ' TYR . 85.1 mt -121.17 39.37 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 68.5 mtt180 63.64 -55.13 0.21 Allowed 'General case' 0 N--CA 1.503 2.207 0 O-C-N 122.03 -0.419 . . . . 0.0 111.578 -179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 132' ' ' ILE . 66.5 p -99.93 -24.14 14.73 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.121 -0.987 . . . . 0.0 110.398 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 56.1 t -126.51 132.39 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.246 -0.909 . . . . 0.0 110.732 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 53.6 t0 -132.55 113.19 12.78 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.39 -0.819 . . . . 0.0 109.02 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.712 HG22 ' CB ' ' A' ' 14' ' ' ALA . 61.3 t -117.54 146.4 22.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.182 -0.949 . . . . 0.0 110.937 -178.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -115.78 114.62 3.17 Favored Glycine 0 N--CA 1.496 2.643 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 178.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.614 HG23 ' HB2' ' A' ' 12' ' ' SER . 27.8 m -109.03 140.56 42.39 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.209 -1.171 . . . . 0.0 112.322 -178.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.469 ' O ' ' HB1' ' A' ' 10' ' ' ALA . 41.6 m95 -109.01 136.75 48.03 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 46.4 pt -124.14 147.06 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 120.98 -1.075 . . . . 0.0 111.654 -178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -154.43 139.6 17.48 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -168.59 -153.21 8.12 Favored Glycine 0 N--CA 1.49 2.283 0 C-N-CA 118.695 -1.717 . . . . 0.0 112.072 -179.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.785 ' O ' HG23 ' A' ' 6' ' ' THR . 34.5 m -116.97 177.64 2.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 122.236 -0.567 . . . . 0.0 110.738 -179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -156.4 140.21 7.06 Favored Glycine 0 N--CA 1.491 2.328 0 C-N-CA 120.066 -1.064 . . . . 0.0 110.485 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -130.34 152.31 49.88 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.578 -0.954 . . . . 0.0 109.654 179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 40.5 ttm180 -128.04 120.68 27.98 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.206 -0.934 . . . . 0.0 110.81 -179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 64.5 t80 . . . . . 0 N--CA 1.493 1.68 0 O-C-N 121.48 -0.763 . . . . 0.0 110.205 179.934 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 80.6 p . . . . . 0 N--CA 1.493 1.695 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 50.5 m -116.44 145.21 43.44 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.9 . . . . 0.0 109.453 179.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.47 ' HB ' ' HB3' ' A' ' 29' ' ' ARG . 57.9 m -136.21 142.0 44.04 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.269 -0.895 . . . . 0.0 110.673 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.435 ' O ' ' HA2' ' A' ' 145' ' ' GLY . 14.7 p -128.61 141.39 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.655 -0.653 . . . . 0.0 109.571 179.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.784 HG23 ' O ' ' A' ' 144' ' ' VAL . 71.8 m -156.68 133.07 9.95 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.51 -0.744 . . . . 0.0 109.815 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 25' ' ' ASN . . . -166.23 173.47 41.73 Favored Glycine 0 N--CA 1.493 2.464 0 C-N-CA 119.453 -1.356 . . . . 0.0 110.156 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.85 -128.23 1.19 Allowed Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -118.35 152.77 35.17 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.406 -1.055 . . . . 0.0 109.866 -179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.02 116.52 22.26 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.198 -0.939 . . . . 0.0 110.688 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 97.2 mm-40 -110.62 142.71 42.11 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 25.3 t -148.49 145.35 27.9 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.699 -1.2 . . . . 0.0 112.42 -178.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -73.3 150.86 41.6 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.899 ' HB1' ' HB2' ' A' ' 17' ' ' GLN . . . -127.94 90.52 3.11 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 118.959 -1.096 . . . . 0.0 112.046 -178.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -80.91 116.09 20.71 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 99.87 -14.41 60.22 Favored Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.043 -1.223 . . . . 0.0 110.043 -179.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.899 ' HB2' ' HB1' ' A' ' 14' ' ' ALA . 93.2 mt-30 -100.83 172.75 6.86 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.018 -1.283 . . . . 0.0 110.463 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 88.0 mtp -57.55 -49.39 76.51 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.432 -0.792 . . . . 0.0 112.11 -178.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 18.4 t30 -164.55 -158.26 0.41 Allowed 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.771 -1.206 . . . . 0.0 110.655 -179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.8 tttp -77.68 159.98 28.78 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.437 -0.79 . . . . 0.0 110.304 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.733 ' HB3' HG22 ' A' ' 46' ' ' THR . 85.9 mtp -126.75 163.98 22.35 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.26 -0.9 . . . . 0.0 111.083 -179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.736 ' C ' HG23 ' A' ' 46' ' ' THR . . . -145.96 126.02 2.42 Favored Glycine 0 N--CA 1.498 2.784 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.573 ' N ' HG23 ' A' ' 46' ' ' THR . . . -142.75 -171.78 13.53 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.567 -1.302 . . . . 0.0 110.771 -178.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -114.48 146.62 40.46 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.636 -0.92 . . . . 0.0 109.988 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.418 ' O ' ' CA ' ' A' ' 7' ' ' GLY . 51.2 t-20 -130.85 127.85 39.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.371 -0.831 . . . . 0.0 110.997 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.794 HD13 ' N ' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -115.83 141.62 47.85 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.794 ' N ' HD13 ' A' ' 26' ' ' LEU . 31.9 mttm -130.8 144.86 51.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.419 -1.425 . . . . 0.0 110.501 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -122.75 124.46 43.41 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 178.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.47 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 59.0 ttt180 -122.74 142.72 50.41 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.147 -0.971 . . . . 0.0 111.953 -178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 69.3 t80 -114.07 137.23 51.99 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -138.44 152.01 47.95 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.4 -0.813 . . . . 0.0 109.61 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -96.21 178.22 5.46 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.045 -1.034 . . . . 0.0 109.93 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.11 -37.0 78.7 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.385 -0.822 . . . . 0.0 110.425 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 81.2 m-20 -90.97 12.16 20.53 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.431 -0.793 . . . . 0.0 111.338 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.576 ' N ' ' HD3' ' A' ' 36' ' ' PRO . 13.4 p 38.79 51.81 3.3 Favored Pre-proline 0 N--CA 1.503 2.178 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 179.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.576 ' HD3' ' N ' ' A' ' 35' ' ' SER . 44.4 Cg_endo -94.66 -66.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.316 -1.156 0 O-C-N 122.882 0.938 . . . . 0.0 110.547 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 24.1 tp -94.48 120.35 34.58 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.843 -0.536 . . . . 0.0 110.909 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.49 134.19 9.57 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 55.4 t -130.8 135.13 60.82 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.879 0 O-C-N 121.341 -1.094 . . . . 0.0 109.044 179.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.525 HD12 ' HB2' ' A' ' 80' ' ' TYR . 73.5 mt -119.87 140.59 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.855 -1.153 . . . . 0.0 110.936 -179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.43 125.63 6.68 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 107.758 -2.137 . . . . 0.0 107.758 178.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.45 ' CB ' ' HG2' ' A' ' 27' ' ' LYS . 92.7 p -134.02 144.98 49.03 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.012 -1.287 . . . . 0.0 112.577 -178.117 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -125.54 140.27 52.89 Favored 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 52.5 m -132.34 142.42 49.32 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.912 -1.117 . . . . 0.0 111.402 -179.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.417 ' O ' ' HA3' ' A' ' 23' ' ' GLY . 78.3 t80 -131.79 109.67 10.3 Favored 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 178.003 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.736 HG23 ' C ' ' A' ' 22' ' ' GLY . 9.1 m -122.1 145.62 47.99 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.467 -0.771 . . . . 0.0 110.733 -178.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.3 pt-20 -147.32 167.6 23.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.288 -0.882 . . . . 0.0 110.275 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -94.21 140.54 29.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.439 -0.788 . . . . 0.0 109.976 179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 32.3 t -124.77 134.72 52.69 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.418 -0.801 . . . . 0.0 110.506 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 50.5 mtm-85 -144.1 159.39 42.7 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.496 -0.752 . . . . 0.0 110.055 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 48.1 m -114.54 133.33 55.87 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.415 -0.803 . . . . 0.0 110.077 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -155.96 157.59 36.5 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.44 -0.788 . . . . 0.0 110.195 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 84.3 p -62.07 -24.06 66.87 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.421 -0.8 . . . . 0.0 110.256 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 27.9 t -102.32 150.88 22.88 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.405 -0.81 . . . . 0.0 110.3 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.423 ' HA2' ' CE2' ' A' ' 57' ' ' TYR . . . -91.75 20.68 40.52 Favored Glycine 0 N--CA 1.493 2.473 0 N-CA-C 110.302 -1.119 . . . . 0.0 110.302 -179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -81.98 112.05 18.71 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.144 -1.209 . . . . 0.0 110.146 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.423 ' CE2' ' HA2' ' A' ' 55' ' ' GLY . 91.5 m-85 -126.53 150.89 48.52 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.471 -0.768 . . . . 0.0 110.64 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -59.03 -29.84 67.57 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.536 -0.727 . . . . 0.0 109.884 179.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 80.0 tttt 63.32 39.65 9.29 Favored 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.65 -0.657 . . . . 0.0 110.527 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -84.35 153.58 23.38 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.314 -0.866 . . . . 0.0 109.438 179.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -136.4 157.72 46.13 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.169 -0.957 . . . . 0.0 110.261 -179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -125.02 117.6 24.34 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.384 -0.822 . . . . 0.0 110.851 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.41 ' HB2' ' HB2' ' A' ' 87' ' ' TYR . 95.5 m-85 -109.78 139.11 45.21 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -149.58 125.93 2.1 Favored Glycine 0 N--CA 1.485 1.957 0 C-N-CA 119.094 -1.527 . . . . 0.0 110.292 -179.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.578 ' CG2' HG12 ' A' ' 85' ' ' VAL . 16.7 tt -108.43 137.59 39.38 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 178.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.527 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 0.7 OUTLIER -151.41 140.19 20.84 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 119.018 -1.073 . . . . 0.0 111.126 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.793 ' O ' HG22 ' A' ' 83' ' ' VAL . . . -156.34 152.07 27.15 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 178.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -170.36 178.32 43.13 Favored Glycine 0 N--CA 1.493 2.461 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.601 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.26 169.23 21.21 Favored 'Trans proline' 0 C--N 1.314 -1.278 0 O-C-N 123.949 1.5 . . . . 0.0 110.638 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -155.93 145.89 21.36 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.586 -0.696 . . . . 0.0 110.028 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 98.5 m-85 -120.99 141.18 50.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.655 -0.653 . . . . 0.0 109.948 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.46 ' O ' HD13 ' A' ' 73' ' ' ILE . 44.8 ttt180 -108.05 126.84 53.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.499 -0.75 . . . . 0.0 110.263 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.46 HD13 ' O ' ' A' ' 72' ' ' ARG . 46.8 mm -124.43 115.16 43.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 179.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 45.3 t30 59.34 177.63 0.08 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.377 -0.827 . . . . 0.0 109.86 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -57.36 -36.69 71.53 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.412 -0.805 . . . . 0.0 111.198 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . 0.628 ' O ' ' HB3' ' A' ' 77' ' ' ALA . 11.3 m0 -119.18 175.43 5.8 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.246 -0.909 . . . . 0.0 110.885 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.628 ' HB3' ' O ' ' A' ' 76' ' ' TRP . . . 72.3 95.4 0.07 Allowed 'General case' 0 N--CA 1.506 2.367 0 CA-C-O 121.447 0.641 . . . . 0.0 111.045 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.806 ' O ' HD12 ' A' ' 113' ' ' LEU . 50.6 m -125.83 148.74 49.06 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.542 -0.724 . . . . 0.0 109.8 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.58 HG12 HD13 ' A' ' 113' ' ' LEU . 81.1 mt -123.41 137.17 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 121.151 -0.968 . . . . 0.0 110.474 -179.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.525 ' HB2' HD12 ' A' ' 40' ' ' ILE . 39.7 p90 -146.9 166.19 27.5 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.367 -0.833 . . . . 0.0 110.878 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -125.41 162.15 19.73 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.076 -1.61 . . . . 0.0 109.076 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.409 ' HB ' ' HB ' ' A' ' 66' ' ' THR . 34.6 m -135.26 141.07 43.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.317 -1.108 . . . . 0.0 111.232 -179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 67' ' ' ALA . 36.0 m -142.63 151.44 17.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.791 -0.818 . . . . 0.0 108.791 178.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.453 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 160.36 -149.34 18.62 Favored Glycine 0 N--CA 1.483 1.772 0 C-N-CA 119.265 -1.445 . . . . 0.0 110.953 179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.578 HG12 ' CG2' ' A' ' 65' ' ' ILE . 11.1 p -133.04 144.29 36.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-O 122.459 1.123 . . . . 0.0 113.567 -177.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.2 137.68 14.46 Favored Glycine 0 N--CA 1.494 2.551 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.525 ' CE2' HG13 ' A' ' 85' ' ' VAL . 90.0 m-85 -120.65 143.56 48.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.141 -1.211 . . . . 0.0 110.796 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -125.02 114.59 2.22 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.32 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 17.0 tptm -101.74 121.08 41.39 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.491 -1.005 . . . . 0.0 110.253 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 99.2 m-85 -119.89 146.69 45.54 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.536 -0.728 . . . . 0.0 110.254 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -59.0 -36.65 75.27 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.404 -0.81 . . . . 0.0 110.53 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.65 HG22 ' HG3' ' A' ' 94' ' ' GLU . 2.2 m 59.66 154.96 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.504 -0.747 . . . . 0.0 110.432 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 77.7 p -109.74 12.33 24.14 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.32 -0.862 . . . . 0.0 110.936 -179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.65 ' HG3' HG22 ' A' ' 92' ' ' THR . 97.0 mt-10 -60.09 143.03 53.13 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.123 -0.986 . . . . 0.0 110.285 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -60.31 151.16 69.5 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.398 -0.814 . . . . 0.0 110.292 -179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -68.4 -21.53 40.68 Favored 'Trans proline' 0 C--N 1.313 -1.337 0 O-C-N 123.624 1.328 . . . . 0.0 111.05 -179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.6 HG22 ' CE2' ' A' ' 98' ' ' TYR . 31.0 m -59.38 -43.77 92.86 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.119 -0.988 . . . . 0.0 110.389 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . 0.6 ' CE2' HG22 ' A' ' 97' ' ' THR . 86.9 m-85 -130.34 142.43 50.53 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.473 -0.767 . . . . 0.0 110.446 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt 55.21 66.51 1.21 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.394 -0.817 . . . . 0.0 110.697 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 79.8 m-20 -53.33 -39.73 64.3 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.27 -0.893 . . . . 0.0 110.538 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -170.13 137.52 1.56 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.375 -0.828 . . . . 0.0 110.18 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 15.0 t -138.41 154.31 48.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.364 -0.835 . . . . 0.0 110.623 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 88.9 p -130.8 154.99 47.44 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.435 -0.791 . . . . 0.0 110.121 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.527 ' HB3' HD12 ' A' ' 132' ' ' ILE . 52.4 t0 -110.27 148.56 31.64 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.391 -0.818 . . . . 0.0 110.194 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.453 ' HB3' ' CD1' ' A' ' 87' ' ' TYR . 43.4 p90 -127.6 168.83 14.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.275 -0.89 . . . . 0.0 110.305 -179.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.682 ' HA3' HG22 ' A' ' 132' ' ' ILE . . . -159.83 -175.86 31.27 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -103.38 144.71 31.02 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.134 -1.215 . . . . 0.0 111.333 -178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.0 m -118.08 150.33 39.51 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.513 -0.742 . . . . 0.0 110.059 179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -154.63 146.57 23.52 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.452 -0.78 . . . . 0.0 109.978 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 167.91 -176.27 42.55 Favored Glycine 0 N--CA 1.495 2.573 0 C-N-CA 119.53 -1.319 . . . . 0.0 111.016 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 80' ' ' TYR . . . -160.81 162.89 32.43 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -149.46 -178.07 24.12 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 119.289 -1.434 . . . . 0.0 110.221 -179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.806 HD12 ' O ' ' A' ' 78' ' ' SER . 20.2 tp -139.51 149.39 43.88 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.609 -0.936 . . . . 0.0 109.923 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -127.06 151.81 48.12 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.185 -0.947 . . . . 0.0 109.824 179.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -156.88 161.19 39.68 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.359 -0.838 . . . . 0.0 110.883 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . 0.489 ' HB2' ' HA ' ' A' ' 122' ' ' ALA . 0.2 OUTLIER 172.77 140.36 0.13 Allowed Pre-proline 0 N--CA 1.504 2.266 0 O-C-N 121.643 -0.661 . . . . 0.0 111.323 179.251 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 116' ' ' ASN . 52.2 Cg_endo -88.37 50.6 1.7 Allowed 'Trans proline' 0 C--N 1.316 -1.172 0 O-C-N 123.581 1.306 . . . . 0.0 109.011 177.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.457 ' HB2' ' HB ' ' A' ' 121' ' ' VAL . 86.6 mtp -146.25 140.58 26.63 Favored 'General case' 0 C--N 1.309 -1.171 0 O-C-N 121.527 -0.733 . . . . 0.0 109.068 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -65.48 -39.46 91.95 Favored 'General case' 0 C--N 1.292 -1.914 0 O-C-N 121.781 -0.574 . . . . 0.0 112.423 -178.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -115.46 13.6 16.5 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.665 -1.272 . . . . 0.0 112.631 -178.075 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.457 ' HB ' ' HB2' ' A' ' 118' ' ' MET . 47.1 t -123.94 136.28 60.81 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 120.781 -1.199 . . . . 0.0 109.787 179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.489 ' HA ' ' HB2' ' A' ' 116' ' ' ASN . . . -153.3 138.15 17.11 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 119.22 -0.992 . . . . 0.0 112.643 -179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 84.1 mt -103.13 153.1 20.67 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 178.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 142' ' ' ALA . 52.5 t0 -143.97 136.52 26.96 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.569 -1.332 . . . . 0.0 110.361 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 51.8 t80 -128.71 142.28 51.06 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.126 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 26.6 t -145.91 155.74 43.07 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.132 -0.98 . . . . 0.0 111.375 -179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -107.14 119.27 38.91 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 178.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.532 ' HB3' HG23 ' A' ' 139' ' ' THR . 84.5 tt0 -131.96 144.32 50.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.253 -0.904 . . . . 0.0 110.9 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 14.7 pt20 -141.26 155.0 46.05 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.577 -0.702 . . . . 0.0 109.609 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 29.3 t -142.46 141.3 32.14 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.397 -0.814 . . . . 0.0 110.294 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 51.1 mtm-85 -129.42 133.35 47.3 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.472 -0.768 . . . . 0.0 109.87 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.682 HG22 ' HA3' ' A' ' 106' ' ' GLY . 24.6 pt -125.15 48.76 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 179.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 76.7 mtt85 60.59 -56.62 0.08 Allowed 'General case' 0 N--CA 1.503 2.21 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.514 ' N ' ' O ' ' A' ' 132' ' ' ILE . 53.4 m -92.18 -21.67 20.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 0.0 111.006 -179.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.468 ' HB ' HG12 ' A' ' 132' ' ' ILE . 37.6 t -135.12 137.55 50.21 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.093 0 C-N-CA 118.782 -1.167 . . . . 0.0 111.646 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -132.74 113.69 13.27 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.847 HG12 ' HA ' ' A' ' 14' ' ' ALA . 34.0 m -121.33 149.19 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.234 -0.916 . . . . 0.0 110.835 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -114.28 129.35 8.68 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 107.887 -2.085 . . . . 0.0 107.887 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.532 HG23 ' HB3' ' A' ' 128' ' ' GLU . 14.7 t -126.31 143.9 51.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.272 -1.134 . . . . 0.0 112.263 -178.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -123.06 140.89 52.55 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.542 HD12 ' HE3' ' A' ' 27' ' ' LYS . 49.6 pt -120.5 149.94 23.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.122 -0.986 . . . . 0.0 111.187 -179.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.409 ' HA ' ' O ' ' A' ' 124' ' ' ASP . . . -150.07 140.08 21.99 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -173.53 -146.3 5.47 Favored Glycine 0 N--CA 1.49 2.297 0 C-N-CA 118.783 -1.675 . . . . 0.0 111.906 -179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.784 ' O ' HG23 ' A' ' 6' ' ' THR . 35.4 m -118.77 179.87 1.77 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 122.229 -0.571 . . . . 0.0 110.908 -178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.435 ' HA2' ' O ' ' A' ' 5' ' ' VAL . . . -160.84 143.61 9.11 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.899 -1.143 . . . . 0.0 110.729 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -132.73 156.12 47.62 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.655 -0.909 . . . . 0.0 109.726 179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 46.3 ptt85 -133.96 123.85 25.32 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.346 -0.846 . . . . 0.0 111.268 179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 48.8 p90 . . . . . 0 N--CA 1.493 1.697 0 O-C-N 121.346 -0.846 . . . . 0.0 110.397 179.939 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 48.5 m . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 95.0 p -117.34 144.31 45.04 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.211 -0.931 . . . . 0.0 109.751 179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.71 HG23 ' O ' ' A' ' 146' ' ' TYR . 56.7 m -135.83 140.21 44.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.418 -0.801 . . . . 0.0 110.505 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 62.0 t -115.18 138.31 45.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 179.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.745 HG23 ' O ' ' A' ' 144' ' ' VAL . 27.6 m -156.34 132.54 9.93 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.237 -0.914 . . . . 0.0 110.023 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.99 171.95 38.89 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -179.82 -148.43 7.91 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.405 ' HA ' ' O ' ' A' ' 23' ' ' GLY . 46.2 p90 -139.36 159.86 41.17 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 121.442 -1.034 . . . . 0.0 109.85 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.829 ' HB2' HG22 ' A' ' 141' ' ' ILE . . . -145.67 147.07 31.58 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 118.838 -1.145 . . . . 0.0 111.628 -179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.89 ' O ' HG23 ' A' ' 139' ' ' THR . 94.5 mt-30 -99.19 138.16 36.68 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.404 ' HB3' HG11 ' A' ' 137' ' ' VAL . 43.5 m -119.73 145.13 46.82 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 119.023 -1.071 . . . . 0.0 113.193 -177.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -136.69 141.09 43.09 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 106.071 -1.825 . . . . 0.0 106.071 177.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.894 ' CB ' HG22 ' A' ' 137' ' ' VAL . . . -153.96 149.52 27.34 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 120.411 -1.431 . . . . 0.0 112.482 -177.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 63.4 tt0 -79.32 128.03 32.82 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 105.6 -28.29 14.77 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 108.783 -1.727 . . . . 0.0 108.783 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . 0.536 ' NE2' HG11 ' A' ' 135' ' ' VAL . 96.5 mt-30 -114.02 157.26 22.73 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.457 -1.025 . . . . 0.0 110.212 179.086 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . 0.406 ' O ' ' HB2' ' A' ' 19' ' ' ASN . 64.8 mtt -121.46 171.33 8.87 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.442 -0.786 . . . . 0.0 110.29 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.406 ' HB2' ' O ' ' A' ' 18' ' ' MET . 18.2 m120 61.7 115.97 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.631 -0.668 . . . . 0.0 110.511 -179.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 32.6 mttp -65.95 164.09 15.8 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.578 -0.701 . . . . 0.0 110.305 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 87.2 mtp -126.19 165.75 18.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.46 -0.775 . . . . 0.0 110.713 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -146.1 123.37 1.83 Allowed Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.709 ' HA3' HG22 ' A' ' 46' ' ' THR . . . -135.73 -172.67 12.74 Favored Glycine 0 N--CA 1.493 2.456 0 C-N-CA 119.153 -1.498 . . . . 0.0 110.754 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -119.0 148.6 42.82 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.804 -0.821 . . . . 0.0 108.999 179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.405 ' ND2' ' HE2' ' A' ' 27' ' ' LYS . 44.9 t-20 -125.59 134.65 51.85 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.222 -0.924 . . . . 0.0 111.265 -179.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 80.2 mt -113.27 147.72 37.02 Favored 'General case' 0 N--CA 1.494 1.762 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 178.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.425 ' HA ' ' O ' ' A' ' 41' ' ' GLY . 26.5 mttt -147.89 137.34 22.37 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.63 -1.294 . . . . 0.0 110.979 -179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -119.84 130.9 55.11 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.459 -0.776 . . . . 0.0 108.928 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.414 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 14.2 ttp180 -132.27 140.27 48.56 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.14 -0.975 . . . . 0.0 111.878 -179.094 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 95.9 m-85 -119.0 133.3 55.91 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 83.4 tt0 -141.97 142.75 32.99 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.199 -0.938 . . . . 0.0 110.459 -179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -104.5 129.74 52.5 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.419 -0.8 . . . . 0.0 109.879 179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 30.2 p-10 -54.35 -22.49 12.3 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.565 -0.709 . . . . 0.0 111.657 -178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.2 p-10 -60.64 -36.09 77.81 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.238 -0.914 . . . . 0.0 110.686 -179.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 6.3 m -145.51 160.39 45.01 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.151 -0.968 . . . . 0.0 110.539 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -88.11 33.99 0.4 Allowed 'Trans proline' 0 C--N 1.315 -1.214 0 O-C-N 123.695 1.366 . . . . 0.0 111.183 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 28.1 tp -116.59 84.72 2.18 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.26 -0.9 . . . . 0.0 110.595 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -104.74 -175.83 24.8 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.8 m -135.02 147.04 29.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.488 -1.007 . . . . 0.0 109.342 179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.77 HG22 ' O ' ' A' ' 68' ' ' GLY . 16.5 tt -135.75 146.64 29.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.239 -0.913 . . . . 0.0 111.451 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.425 ' O ' ' HA ' ' A' ' 27' ' ' LYS . . . -115.73 151.16 18.49 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 107.77 -2.132 . . . . 0.0 107.77 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 42.5 t -140.35 142.27 35.59 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.075 -1.25 . . . . 0.0 111.788 -178.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.2 t80 -129.95 138.67 50.99 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 178.332 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.4 t -134.04 148.55 51.09 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.95 -1.094 . . . . 0.0 111.677 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -141.59 114.37 8.48 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.709 HG22 ' HA3' ' A' ' 23' ' ' GLY . 32.3 p -122.11 159.73 26.53 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 119.611 -0.836 . . . . 0.0 110.418 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.8 pt-20 -142.35 170.9 14.84 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.747 . . . . 0.0 110.418 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 40.0 pttt -128.99 155.48 45.31 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.398 -0.814 . . . . 0.0 110.305 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 59.1 m -96.71 156.42 16.35 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.49 -0.756 . . . . 0.0 110.185 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.3 ptt-85 -141.35 161.1 38.71 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.431 -0.793 . . . . 0.0 110.542 -179.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 51.2 m -120.92 142.55 49.62 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.432 -0.793 . . . . 0.0 110.11 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.405 ' O ' ' O ' ' A' ' 53' ' ' SER . . . -60.1 142.68 53.77 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.456 -0.778 . . . . 0.0 110.144 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.405 ' O ' ' O ' ' A' ' 52' ' ' ALA . 0.6 OUTLIER 60.09 132.44 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 O-C-N 121.557 -0.715 . . . . 0.0 110.435 -179.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.1 m 52.41 64.47 1.84 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.176 -0.953 . . . . 0.0 110.324 -179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -172.17 -171.06 36.76 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 -65.47 130.17 42.34 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.332 -1.099 . . . . 0.0 110.155 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.424 ' CE2' ' HB3' ' A' ' 58' ' ' ASN . 39.9 p90 -85.0 -15.83 42.88 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.479 -0.763 . . . . 0.0 111.042 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.424 ' HB3' ' CE2' ' A' ' 57' ' ' TYR . 48.0 p-10 -126.68 -164.28 1.32 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.262 -0.899 . . . . 0.0 110.784 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -143.97 117.01 8.87 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.519 -0.738 . . . . 0.0 109.482 179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.413 ' HA ' ' O ' ' A' ' 89' ' ' LYS . 84.2 m-20 -98.41 148.45 23.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.354 -0.842 . . . . 0.0 111.169 -178.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -109.77 145.52 36.51 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.613 -0.679 . . . . 0.0 109.752 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.415 ' HB3' ' OG1' ' A' ' 46' ' ' THR . 69.4 t80 -110.48 117.53 33.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.453 -0.779 . . . . 0.0 110.98 -179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' A' ' 87' ' ' TYR . 86.4 m-85 -113.62 135.08 54.31 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.098 0.475 . . . . 0.0 109.776 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.01 126.8 2.52 Favored Glycine 0 N--CA 1.487 2.048 0 C-N-CA 119.685 -1.245 . . . . 0.0 110.547 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.551 ' O ' ' HA3' ' A' ' 84' ' ' GLY . 14.0 tt -122.03 134.63 64.69 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 1.1 p -149.71 143.79 25.68 Favored 'General case' 0 N--CA 1.491 1.606 0 C-N-CA 119.332 -0.947 . . . . 0.0 110.668 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 40' ' ' ILE . . . -141.23 150.09 42.2 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.0 109.685 179.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.77 ' O ' HG22 ' A' ' 40' ' ' ILE . . . -167.84 168.24 40.58 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.161 -1.176 . . . . 0.0 110.161 -179.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -72.65 176.97 8.1 Favored 'Trans proline' 0 C--N 1.315 -1.222 0 O-C-N 123.788 1.415 . . . . 0.0 110.681 179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.404 ' CB ' ' HD2' ' A' ' 29' ' ' ARG . . . -157.49 147.99 21.02 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.476 -0.765 . . . . 0.0 110.847 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -118.49 134.81 54.78 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.429 -0.795 . . . . 0.0 109.646 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 79.5 ttt-85 -68.97 150.93 47.16 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.456 -0.777 . . . . 0.0 110.765 -179.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.614 ' O ' HG23 ' A' ' 73' ' ' ILE . 15.0 tt -63.83 82.33 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 CA-C-O 121.486 0.66 . . . . 0.0 110.116 179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 90.1 m-20 -55.6 -33.92 64.39 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.521 -0.737 . . . . 0.0 110.52 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -164.08 -39.37 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.413 -0.804 . . . . 0.0 110.717 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 18.2 m0 -93.85 -69.77 0.73 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.29 -0.881 . . . . 0.0 110.854 -179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.453 ' HA ' HD12 ' A' ' 73' ' ' ILE . . . -160.56 172.06 17.86 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.333 -0.854 . . . . 0.0 110.521 -179.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 113' ' ' LEU . 33.7 t -95.77 142.44 28.05 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.492 -0.755 . . . . 0.0 109.8 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 16.0 tt -132.62 144.43 36.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.361 -0.837 . . . . 0.0 110.451 -179.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -142.96 153.98 43.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.402 -0.812 . . . . 0.0 110.882 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -97.48 161.79 21.42 Favored Glycine 0 N--CA 1.492 2.426 0 N-CA-C 108.764 -1.734 . . . . 0.0 108.764 179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.404 ' N ' ' O ' ' A' ' 110' ' ' GLY . 47.3 t -134.45 132.77 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.119 -1.224 . . . . 0.0 111.467 -179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.598 ' O ' ' HA ' ' A' ' 66' ' ' THR . 60.5 t -137.29 145.59 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 178.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 65' ' ' ILE . . . 170.7 -166.39 39.59 Favored Glycine 0 N--CA 1.477 1.412 0 C-N-CA 118.537 -1.792 . . . . 0.0 111.337 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.595 HG11 ' CE2' ' A' ' 105' ' ' TYR . 33.2 m -133.84 177.07 7.55 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 CA-C-O 121.838 0.827 . . . . 0.0 111.529 -178.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -140.39 145.05 15.67 Favored Glycine 0 N--CA 1.494 2.51 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 179.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.534 ' HB2' ' HB2' ' A' ' 63' ' ' TYR . 99.2 m-85 -126.06 132.49 51.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.201 -1.176 . . . . 0.0 109.732 179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -110.06 129.02 9.15 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' A' ' 60' ' ' ASN . 26.3 tttt -127.15 132.91 50.44 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.594 -0.945 . . . . 0.0 109.676 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.9 p90 -131.79 165.85 22.87 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.441 -0.787 . . . . 0.0 110.467 -179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -104.85 147.01 28.21 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.526 -0.733 . . . . 0.0 110.358 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.5 m -84.58 152.39 23.89 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.529 -0.732 . . . . 0.0 110.079 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.762 HG22 ' HG3' ' A' ' 94' ' ' GLU . 40.8 m -57.27 144.34 36.0 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 121.44 -0.787 . . . . 0.0 110.156 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.762 ' HG3' HG22 ' A' ' 93' ' ' THR . 96.1 mt-10 56.27 171.47 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.503 -0.748 . . . . 0.0 110.209 -179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -61.14 115.17 13.0 Favored Pre-proline 0 N--CA 1.495 1.819 0 O-C-N 121.375 -0.828 . . . . 0.0 110.444 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.87 -19.86 35.04 Favored 'Trans proline' 0 C--N 1.316 -1.163 0 O-C-N 123.482 1.254 . . . . 0.0 110.803 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 68.5 p 45.42 28.18 0.45 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.572 -0.705 . . . . 0.0 111.257 -179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -135.84 134.65 39.09 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.371 -0.831 . . . . 0.0 109.662 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.418 ' O ' ' N ' ' A' ' 101' ' ' ASP . 99.1 mttt -55.12 -40.94 71.06 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.387 -0.821 . . . . 0.0 110.976 -178.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.582 ' O ' HG23 ' A' ' 102' ' ' THR . 26.9 t-20 49.5 -90.29 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.538 -0.726 . . . . 0.0 111.191 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 99' ' ' LYS . 84.7 m-20 53.57 46.76 25.42 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 120.852 -1.155 . . . . 0.0 110.848 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.582 HG23 ' O ' ' A' ' 100' ' ' ASN . 63.2 p -125.24 143.07 51.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.338 -0.851 . . . . 0.0 110.218 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 49.4 m -136.03 152.63 51.11 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.44 -0.788 . . . . 0.0 110.352 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -83.27 131.12 35.1 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.395 -0.816 . . . . 0.0 109.571 179.133 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.595 ' CE2' HG11 ' A' ' 85' ' ' VAL . 39.4 t80 -81.69 131.0 35.25 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.108 -0.995 . . . . 0.0 111.443 -178.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.714 ' HA3' HD13 ' A' ' 132' ' ' ILE . . . -117.96 -164.13 13.02 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.414 ' HA ' ' HA ' ' A' ' 85' ' ' VAL . 66.0 t80 -140.8 148.86 41.28 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.443 -1.033 . . . . 0.0 109.917 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 48.7 m -136.6 143.57 43.65 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.198 -0.939 . . . . 0.0 110.858 179.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.406 ' O ' ' HA ' ' A' ' 128' ' ' GLU . 69.2 t80 -151.7 141.38 21.8 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.449 -0.782 . . . . 0.0 110.014 179.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 82' ' ' VAL . . . 174.87 -176.07 47.04 Favored Glycine 0 N--CA 1.497 2.727 0 C-N-CA 119.631 -1.271 . . . . 0.0 110.451 179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -169.2 161.23 10.13 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.458 -1.025 . . . . 0.0 109.0 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -156.06 -174.89 26.42 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 119.303 -1.427 . . . . 0.0 109.946 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 78' ' ' SER . 0.5 OUTLIER -124.01 162.42 23.49 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.43 -1.041 . . . . 0.0 110.069 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . 0.537 ' HG2' ' HB3' ' A' ' 124' ' ' ASP . 75.2 mt-30 -119.21 131.85 55.87 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.862 -1.148 . . . . 0.0 109.04 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -129.28 129.2 44.61 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.293 -0.879 . . . . 0.0 110.629 179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -177.34 150.69 0.86 Allowed Pre-proline 0 N--CA 1.498 1.962 0 O-C-N 121.331 -0.855 . . . . 0.0 110.471 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -77.01 -77.7 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.256 0 O-C-N 123.577 1.304 . . . . 0.0 110.131 179.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . 0.415 ' HB2' HG22 ' A' ' 121' ' ' VAL . 89.0 mtp -47.22 119.17 2.47 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 122.435 1.112 . . . . 0.0 110.596 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -61.5 -10.43 7.82 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.437 -178.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -92.06 -4.06 54.93 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.531 -1.356 . . . . 0.0 110.743 179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.415 HG22 ' HB2' ' A' ' 118' ' ' MET . 34.1 m -128.28 161.1 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.3 -0.875 . . . . 0.0 110.51 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.447 ' O ' ' HA ' ' A' ' 144' ' ' VAL . . . -156.11 138.64 14.98 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 119.666 -0.813 . . . . 0.0 111.685 179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . 0.837 HD12 ' O ' ' A' ' 143' ' ' GLY . 18.3 tp -119.68 132.31 55.64 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 107.235 -1.394 . . . . 0.0 107.235 177.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.537 ' HB3' ' HG2' ' A' ' 114' ' ' GLN . 49.5 p30 -143.85 156.72 44.56 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 118.088 -1.445 . . . . 0.0 113.797 -177.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -124.51 134.86 52.88 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.615 ' HB3' HD11 ' A' ' 141' ' ' ILE . 31.2 t -138.45 142.82 39.47 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.23 -0.919 . . . . 0.0 111.016 -179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.44 ' CD1' ' CZ2' ' A' ' 140' ' ' TRP . 81.0 t80 -109.23 127.54 54.33 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.406 ' HA ' ' O ' ' A' ' 109' ' ' TYR . 21.9 pt-20 -142.14 147.39 36.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.526 -0.734 . . . . 0.0 110.41 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -112.22 135.14 53.26 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.547 -0.72 . . . . 0.0 110.106 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 107' ' ' PHE . 50.7 m -128.4 143.61 51.02 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.608 -0.682 . . . . 0.0 109.315 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . 0.527 ' HA ' ' O ' ' A' ' 135' ' ' VAL . 39.5 ptt180 -147.06 144.7 29.29 Favored 'General case' 0 N--CA 1.493 1.688 0 C-N-CA 119.148 -1.021 . . . . 0.0 111.81 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.714 HD13 ' HA3' ' A' ' 106' ' ' GLY . 44.8 mm -122.67 90.52 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.57 -0.706 . . . . 0.0 110.031 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 132' ' ' ILE . 51.7 mtt180 61.75 -66.45 0.07 Allowed 'General case' 0 N--CA 1.501 2.093 0 O-C-N 121.667 -0.645 . . . . 0.0 112.385 179.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . 0.443 ' N ' ' O ' ' A' ' 132' ' ' ILE . 32.2 p -125.86 20.84 7.68 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.033 -1.042 . . . . 0.0 110.96 -178.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.536 HG11 ' NE2' ' A' ' 17' ' ' GLN . 61.5 t -124.57 133.94 68.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 C-N-CA 119.261 -0.975 . . . . 0.0 111.024 -179.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 51.2 t0 -129.3 111.89 13.32 Favored 'General case' 0 N--CA 1.492 1.663 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 178.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.894 HG22 ' CB ' ' A' ' 14' ' ' ALA . 18.6 t -113.15 144.2 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 120.807 -1.183 . . . . 0.0 111.276 -177.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -117.12 107.12 1.52 Allowed Glycine 0 N--CA 1.489 2.215 0 N-CA-C 107.125 -2.39 . . . . 0.0 107.125 177.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . 0.89 HG23 ' O ' ' A' ' 11' ' ' GLN . 90.5 m -121.81 142.33 50.33 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -1.13 . . . . 0.0 112.051 -177.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.44 ' CZ2' ' CD1' ' A' ' 127' ' ' TYR . 89.3 m95 -105.63 135.51 46.9 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.299 -1.0 . . . . 0.0 108.299 178.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.829 HG22 ' HB2' ' A' ' 10' ' ' ALA . 49.3 pt -119.53 150.5 22.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.147 -0.97 . . . . 0.0 111.312 -178.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -151.66 139.03 19.42 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.837 ' O ' HD12 ' A' ' 123' ' ' LEU . . . -164.23 -157.71 9.65 Favored Glycine 0 N--CA 1.491 2.333 0 C-N-CA 118.92 -1.61 . . . . 0.0 111.745 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.745 ' O ' HG23 ' A' ' 6' ' ' THR . 34.8 m -117.38 173.71 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 122.135 -0.626 . . . . 0.0 110.385 -179.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 121' ' ' VAL . . . -152.41 138.75 6.59 Favored Glycine 0 N--CA 1.492 2.397 0 C-N-CA 119.849 -1.167 . . . . 0.0 110.699 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.71 ' O ' HG23 ' A' ' 4' ' ' THR . 84.7 m-85 -127.04 147.35 50.15 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.582 -0.952 . . . . 0.0 109.357 179.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -129.22 122.89 30.66 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.133 -0.979 . . . . 0.0 111.046 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 69.0 t80 . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.466 -0.771 . . . . 0.0 110.2 179.862 . . . . . . . . 0 0 . 1 stop_ save_